<SEC-DOCUMENT>0000947871-20-000519.txt : 20200528
<SEC-HEADER>0000947871-20-000519.hdr.sgml : 20200528
<ACCEPTANCE-DATETIME>20200527215433
ACCESSION NUMBER:		0000947871-20-000519
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20200521
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200528
DATE AS OF CHANGE:		20200527

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		20916812

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ss174270_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:BSX="http://BSX/20200521">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" /></head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_BSX_BSX_20200521 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20200521_20200521 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000885725 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DCurrentFiscalYearEndDate_12%2D31 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:EntityCentralIndexKey">0000885725</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">12-31</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="bsx-20200521.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-05-21to2020-05-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-21</xbrli:startDate>
        <xbrli:endDate>2020-05-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-212020-05-21_custom_CommonStock0.01ParValuePerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BSX:CommonStock0.01ParValuePerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-21</xbrli:startDate>
        <xbrli:endDate>2020-05-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-212020-05-21_custom_Sec0.625SeniorNotesDue2027Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BSX:Sec0.625SeniorNotesDue2027Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-21</xbrli:startDate>
        <xbrli:endDate>2020-05-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 14pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 14pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, DC 20549</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-decoration: underline">_____________________________________________________________________</span></p>

<p style="font: 14pt/120% Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20200521__20200521_zCBHIXsSi9J4"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:DocumentType">8-K</ix:nonNumeric></span> </b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-decoration: underline">_____________________________________________________________________</span></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><b>Date of Report (Date of earliest event
reported): May 27, 2020 (<span id="xdx_90A_edei--DocumentPeriodEndDate_c20200521__20200521_zK5rv0lFYBm8"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 21, 2020</ix:nonNumeric></span>)</b></p>

<p style="font: 16pt/120% Times New Roman, Times, Serif; margin: 2pt 0 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90D_edei--EntityRegistrantName_c20200521__20200521_zmshh24Eh33e"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:EntityRegistrantName">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified
in its charter)</p>

<p style="font: 2pt Calibri Light; margin: 0; text-align: center"><span style="font-weight: normal">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="padding: 1.5pt; width: 31%; vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20200521__20200521_z3oH2uhkoHfc"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></span></td>
    <td style="padding: 1.5pt; width: 2%; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; width: 32%; vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_901_edei--EntityFileNumber_c20200521__20200521_zWga22gCZxY8"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:EntityFileNumber">1-11083</ix:nonNumeric></span></span></b></span></td>
    <td style="padding: 1.5pt; width: 2%; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; width: 32%; vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20200521__20200521_zZmaIf21i7Dh"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:EntityTaxIdentificationNumber">04-2695240</ix:nonNumeric></span></span></b></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt">(State or other jurisdiction of incorporation or organization)</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt">(I.R.S. Employer Identification No.)</span></td></tr>
</table>
<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 31.5pt"><b>&#160;</b></p>


<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt/120% Times New Roman, Times, Serif; width: 66%; text-align: center"><span style="font-size: 10pt; line-height: 120%"><b><span style="text-decoration: underline"><span id="xdx_90B_edei--EntityAddressAddressLine1_c20200521__20200521_zVs5vrB7ONp8"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:EntityAddressAddressLine1">300 Boston Scientific Way</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressCityOrTown_c20200521__20200521_zM9pGNpQM2g5"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:EntityAddressCityOrTown">Marlborough</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20200521__20200521_z5ae0E876UAj"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span></span></b></span></td>
    <td style="font: 12pt/120% Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-size: 10pt; line-height: 120%"><b><span style="text-decoration: underline"><span id="xdx_907_edei--EntityAddressPostalZipCode_c20200521__20200521_zrdP3EyvCHxf"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:EntityAddressPostalZipCode">01752-1234</ix:nonNumeric></span></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="font: 12pt/120% Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt; line-height: 120%">(Address of Principal Executive Offices)</span></td>
    <td style="font: 12pt/120% Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt; line-height: 120%">(Zip Code)</span></td></tr>
</table>


<p style="font: 6pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 31.5pt">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0 0 2pt; text-align: center"><b><span id="xdx_909_edei--CityAreaCode_c20200521__20200521_zAMO0zWGBdR4"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:CityAreaCode">(508)</ix:nonNumeric></span> <span id="xdx_900_edei--LocalPhoneNumber_c20200521__20200521_zEzZRSaslCE4"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" name="dei:LocalPhoneNumber">683-4000</ix:nonNumeric></span> </b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 4pt 0 10pt">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font: 10pt Arial Unicode MS,serif"><span id="xdx_901_edei--WrittenCommunications_c20200521__20200521_ztvHCzheXOJg"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font: 10pt Arial Unicode MS,serif"><span id="xdx_903_edei--SolicitingMaterial_c20200521__20200521_zcoBCvNdOgi3"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font: 10pt Arial Unicode MS,serif"><span id="xdx_905_edei--PreCommencementTenderOffer_c20200521__20200521_zz4sJZxCQ7hc"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font: 10pt Arial Unicode MS,serif"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20200521__20200521_zeRXa9RAOe9f"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 6pt 0; border-top-width: 0in; border-top-color: Black">Securities
registered pursuant to Section 12(b) of the Act:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 1.5pt; text-align: center"><span style="font-size: 8pt"><b>Title of each class</b></span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt; text-align: center"><span style="font-size: 8pt"><b>Trading Symbol</b></span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt; text-align: center"><span style="font-size: 8pt"><b>Name of each exchange on which registered</b></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20200521__20200521__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.01ParValuePerShareMember_zJVEDSfPMwW5"><ix:nonNumeric contextRef="From2020-05-212020-05-21_custom_CommonStock0.01ParValuePerShareMember" name="dei:Security12bTitle">Common Stock, $0.01 par value per share</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20200521__20200521__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.01ParValuePerShareMember_z8ASkGVZqsc1"><ix:nonNumeric contextRef="From2020-05-212020-05-21_custom_CommonStock0.01ParValuePerShareMember" name="dei:TradingSymbol">BSX</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_edei--SecurityExchangeName_c20200521__20200521__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.01ParValuePerShareMember_zPUl7KVAokJ"><ix:nonNumeric contextRef="From2020-05-212020-05-21_custom_CommonStock0.01ParValuePerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20200521__20200521__us-gaap--StatementClassOfStockAxis__custom--Sec0.625SeniorNotesDue2027Member_zPf2nob1N8kl"><ix:nonNumeric contextRef="From2020-05-212020-05-21_custom_Sec0.625SeniorNotesDue2027Member" name="dei:Security12bTitle">0.625% Senior Notes due 2027</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20200521__20200521__us-gaap--StatementClassOfStockAxis__custom--Sec0.625SeniorNotesDue2027Member_zba2iTSMbLyl"><ix:nonNumeric contextRef="From2020-05-212020-05-21_custom_Sec0.625SeniorNotesDue2027Member" name="dei:TradingSymbol">BSX27</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--SecurityExchangeName_c20200521__20200521__us-gaap--StatementClassOfStockAxis__custom--Sec0.625SeniorNotesDue2027Member_zdA3dKuNm2G5"><ix:nonNumeric contextRef="From2020-05-212020-05-21_custom_Sec0.625SeniorNotesDue2027Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; border-top-width: 0in; border-top-color: Black">Indicate by
check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 6pt 0 0; border-top-width: 0in; border-top-color: Black">Emerging growth
company&#160;&#160;&#160;<span style="font-family: Arial Unicode MS,serif"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20200521__20200521_zZLoisxLwmh9"><ix:nonNumeric contextRef="From2020-05-21to2020-05-21" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 6pt 0 0; border-top-width: 0in; border-top-color: Black">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;<span style="font-family: Arial Unicode MS,serif">&#9744;</span></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>ITEM 1.01 &#160;&#160;&#160;ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="color: #212529">On May 21,
2020, <span style="font-family: inherit,serif">Boston Scientific Corporation (the &#8220;Company&#8221;)</span> entered into underwriting
agreements (the &#8220;Underwriting Agreements&#8221;) with J.P. Morgan Securities LLC and BofA Securities, Inc., as representatives
of the several underwriters named in each agreement (collectively, the &#8220;Underwriters&#8221;), in connection with the public
offering, issuance and sale by the Company of (i) </span>29,382,500 <span style="color: #212529">shares of common stock, par value
$0.01 per share (the &#8220;Common Stock&#8221;), <span style="font-family: inherit,serif">which includes the exercise in full
by the underwriters of their option to purchase up to </span></span>3,832,500 additional shares of Common Stock, <span style="color: #212529">at
a price to the public of $34.25 per share, less underwriting discounts and commissions and (ii) 10,062,500 shares of the Company&#8217;s
5.50% Mandatory Convertible Preferred Stock, Series A (the &#8220;Mandatory Convertible Preferred Stock&#8221;), <span style="font-family: inherit,serif">which
includes the exercise in full by the underwriters of their overallotment option to purchase up to </span></span>1,312,500 additional
shares of Common Stock, <span style="color: #212529">at a price to the public and liquidation preference of $100.00 per share,
less underwriting discounts and commissions, respectively, pursuant to an effective shelf registration statement on Form S-3 (Registration
No. 333-238526) and related prospectus supplements filed with the Securities and Exchange Commission (collectively, the &#8220;offerings&#8221;).
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">The Underwriting Agreements
contain customary representations, warranties and agreements of the Company and customary conditions to closing, indemnification
rights and obligations of the parties and termination provisions. The Underwriters and their affiliates have performed commercial
banking, investment banking and advisory services for the Company from time to time for which they have received customary fees
and expenses. The Underwriters and their affiliates may, from time to time, engage in transactions with and perform services for
the Company in the ordinary course of their business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">The foregoing description
of the Underwriting Agreements is not complete and is qualified in its entirety by reference to the full text of the Underwriting
Agreements, copies of which are filed as Exhibit 1.1 and Exhibit 1.2 to this Current Report on Form 8-K and incorporated herein
by reference.</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>ITEM 3.03</b>&#160;&#160;&#160;&#160;<b>MATERIAL MODIFICATION
TO RIGHTS OF SECURITY HOLDERS</b></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: inherit,serif; color: #212529">In
connection with the public offering by the Company of the </span>Mandatory Convertible Preferred Stock<span style="font-family: inherit,serif; color: #212529">,
the Company filed a Certificate of Designations (the &#8220;Certificate of Designations&#8221;) with the Secretary of State of
the State of Delaware on May 26, 2020 to establish the designations, powers, preferences and rights of the Mandatory Convertible
Preferred Stock and the qualifications, limitations and restrictions thereof, including the dividend rate, the amount payable with
respect thereto in the event of the Company&#8217;s voluntary or involuntary liquidation, winding-up or dissolution, restrictions
on the issuance of senior securities, the terms and conditions of conversion of the Mandatory Convertible Preferred Stock and the
voting rights of the Mandatory Convertible Preferred Stock. The Certificate of Designations became effective upon acceptance of
such filing.</span></p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; background-color: white; color: #212529">Subject to certain exceptions, so
long as any share of Mandatory Convertible Preferred Stock remains outstanding, no dividend or distribution will be declared or
paid on shares of Common Stock or any other class or series of stock ranking junior to the Mandatory Convertible Preferred Stock,
and no common stock or any other class or series stock ranking on parity with or junior to the Mandatory Convertible Preferred
Stock will be purchased, redeemed or otherwise acquired for consideration by the Company or any of its subsidiaries unless, in
each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient
amount of cash or number of shares of Common Stock has been set apart for the payment of such dividends, on all outstanding shares
of Mandatory Convertible Preferred Stock. In addition, when dividends on shares of the Mandatory Convertible Preferred Stock (i)
have not been declared and paid in full on any dividend payment date, or (ii) have been declared but a sum of cash or number of
shares of Common Stock sufficient for payment thereof has not been set aside for the benefit of the holders, no dividends may be
declared or paid on any parity stock unless dividends are declared on the shares of Mandatory Convertible Preferred Stock on a
pro rata basis.</p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>
<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/12pt inherit,serif; margin: 0; background-color: white; color: #212529">Unless earlier converted in accordance
with the terms of the Certificate of Designations, each share of Mandatory Convertible Preferred Stock will automatically convert
on June 1, 2023 (subject to postponement for certain market disruption events) into between 2.3834 and 2.9197 shares of Common
Stock, subject to customary anti-dilution adjustments. The number of shares of Common Stock issuable upon conversion will be determined
based on the average volume-weighted average price (VWAP) per share of Common Stock over the 20 consecutive trading day period
beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: inherit,serif; color: #212529">Subject
to the rights of holders of any class or series of the Company&#8217;s capital stock ranking senior to the Mandatory Convertible
Preferred Stock with respect to dividends, holders of Mandatory Convertible Preferred Stock will be entitled to receive, when,
as and if declared by the Company&#8217;s board of directors, or an authorized committee thereof, out of funds legally available
for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash
or, subject to certain limitations, by delivery of shares of Common Stock or any combination of cash and shares of Common Stock,
at the Company&#8217;s election. If declared, dividends on the Mandatory Convertible Preferred Stock will be payable quarterly
on March 1, June 1, September 1 and December 1 of each year, commencing on September 1, 2020 and continuing to, and including,
June 1, 2023 to the holders of record of the Mandatory Convertible Preferred Stock as they appear on the Company&#8217;s stock
register at the close of business on the immediately preceding </span>February 15, May 15, August 15 and November 15<span style="font-family: inherit,serif; color: #212529">,
respectively. Until the Company amends or terminates its existing credit agreements that contain a restriction on its ability to
pay cash dividends on its capital stock, or such restrictions are no longer effective under the terms of such credit agreements,
the Company will pay the relevant dividend in shares of its Common Stock.</span></p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; background-color: white; color: #212529">Upon the Company&#8217;s voluntary
or involuntary liquidation, winding-up or dissolution, each holder of Mandatory Convertible Preferred Stock will be entitled to
receive a liquidation preference in the amount of $100 per share of Mandatory Convertible Preferred Stock, plus an amount equal
to accumulated and unpaid dividends on such share, whether or not declared, to, but excluding, the date fixed for liquidation,
winding-up or dissolution to be paid out of the Company&#8217;s assets legally available for distribution to its stockholders,
after satisfaction of debt and other liabilities owed to the Company&#8217;s creditors and holders of shares of its stock ranking
senior to the Mandatory Convertible Preferred Stock and before any payment or distribution is made to holders of any stock ranking
junior to the Mandatory Convertible Preferred Stock (including Common Stock).</p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; text-indent: 34.5pt; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; background-color: white; color: #212529">The above description of the Certificate
of Designations is qualified in its entirety by reference to the Certificate of Designations, which is filed as Exhibit 3.1 to
this Current Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>ITEM 5.03 &#160;&#160;&#160;&#160;AMENDMENTS TO ARTICLES
OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt/12pt inherit,serif; margin: 0; background-color: white; color: #212529">On May 26, 2020, the Company filed
the Certificate of Designations with the Secretary of State of the State of Delaware, which became effective upon acceptance of
such filing. The information set forth under Item 3.03 above is incorporated herein by reference.</p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>ITEM 8.01 &#160;&#160;&#160;&#160;OTHER EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">The closing of the offerings occurred on
May 27, 2020. The net proceeds from the offerings, after deducting underwriting discounts and estimated offering expenses, were
approximately $1,949.3 million. As previously announced, the Company used a portion of the combined net proceeds from the offerings
to repay in full the remaining $750.0 million outstanding under its $1.25 billion term loan credit facility maturing in April 2021
and to pay related fees, expenses and premiums, after which it was terminated. The remaining proceeds will be used for general
corporate purposes, which may include refinancing or repayment of other outstanding indebtedness and funding potential future acquisitions
and investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">A copy of the press release
pertaining to the completion of the offerings is filed with this report as Exhibit&#160;99.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">&#160;</p>
<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">Additionally, in connection
with the offerings, the Company is filing legal opinions regarding the validity of the Common Stock and Mandatory Convertible Preferred
Stock, attached as Exhibit 5.1 and 5.2, respectively, to this Current Report on Form 8-K.</p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>ITEM 9.01. &#160;&#160;&#160;&#160;FINANCIAL STATEMENTS
AND EXHIBITS</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">(d)&#160;&#160;Exhibits</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 15%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 84%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 1.5pt"><span style="font-size: 9pt"><b>Exhibit No.</b></span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt"><span style="font-size: 9pt"><b>Description </b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt">1.1</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt"><a href="ss174270_ex0101.htm" style="-sec-extract: exhibit">Underwriting Agreement relating to the Common Stock, dated as of May 21, 2020, among Boston Scientific Corporation and J.P. Morgan Securities LLC and BofA Securities Inc., as representatives of the underwriters.</a></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt">1.2</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt"><a href="ss174270_ex0102.htm" style="-sec-extract: exhibit">Underwriting Agreement relating to the Mandatory Convertible Preferred Stock, dated as of May 21, 2020, among Boston Scientific Corporation and J.P. Morgan Securities LLC and BofA Securities Inc., as representatives of the underwriters.</a></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt">3.1</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt"><a href="ss174270_ex0301.htm">Certificate of Designations of the Mandatory Convertible Preferred Stock filed with the Secretary of State of the State of Delaware on May 26, 2020.</a></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt">4.1</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt"><a href="ss174270_ex0301.htm">Specimen Certificate of the Mandatory Convertible Preferred Stock (contained in Exhibit 3.1 above).</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt; text-align: left; vertical-align: top"><span style="font-size: 10pt">5.1</span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss174270_ex0501.htm" style="-sec-extract: exhibit">Opinion of Shearman&#160;&#38; Sterling LLP regarding the legality of the shares of Common Stock, dated May 27, 2020.</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt; text-align: left; vertical-align: top"><span style="font-size: 10pt">5.2</span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss174270_ex0502.htm" style="-sec-extract: exhibit">Opinion of Shearman &#38; Sterling LLP regarding the legality of the shares of Mandatory Convertible Preferred Stock, dated May 27, 2020.</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font-size: 10pt">23.1</span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss174270_ex0501.htm" style="-sec-extract: exhibit">Consent of Shearman&#160;&#38; Sterling LLP (included in Exhibit&#160;5.1).</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font-size: 10pt">23.2</span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss174270_ex0502.htm" style="-sec-extract: exhibit">Consent of Shearman&#160;&#38; Sterling LLP (included in Exhibit&#160;5.2).</a></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt">99.1</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt"><a href="ss174270_ex9901.htm" style="-sec-extract: exhibit">Press Release issued by Boston Scientific Corporation, dated May 27, 2020.</a></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt">104</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0.75pt 6pt 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0.75pt">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0.75pt">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0.75pt">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0.75pt 6pt 0">&#160;</p>
<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-indent: 4in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td colspan="4">&#160;</td></tr>
<tr>
    <td style="width: 6%">&#160;</td>
    <td style="width: 38%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 51%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt; text-align: right"><span style="font-size: 10pt">Date:</span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">May 27, 2020</span></td>
    <td colspan="2" style="padding: 1.5pt"><span style="font-size: 10pt">BOSTON SCIENTIFIC CORPORATION</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt"><span style="font-size: 10pt">/s/ Vance R. Brown</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Vance R. Brown</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Vice President and Chief Corporate Counsel</p></td></tr>
</table>
<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>

<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>

<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>

<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>

<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>

<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>

<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>

<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>

<p style="font: 9pt/120% Times New Roman, Times, Serif; margin: 0 0.25in 0 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kNFKwzAUhp9g73Aoeje6NFKnvbTOIW6jrGN4G9szDWtzykk63SP5lqYpwxsNgZCc/ztfOFE0jZb0pBtkeH3YrmCHbdcoh7DFAzKaCn0if37JwJ9bfNfWsTIuXC9gTp5Bz6TxjfLvIXnSFusMRDqT85kUIO4zcQfFOpoM9ZzMQddonFYNKFNDwdSxRqf4PHbYqS8y1J6DaY9sNZkMkliM5W+QIpGwoZP6JD5aWK3yaDINaxItmfpu0PTWUQuLBlvvsiP6u8NXqpDJSqxEfCvTEo0m3pBD+9ijFHK+xvYN2ScTIb00XYx0SF/DmIcAQN0jDMgf/f2QWjKlo+ooYpEUiveq6bFALj8U4z+SkYKATeFqIKFTDKeBhc4P3w70xfcDGSuFkg== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ss174270_ex0101.htm
<DESCRIPTION>UNDERWRITING AGREEMENT RELATING TO THE COMMON STOCK
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>EXECUTION VERSION</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">BOSTON SCIENTIFIC CORPORATION<BR>
<BR>
25,550,000 Shares of Common Stock</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Underwriting Agreement</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: right">May 21, 2020</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5">J.P. Morgan Securities LLC<BR>
BofA Securities, Inc.<BR>
As Representatives of the<BR>
&#9;&nbsp;&nbsp;&nbsp;several Underwriters listed<BR>
&#9;&nbsp;&nbsp;&nbsp;in Schedule 1 hereto</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><BR>
c/o J.P. Morgan Securities LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">383 Madison Avenue</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">New York, New York 10179</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">c/o BofA Securities, Inc.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">One Bryant Park</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">New York, New York 10036</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Boston Scientific Corporation, a Delaware
corporation (the &ldquo;Company&rdquo;), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the
&ldquo;Underwriters&rdquo;), for whom you are acting as representatives (the &ldquo;Representatives&rdquo;), an aggregate of 25,550,000
shares of common stock, $0.01 par value per share, of the Company (the &ldquo;Underwritten Shares&rdquo;) and, at the option of
the Underwriters, up to an additional 3,832,500 shares of Common Stock of the Company (the &ldquo;Option Shares&rdquo;). The Underwritten
Shares and the Option Shares are herein referred to as the &ldquo;Shares&rdquo;. The shares of Common Stock of the Company to be
outstanding after giving effect to the sale of the Shares are referred to herein as the &ldquo;Stock&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Company is concurrently publicly
offering (the &ldquo;Mandatory Convertible Preferred Stock Offering&rdquo;) shares of its Mandatory Convertible Preferred Stock,
Series A, with a liquidation preference of $100.00 per share (the &ldquo;Mandatory Convertible Preferred Stock&rdquo;) pursuant
to a separate underwriting agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Company hereby confirms its agreement
with the several Underwriters concerning the purchase and sale of the Shares, as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Statement</U>. The Company has prepared and filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the
&ldquo;Securities Act&rdquo;), a registration statement (File No. 333-238526), including a prospectus, relating to the
Shares. Such registration statement, as amended at the time it became effective, including the information, if any, deemed
pursuant to Rule 430B under the Securities Act to be part of the registration statement at the time of its effectiveness (&ldquo;Rule 430 </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in"> Information&rdquo;), is referred to
herein as the &ldquo;Registration Statement&rdquo;; and as used herein, the term &ldquo;Preliminary Prospectus&rdquo; means
each prospectus included in such registration statement (and any amendments thereto) before effectiveness, any prospectus
filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration
Statement at the time of its effectiveness that omits Rule 430 Information, and the term &ldquo;Prospectus&rdquo; means the
prospectus in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities
Act) in connection with confirmation of sales of the Shares. If the Company has filed an abbreviated registration statement
pursuant to Rule 462(b) under the Securities Act (the &ldquo;Rule 462 Registration Statement&rdquo;), then any reference
herein to the term &ldquo;Registration Statement&rdquo; shall be deemed to include such Rule 462 Registration Statement. Any
reference in this underwriting agreement (this &ldquo;Agreement&rdquo;) to the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant
to Item 12 of Form S-3 under the Securities Act, as of the effective date of the Registration Statement or the date of such
Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &ldquo;amend&rdquo;,
&ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to the Registration Statement, any Preliminary Prospectus or
the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities Exchange Act
of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &ldquo;Exchange
Act&rdquo;) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have
the meanings given to such terms in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">At or prior to the Applicable Time (as
defined below), the Company had prepared the following information (collectively with the pricing information set forth on Annex
A, the &ldquo;Pricing Disclosure Package&rdquo;): a Preliminary Prospectus dated May 20, 2020 and each &ldquo;free-writing prospectus&rdquo;
(as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;Applicable Time&rdquo; means 7:00
P.M., New York City time, on May 21, 2020.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
of the Shares</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each Underwriter,
on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein,
agrees, severally and not jointly, to purchase at a price per share of $33.2225 (the &ldquo;Purchase Price&rdquo;) from the Company
the respective number of Underwritten Shares set forth opposite such Underwriter&rsquo;s name in Schedule 1 hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In addition, the Company agrees to issue
and sell the Option Shares to the several Underwriters as provided in this Agreement, and the Underwriters, on the basis of the
representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option
to purchase, severally and not jointly, from the Company the Option Shares at the Purchase Price less an amount per share equal
to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option
Shares.</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If any Option Shares are to be purchased,
the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears the same ratio
to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such
Underwriter in Schedule 1 hereto (or such number increased as set forth in Section 10 hereof) bears to the aggregate number of
Underwritten Shares being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate
any fractional Shares as the Representatives in their sole discretion shall make.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Underwriters may exercise the option
to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the date
of the Prospectus, by written notice from the Representatives to the Company. Such notice shall set forth the aggregate number
of Option Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and
paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing
Date nor later than the tenth full business day (as hereinafter defined) after the date of such notice (unless such time and date
are postponed in accordance with the provisions of Section 10 hereof). Any such notice shall be given at least two business days
prior to the date and time of delivery specified therein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company understands that the Underwriters intend to make a public offering of the Shares, and initially to offer the Shares on
the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and
sell Shares to or through any affiliate of an Underwriter.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the Representatives
in the case of the Underwritten Shares, at the offices of Simpson Thacher &amp; Bartlett LLP, 425 Lexington Avenue, New York, New
York 10017 at 10:00 A.M. New York City time on May 27, 2020, or at such other time or place on the same or such other date, not
later than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing or, in the case
of the Option Shares, on the date and at the time and place specified by the Representatives in the written notice of the Underwriters&rsquo;
election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as
the &ldquo;Closing Date&rdquo;, and the time and date for such payment for the Option Shares, if other than the Closing Date, is
herein referred to as the &ldquo;Additional Closing Date&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Payment for the Shares to be purchased
on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Representatives for
the respective accounts of the several Underwriters of the Shares to be purchased on the Closing Date or the Additional Closing
Date, as the case may be, with any transfer taxes payable in connection with the sale of such Shares duly paid by the Company.
Delivery of the Shares shall be made through the facilities of The Depository Trust Company unless the Representatives shall otherwise
instruct.</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company acknowledges and agrees that the Representatives and the other Underwriters are acting solely in the capacity of an arm&rsquo;s
length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection
with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any
other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company or any other person as
to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors
concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and neither the Representatives nor the other Underwriters shall have any responsibility or liability to the
Company with respect thereto. Any review by the Representatives and the other Underwriters of the Company, the transactions contemplated
hereby or other matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall not
be on behalf of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Company</U>. The Company represents and warrants to each Underwriter that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Preliminary
Prospectus.</I> No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and
each Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material
respects with the Securities Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement
of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to
any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the
Company in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus, it being understood
and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section
7(b) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Pricing
Disclosure Package</I>. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of
the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
<U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance
upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use in such Pricing Disclosure Package, it being understood and agreed that the only such information
furnished by any Underwriter consists of the information described as such in Section 7(b) hereof. No statement of material fact
included in the Prospectus has been omitted from the Pricing Disclosure Package and no statement of material fact included in the
Pricing Disclosure Package that is required to be included in the Prospectus has been omitted therefrom.</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Issuer
Free Writing Prospectus. </I>Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company
(including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used,
authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &ldquo;written communication&rdquo;
(as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares
(each such communication by the Company or its agents and representatives (other than a communication referred to in clause (i)
below) an &ldquo;Issuer Free Writing Prospectus&rdquo;) other than (i) any document not constituting a prospectus pursuant to Section
2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex A hereto, each electronic
road show and any other written communications approved in writing in advance by the Representatives. Each such Issuer Free Writing
Prospectus complies in all material respects with the Securities Act, has been or will be (within the time period specified in
Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and does not conflict with the information
contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus
filed prior to the first use of such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional
Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>
that the Company makes no representation or warranty with respect to any statements or omissions made in each such Issuer Free
Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished
to the Company in writing by such Underwriter through the Representatives expressly for use in such Issuer Free Writing Prospectus
or Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists
of the information described as such in Section 7(b) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Registration
Statement and Prospectus.</I> The Registration Statement is an &ldquo;automatic shelf registration statement&rdquo; as defined
under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof;
and no notice of objection of the Commission to the use of such registration statement or any post-effective amendment thereto
pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of
the Registration Statement has been issued by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the
Securities Act against the Company or related to the offering of the Shares has been initiated or threatened by the Commission;
as of the applicable effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement
and any such post-effective amendment complied and will comply in all material respects with the Securities Act, and did not and
will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto
and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus will comply in all material
respects with the Securities Act and will not contain any untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
<U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance
upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto,
it being understood and agreed that the only such information furnished by any Underwriter consists of the information described
as such in Section 7(b) hereof.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Incorporated
Documents.</I> The documents incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure
Package, at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with
the requirements of the Exchange Act and the rules and regulations thereunder, and, when read together and with the other information
in the Prospectus, the Pricing Disclosure Package and the Registration Statement did not and will not contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Financial
Statements.</I> The consolidated financial statements included or incorporated by reference in the Registration Statement, the
Pricing Disclosure Package and the Prospectus present fairly in all material respects the consolidated financial position of the
Company and its consolidated subsidiaries as at the dates indicated and the results of their operations for the periods specified;
said financial statements have been prepared in conformity with generally accepted accounting principles applied on a consistent
basis during the periods involved, except as indicated therein; the supporting schedules included or incorporated by reference
in the Registration Statement, if any, present fairly the information required to be stated therein. No pro forma financial information
is required to be filed with the Commission pursuant to any acquisitions or dispositions by the Company pursuant to Regulation
S-X with respect to any acquisitions or dispositions by the Company since January 1, 2017.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Material Adverse Change.</I> Since the respective dates as of which information is given in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except as may otherwise be stated therein or contemplated thereby, (i) there has been no
material adverse change in the condition (financial or other), earnings, results of operations, business or properties of the Company
and its subsidiaries, considered as one enterprise, whether or not arising from transactions in the ordinary course of business
and (ii) there have been no material transactions entered into by the Company or any of its subsidiaries, other than those in the
ordinary course of business.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Organization
and Good Standing.</I> The Company has been duly incorporated and is validly existing as a corporation in good standing under the
laws of the State of Delaware with corporate power and authority to own, lease and operate its properties and conduct its business
as now being conducted and as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and the
Company is duly qualified as a foreign corporation to transact business and is in good standing in each jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the
failure to so qualify would not have a material adverse effect on the condition (financial or other), earnings, results of operations,
business or properties of the Company and its subsidiaries, considered as one enterprise (a &ldquo;Material Adverse Effect&rdquo;).</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Material
Subsidiaries</I>. Schedule 2 hereto sets forth each domestic and foreign subsidiary of the Company which the Company deems to be
a &ldquo;significant subsidiary&rdquo; (each, a &ldquo;Material Subsidiary&rdquo; and collectively, the &ldquo;Material Subsidiaries&rdquo;).
Each Material Subsidiary of the Company has been duly incorporated and is validly existing as a corporation in good standing under
the laws of the jurisdiction of its incorporation, has corporate power and authority to own, lease and operate its properties and
conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and is duly
qualified as a foreign corporation to transact business and is in good standing in each jurisdiction in which such qualification
is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to
be in good standing or to so qualify would not have a Material Adverse Effect, and, except as otherwise disclosed in the Registration
Statement, the Pricing Disclosure Package or the Prospectus, all of the issued and outstanding capital stock of each such Material
Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable and is owned by the Company (except for
directors&rsquo; qualifying shares and shares held by individuals for the purpose of satisfying the legal requirements of the jurisdiction
of incorporation), directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance,
claim or equity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Capitalization.</I>
The Company has an authorized capitalization as set forth in the Registration Statement, the Pricing Disclosure Package and the
Prospectus under the heading &ldquo;Capitalization&rdquo;; all the outstanding shares of capital stock of the Company have been
duly and validly authorized and issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar
rights; except as described in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the
Prospectus, there are no outstanding rights (including, without limitation, pre-emptive rights), warrants or options to acquire,
or instruments convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any
of its subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance
of any capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights,
warrants or options; and the capital stock of the Company conforms in all material respects to the description thereof contained
in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Due
Authorization.</I> The Company has full right, power and authority to execute and deliver this Agreement and to perform its obligations
hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Underwriting
Agreement. </I> This Agreement has been duly authorized, executed and delivered by the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The
Shares. </I>The Shares to be issued and sold by the Company hereunder have been duly authorized by the Company and, when issued
and delivered and paid for as provided herein, will be duly and validly issued, will be fully paid and nonassessable and will conform
to the descriptions thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and the issuance
of the Shares is not subject to any preemptive or similar rights.</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Accuracy
of Disclosure</I>. The statements set forth in the Pricing Disclosure Package and the Prospectus, as amended or supplemented, under
the caption &ldquo;Description of Capital Stock.&rdquo; insofar as they purport to constitute a summary of the terms of the Shares
or the Company&rsquo;s Third Restated Certificate of Incorporation or Amended and Restated By-laws, insofar as they purport to
describe the provisions of the documents referred to therein, are accurate, complete and fair in all material respects.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Descriptions
of the Underwriting Agreement.</I> This Agreement conforms in all material respects to the description thereof contained in the
Registration Statement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Violation or Default; No Conflict; No Consent.</I> Neither the Company nor any of its subsidiaries is in violation of its or any
of their charters or bylaws, or in default in the performance or observance of any obligation, agreement, covenant or condition
contained in any contract, indenture, mortgage, loan agreement, note, lease or other instrument to which it or any of them is a
party or by which it or any of them or their properties may be bound where any such violation or default would have a Material
Adverse Effect; and the execution of this Agreement, the issuance and sale of the Shares and the consummation of the transactions
contemplated by this Agreement or the Pricing Disclosure Package and the Prospectus have been duly authorized by all necessary
corporate action and will not conflict with or constitute a breach of, or default under, or result in the creation or imposition
of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, any contract,
indenture, mortgage, loan agreement, note, lease or other instrument to which the Company or any of its subsidiaries is a party
or by which it or any of them may be bound or to which any of the property or assets of the Company or any of its subsidiaries
is subject where any such conflict, breach, default, creation or imposition would have a Material Adverse Effect, nor will such
action result in any violation of the provisions of the charter or bylaws of the Company or, to the best of its knowledge, any
law, administrative regulation or administrative or court decree (except for such violations of any law, administrative regulation
or administrative or court decree that would not have a Material Adverse Effect and would not have a material adverse effect on
the Company&rsquo;s ability to consummate the transactions contemplated by this Agreement), and no consent, approval, authorization
or order of any court or governmental authority or agency is required for the consummation by the Company of the transactions contemplated
by this Agreement, (including the issuance and sale of the Shares) except such as may be required under the Securities Act or state
securities or &ldquo;blue sky&rdquo; laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Permits</I>.
The Company and its Material Subsidiaries possess adequate certificates, authorities or permits issued by the appropriate state,
federal or foreign regulatory agencies or bodies necessary to conduct the business now operated by them, except such certificates,
authorities or permits which are not material to such conduct of their business, and neither the Company nor any of its Material
Subsidiaries has, to the knowledge of the Company, received any notice of proceedings relating to the revocation or modification
of any such certificate, authority or permit which, singly or in the aggregate, if the subject of any unfavorable decision, ruling
or finding, would have a Material Adverse Effect.</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(r)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Legal Proceedings.</I>
&#9;Except as set forth in the Registration Statement or the Pricing Disclosure Package and the Prospectus, there is no action,
suit or proceeding before or by any court or governmental agency or body, domestic or foreign, now pending or, to the knowledge
of the Company, threatened against or affecting the Company or any of its subsidiaries that might reasonably be expected to result
in a Material Adverse Effect, or that might reasonably be expected to materially and adversely affect the offering of the Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Contracts</I>.
There are no contracts or documents of the Company or any of its subsidiaries which are required to be filed as exhibits to the
Registration Statement (including the documents incorporated by reference therein) by the Securities Act which have not been so
filed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="letter-spacing: -0.15pt"><I>Intellectual
Property.</I> Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and except
as where such failure would not have a Material Adverse Effect, the Company and its subsidiaries own, possess, license or have
the right to use the patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names and
other rights or interests in items of intellectual property as are necessary for the operation and conduct of the businesses now
operated by them (the &ldquo;patent and proprietary rights&rdquo;); and except as disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, the Company has no knowledge of any infringement of or conflict with asserted rights
of others with respect to any patent and proprietary rights which, singly or in the aggregate, if the subject of an unfavorable
decision, ruling or finding, would have a Material Adverse Effect, and, except as disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, the Company has no knowledge that any person or entity is infringing or otherwise
violating any of the Company&rsquo;s patents, trademarks, servicemarks or copyrights in a manner that could materially affect the
use thereof by the Company or any of its subsidiaries and which infringement would have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(u)&#9;<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment Company Act</I>.
&#9;The Company is not, and, after giving effect to the offering and sale of the Shares, the offering and sale of the Mandatory
Convertible Preferred Stock in the Mandatory Convertible Preferred Stock Offering and the application of the proceeds thereof as
described in the Pricing Disclosure Package and the Prospectus, will not be an &ldquo;investment company&rdquo; or an entity &ldquo;controlled&rdquo;
by an &ldquo;investment company&rdquo; as such terms are defined in the Investment Company Act of 1940, as amended.</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Labor Disputes.</I> No labor disturbance by the employees of the Company or any subsidiary exists or, to the knowledge of the Company,
is imminent which might reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certain
Environmental Matters</I>. Except as described in the Registration Statement or the Pricing Disclosure Package and the Prospectus
and except as could not reasonably be expected to have a Material Adverse Effect, to the knowledge of the Company, the properties,
assets and operations of each of the Company and its subsidiaries are in compliance with all applicable federal, state, local and
foreign laws (including, without limitation, common law), rules and regulations, orders, decrees, judgments, permits and licenses
relating to worker health and safety, and to the protection and clean-up of the natural environment and to the protection or preservation
of natural resources, including, without limitation, those relating to the processing, manufacturing, generation, handling, disposal,
transportation or release of hazardous materials (collectively, &ldquo;Environmental Laws&rdquo;). With respect to such properties,
assets and operations, there are no events, conditions, circumstances, activities, practices, incidents, actions or plans of the
Company or any of its subsidiaries of which the Company is aware that may interfere with or prevent compliance or continued compliance
with applicable Environmental Laws or otherwise result in liability to the Company or any of its subsidiaries pursuant to applicable
Environmental Law in a manner that could reasonably be expected to have a Material Adverse Effect. Except as described in the Registration
Statement or the Pricing Disclosure Package and the Prospectus and except as could not reasonably be expected to have a Material
Adverse Effect, (A) to the Company&rsquo;s knowledge, none of the Company or any of its subsidiaries is the subject of any federal,
state, local or foreign investigation pursuant to Environmental Laws, (B) none of the Company or any of its subsidiaries has received
any written notice or claim pursuant to Environmental Laws and (C) there are no pending, or, to the knowledge of the Company, threatened
actions, suits or proceedings against the Company, any of its subsidiaries or its properties, assets or operations, in connection
with any Environmental Laws. The term &ldquo;hazardous materials&rdquo; shall mean those substances that are regulated by or pursuant
to any applicable Environmental Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Accounting
Controls.</I> The Company maintains &ldquo;internal control over financial reporting&rdquo; (as defined in Rule 13a-15(f) of the
Exchange Act) that have been designed by, or under the supervision of, the Company&rsquo;s principal executive and principal financial
officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Conflicts with Sanctions Laws. </I>The Company has implemented and maintains in effect policies and procedures reasonably designed
to promote compliance by the Company, its subsidiaries and their respective directors, officers and employees with Anti-Corruption
Laws and Sanctions applicable to the Company, its subsidiaries and their respective directors, officers and employees, and the
Company, its subsidiaries and, to the knowledge of the Company, their respective officers and employees and directors are in compliance
with Anti-Corruption Laws and applicable Sanctions in all material respects. As of the Applicable Time, at the Closing Date and
at the Additional Closing Date, </P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.0in"> none of (a) the Company, any
subsidiary or, to the knowledge of the Company, any of their respective directors or officers or (b) to the knowledge of the
Company, any of the Company or such subsidiary&rsquo;s respective employees is or will be a Sanctioned Person or organized or
resident in a Sanctioned Country. No use of proceeds of the offering of the Shares hereunder will be used by the Company or
any of its subsidiaries directly or to its knowledge indirectly to violate applicable Anti-Corruption Laws or applicable
Sanctions. The term &ldquo;Anti-Corruption Laws&rdquo; shall mean the United States Foreign Corrupt Practices Act of 1977, as
amended, and all similar laws, rules, and regulations of any jurisdiction applicable to the Company or its subsidiaries
prohibiting bribery or corruption. &ldquo;Sanctioned Country&rdquo; shall mean a country or territory, which is itself a
subject or target of any Sanctions (as of the Applicable Time and at the Closing Time, the Crimea region of Ukraine, Cuba,
Iran, North Korea, and Syria). &ldquo;Sanctioned Person&rdquo; shall mean (a) any person listed in any Sanctions-related list
of designated persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S.
Department of State, the United Nations Security Council, the European Union or the United Kingdom, (b) any person operating,
organized or resident in a Sanctioned Country or (c) any person 50 percent or more owned or controlled by any such person.
&ldquo;Sanctions&rdquo; shall mean economic or financial sanctions or trade embargoes imposed, administered or enforced from
time to time by (a) the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S.
Department of the Treasury or the U.S. Department of State or (b) the United Nations Security Council, the European Union or
the United Kingdom.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Registration Rights</I>. No holders of securities of the Company have rights to the registration of such securities under the Registration
Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(aa)&#9;<I>&nbsp;&nbsp;&nbsp;&nbsp;Status under the Securities
Act</I>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter
that the Company or any offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) under the Securities
Act) of the Shares and at the date hereof, the Company was not and is not an &ldquo;ineligible issuer,&rdquo; and is a well-known
seasoned issuer, in each case as defined in Rule 405 under the Securities Act. The Company has paid the registration fee for this
offering pursuant to Rule 456(b)(1) under the Securities Act or will pay such fee within the time period required by such rule
(without giving effect to the proviso therein) and in any event prior to the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Any certificate signed by any officer
of the Company and delivered to the Representatives or counsel for the Underwriters in connection with an offering of Securities
shall be deemed a representation and warranty by the Company, as to the matters covered thereby, to each Underwriter.</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further
Agreements of the Company</U>. The Company covenants and agrees with each Underwriter that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Required
Filings.</I> The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and
Rule 430B under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities
Act; and the Company will file promptly all reports and any definitive proxy or information statements required to be filed by
the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the
Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Shares; and
the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered)
to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this
Agreement in such quantities as the Representatives may reasonably request. The Company will pay the registration fee for this
offering within the time period required by Rule 456(b)(1) under the Securities Act (without giving effect to the proviso therein)
and in any event prior to the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Delivery
of Copies.</I> The Company will deliver, without charge, (i) to the Representatives, two signed copies of the Registration Statement
as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents
incorporated by reference therein; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally
filed and each amendment thereto (without exhibits) and (B) during the Prospectus Delivery Period (as defined below), as many copies
of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein and each Issuer
Free Writing Prospectus) as the Representatives may reasonably request. As used herein, the term &ldquo;Prospectus Delivery Period&rdquo;
means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters
a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the
Securities Act) in connection with sales of the Shares by any Underwriter or dealer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments
or Supplements, Issuer Free Writing Prospectuses.</I> Before making, preparing, using, authorizing, approving, referring to or
filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing
Disclosure Package or the Prospectus, whether before or after the time that the Registration Statement becomes effective, the Company
will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment
or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus
or file any such proposed amendment or supplement to which the Representatives reasonably object.</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice
to the Representatives.</I> The Company will advise the Representatives promptly, and confirm such advice in writing, (i) when
any amendment to the Registration Statement has been filed or becomes effective; (ii) when any supplement to the Pricing Disclosure
Package, the Prospectus, any Issuer Free Writing Prospectus or any amendment to the Prospectus has been filed or distributed; (iii)
of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus
or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission
for any additional information; (iv) of the issuance by the Commission or any other governmental or regulatory authority of any
order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus,
any of the Pricing Disclosure Package or the Prospectus or the initiation or threatening of any proceeding for that purpose or
pursuant to Section 8A of the Securities Act; (v) of the occurrence of any event or development within the Prospectus Delivery
Period as a result of which the Prospectus, any of the Pricing Disclosure Package or any Issuer Free Writing Prospectus as then
amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package
or any such Issuer Free Writing Prospectus is delivered to a purchaser, not misleading; (vi) of the receipt by the Company of any
notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant
to Rule 401(g)(2) under the Securities Act; and (vii) of the receipt by the Company of any notice with respect to any suspension
of the qualification of the Shares for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for
such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness
of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package
or the Prospectus or suspending any such qualification of the Shares and, if any such order is issued, will obtain as soon as possible
the withdrawal thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Ongoing
Compliance.</I> (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist
as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the
Prospectus is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply
with law, the Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above,
file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments
or supplements to the Prospectus (or any document to be filed with the Commission and incorporated by reference therein) as may
be necessary so that the statements in the Prospectus as so amended or supplemented (or any document to be filed with the Commission
and incorporated by reference therein) will not, in the light of the circumstances existing when the Prospectus is delivered to
a purchaser, be misleading or so that the Prospectus will comply with law and (2) if at any time prior to the Closing Date (i)
any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended
or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser,
not misleading or (ii) it is necessary to amend or supplement the Pricing Disclosure Package to comply with law, the Company will
immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission
(to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments
or supplements to the Pricing Disclosure Package (or any document to be filed with the Commission and incorporated by reference
therein) as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will not, in
the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that
the Pricing Disclosure Package will comply with law.</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(f)&#9;<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Blue Sky Compliance.</I>
&#9;The Company will arrange for the qualification of the Shares for offering and sale under the laws of such jurisdictions as
the Representatives, after consultation with the Company, may collectively designate and will maintain such qualifications in effect
so long as required for the distribution of the Shares, provided, however, that the Company shall not be obligated to file any
general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in
which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not
otherwise so subject.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Earning
Statement. </I>The Company will make generally available to its security holders and to the Representatives as soon as practicable
earnings statements of the Company that will satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 of the
Commission promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Clear
Market.</I> For a period of 90 days after the date of the Prospectus, the Company will not (i) offer, pledge, sell, contract to
sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement
under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for
Stock, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any swap or other agreement that
transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other securities, whether
any such transaction described in clause (i) or (ii) above is to be settled by delivery of Stock or such other securities, in cash
or otherwise, without the prior written consent of the Representatives, other than the Shares to be sold hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 1in">The restrictions described above
do not apply to (i) the issuance of shares of Stock or securities convertible into or exercisable for shares of Stock pursuant
to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise)
or the settlement of restricted stock units (including net settlement), in each case outstanding on the date of this Agreement
and described in the Prospectus; (ii) grants of stock options, stock awards, restricted stock, restricted stock units, or other
equity awards and the issuance of shares of Stock or securities convertible into or exercisable or exchangeable for shares of Stock
(whether upon the exercise of stock options or otherwise) to the Company&rsquo;s employees, officers, directors, advisors, or consultants
pursuant to the terms of an equity compensation plan in effect as of the Closing Date and described in the Prospectus, provided
that such recipients enter into a lock-up agreement with the Underwriters; (iii) the issuance of the Mandatory Convertible Preferred
Stock in the </P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Mandatory Convertible Preferred Stock Offering or
any shares of Common Stock upon settlement thereof; (iv) the issuance of shares of Common Stock issuable as dividends on the
Mandatory Convertible Preferred Stock; (v) the issuance of up to 2.5% of the outstanding shares of Stock, or securities
convertible into, exercisable for, or which are otherwise exchangeable for, Stock, immediately following the Closing Date, in
acquisitions or other similar strategic transactions, provided that such recipients enter into a lock-up agreement with the
Underwriters; or (vi) the filing of any registration statement on Form S-8 relating to securities granted or to be granted
pursuant to any plan in effect on the date of this Agreement and described in the Prospectus or any assumed benefit plan
pursuant to an acquisition or similar strategic transaction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Use
of Proceeds.</I> The Company will apply the net proceeds from the sale of the Shares as described in each of the Registration Statement,
the Pricing Disclosure Package and the Prospectus under the heading &ldquo;Use of Proceeds&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Stabilization.</I> Neither the Company nor its subsidiaries or affiliates will take, <FONT STYLE="letter-spacing: -0.15pt">directly
or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation
of the price of the Stock.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exchange
Listing.</I> The Company will use its reasonable best efforts to list, subject to notice of issuance, the Shares on the New York
Stock Exchange.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Reports.</I>
So long as the Shares are outstanding, the Company will furnish to the Representatives, as soon as they are available, copies of
all reports or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial
statements furnished to or filed with the Commission or any national securities exchange or automatic quotation system; <U>provided</U>
the Company will be deemed to have furnished such reports and financial statements to the Representatives to the extent they are
filed on the Commission&rsquo;s Electronic Data Gathering, Analysis, and Retrieval system.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Record
Retention</I>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing
Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Agreements of the Underwriters</U>. Each Underwriter hereby represents and agrees that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
has not and will not use, authorize use of, refer to or participate in the planning for use of, any &ldquo;free writing prospectus&rdquo;,
as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission
by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other
than (i) a free writing prospectus that contains no &ldquo;issuer information&rdquo; (as defined in Rule 433(h)(2) under the Securities
Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed Issuer
Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section 3(c) or Section
4(c) above (including any electronic road show), or (iii) any free writing prospectus prepared by such underwriter and approved
by the Company in advance in writing.</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final
terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; <I>provided</I>
that Underwriters may use a term sheet substantially in the form of Annex B hereto without the consent of the Company; <I>provided
further</I> that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company,
prior to, or substantially concurrently with, the first use of such term sheet.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly
notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
of Underwriters&rsquo; Obligations.</U> The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date
or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the
Company of its covenants and other obligations hereunder and to the following additional conditions:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Registration
Compliance; No Stop Order.</I> No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding
for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened
by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under
the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act)
and in accordance with Section 4(a) hereof; and all requests by the Commission for additional information shall have been complied
with to the reasonable satisfaction of the Representatives.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Representations
and Warranties.</I> The representations and warranties of the Company contained herein shall be true and correct on the date hereof
and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its
officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date
or the Additional Closing Date, as the case may be.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Downgrade.</I> Subsequent to the earlier of (A) the Applicable Time and (B) the execution and delivery of this Agreement, (i) no
downgrading shall have occurred in the rating accorded any debt securities, convertible securities or preferred stock issued, or
guaranteed by, the Company or any of its subsidiaries by any &ldquo;nationally recognized statistical rating organization,&rdquo;
as such term is defined under Section 3(a)(62) under the Exchange Act and (ii) no such organization shall have publicly announced
that it has under surveillance or review, or has changed its outlook with respect to, its rating of any such debt securities or
preferred stock issued or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications
of a possible upgrading).</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Material Adverse Change.</I> On and as of the Closing Date and the Additional Closing Date there shall not have been, since the
Applicable Time or since the date and time of which information is given in the Pricing Disclosure Package, any material adverse
change in the condition (financial or otherwise), earnings, results of operations, business or properties of the Company and its
subsidiaries considered as one enterprise, whether or not arising from transactions in the ordinary course of business, except
as set forth or contemplated in the Pricing Disclosure Package and the Prospectus (exclusive of any supplement thereto), and the
Company shall have furnished to the Representatives a certificate of the Company, signed by the Chairman of the Board, the Chief
Executive Officer, the President, the principal financial officer or the principal accounting officer of the Company, dated as
of such Closing Date or Additional Closing Date, to the effect that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(i) the representations and warranties
of the Company in this Agreement are true and correct in all material respects on and as of such Closing Date or Additional Closing
Date, as applicable, with the same effect as if made at the Closing Date or Additional Closing Date, as the case may be, and the
Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior
to the Closing Date or Additional Closing Date, as the case may be;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(ii) no stop order suspending the
effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or, to the
Company&rsquo;s knowledge, threatened; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(iii) since the date of the most
recent financial statements or financial data included or incorporated by reference in the Pricing Disclosure Package or the Prospectus
(exclusive of any supplement thereto), there has been no material adverse change in the condition (financial or other), earnings,
results of operations, business or properties of the Company and its subsidiaries, considered as one enterprise, whether or not
arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Pricing Disclosure
Package and the Prospectus (exclusive of any supplement thereto).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Comfort
Letters.</I> On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, Ernst &amp;
Young LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery
thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements
and information of the type customarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect
to the financial statements and certain financial information contained or incorporated by reference in each of the Registration
Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional
Closing Date, as the case may be, shall use a &ldquo;cut-off&rdquo; date no more than five business days prior to such Closing
Date or such Additional Closing Date, as the case may be.</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
of Vice President, Chief Corporate Counsel and Assistant Secretary of the Company</I>. The Representatives shall have received
on and as of the Closing Date or the Additional Closing Date, as the case may be, an opinion, addressed to the Underwriters, of
Vance R. Brown, Vice President, Chief Corporate Counsel and Assistant Secretary of the Company, shall have furnished to the Representatives,
in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex&nbsp;C hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
and 10b-5 Statement of Counsel for the Company.</I> Shearman &amp; Sterling LLP, counsel for the Company, shall have furnished
to the Representatives, at the request of the Company, their written opinion and 10b-5 statement, dated the Closing Date or the
Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to
the Representatives, to the effect set forth in Annex D hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
and 10b-5 Statement of Counsel for the Underwriters.</I> The Representatives shall have received on and as of the Closing Date
or the Additional Closing Date, as the case may be, an opinion and 10b-5 statement, addressed to the Underwriters, of Simpson Thacher
&amp; Bartlett LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and
such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such
matters.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Legal Impediment to Issuance and Sale.</I> No action shall have been taken and no statute, rule, regulation or order shall have
been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing
Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares; and no injunction or order
of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date,
as the case may be, prevent the issuance or sale of the Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Good
Standing</I>. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case
may be, satisfactory evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization
and their good standing in such other jurisdictions as the Representatives may reasonably request, in each case in writing or any
standard form of telecommunication from the appropriate governmental authorities of such jurisdictions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exchange
Listing.</I> The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be, shall have been
approved for listing on the New York Stock Exchange, subject to official notice of issuance.</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Lock-up
Agreements</I>. The &ldquo;lock-up&rdquo; agreements, each substantially in the form of Exhibit A hereto, between you and certain
officers and directors of the Company relating to sales and certain other dispositions of shares of Stock or certain other securities,
delivered to you on or before the date hereof, shall be full force and effect on the Closing Date or the Additional Closing Date,
as the case may be.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Additional
Documents.</I> On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished
to the Representatives such further certificates and documents as the Representatives may reasonably request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">All opinions, letters, certificates and
evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if
they are in form and substance reasonably satisfactory to counsel for the Underwriters.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
and Contribution</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification
of the Underwriters.</I> The Company agrees to indemnify and hold harmless each Underwriter and each person, if any, who controls
any Underwriter within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act, against any and all
losses, liabilities, claims, damages and expenses whatsoever as incurred (including but not limited to reasonable attorneys&rsquo;
fees and any and all expenses reasonably and necessarily incurred in investigating, preparing or defending against any litigation,
commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint
or several, to which they or any of them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as
such losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon (i) any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares,
as originally filed or any amendment thereof, or arise out of or are based upon the omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the statements therein not misleading; or (ii) any untrue statement
or alleged untrue statement of a material fact contained in any related Preliminary Prospectus, any Issuer Free Writing Prospectus,
the Pricing Disclosure Package or the Prospectus, or in any supplement thereto or amendment thereof, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the
Company will not be liable in any such case to the extent, but only to the extent, that any such loss, liability, claim, damage
or expense arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission
made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter
through the Representatives expressly for use therein; it being understood and agreed that the only such information furnished
by any Underwriter consists of the information described as such in paragraph (b) below.</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification
of the Company.</I> Each Underwriter severally, and not jointly, agrees to indemnify and hold harmless the Company, each of the
directors of the Company, each of the officers of the Company who shall have signed the Registration Statement, and each other
person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange
Act, against any losses, liabilities, claims, damages and expenses whatsoever as incurred (including but not limited to reasonable
attorneys&rsquo; fees and any and all expenses reasonably and necessarily incurred in investigating, preparing or defending against
any litigation, commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation)
to which they or any of them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such losses,
liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon (i) any untrue statement
or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares, as originally
filed or any amendment thereof, or arise out of or are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading; or (ii) upon any untrue statement
or alleged untrue statement of a material fact contained in any related Preliminary Prospectus, any Issuer Free Writing Prospectus,
the Pricing Disclosure Package or the Prospectus, or in any supplement thereto or amendment thereof, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading, in each case to the extent,
but only to the extent, that any such loss, liability, claim, damage or expense arises out of or is based upon any such untrue
statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written
information furnished to the Company by or on behalf of such Underwriter expressly for use in the Registration Statement, the Prospectus
(or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any road show or any
Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), it being understood and
agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus
furnished on behalf of each Underwriter: the names of the Underwriters and their respective allocations; the concession and reallowance
figures appearing in the third paragraph under the caption &ldquo;Underwriting&rdquo;, the information relating to the Underwriters&rsquo;
stabilization activities contained in the fifteenth, sixteenth and seventeenth paragraphs under the caption &ldquo;Underwriting&rdquo;
and the information relating to any relationships between the Underwriters and the Company contained in the nineteenth and twentieth
paragraph under the caption &ldquo;Underwriting&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice
and Procedures.</I> Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement
of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such
subsection, notify each party against whom indemnification is to be sought in writing of the commencement thereof (but the failure
so to notify an indemnifying party shall not relieve it from any liability which it may have under this Section 7). In case any
such action is brought against any indemnified party, and it notifies an indemnifying party of the commencement thereof, the indemnifying
party will be entitled to participate </P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">therein, and to the extent it may elect by written notice delivered to the indemnified party
promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel reasonably
satisfactory to such indemnified party. Notwithstanding the foregoing, the indemnified party or parties shall have the right to
employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such indemnified
party or parties unless (i) the employment of such counsel shall have been authorized in writing by one of the indemnifying parties
in connection with the defense of such action, (ii) the indemnifying parties shall not have employed counsel reasonably satisfactory
to the indemnified parties to have charge of the defense of such action within a reasonable time after notice of commencement of
the action, or (iii) such indemnified party or parties shall have reasonably concluded that there may be defenses available to
it or them which are different from or additional to those available to one or all of the indemnifying parties (in which case the
indemnifying parties shall not have the right to direct the defense of such action on behalf of the indemnified party or parties),
in any of which events such fees and expenses shall be borne by the indemnifying parties. Anything in this subsection to the contrary
notwithstanding, an indemnifying party shall not be liable for any settlement of any claim or action effected without its written
consent; provided, however, that such consent was not unreasonably withheld. No indemnifying party shall, without the written consent
of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any indemnified party
is or could have been a party and indemnification could have been sought hereunder by such indemnified party, unless such settlement
(x) includes an unconditional release of such indemnified party, in form and substance reasonably satisfactory to such indemnified
party, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to
or any admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Expenses
of Counsel.</I> If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party
for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated
by Section 7(c) hereof effected without its written consent if (i) such settlement is entered into more than 45 days after receipt
by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such
settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed
such indemnified party in accordance with such request prior to the date of such settlement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Contribution</I>.
In order to provide for contribution in circumstances in which the indemnification provided for in this Section 7(e) is for any
reason held to be unavailable from any indemnifying party or is insufficient to hold harmless a party indemnified thereunder, then
the indemnifying parties shall contribute to the aggregate losses, claims, damages, liabilities and expenses of the nature contemplated
by such indemnification provision (including any </P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">investigation, legal and other expenses incurred
in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claims asserted, but after
deducting in the case of losses, claims, damages, liabilities and expenses suffered by the Company any contribution received
by the Company from persons, other than the Underwriters, who may also be liable for contributions, including persons who
control the Company within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act, officers of
the Company who signed the Registration Statement and directors of the Company) as incurred to which the Company and one or
more of the Underwriters may be subject, in such proportions as is appropriate to reflect the relative benefits received by
the Company and the Underwriters from the offering of the Shares or, if such allocation is not permitted by applicable law or
indemnification is not available as a result of the indemnifying party not having received notice as provided in this Section
7, in such proportion as is appropriate to reflect not only the relative benefits referred to above but also the relative
fault of the Company and the Underwriters in connection with the statements or omissions which resulted in such losses,
claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative benefits
received by the Company and the Underwriters shall be deemed to be in the same proportion as (x) the total proceeds from the
offering (net of underwriting discounts and commissions but before deducting expenses) received by the Company and (y) the
underwriting discounts and commissions received by the Underwriters, respectively, in each case as set forth in the table on
the cover page of the Prospectus. The relative fault of the Company and of the Underwriters shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission
to state a material fact relates to information supplied by the Company or the Underwriters and the parties&rsquo; relative
intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and
the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 7(e) were determined
by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of
allocation which does not take account of the equitable considerations referred to above. Notwithstanding the provisions of
this Section 7(e), in no case shall any Underwriter be liable or responsible for any amount in excess of the underwriting
discount applicable to the securities purchased by such Underwriter hereunder. Notwithstanding the provisions of this Section
7(e) and the preceding sentence, no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
For purposes of this Section 7(e), each person, if any, who controls an Underwriter within the meaning of Section 15 of the
Securities Act or Section 20(a) of the Exchange Act shall have the same rights to contribution as such Underwriter, and each
person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20(a) of the
Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director of the Company
shall have the same rights to contribution as the Company, subject in each case to this Section 7(e). Any party entitled to
contribution will, promptly after receipt of notice of commencement of any action, suit or proceeding against such party in
respect of which a claim for contribution may be made against another party or parties, notify each party or parties from
whom contribution may be sought, but the omission to so notify such party or parties shall not relieve the party or parties
from whom contribution may be sought from any obligation it or they may have under this Section 7 or otherwise. The
obligation of the Underwriters to contribute pursuant to this Section 7 shall be several in proportion to their respective
underwriting obligations and not joint.</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effectiveness
of Agreement</U>. This Agreement shall become effective as of the date first written above.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.
This Agreement may be terminated in the absolute discretion of the Representatives, by notice to the Company, if after the execution
and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional
Closing Date (i) trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange
or The Nasdaq Stock Market; (ii) trading of any securities issued or guaranteed by the Company shall have been suspended on any
exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared
by federal or New York State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change
in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives,
is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares
on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement,
the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Defaulting
Underwriter</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
on the Closing Date or the Additional Closing Date, as the case may be, any <FONT STYLE="letter-spacing: -0.15pt">Underwriter </FONT>defaults
on its obligation to purchase the Shares that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters
may in their discretion arrange for the purchase of such Shares by other persons satisfactory to the Company on the terms contained
in this Agreement. If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange
for the purchase of such Shares, then the Company shall be entitled to a further period of 36 hours within which to procure other
persons satisfactory to the non-defaulting Underwriters to purchase such Shares on such terms. If other persons become obligated
or agree to purchase the Shares of a defaulting Underwriter, either the non-defaulting Underwriters or the Company may postpone
the Closing Date or the Additional Closing Date, as the case may be, for up to five full business days in order to effect any changes
that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and
the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement
to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &ldquo;Underwriter&rdquo;
includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto
that, pursuant to this Section 10, purchases Shares that a defaulting Underwriter agreed but failed to purchase.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the
Closing Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh of the aggregate number of Shares
to be purchased on such date, then the Company shall have the right to require each non-defaulting Underwriter to purchase the
number of Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&rsquo;s pro rata share (based
on the number of Shares that such Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or
Underwriters for which such arrangements have not been made.</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the
Closing Date or the Additional Closing Date, as the case may be, exceeds one-eleventh of the aggregate amount of Shares to be purchased
on such date, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement or, with respect
to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case
may be, shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant
to this Section 10 shall be without liability on the part of the Company, except that the Company will continue to be liable for
the payment of expenses as set forth in Section&nbsp;11 hereof and except that the provisions of Section 7 hereof shall not terminate
and shall remain in effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter
for damages caused by its default.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Expenses</U><I>.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will pay all reasonable and necessary expenses incident to the performance of its obligations under this Agreement, including
(i) the preparing, printing or other production and filing of the Registration Statement (as originally filed) and all amendments
thereto, (ii) the preparation, issuance and delivery of the Shares to the Underwriters, (iii) the reasonable fees and disbursements
of the Company&rsquo;s counsel and accountants, (iv) the qualification of the Shares under securities laws in accordance with the
provisions of Section 4(f) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters
in connection therewith and in connection with the preparation of any Blue Sky Memorandum, (v) the printing or other production
and delivery to the Underwriters in quantities as hereinabove stated of copies of the Preliminary Prospectus, any Issuer Free Writing
Prospectus and the Prospectus and any amendments or supplements thereto, (vi) the production and delivery to the Underwriters of
copies of any Blue Sky Memorandum reasonably requested by the Representatives, (vii) the fees and expenses, if any, incurred in
connection with the listing of the Shares on the New York Stock Exchange, (viii) the cost of preparing stock certificates, (ix)
the costs and charges of any transfer agent and any registrar and (x) (A) the fees and expenses, if any, incurred in connection
with any filing with, and clearance of the offering by, the Financial Industry Regulatory Authority, Inc. and (B) the reasonable
fees and expenses of counsel for the Underwriters in connection therewith.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
(i) this Agreement is terminated pursuant to Section 9, (ii) the Company for any reason fails to tender the Shares for delivery
to the Underwriters or (iii) the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the
Company agrees to reimburse the Underwriters for all out-of-pocket costs and expenses (including the fees and expenses of their
counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby.</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Persons
Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each
Underwriter referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person
any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser
of Shares from any Underwriter shall be deemed to be a successor merely by reason of such purchase.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival</U>.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriters
contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate
delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless
of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors,
officers, controlling persons or affiliates referred to in Section 7 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Defined Terms</U>. For purposes of this Agreement, (a) except where otherwise expressly provided, the term &ldquo;affiliate&rdquo;
has the meaning set forth in Rule 405 under the Securities Act; (b) the term &ldquo;business day&rdquo; means any day other than
a day on which banks are permitted or required to be closed in New York City; (c) the term &ldquo;subsidiary&rdquo; has the meaning
set forth in Rule 405 under the Securities Act; and (d) the term &ldquo;significant subsidiary&rdquo; has the meaning set forth
in Rule 1-02 of Regulation S-X under the Exchange Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into
law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective
clients, including the Company, which information may include the name and address of their respective clients, as well as other
information that will allow the Underwriters to properly identify their respective clients.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notices.</I>
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c/o
J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (Facsimile: (212) 622-8358), Attention Equity Syndicate
Desk; and BofA Securities, Inc., One Bryant Park, New York, New York 10036 Facsimile: (646) 855 3073, Attention: Syndicate Department
with a copy to: Facsimile: (212) 230-8730 Attention: ECM Legal. Notices to the Company shall be given to it at Boston Scientific
Corporation, 300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234 (fax: 508-683-4350); Attention of the General Counsel
and Corporate Secretary with a copy to the Assistant General Counsel.</P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Governing
Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and
construed in accordance with the laws of the State of New York.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Submission
to Jurisdiction</I>. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in
the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of
any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought
in such court shall be conclusive and binding upon the Company and may be enforced in any court to the jurisdiction of which Company
is subject by a suit upon such judgment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Waiver
of Jury Trial.</I> Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of
or relating to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Recognition
of the U.S. Special Resolution Regimes</I>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i) In the event that any Underwriter
that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter
of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer
would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed
by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii) In the event that any Underwriter
that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution
Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no
greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed
by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">As used in this Section 16(e):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 110pt; text-indent: 0in">&ldquo;BHC Act Affiliate&rdquo; has
the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&ldquo;Covered Entity&rdquo; means
any of the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 125pt; text-indent: 0in">(i) a &ldquo;covered entity&rdquo;
as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 125pt; text-indent: 0in">(ii) a &ldquo;covered bank&rdquo;
as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 125pt; text-indent: 0in">(iii) a &ldquo;covered FSI&rdquo;
as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.25in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.25in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 110pt; text-indent: 0pt; text-align: justify">&ldquo;Default
Right&rdquo; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81,
47.2 or 382.1, as applicable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 110pt; text-indent: 0pt; text-align: justify">&ldquo;U.S.
Special Resolution Regime&rdquo; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Bail-in
Clause.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i) Notwithstanding and to the
exclusion of any other term of this Agreement or any other agreements, arrangements, or understanding between the Company and any
BRRD Party, the Company acknowledges and accepts that a BRRD Liability arising under this Agreement may be subject to the exercise
of Bail-in Powers by the Relevant Resolution Authority, and acknowledges, accepts, and agrees to be bound by:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(A) the effect of the exercise of
Bail-in Powers by the Relevant Resolution Authority in relation to any BRRD Liability of any BRRD Party to the Company under this
Agreement, that (without limitation) may include and result in any of the following, or some combination thereof:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(1) the reduction of all, or a
portion, of the BRRD Liability or outstanding amounts due thereon;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(2) the conversion of all, or a
portion, of the BRRD Liability into shares, other securities or other obligations of the relevant BRRD Party or another person,
and the issue to or conferral on the Company of such shares, securities or obligations;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(3) the cancellation of the BRRD
Liability;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(4) the amendment or alteration
of any interest, if applicable, thereon, the maturity or the dates on which any payments are due, including by suspending payment
for a temporary period; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(B) the variation of the terms of
this Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of Bail-in Powers by the
Relevant Resolution Authority.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii) For the purposes of this Section
16(f), the following definitions shall apply:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;Bail-in Legislation&rdquo;
means in relation to the United Kingdom or a member state of the European Economic Area which has implemented, or which at any
time implements, the BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU Bail-in Legislation
Schedule from time to time;</P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;Bail-in Powers&rdquo; means
any Write-down and Conversion Powers as defined in the EU Bail-in Legislation Schedule, in relation to the relevant Bail-in Legislation;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;BRRD&rdquo; means Directive
2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms, as amended;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;BRRD Liability&rdquo; means
a liability in respect of which the relevant Write Down and Conversion Powers in the applicable Bail-in Legislation may be exercised;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;BRRD Party&rdquo; means any
Underwriter which qualifies as an institution or entity referred to in paragraphs (a), (b), (c) or (d) of Article 1 of the BRRD,
as implemented in the applicable Bail-in Legislation;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;EU Bail-in Legislation Schedule&rdquo;
means the document described as such, then in effect, and published by the Loan Market Association (or any successor person) from
time to time at http://www.lma.eu.com/pages.aspx?p=499 (or any such successor webpage); and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;Relevant Resolution Authority&rdquo;
means the resolution authority with the ability to exercise any Bail-in Powers in relation to the relevant BRRD Party.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Counterparts.</I>
This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication),
each of which shall be an original and all of which together shall constitute one and the same instrument. The words &ldquo;execution,&rdquo;
&ldquo;signed,&rdquo; &ldquo;signature,&rdquo; &ldquo;delivery,&rdquo; and words of like import in or relating to this Agreement
or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or
the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually
executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties
hereto consent to conduct the transactions contemplated hereunder by electronic means.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments
or Waivers.</I> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom,
shall in any event be effective unless the same shall be in writing and signed by the parties hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Headings.</I>
The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning
or interpretation of, this Agreement..</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If the foregoing is in accordance with
your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Very truly yours,</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="4">BOSTON SCIENTIFIC CORPORATION</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 28%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Robert J. Castagna</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Robert J. Castagna</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Vice President and Treasurer</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Accepted: As of the date first written above</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">J.P. MORGAN SECURITIES LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">For itself and on behalf of the<BR>
several Underwriters listed<BR>
in Schedule 1 hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Tommy Rueger</TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-align: center">
    <TD>&nbsp;</TD>
    <TD>Authorized Signatory</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">Accepted: As of the date first written above</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">BOFA SECURITIES, INC.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">For itself and on behalf of the<BR>
several Underwriters listed<BR>
in Schedule 1 hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Milton Hsu</TD>
    <TD STYLE="width: 65%">&nbsp;</TD>
</TR>
<TR STYLE="vertical-align: bottom; text-align: center">
    <TD>&nbsp;</TD>
    <TD>Authorized Signatory</TD>
    <TD>&nbsp;</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">SCHEDULE 1</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: right">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">Underwriters</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Number of Shares</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; padding-left: 5.4pt">J.P. Morgan Securities LLC&#9;</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">7,026,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">BofA Securities, Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,026,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Citigroup Global Markets Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,916,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Goldman Sachs &amp; Co. LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,916,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Wells Fargo Securities, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,277,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Morgan Stanley &amp; Co. LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,022,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Barclays Capital Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,022,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">RBC Capital Markets, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,022,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Cowen and Company, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">702,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Evercore Group L.L.C.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">702,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">SVB Leerink LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">702,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Stifel, Nicolaus &amp; Company, Incorporated&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">702,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Scotia Capital (USA) Inc.&#9;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">511,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right; padding-bottom: 2.5pt; padding-left: 5.4pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">25,550,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">SCHEDULE 2</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Material Subsidiaries</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>Boston Scientific Scimed, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Target Therapeutics, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Boston Scientific Group plc</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>Boston Scientific Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD>Guidant Delaware Holding Corporation</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD>Cardiac Pacemakers, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD>Boston Scientific de Costa Rica S.R.L.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD>Bravo Bidco Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD>Boston Scientific Medical Device Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD>BTG Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 12pt">11.</FONT></TD><TD>BTG International (Holdings) Limited</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">ANNEX A</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Pricing Disclosure
Package</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-indent: -0.5in">Final term sheet containing the
terms of the Shares and the Mandatory Convertible Preferred Stock, substantially in the form of Annex B</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Pricing Information
Provided Orally by Underwriters</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">None.</TD><TD></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">ANNEX B</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Issuer Free Writing Prospectus</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Filed Pursuant to Rule 433</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Supplementing the<BR>
Preliminary Prospectuses<BR>
dated May 20, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Registration No. 333-238526</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Boston Scientific Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(the &ldquo;Issuer&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Pricing Term Sheet</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">May 21, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Concurrent Offerings of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">25,550,000 Shares of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(the &ldquo;Common Stock Offering&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">8,750,000 Shares of 5.50% Mandatory Convertible
Preferred Stock, Series A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(the &ldquo;Mandatory Convertible Preferred
Stock Offering&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This pricing term sheet relates only to the securities described
below and should be read together with (i)&nbsp;in the case of investors purchasing in the Common Stock Offering, the Issuer&rsquo;s
preliminary prospectus supplement dated May 20, 2020 relating to the Common Stock Offering (the &ldquo;Common Stock Preliminary
Prospectus Supplement&rdquo;), and (ii)&nbsp;in the case of investors purchasing in the Mandatory Convertible Preferred Stock Offering,
the Issuer&rsquo;s preliminary prospectus supplement dated May 20, 2020 relating to the Mandatory Convertible Preferred Stock Offering
(the &ldquo;Mandatory Convertible Preferred Stock Preliminary Prospectus Supplement&rdquo; and, together with the Common Stock
Preliminary Prospectus Supplement, the &ldquo;Preliminary Prospectus Supplements&rdquo;), each as filed with the Securities and
Exchange Commission (the &ldquo;SEC&rdquo;) pursuant to Rule 424(b) under the Securities Act of 1933, as amended, and (ii) the
accompanying prospectus dated May 20, 2020, included in the Registration Statement (File No. 333-238526), in each case, including
the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Boston Scientific Corporation has increased the size of the
Common Stock Offering to $875,087,500 (or $1,006,350,625 if the underwriters&rsquo; option to purchase additional shares of common
stock is exercised) and the Mandatory Convertible Preferred Stock Offering to $875,000,000 (or $1,006,250,000 if the underwriters&rsquo;
over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock is exercised). The final prospectus
supplement, dated May 21, 2020, relating to the Common Stock Offering and the final prospectus supplement, dated May 21, 2020,
relating to the Mandatory Convertible Preferred Stock Offering will reflect conforming changes relating to increases in the size
of the offerings.</P>

<P STYLE="padding-bottom: 12pt; font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Neither the Common Stock Offering nor the Mandatory Convertible
Preferred Stock Offering is contingent on the completion of the other offering. Certain capitalized terms used in this pricing
term sheet that are not defined herein but that are defined in the Common Stock Preliminary Prospectus Supplement or the Mandatory
Convertible Preferred Stock Preliminary Prospectus Supplement, as applicable, have the respective meanings given to such terms
in such Preliminary Prospectus Supplement.&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 35%; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Issuer:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 64%; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Boston Scientific Corporation, a Delaware corporation</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Pricing Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">May 21, 2020</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Trade Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">May 22, 2020</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Settlement Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">May 27, 2020 (T+2) </FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 35%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 64%"><FONT STYLE="font-size: 10pt"><B><U>Common Stock Offering</U></B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Title of Securities:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Common stock, par value $0.01 per share, of the Issuer (&ldquo;Common Stock&rdquo;)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Number of Shares of Common Stock Offered: </FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">25,550,000 shares (or 29,382,500 shares if the underwriters of the Common Stock Offering exercise in full their option to purchase additional shares of Common Stock)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Common Stock Outstanding after Common Stock Offering:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><BR>
<BR>
1,672,427,242 shares (or 1,676,259,742 shares if the underwriters of the Common Stock Offering exercise in full their option to purchase additional shares of common stock), based on shares outstanding as of March 31, 2020</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Symbol/Exchange:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">BSX/The New York Stock Exchange (&ldquo;NYSE&rdquo;)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Last Reported Sale Price of Common Stock on the NYSE on the Pricing Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">$34.79 per share of Common Stock</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Public Offering Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">$34.25 per share of Common Stock</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Underwriting Discount:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">$1.0275 per share of Common Stock</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">$26,252,625 in aggregate (or $30,190,518.75 in aggregate if the
        underwriters of the Common Stock Offering exercise in full their option to purchase additional shares of Common Stock)</P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Net Proceeds:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The net proceeds from the Common Stock Offering, after deducting underwriting discounts and commissions and estimated offering expenses, will be approximately $847.3 million (or approximately $974.7 million if the underwriters of the Common Stock Offering exercise in full their option to purchase additional shares of Common Stock)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">CUSIP / ISIN:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">101137 107 / US1011371077</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Joint Bookrunners:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">J.P. Morgan Securities LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BofA Securities, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Citigroup Global Markets Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Goldman Sachs &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Wells Fargo Securities, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Morgan Stanley &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Barclays Capital Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">RBC Capital Markets, LLC</P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Co-Managers:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Cowen and Company, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Evercore Group L.L.C.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Stifel, Nicolaus &amp; Company, Incorporated</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">SVB Leerink LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Scotia Capital (USA) Inc.</P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><B><U>Mandatory Convertible Preferred Stock Offering</U></B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Title of Securities:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share, of the Issuer (the &ldquo;Mandatory Convertible Preferred Stock&rdquo;)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Number of Shares of Mandatory Convertible Preferred Stock Offered:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><BR>
<BR>
8,750,000 shares (or 10,062,500 shares if the underwriters of the Mandatory Convertible Preferred Stock Offering exercise in full their over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 35%"><FONT STYLE="font-size: 10pt">Public Offering Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 64%"><FONT STYLE="font-size: 10pt">$100.00 per share of Mandatory Convertible Preferred Stock</FONT></TD>
    </TR>
<TR>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Underwriting Discount:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">$3.00 per share of Mandatory Convertible Preferred Stock</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">$26,250,000 in aggregate (or $30,187,500 in aggregate if the underwriters
        of the Mandatory Convertible Preferred Stock Offering exercise in full their option to purchase additional shares of Mandatory
        Convertible Preferred Stock)</P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Net Proceeds:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The net proceeds from the Mandatory Convertible Preferred Stock Offering, after deducting underwriting discounts and commissions and estimated offering expenses, will be approximately $847.3 million (or approximately $974.6 million if the underwriters of the Mandatory Convertible Preferred Stock Offering exercise in full their over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock).</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Use of Proceeds:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The Issuer intends to use a portion of the combined net proceeds from the Mandatory Convertible Preferred Stock Offering and the Common Stock Offerings of $1,694.6 million (or $1,949.3 million if the underwriters for both offerings exercise their options in full) to repay in full the remaining $750.0 million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it will be terminated. The remaining proceeds will be used for general corporate purposes, which may include refinancing or repayment of other outstanding indebtedness and funding potential future acquisitions and investments.</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Liquidation Preference:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">$100.00 per share of the Mandatory Convertible Preferred Stock.</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Dividends:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">5.50<FONT STYLE="font-family: Times-Roman,serif">% of the liquidation
        preference of $100.00 per share of Mandatory Convertible Preferred Stock per annum. Dividends will accumulate from the most recent
        date as to which dividends shall have been paid or, if no dividends have been paid, from the first original issue date of the Mandatory
        Convertible Preferred Stock, and, to the extent the Issuer&rsquo;s board of directors, or an authorized committee thereof, declares</FONT>
        <FONT STYLE="background-color: white">(out of funds legally available for payment in the case of dividends paid in cash or if legally
        permitted to be issued in the case of dividends paid in shares of Common Stock)&nbsp;</FONT>a dividend payable with respect to
        the Mandatory Convertible Preferred Stock, the Issuer will pay such dividends in cash, by delivery of shares of Common Stock or
        through any combination of cash and shares of Common Stock, as determined by the Issuer in its sole discretion; provided that any
        unpaid dividends will continue to accumulate on the Mandatory Convertible Preferred Stock, subject to certain exceptions. The Issuer
        will pay the relevant dividend in shares of common stock until it amends or terminates its Term Loans and Revolving Credit Facility
        that contain a restriction on its ability to pay cash dividends on its capital stock, or such restrictions are no longer effective
        under the terms of such credit agreements. The Issuer intends to use a portion of the net proceeds from the Mandatory Convertible
        Preferred Stock Offering and the Common Stock Offering to repay in full remaining borrowings under, and terminate, the April 2021
        Term Loan. Following consummation of the Mandatory Convertible Preferred Stock Offering, the Issuer intends to seek amendments
        to its Revolving Credit Facility and the February 2021 Term Loan to permit it to pay cash dividends and other distributions on
        the Mandatory Convertible Preferred Stock. There can be no assurance that the Issuer will be successful in securing any such amendment.</P>
        <P STYLE="font: 10pt Times-Roman,serif; margin: 0"></P>
        <P STYLE="font: 10pt Times-Roman,serif; margin: 0"></P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">The expected dividend payable on the first Dividend Payment Date of September
        1, 2020 is approximately $1.4361 per share of the Mandatory Convertible Preferred Stock. Each subsequent dividend is expected to
        be $1.375 per share of the Mandatory Convertible Preferred Stock.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 35%"><FONT STYLE="font-size: 10pt">Dividend Payment Dates:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 64%"><FONT STYLE="font-size: 10pt">March 1, June 1, September 1 and December 1 of each year, commencing on September 1, 2020, and to, and including, June 1, 2023</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Dividend Regular Record Dates: </FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">February 15, May 15, August 15 and November 15 immediately preceding the relevant Dividend Payment Date</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Initial Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Times-Roman,serif; font-size: 10pt">$100.00, <I>divided by</I> the Maximum Conversion Rate (as defined below), which is initially </FONT><FONT STYLE="font-size: 10pt">$34.25 and equal to the Common Stock Public Offering Price per share in the concurrent Common Stock Offering described above</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Threshold Appreciation Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">$100.00, <I>divided by</I> the Minimum Conversion Rate (as defined below), which is initially $41.96, which represents an approximate 22.50% appreciation of the Initial Price</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Mandatory Conversion Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The second business day immediately following the last Trading Day of the Settlement Period. The Mandatory Conversion Date is expected to be June 1, 2023.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 1pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Conversion Rate:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0">Upon conversion on the Mandatory Conversion Date, the conversion
        rate for each share of Mandatory Convertible Preferred Stock will not be more than 2.9197 shares of the Issuer&rsquo;s Common Stock
        (the &ldquo;Maximum Conversion Rate&rdquo;) and not less than 2.3834 shares of its Common Stock (the &ldquo;Minimum Conversion
        Rate&rdquo;), depending on the Applicable Market Value of its Common Stock, as described below, and subject to certain anti-dilution
        adjustments.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The &ldquo;Applicable Market Value&rdquo; of the Issuer&rsquo;s
        Common Stock is the Average VWAP per share of its Common Stock over the 20 consecutive Trading Day period commencing on, and including,
        the 21st Scheduled Trading Day immediately preceding June 1, 2023 (the &ldquo;Settlement Period&rdquo;). The conversion rate will
        be calculated as described in the Mandatory Convertible Preferred Stock Preliminary Prospectus Supplement and the following table
        illustrates hypothetical conversion rates per share of the Mandatory Convertible Preferred Stock (assuming no anti-dilution adjustments
        and assuming that dividends are declared and paid in cash and subject to the provisions described in the Mandatory Convertible
        Preferred Stock Preliminary Prospectus Supplement with respect to any fractional share of Common Stock).</P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 1pt; padding-left: 3pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; width: 35%">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; width: 31%"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0">Assumed <BR>
Applicable Market Value <BR>
of Common Stock</P></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; width: 1%"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; width: 32%"><B>Conversion Rate (number of shares of Common Stock to be received
    upon mandatory conversion of each share of the Mandatory Convertible Preferred Stock)</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Times-Roman,serif; font-size: 10pt">Greater than the Threshold Appreciation Price</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">2.3834 <FONT STYLE="font-family: Times-Roman,serif">shares of Common Stock, which is the Minimum Conversion Rate </FONT></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Times-Roman,serif; font-size: 10pt">Equal to or less than the Threshold Appreciation Price but greater
than or equal to the Initial Price</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Times-Roman,serif; font-size: 10pt">Between </FONT><FONT STYLE="font-size: 10pt">2.3834 <FONT STYLE="font-family: Times-Roman,serif">and </FONT>2.9197 <FONT STYLE="font-family: Times-Roman,serif">shares of Common Stock, determined by dividing $100.00 by the Applicable Market Value </FONT></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Times-Roman,serif; font-size: 10pt">Less than the Initial Price</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">2.9197 <FONT STYLE="font-family: Times-Roman,serif">shares of Common Stock, which is the Maximum Conversion Rate </FONT></FONT></TD></TR>
<TR>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Early Conversion at the Option of the Holder:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><BR>
Other than during a Fundamental Change Conversion Period, at any time prior to June 1, 2023, holders of the Mandatory Convertible Preferred Stock have the option to elect to convert their shares of the Mandatory Convertible Preferred Stock, in whole or in part, at the Minimum Conversion Rate.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Conversion at the Option of the Holder Upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <BR>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><BR>
If a Fundamental Change occurs on or prior to June 1, 2023, holders
        of the Mandatory Convertible Preferred Stock will have the right during the Fundamental Change Conversion Period to convert their
        shares of the Mandatory Convertible Preferred Stock, in whole or in part, into shares of Common Stock (or Units of Exchange Property
        as described in the Mandatory Convertible Preferred Stock Preliminary Prospectus) at the Fundamental Change Conversion Rate described
        below.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Holders who convert their Mandatory Convertible Preferred Stock
        within the Fundamental Change Conversion Period will also receive (1) a &ldquo;Fundamental Change Dividend Make-Whole Amount&rdquo;
        equal to the present value (calculated using a discount rate of 5.00% per annum) of all dividend payments (excluding any Accumulated
        Dividend Amount) on their shares of the Mandatory Convertible Preferred Stock for (i) the partial dividend period, if any, from,
        and including, the Fundamental Change Effective Date to, but excluding, the next Dividend Payment Date and (ii) all remaining full
        dividend periods from, and including, the Dividend Payment Date following the Fundamental Change Effective Date to, but excluding,
        the Mandatory Conversion Date, as described in the Mandatory Convertible Preferred Stock Preliminary Prospectus, and (2) the Accumulated
        Dividend Amount, which equals the aggregate amount of accumulated and unpaid dividends, if any, that have not been declared for
        dividend periods prior to the relevant Fundamental Change Effective Date, including (but subject to certain exceptions) for the
        partial dividend period, if any, from, and including, the Dividend Payment Date immediately preceding such Fundamental Change Effective
        Date to, but excluding, such Fundamental Change Effective Date.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">The Issuer may satisfy the Fundamental Change Dividend Make-Whole
        Amount and/or the Accumulated Dividend Amount in cash, by delivery of shares of Common Stock or through any combination of cash
        and shares of Common Stock, as determined by the Issuer in its sole discretion, subject to the limitations in its Term Loans and
        Revolving Credit Facility that contain a restriction on its ability to pay cash distributions on its capital stock. The Issuer
        intends to use a portion of the net proceeds from the Mandatory Convertible Preferred Stock Offering and the Common Stock Offering
        to repay in full remaining borrowings under, and terminate, the April 2021 Term Loan. Following consummation of the Mandatory Convertible
        Preferred Stock Offering, the Issuer intends to seek amendments to its Revolving Credit Facility and the February 2021 Term Loan
        to permit it to pay cash dividends and other distributions on the Mandatory Convertible Preferred Stock. There can be no assurance
        that the Issuer will be successful in securing any such amendment.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 35%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 64%">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Fundamental Change Conversion Rate:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Times-Roman,serif; font-size: 10pt">The following table sets forth the Fundamental Change Conversion Rate per share of the Mandatory Convertible Preferred Stock for each Fundamental Change Share Price and Fundamental Change Effective Date set forth below:</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 7pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid; padding-left: 3pt">Fundamental <BR> Change <BR> Effective Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="59" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fundamental Change Share Price</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-size: 11pt; padding-bottom: 1pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">10.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">15.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">20.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">25.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">30.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">34.25</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">37.50</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">40.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">41.96</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">45.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">50.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">55.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">60.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">75.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: right">100.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 3pt">May 27, 2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8542</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7933</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6255</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5532</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5037</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4729</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4529</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4394</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4214</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3988</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3828</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3715</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3544</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3477</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 3pt">June 1, 2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8856</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8539</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6998</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6145</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5520</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5122</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4687</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4455</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4169</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3973</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3842</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3660</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3601</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 3Pt">June 1, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9050</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9007</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8724</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8033</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7052</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6193</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5225</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4965</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4633</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3878</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3739</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3716</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 3pt">June 1, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>




<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The exact Fundamental Change Effective Date and Fundamental Change Share Price may not be set forth in the table, in which case:</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 34%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 62%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#159;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">if the Fundamental Change Share Price is between two Fundamental Change Share Prices in the table or the Fundamental Change Effective Date is between two Fundamental Change Effective Dates in the table, the Fundamental Change Conversion Rate will be determined by a straight-line interpolation between the Fundamental Change Conversion Rates set forth for the higher and lower Fundamental Change Share Price amounts and the earlier and later Fundamental Change Effective Dates, as applicable, based on a 365- or 366-day year, as applicable;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#159;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">if the Fundamental Change Share Price is in excess of $100.00 per share (subject to adjustment in the same manner as the Fundamental Change Share Prices set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Minimum Conversion Rate; and</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#159;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">if the Fundamental Change Share Price is less than $10.00 per share (subject to adjustment in the same manner as the Fundamental Change Share Prices set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Maximum Conversion Rate.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Floor Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Initially $11.9875 (approximately 35% of the Initial Price), subject to adjustment as described in the Mandatory Convertible Preferred Stock Preliminary Prospectus.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Maximum Number of Shares of Common Stock Issuable Upon Conversion (Exclusive of Shares Issuable as Payment of Dividends):</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><BR>
<BR>
<BR>
25,547,375 shares (or 29,379,482 shares if the underwriters of the Mandatory Convertible Preferred Stock Offering exercise in full their option to purchase additional shares of Mandatory Convertible Preferred Stock)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 34%; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Symbol/Exchange:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 65%; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The Issuer intends to apply to list the Mandatory Convertible Preferred Stock on the NYSE under the symbol &ldquo;BSX PR A&rdquo; and, if approved, the Issuer expects trading to commence within 30 days of the first original issue date of the Mandatory Convertible Preferred Stock</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">CUSIP / ISIN:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">101137 206 / US1011372067</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; text-indent: 1in">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Bookrunners:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">J.P. Morgan Securities LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BofA Securities, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Citigroup Global Markets Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Goldman Sachs &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Wells Fargo Securities, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Morgan Stanley &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Barclays Capital Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">RBC Capital Markets, LLC</P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; text-indent: 1in">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Co-Managers:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BNP Paribas Securities Corp.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">DNB Markets, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">MUFG Securities Americas Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">SG Americas Securities, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Standard Chartered Bank</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">TD Securities (USA) LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">U.S. Bancorp Investments, Inc.</P></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>The Issuer has filed a registration statement (including a prospectus)
with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) for the offerings to which this communication relates.
Before you invest, you should read the applicable Preliminary Prospectus Supplement referred to above and the accompanying prospectus
in that registration statement for a more complete information about the Issuer and the applicable offering. You may get these
documents for free by visiting EDGAR on the SEC website at <I>www.sec.gov</I>. Alternatively, the Issuer, any underwriter or any
dealer participating in the applicable offering will arrange to send you the prospectus and the applicable Preliminary Prospectus
Supplement if you request it by calling J.P. Morgan Securities LLC at (866) 803-9204 or BofA Securities, Inc. at 1-800-294-1322.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>The information in this pricing term sheet should be read
in conjunction with the applicable Preliminary Prospectus Supplement and the prospectus. The information in this pricing term sheet
supersedes the information in the applicable Preliminary Prospectus Supplement and the prospectus to the extent it is inconsistent
with the information in the applicable Preliminary Prospectus Supplement or the prospectus. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"><B>Any legends, disclaimers or other notices that may appear
below are not applicable to this communication and should be disregarded. Such legends, disclaimers or other notices have been
automatically generated as a result of this communication having been sent via Bloomberg or another system.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"><B></B></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">ANNEX C</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0; text-align: center">Form of Opinion of Vice President, Chief
Corporate Counsel and Assistant Secretary of the Company</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">ANNEX D</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0; text-align: center">Form of Opinion of Counsel for the Company</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right; text-indent: 0.5in">EXHIBIT A</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: center">FORM OF LOCK-UP AGREEMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: right">May [&#9679;], 2020</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">J.P. MORGAN SECURITIES LLC<BR>
BOFA SECURITIES, INC.<BR>
As Representatives of<BR>
the several Underwriters listed in<BR>
Schedule 1 to the Underwriting<BR>
Agreement referred to below<BR>
<BR>
c/o J.P. Morgan Securities LLC<BR>
383 Madison Avenue<BR>
New York, NY 10179</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">c/o BofA Securities, Inc.<BR>
One Bryant Park<BR>
New York, New York 10036</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Re:&#9;Boston Scientific Corporation
--- Public Offering</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">Ladies and Gentlemen:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The undersigned understands that you, as
Representatives of the several Underwriters, propose to enter into an underwriting agreement (the &ldquo;Underwriting Agreement&rdquo;)
with Boston Scientific Corporation, a Delaware corporation (the &ldquo;Company&rdquo;), providing for the public offering (the
&ldquo;Public Offering&rdquo;) by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the &ldquo;Underwriters&rdquo;),
of common stock, $0.01 par value per share, of the Company (the &ldquo;Shares&rdquo;). Capitalized terms used herein and not otherwise
defined shall have the meanings set forth in the Underwriting Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In consideration of the Underwriters&rsquo;
agreement to purchase and make the Public Offering of the Shares, and for other good and valuable consideration receipt of which
is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of the Representatives on behalf
of the Underwriters, the undersigned will not, and will not cause any direct or indirect affiliate to, during the period beginning
on the date of this letter agreement (this &ldquo;Letter Agreement&rdquo;) and ending at the close of business 90 days after the
date of the final prospectus relating to the Public Offering (the &ldquo;Prospectus&rdquo;) (such period, the &ldquo;Restricted
Period&rdquo;), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any
shares of common stock, $0.01 par value per share, of the Company (the &ldquo;Common Stock&rdquo;) or any securities convertible
into or exercisable or exchangeable for Common Stock (including without limitation, Common Stock or such other securities which
may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange
Commission and securities which may be issued upon exercise of a stock option or warrant)</P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.0in">collectively with the Common Stock,
&ldquo;Lock-Up Securities&rdquo;), (2) enter into any hedging, swap or other agreement or transaction that transfers, in whole
or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction described in
clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise, (3) make any demand for or exercise
any right with respect to the registration of any Lock-Up Securities, or (4) publicly disclose the intention to do any of the foregoing.
The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions
or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option,
or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed
or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by the undersigned
or any other person) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any Lock-Up Securities,
whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of Lock-Up Securities,
in cash or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Notwithstanding the foregoing, the undersigned
may:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp; transfer the undersigned&rsquo;s
Lock-Up Securities:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(i) as a bona fide gift or gifts, or
for bona fide estate planning purposes,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(ii) by will or intestacy,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(iii) to any trust for the direct or
indirect benefit of the undersigned or the immediate family of the undersigned, or if the undersigned is a trust, to a trustor
or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes of this Letter Agreement, &ldquo;immediate
family&rdquo; shall mean any relationship by blood, current or former marriage, domestic partnership or adoption, not more remote
than first cousin),</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(iv) to a partnership, limited liability
company or other entity of which the undersigned and the immediate family of the undersigned are the legal and beneficial owner
of all of the outstanding equity securities or similar interests,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(v) to a nominee or custodian of a person
or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) above,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(vi)&nbsp;if the undersigned is a corporation,
partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited liability
company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933,
as amended) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing or managed by or
under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned
is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or
(B) as part of a distribution to members or shareholders of the undersigned,</P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(vii) by operation of law, such as pursuant
to a qualified domestic order, divorce settlement, divorce decree or separation agreement,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(viii) to the Company from an employee
of the Company upon death, disability or termination of employment, in each case, of such employee,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(ix) as part of a sale of the undersigned&rsquo;s
Lock-Up Securities acquired in open market transactions after the closing date for the Public Offering,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(x) to the Company in connection with
the vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase shares of Common
Stock (including, in each case, by way of &ldquo;net&rdquo; or &ldquo;cashless&rdquo; exercise), including for the payment of exercise
price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options,
warrants or rights, provided that any such shares of Common Stock received upon such exercise, vesting or settlement shall be subject
to the terms of this Letter Agreement, and provided further that any such restricted stock units, options, warrants or rights are
held by the undersigned pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award plan,
each such agreement or plan which is described in the Registration Statement, the Pricing Disclosure Package and the Prospectus,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(xi) pursuant to a bona fide third-party
tender offer, merger, consolidation or other similar transaction that is approved by the Board of Directors of the Company and
made to all holders of the Company&rsquo;s capital stock involving a Change of Control (as defined below) of the Company (for purposes
hereof, &ldquo;Change of Control&rdquo; shall mean the transfer (whether by tender offer, merger, consolidation or other similar
transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of shares of
capital stock if, after such transfer, such person or group of affiliated persons would hold at least a majority of the outstanding
voting securities of the Company (or the surviving entity)); <U>provided</U> that in the event that such tender offer, merger,
consolidation or other similar transaction is not completed, the undersigned&rsquo;s Lock-Up Securities shall remain subject to
the provisions of this Letter Agreement; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(xii) pursuant to a trading plan pursuant
to Rule 10b5-1 under the Exchange Act (a &ldquo;10b5-1 Plan&rdquo;) that was in effect as of, and only shares scheduled for sale
thereunder on, the date hereof;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><U>provided</U> that (A) in the case of any transfer or distribution
pursuant to clause (a)(i), (ii), (iii), (iv), (v), (vi) and (vii), such transfer shall not involve a disposition for value and
each donee, devisee, transferee or distributee shall execute and deliver to the Representatives a lock-up letter in the form of
this Letter Agreement, (B) in the case of any transfer or distribution pursuant to clause (a) (i), (ii), (iii), (iv), (v), (vi),
(ix) and (x), no filing by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or other public announcement shall be required or shall be made
voluntarily in connection with such transfer or distribution (other than a filing on a Form 5 made after the expiration of the
Restricted Period referred to above) and (C) in the case of any sale or disposition of Lock-Up Securities pursuant to clause (a)(xii),
that no filing under Section 16(a) of the Exchange Act or other public announcement shall be required or shall be voluntarily made
in connection with such sale or disposition during the 90-day restricted period (other than, if required, a Section 16 filing,
which filing shall indicate that such transaction was effected pursuant to a 10b5-1 Plan);</P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b) exercise options, settle restricted
stock units or other equity awards or exercise warrants outstanding as of the date granted pursuant to plans described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus; provided that any Lock-up Securities received upon such exercise,
vesting or settlement shall be subject to the terms of this Letter Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c) convert outstanding preferred stock,
warrants to acquire preferred stock or convertible securities into shares of Common Stock or warrants to acquire shares of Common
Stock; provided that any such shares of Common Stock or warrants received upon such conversion shall be subject to the terms of
this Letter Agreement; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d) establish trading plans pursuant
to Rule 10b5-1 under the Exchange Act for the transfer of shares of Lock-Up Securities; <U>provided</U> that (1) such plans do
not provide for the transfer of Lock-Up Securities during the Restricted Period and (2) no filing by any party under the Exchange
Act or other public announcement shall be required or made voluntarily in connection with such trading plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In furtherance of the foregoing, the
Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby
authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter
Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The undersigned hereby represents and
warrants that the undersigned has full power and authority to enter into this Letter Agreement. All authority herein conferred
or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal
representatives of the undersigned.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The undersigned understands that, if
the Underwriting Agreement does not become effective by June 30, 2020, or if the Underwriting Agreement (other than the provisions
thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be
sold thereunder, the undersigned shall be released from all obligations under this Letter Agreement. The undersigned understands
that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this
Letter Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This Letter Agreement and any claim,
controversy or dispute arising under or related to this Letter Agreement shall be governed by and construed in accordance with
the laws of the State of New York.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Any signature to, and delivery of, this
Letter Agreement shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each
of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof
or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions
contemplated hereunder by electronic means.</P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Very truly yours,</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="4">[<I>NAME OF STOCKHOLDER</I>]</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 28%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>3
<FILENAME>ss174270_ex0102.htm
<DESCRIPTION>UNDERWRITING AGREEMENT RELATING TO THE MANDATORY CONVERTIBLE PREFERRED STOCK
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: right"><B>Exhibit 1.2</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: right"><B>EXECUTION VERSION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;BOSTON SCIENTIFIC CORPORATION<BR>
<BR>
8,750,000 Shares of 5.50% Mandatory Convertible Preferred Stock, Series A</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Underwriting Agreement</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: right">May 21, 2020</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">J.P. Morgan Securities LLC<BR>
BofA Securities, Inc.<BR>
As Representatives of the<BR>
&#9;&nbsp;&nbsp;&nbsp;several Underwriters listed<BR>
&#9;&nbsp;&nbsp;&nbsp;in Schedule 1 hereto</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><BR>
c/o J.P. Morgan Securities LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">383 Madison Avenue</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">New York, New York 10179</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">c/o BofA Securities, Inc.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">One Bryant Park</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">New York, New York 10036</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Boston Scientific Corporation, a Delaware
corporation (the &ldquo;Company&rdquo;), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the
&ldquo;Underwriters&rdquo;), for whom you are acting as representatives (the &ldquo;Representatives&rdquo;), an aggregate of 8,750,000
shares of 5.50% Mandatory Convertible Preferred Stock, Series A, with a liquidation preference of $100.00 per share (the &ldquo;Mandatory
Convertible Preferred Stock&rdquo;), of the Company (the &ldquo;Underwritten Shares&rdquo;) and, at the option of the Underwriters,
up to an additional 1,312,500 shares of Mandatory Convertible Preferred Stock (the &ldquo;Option Shares&rdquo;). The Underwritten
Shares and the Option Shares are herein referred to as the &ldquo;Shares&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Mandatory Convertible Preferred Stock
will be convertible into a variable number of shares of the Company&rsquo;s common stock, $0.01 par value per share (the &ldquo;Common
Stock&rdquo;). Such Common Stock of the Company into which the Shares are convertible are referred to herein as the &ldquo;Conversion
Shares.&rdquo; The terms of the Mandatory Convertible Preferred Stock will be set forth in the Certificate of Designations (the
&ldquo;Certificate of Designations&rdquo;) to be filed by the Company with the Secretary of State of the State of Delaware as an
amendment to the Company&rsquo;s Third Restated Certificate of Incorporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Company is concurrently publicly
offering (the &ldquo;Common Stock Offering&rdquo;) shares of its Common Stock, pursuant to a separate underwriting agreement (the
&ldquo;Common Stock Underwriting Agreement&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Company hereby confirms its agreement
with the several Underwriters concerning the purchase and sale of the Shares, as follows:</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Statement</U>. The Company has prepared and filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) under
the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &ldquo;Securities
Act&rdquo;), a registration statement (File No. 333-238526), including a prospectus, relating to the Shares and the Conversion
Shares. Such registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant
to Rule 430B under the Securities Act to be part of the registration statement at the time of its effectiveness (&ldquo;Rule 430
Information&rdquo;), is referred to herein as the &ldquo;Registration Statement&rdquo;; and as used herein, the term &ldquo;Preliminary
Prospectus&rdquo; means each prospectus included in such registration statement (and any amendments thereto) before effectiveness,
any prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration
Statement at the time of its effectiveness that omits Rule 430 Information, and the term &ldquo;Prospectus&rdquo; means the prospectus
in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection
with confirmation of sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b)
under the Securities Act (the &ldquo;Rule 462 Registration Statement&rdquo;), then any reference herein to the term &ldquo;Registration
Statement&rdquo; shall be deemed to include such Rule 462 Registration Statement. Any reference in this underwriting agreement
(this &ldquo;Agreement&rdquo;) to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer
to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of
the effective date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may
be, and any reference to &ldquo;amend&rdquo;, &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such
date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively,
the &ldquo;Exchange Act&rdquo;) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined
herein shall have the meanings given to such terms in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">At or prior to the Applicable Time (as
defined below), the Company had prepared the following information (collectively with the pricing information set forth on Annex
A, the &ldquo;Pricing Disclosure Package&rdquo;): a Preliminary Prospectus dated May 20, 2020 and each &ldquo;free-writing prospectus&rdquo;
(as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;Applicable Time&rdquo; means 7:00
P.M., New York City time, on May 21, 2020.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
of the Shares</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each Underwriter,
on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein,
agrees, severally and not jointly, to purchase at a price per share of $97.00 (the &ldquo;Purchase Price&rdquo;) from the Company
the respective number of Underwritten Shares set forth opposite such Underwriter&rsquo;s name in Schedule 1 hereto.</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In addition, the Company agrees to issue
and sell the Option Shares to the several Underwriters as provided in this Agreement, and the Underwriters, on the basis of the
representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option
to purchase, severally and not jointly, from the Company the Option Shares at the Purchase Price less an amount per share equal
to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option
Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If any Option Shares are to be purchased,
the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears the same ratio
to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such
Underwriter in Schedule 1 hereto (or such number increased as set forth in Section 10 hereof) bears to the aggregate number of
Underwritten Shares being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate
any fractional Shares as the Representatives in their sole discretion shall make.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Underwriters may exercise the option
to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the date
of the Prospectus, by written notice from the Representatives to the Company. Such notice shall set forth the aggregate number
of Option Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and
paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing
Date nor later than the tenth full business day (as hereinafter defined) after the date of such notice (unless such time and date
are postponed in accordance with the provisions of Section 10 hereof). Any such notice shall be given at least two business days
prior to the date and time of delivery specified therein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company understands that the Underwriters intend to make a public offering of the Shares, and initially to offer the Shares on
the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and
sell Shares to or through any affiliate of an Underwriter.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the Representatives
in the case of the Underwritten Shares, at the offices of Simpson Thacher &amp; Bartlett LLP, 425 Lexington Avenue, New York, New
York 10017 at 10:00 A.M. New York City time on May 27, 2020, or at such other time or place on the same or such other date, not
later than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing or, in the case
of the Option Shares, on the date and at the time and place specified by the Representatives in the written notice of the Underwriters&rsquo;
election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as
the &ldquo;Closing Date&rdquo;, and the time and date for such payment for the Option Shares, if other than the Closing Date, is
herein referred to as the &ldquo;Additional Closing Date&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Payment for the Shares to be purchased
on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Representatives for
the respective accounts of the several Underwriters of the Shares to be purchased on the Closing Date or the Additional Closing
Date, as the case may be, with any transfer taxes payable in connection with the sale of such Shares duly paid by the Company.
Delivery of the Shares shall be made through the facilities of The Depository Trust Company unless the Representatives shall otherwise
instruct.</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company acknowledges and agrees that the Representatives and the other Underwriters are acting solely in the capacity of an arm&rsquo;s
length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection
with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any
other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company or any other person as
to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors
concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and neither the Representatives nor the other Underwriters shall have any responsibility or liability to the
Company with respect thereto. Any review by the Representatives and the other Underwriters of the Company, the transactions contemplated
hereby or other matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall not
be on behalf of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Company</U>. The Company represents and warrants to each Underwriter that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Preliminary
Prospectus.</I> No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and
each Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material
respects with the Securities Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement
of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to
any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the
Company in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus, it being understood
and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section
7(b) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Pricing
Disclosure Package</I>. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of
the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
<U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance
upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use in such Pricing Disclosure Package, it being understood and agreed that the only such information
furnished by any Underwriter consists of the information described as such in Section 7(b) hereof. No statement of material fact
included in the Prospectus has been omitted from the Pricing Disclosure Package and no statement of material fact included in the
Pricing Disclosure Package that is required to be included in the Prospectus has been omitted therefrom.</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Issuer
Free Writing Prospectus. </I>Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company
(including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used,
authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &ldquo;written communication&rdquo;
(as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares
(each such communication by the Company or its agents and representatives (other than a communication referred to in clause (i)
below) an &ldquo;Issuer Free Writing Prospectus&rdquo;) other than (i) any document not constituting a prospectus pursuant to Section
2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex A hereto, each electronic
road show and any other written communications approved in writing in advance by the Representatives. Each such Issuer Free Writing
Prospectus complies in all material respects with the Securities Act, has been or will be (within the time period specified in
Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and does not conflict with the information
contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus
filed prior to the first use of such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional
Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>
that the Company makes no representation or warranty with respect to any statements or omissions made in each such Issuer Free
Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished
to the Company in writing by such Underwriter through the Representatives expressly for use in such Issuer Free Writing Prospectus
or Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists
of the information described as such in Section 7(b) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Registration
Statement and Prospectus.</I> The Registration Statement is an &ldquo;automatic shelf registration statement&rdquo; as defined
under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof;
and no notice of objection of the Commission to the use of such registration statement or any post-effective amendment thereto
pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of
the Registration Statement has been issued by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the
Securities Act against the Company or related to the offering of the Shares has been initiated or threatened by the Commission;
as of the applicable effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement
and any such post-effective amendment complied and will comply in all material respects with the Securities Act, and did not and
will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto
and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus will comply in all material
respects with the Securities Act and will not contain any untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
<U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance
upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto,
it being understood and agreed that the only such information furnished by any Underwriter consists of the information described
as such in Section 7(b) hereof.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Incorporated
Documents.</I> The documents incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure
Package, at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with
the requirements of the Exchange Act and the rules and regulations thereunder, and, when read together and with the other information
in the Prospectus, the Pricing Disclosure Package and the Registration Statement did not and will not contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Financial
Statements.</I> The consolidated financial statements included or incorporated by reference in the Registration Statement, the
Pricing Disclosure Package and the Prospectus present fairly in all material respects the consolidated financial position of the
Company and its consolidated subsidiaries as at the dates indicated and the results of their operations for the periods specified;
said financial statements have been prepared in conformity with generally accepted accounting principles applied on a consistent
basis during the periods involved, except as indicated therein; the supporting schedules included or incorporated by reference
in the Registration Statement, if any, present fairly the information required to be stated therein. No pro forma financial information
is required to be filed with the Commission pursuant to any acquisitions or dispositions by the Company pursuant to Regulation
S-X with respect to any acquisitions or dispositions by the Company since January 1, 2017.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Material Adverse Change.</I> Since the respective dates as of which information is given in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except as may otherwise be stated therein or contemplated thereby, (i) there has been no
material adverse change in the condition (financial or other), earnings, results of operations, business or properties of the Company
and its subsidiaries, considered as one enterprise, whether or not arising from transactions in the ordinary course of business
and (ii) there have been no material transactions entered into by the Company or any of its subsidiaries, other than those in the
ordinary course of business.</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Organization
and Good Standing.</I> The Company has been duly incorporated and is validly existing as a corporation in good standing under the
laws of the State of Delaware with corporate power and authority to own, lease and operate its properties and conduct its business
as now being conducted and as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and the
Company is duly qualified as a foreign corporation to transact business and is in good standing in each jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the
failure to so qualify would not have a material adverse effect on the condition (financial or other), earnings, results of operations,
business or properties of the Company and its subsidiaries, considered as one enterprise (a &ldquo;Material Adverse Effect&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Material
Subsidiaries</I>. Schedule 2 hereto sets forth each domestic and foreign subsidiary of the Company which the Company deems to be
a &ldquo;significant subsidiary&rdquo; (each, a &ldquo;Material Subsidiary&rdquo; and collectively, the &ldquo;Material Subsidiaries&rdquo;).
Each Material Subsidiary of the Company has been duly incorporated and is validly existing as a corporation in good standing under
the laws of the jurisdiction of its incorporation, has corporate power and authority to own, lease and operate its properties and
conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and is duly
qualified as a foreign corporation to transact business and is in good standing in each jurisdiction in which such qualification
is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to
be in good standing or to so qualify would not have a Material Adverse Effect, and, except as otherwise disclosed in the Registration
Statement, the Pricing Disclosure Package or the Prospectus, all of the issued and outstanding capital stock of each such Material
Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable and is owned by the Company (except for
directors&rsquo; qualifying shares and shares held by individuals for the purpose of satisfying the legal requirements of the jurisdiction
of incorporation), directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance,
claim or equity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certificate
of Designations</I>. The Certificate of Designations has been duly authorized by the Company and will have been duly executed and
delivered by the Company and duly filed with the Secretary of State of the State of Delaware before the Applicable Time. The holders
of the Mandatory Convertible Preferred Stock will have the rights set forth in the Certificate of Designations upon filing of the
Certificate of Designations with the Secretary of State of the State of Delaware.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Capitalization.</I>
The Company has an authorized capitalization as set forth in the Registration Statement, the Pricing Disclosure Package and the
Prospectus under the heading &ldquo;Capitalization&rdquo;; all the outstanding shares of capital stock of the Company have been
duly and validly authorized and issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar
rights; except as described in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the
Prospectus, there are no outstanding rights (including, without limitation, pre-emptive rights), warrants or options to acquire,
or instruments convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any
of its subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance
of any capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights,
warrants or options; and the capital stock of the Company conforms in all material respects to the description thereof contained
in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Due
Authorization.</I> The Company has full right, power and authority to execute and deliver this Agreement and to perform its obligations
hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;
&nbsp;<I>Underwriting Agreement. </I> This Agreement has been duly authorized, executed and delivered by
the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The
Shares. </I>The Shares to be issued and sold by the Company hereunder have been duly authorized by the Company and, when issued
and delivered and paid for as provided herein, will be duly and validly issued, will be fully paid and nonassessable and will have
the rights, preferences and priorities set forth in the Company&rsquo;s Third Restated Certificate of Incorporation (including
the Certificate of Designations); and the issuance of the Shares will not be subject to any preemptive or similar rights.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The
Conversion Shares</I>. Upon issuance of the Shares in accordance with this Agreement and the Certificate of Designations, the Shares
will be convertible into the Conversion Shares in accordance with the terms of the Mandatory Convertible Preferred Stock set forth
in the Certificate of Designations; a number of Conversion Shares (the &ldquo;Maximum Number of Conversion Shares&rdquo;) equal
to the sum of (x) the product of (A)&nbsp;the initial maximum conversion rate for the Mandatory Convertible Preferred Stock set
forth in the Certificate of Designations and (B) the aggregate number of Shares and (y) the product of (A) the maximum number of
shares of Common Stock that would be added to the conversion rate as set forth in the Certificate of Designations assuming (i)&nbsp;the
Company paid no dividends on the Shares prior to the mandatory conversion date set forth in the Certificate of Designations and
(ii) the Floor Price set forth in the Certificate of Designations is greater than 97% of the relevant Average Price set forth in
the Certificate of Designations and (B) the aggregate number of Shares that has been and will be duly authorized and reserved for
issuance by all necessary corporate action of the Company; all Conversion Shares, when issued upon such conversion or delivery
(as the case may be) in accordance with the terms of the Mandatory Convertible Preferred Stock set forth in the Certificate of
Designations, will be validly issued, fully paid and non-assessable, will conform in all material respects to the descriptions
thereof in the Pricing Disclosure Package and the Prospectus and will not be subject to any preemptive or similar rights other
than as described in the Pricing Disclosure Package and the Prospectus.</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Accuracy
of Disclosure</I>. The statements set forth in the Pricing Disclosure Package and the Prospectus, as amended or supplemented, under
the captions &ldquo;Description of Mandatory Convertible Preferred Stock&rdquo; and &ldquo;Description of Capital Stock,&rdquo;
insofar as they purport to constitute a summary of the terms of the Mandatory Convertible Preferred Stock, the Common Stock (including
the Conversion Shares), the Company&rsquo;s authorized but unissued preferred stock, par value $0.01 per share, or the Company&rsquo;s
Third Restated Certificate of Incorporation (including the Certificate of Designations) or Amended and Restated By-laws, insofar
as they purport to describe the provisions of the documents referred to therein, are accurate, complete and fair in all material
respects.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Descriptions
of the Underwriting Agreement.</I> This Agreement conforms in all material respects to the description thereof contained in the
Registration Statement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Violation or Default; No Conflict; No Consent.</I> Neither the Company nor any of its subsidiaries is in violation of its or any
of their charters or bylaws, or in default in the performance or observance of any obligation, agreement, covenant or condition
contained in any contract, indenture, mortgage, loan agreement, note, lease or other instrument to which it or any of them is a
party or by which it or any of them or their properties may be bound where any such violation or default would have a Material
Adverse Effect; and the execution of this Agreement, the issuance and sale of the Shares, the issuance of a number of Conversion
Shares equal to the Maximum Number of Conversion Shares issuable by the Company in accordance with the terms of the Mandatory Convertible
Preferred Stock set forth in the Certificate of Designations and the consummation of the transactions contemplated by this Agreement
or the Pricing Disclosure Package and the Prospectus have been duly authorized by all necessary corporate action and will not conflict
with or constitute a breach of, or default under, or result in the creation or imposition of any lien, charge or encumbrance upon
any property or assets of the Company or any of its subsidiaries pursuant to, any contract, indenture, mortgage, loan agreement,
note, lease or other instrument to which the Company or any of its subsidiaries is a party or by which it or any of them may be
bound or to which any of the property or assets of the Company or any of its subsidiaries is subject where any such conflict, breach,
default, creation or imposition would have a Material Adverse Effect, nor will such action result in any violation of the provisions
of the charter or bylaws of the Company or, to the best of its knowledge, any law, administrative regulation or administrative
or court decree (except for such violations of any law, administrative regulation or administrative or court decree that would
not have a Material Adverse Effect and would not have a material adverse effect on the Company&rsquo;s ability to consummate the
transactions contemplated by this Agreement), and no consent, approval, authorization or order of any court or governmental authority
or agency is required for the consummation by the Company of the transactions contemplated by this Agreement or the Certificate
of Designations, (including the issuance and sale of the Shares and the issuance of a number of Conversion Shares equal to the
Maximum Number of Conversion Shares issuable by the Company in accordance with the terms of the Certificate of Designations) except
such as may be required under the Securities Act or state securities or &ldquo;blue sky&rdquo; laws.</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Permits</I>.
The Company and its Material Subsidiaries possess adequate certificates, authorities or permits issued by the appropriate state,
federal or foreign regulatory agencies or bodies necessary to conduct the business now operated by them, except such certificates,
authorities or permits which are not material to such conduct of their business, and neither the Company nor any of its Material
Subsidiaries has, to the knowledge of the Company, received any notice of proceedings relating to the revocation or modification
of any such certificate, authority or permit which, singly or in the aggregate, if the subject of any unfavorable decision, ruling
or finding, would have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<I>Legal Proceedings.</I>
&#9;Except as set forth in the Registration Statement or the Pricing Disclosure Package and the Prospectus, there is no action,
suit or proceeding before or by any court or governmental agency or body, domestic or foreign, now pending or, to the knowledge
of the Company, threatened against or affecting the Company or any of its subsidiaries that might reasonably be expected to result
in a Material Adverse Effect, or that might reasonably be expected to materially and adversely affect the offering of the Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Contracts</I>.
There are no contracts or documents of the Company or any of its subsidiaries which are required to be filed as exhibits to the
Registration Statement (including the documents incorporated by reference therein) by the Securities Act which have not been so
filed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="letter-spacing: -0.15pt"><I>Intellectual
Property.</I> Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and except
as where such failure would not have a Material Adverse Effect, the Company and its subsidiaries own, possess, license or have
the right to use the patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names and
other rights or interests in items of intellectual property as are necessary for the operation and conduct of the businesses now
operated by them (the &ldquo;patent and proprietary rights&rdquo;); and except as disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, the Company has no knowledge of any infringement of or conflict with asserted rights
of others with respect to any patent and proprietary rights which, singly or in the aggregate, if the subject of an unfavorable
decision, ruling or finding, would have a Material Adverse Effect, and, except as disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, the Company has no knowledge that any person or entity is infringing or otherwise
violating any of the Company&rsquo;s patents, trademarks, servicemarks or copyrights in a manner that could materially affect the
use thereof by the Company or any of its subsidiaries and which infringement would have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<I>Investment Company Act</I>.
&#9;The Company is not, and, after giving effect to the offering and sale of the Shares, the offering and sale of the Common Stock
in the Common Stock Offering and the application of the proceeds thereof as described in the Pricing Disclosure Package and the
Prospectus, will not be an &ldquo;investment company&rdquo; or an entity &ldquo;controlled&rdquo; by an &ldquo;investment company&rdquo;
as such terms are defined in the Investment Company Act of 1940, as amended.</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Labor Disputes.</I> No labor disturbance by the employees of the Company or any subsidiary exists or, to the knowledge of the Company,
is imminent which might reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certain
Environmental Matters</I>. Except as described in the Registration Statement or the Pricing Disclosure Package and the Prospectus
and except as could not reasonably be expected to have a Material Adverse Effect, to the knowledge of the Company, the properties,
assets and operations of each of the Company and its subsidiaries are in compliance with all applicable federal, state, local and
foreign laws (including, without limitation, common law), rules and regulations, orders, decrees, judgments, permits and licenses
relating to worker health and safety, and to the protection and clean-up of the natural environment and to the protection or preservation
of natural resources, including, without limitation, those relating to the processing, manufacturing, generation, handling, disposal,
transportation or release of hazardous materials (collectively, &ldquo;Environmental Laws&rdquo;). With respect to such properties,
assets and operations, there are no events, conditions, circumstances, activities, practices, incidents, actions or plans of the
Company or any of its subsidiaries of which the Company is aware that may interfere with or prevent compliance or continued compliance
with applicable Environmental Laws or otherwise result in liability to the Company or any of its subsidiaries pursuant to applicable
Environmental Law in a manner that could reasonably be expected to have a Material Adverse Effect. Except as described in the Registration
Statement or the Pricing Disclosure Package and the Prospectus and except as could not reasonably be expected to have a Material
Adverse Effect, (A) to the Company&rsquo;s knowledge, none of the Company or any of its subsidiaries is the subject of any federal,
state, local or foreign investigation pursuant to Environmental Laws, (B) none of the Company or any of its subsidiaries has received
any written notice or claim pursuant to Environmental Laws and (C) there are no pending, or, to the knowledge of the Company, threatened
actions, suits or proceedings against the Company, any of its subsidiaries or its properties, assets or operations, in connection
with any Environmental Laws. The term &ldquo;hazardous materials&rdquo; shall mean those substances that are regulated by or pursuant
to any applicable Environmental Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Accounting
Controls.</I> The Company maintains &ldquo;internal control over financial reporting&rdquo; (as defined in Rule 13a-15(f) of the
Exchange Act) that have been designed by, or under the supervision of, the Company&rsquo;s principal executive and principal financial
officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<I>No Conflicts with Sanctions
Laws. </I>The Company has implemented and maintains in effect policies and procedures reasonably designed to promote compliance
by the Company, its subsidiaries and their respective directors, officers and employees with Anti-Corruption Laws and Sanctions
applicable to the Company, its subsidiaries and their respective directors, officers and employees, and the Company, its subsidiaries
and, to the knowledge of the Company, their respective officers and employees and directors are in compliance with Anti-Corruption
Laws and applicable</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Sanctions in all material respects. As of the Applicable Time, at the Closing Date and at the Additional Closing
Date, none of (a) the Company, any subsidiary or, to the knowledge of the Company, any of their respective directors or officers
or (b) to the knowledge of the Company, any of the Company or such subsidiary&rsquo;s respective employees is or will be a Sanctioned
Person or organized or resident in a Sanctioned Country. No use of proceeds of the offering of the Shares hereunder will be used
by the Company or any of its subsidiaries directly or to its knowledge indirectly to violate applicable Anti-Corruption Laws or
applicable Sanctions. The term &ldquo;Anti-Corruption Laws&rdquo; shall mean the United States Foreign Corrupt Practices Act of
1977, as amended, and all similar laws, rules, and regulations of any jurisdiction applicable to the Company or its subsidiaries
prohibiting bribery or corruption. &ldquo;Sanctioned Country&rdquo; shall mean a country or territory, which is itself a subject
or target of any Sanctions (as of the Applicable Time and at the Closing Time, the Crimea region of Ukraine, Cuba, Iran, North
Korea, and Syria). &ldquo;Sanctioned Person&rdquo; shall mean (a) any person listed in any Sanctions-related list of designated
persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State,
the United Nations Security Council, the European Union or the United Kingdom, (b) any person operating, organized or resident
in a Sanctioned Country or (c) any person 50 percent or more owned or controlled by any such person. &ldquo;Sanctions&rdquo; shall
mean economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government,
including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department
of State or (b) the United Nations Security Council, the European Union or the United Kingdom.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<I>No Registration Rights</I>.
&#9;No holders of securities of the Company have rights to the registration of such securities under the Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(cc)&#9;<I>&nbsp;&nbsp;&nbsp;&nbsp;Status under the Securities
Act</I>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter
that the Company or any offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) under the Securities
Act) of the Shares and at the date hereof, the Company was not and is not an &ldquo;ineligible issuer,&rdquo; and is a well-known
seasoned issuer, in each case as defined in Rule 405 under the Securities Act. The Company has paid the registration fee for this
offering pursuant to Rule 456(b)(1) under the Securities Act or will pay such fee within the time period required by such rule
(without giving effect to the proviso therein) and in any event prior to the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Any certificate signed by any officer
of the Company and delivered to the Representatives or counsel for the Underwriters in connection with an offering of Securities
shall be deemed a representation and warranty by the Company, as to the matters covered thereby, to each Underwriter.</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further
Agreements of the Company</U>. The Company covenants and agrees with each Underwriter that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Required
Filings.</I> The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and
Rule 430B under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities
Act; and the Company will file promptly all reports and any definitive proxy or information statements required to be filed by
the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the
Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Shares; and
the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered)
to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this
Agreement in such quantities as the Representatives may reasonably request. The Company will pay the registration fee for this
offering within the time period required by Rule 456(b)(1) under the Securities Act (without giving effect to the proviso therein)
and in any event prior to the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Delivery
of Copies.</I> The Company will deliver, without charge, (i) to the Representatives, two signed copies of the Registration Statement
as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents
incorporated by reference therein; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally
filed and each amendment thereto (without exhibits) and (B) during the Prospectus Delivery Period (as defined below), as many copies
of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein and each Issuer
Free Writing Prospectus) as the Representatives may reasonably request. As used herein, the term &ldquo;Prospectus Delivery Period&rdquo;
means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters
a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the
Securities Act) in connection with sales of the Shares by any Underwriter or dealer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments
or Supplements, Issuer Free Writing Prospectuses.</I> Before making, preparing, using, authorizing, approving, referring to or
filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing
Disclosure Package or the Prospectus, whether before or after the time that the Registration Statement becomes effective, the Company
will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment
or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus
or file any such proposed amendment or supplement to which the Representatives reasonably object.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice
to the Representatives.</I> The Company will advise the Representatives promptly, and confirm such advice in writing, (i) when
any amendment to the Registration Statement has been filed or becomes effective; (ii) when any supplement to the Pricing Disclosure
Package, the Prospectus, any Issuer Free Writing Prospectus or any amendment to the Prospectus has been filed or distributed; (iii)
of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus
or the receipt of any comments from the </P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Commission relating to the Registration Statement or any other request by the Commission
for any additional information; (iv) of the issuance by the Commission or any other governmental or regulatory authority of any
order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus,
any of the Pricing Disclosure Package or the Prospectus or the initiation or threatening of any proceeding for that purpose or
pursuant to Section 8A of the Securities Act; (v) of the occurrence of any event or development within the Prospectus Delivery
Period as a result of which the Prospectus, any of the Pricing Disclosure Package or any Issuer Free Writing Prospectus as then
amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package
or any such Issuer Free Writing Prospectus is delivered to a purchaser, not misleading; (vi) of the receipt by the Company of any
notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant
to Rule 401(g)(2) under the Securities Act; and (vii) of the receipt by the Company of any notice with respect to any suspension
of the qualification of the Shares for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for
such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness
of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package
or the Prospectus or suspending any such qualification of the Shares and, if any such order is issued, will obtain as soon as possible
the withdrawal thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Ongoing
Compliance.</I> (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist
as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the
Prospectus is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply
with law, the Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above,
file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments
or supplements to the Prospectus (or any document to be filed with the Commission and incorporated by reference therein) as may
be necessary so that the statements in the Prospectus as so amended or supplemented (or any document to be filed with the Commission
and incorporated by reference therein) will not, in the light of the circumstances existing when the Prospectus is delivered to
a purchaser, be misleading or so that the Prospectus will comply with law and (2) if at any time prior to the Closing Date (i)
any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended
or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser,
not misleading or (ii) it is necessary to amend or supplement the Pricing Disclosure Package to comply with law, the Company will
immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission
(to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments
or supplements to the Pricing Disclosure Package (or any document to be filed with the Commission and incorporated by reference
therein) as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will not, in
the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that
the Pricing Disclosure Package will comply with law.</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(f)&#9;<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Blue Sky Compliance.</I>
&#9;The Company will arrange for the qualification of the Shares for offering and sale under the laws of such jurisdictions as
the Representatives, after consultation with the Company, may collectively designate and will maintain such qualifications in effect
so long as required for the distribution of the Shares, provided, however, that the Company shall not be obligated to file any
general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in
which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not
otherwise so subject.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Earning
Statement. </I>The Company will make generally available to its security holders and to the Representatives as soon as practicable
earnings statements of the Company that will satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 of the
Commission promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Clear
Market.</I> For a period of 90 days after the date of the Prospectus, the Company will not (i) offer, pledge, sell, contract to
sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement
under the Securities Act relating to, any shares of Mandatory Convertible Preferred Stock, Common Stock or any securities convertible
into or exercisable or exchangeable for Common Stock, or publicly disclose the intention to undertake any of the foregoing, or
(ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership
of the Mandatory Convertible Preferred Stock or the Common Stock or any such other securities, whether any such transaction described
in clause (i) or (ii) above is to be settled by delivery of Mandatory Convertible Preferred Stock, Common Stock or such other securities,
in cash or otherwise, without the prior written consent of the Representatives, other than the Shares to be sold hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 1in">The restrictions described above
do not apply to (i) the issuance of shares of Common Stock or securities convertible into or exercisable for shares of Common Stock
pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including
net exercise) or the settlement of restricted stock units (including net settlement), in each case outstanding on the date of this
Agreement and described in the Prospectus; (ii) grants of stock options, stock awards, restricted stock, restricted stock units,
or other equity awards and the issuance of shares of Common Stock or securities convertible into or exercisable or exchangeable
for shares of Common Stock (whether upon the exercise of stock options or otherwise) to the Company&rsquo;s employees, officers,
directors, advisors, or </P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">consultants pursuant to the terms of an equity
compensation plan in effect as of the Closing Date and described in the Prospectus, provided that such recipients enter into
a lock-up agreement with the Underwriters; (iii) the issuance of the Common Stock in the Common Stock Offering; (iv) the
issuance of shares of Common Stock issuable as dividends on the Mandatory Convertible Preferred Stock; (v) the issuance of up
to 2.5% of the outstanding shares of Common Stock, or securities convertible into, exercisable for, or which are otherwise
exchangeable for, Common Stock, immediately following the Closing Date, in acquisitions or other similar strategic
transactions, provided that such recipients enter into a lock-up agreement with the Underwriters; (vi) the filing of any
registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan in effect on the date
of this Agreement and described in the Prospectus or any assumed benefit plan pursuant to an acquisition or similar strategic
transaction; or (vii)&nbsp;the issuance, if any, of Conversion Shares pursuant to the terms of the Certificate of
Designations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Use
of Proceeds.</I> The Company will apply the net proceeds from the sale of the Shares as described in each of the Registration Statement,
the Pricing Disclosure Package and the Prospectus under the heading &ldquo;Use of Proceeds&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Stabilization.</I> Neither the Company nor its subsidiaries or affiliates will take, <FONT STYLE="letter-spacing: -0.15pt">directly
or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation
of the price of the Stock.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exchange
Listing.</I> The Company will use its reasonable best efforts to list, subject to notice of issuance, the Shares and a number of
Conversion Shares equal to the Maximum Number of Conversion Shares on the New York Stock Exchange.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Reports.</I>
So long as the Shares are outstanding, the Company will furnish to the Representatives, as soon as they are available, copies of
all reports or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial
statements furnished to or filed with the Commission or any national securities exchange or automatic quotation system; <U>provided</U>
the Company will be deemed to have furnished such reports and financial statements to the Representatives to the extent they are
filed on the Commission&rsquo;s Electronic Data Gathering, Analysis, and Retrieval system.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Record
Retention</I>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing
Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Maximum
Number of Conversion Shares</I>. The Company will reserve and keep available at all times, beginning at the Applicable Time, free
of preemptive or similar rights, a number of Conversion Shares equal to the Maximum Number of Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Adjustment of the Conversion Rate</I>. During the period from and including the date hereof through and including the earlier of
(a) the purchase by the Underwriters of all of the Option Shares and (b) the expiration of the Underwriters&rsquo; option to purchase
Option Shares, the Company will not authorize or cause any act or thing that would result in an adjustment of the conversion rate
of the Mandatory Convertible Preferred Stock.</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Agreements of the Underwriters</U>. Each Underwriter hereby represents and agrees that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
has not and will not use, authorize use of, refer to or participate in the planning for use of, any &ldquo;free writing prospectus&rdquo;,
as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission
by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other
than (i) a free writing prospectus that contains no &ldquo;issuer information&rdquo; (as defined in Rule 433(h)(2) under the Securities
Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed Issuer
Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section 3(c) or Section
4(c) above (including any electronic road show), or (iii) any free writing prospectus prepared by such underwriter and approved
by the Company in advance in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final
terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; <I>provided</I>
that Underwriters may use a term sheet substantially in the form of Annex B hereto without the consent of the Company; <I>provided
further</I> that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company,
prior to, or substantially concurrently with, the first use of such term sheet.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly
notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
of Underwriters&rsquo; Obligations.</U> The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date
or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the
Company of its covenants and other obligations hereunder and to the following additional conditions:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Registration
Compliance; No Stop Order.</I> No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding
for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened
by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under
the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act)
and in accordance with Section 4(a) hereof; and all requests by the Commission for additional information shall have been complied
with to the reasonable satisfaction of the Representatives.</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Representations
and Warranties.</I> The representations and warranties of the Company contained herein shall be true and correct on the date hereof
and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its
officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date
or the Additional Closing Date, as the case may be.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Downgrade.</I> Subsequent to the earlier of (A) the Applicable Time and (B) the execution and delivery of this Agreement, (i) no
downgrading shall have occurred in the rating accorded any debt securities, convertible securities or preferred stock issued, or
guaranteed by, the Company or any of its subsidiaries by any &ldquo;nationally recognized statistical rating organization,&rdquo;
as such term is defined under Section 3(a)(62) under the Exchange Act and (ii) no such organization shall have publicly announced
that it has under surveillance or review, or has changed its outlook with respect to, its rating of any such debt securities or
preferred stock issued or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications
of a possible upgrading).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Material Adverse Change.</I> On and as of the Closing Date and the Additional Closing Date there shall not have been, since the
Applicable Time or since the date and time of which information is given in the Pricing Disclosure Package, any material adverse
change in the condition (financial or otherwise), earnings, results of operations, business or properties of the Company and its
subsidiaries considered as one enterprise, whether or not arising from transactions in the ordinary course of business, except
as set forth or contemplated in the Pricing Disclosure Package and the Prospectus (exclusive of any supplement thereto), and the
Company shall have furnished to the Representatives a certificate of the Company, signed by the Chairman of the Board, the Chief
Executive Officer, the President, the principal financial officer or the principal accounting officer of the Company, dated as
of such Closing Date or Additional Closing Date, to the effect that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(i) the representations and warranties
of the Company in this Agreement are true and correct in all material respects on and as of such Closing Date or Additional Closing
Date, as applicable, with the same effect as if made at the Closing Date or Additional Closing Date, as the case may be, and the
Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior
to the Closing Date or Additional Closing Date, as the case may be;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(ii) no stop order suspending the
effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or, to the
Company&rsquo;s knowledge, threatened; and</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(iii) since the date of the most
recent financial statements or financial data included or incorporated by reference in the Pricing Disclosure Package or the Prospectus
(exclusive of any supplement thereto), there has been no material adverse change in the condition (financial or other), earnings,
results of operations, business or properties of the Company and its subsidiaries, considered as one enterprise, whether or not
arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Pricing Disclosure
Package and the Prospectus (exclusive of any supplement thereto).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Comfort
Letters.</I> On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, Ernst &amp;
Young LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery
thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements
and information of the type customarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect
to the financial statements and certain financial information contained or incorporated by reference in each of the Registration
Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional
Closing Date, as the case may be, shall use a &ldquo;cut-off&rdquo; date no more than five business days prior to such Closing
Date or such Additional Closing Date, as the case may be.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
of Vice President, Chief Corporate Counsel and Assistant Secretary of the Company</I>. The Representatives shall have received
on and as of the Closing Date or the Additional Closing Date, as the case may be, an opinion, addressed to the Underwriters, of
Vance R. Brown, Vice President, Chief Corporate Counsel and Assistant Secretary of the Company, shall have furnished to the Representatives,
in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex&nbsp;C hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
and 10b-5 Statement of Counsel for the Company.</I> Shearman &amp; Sterling LLP, counsel for the Company, shall have furnished
to the Representatives, at the request of the Company, their written opinion and 10b-5 statement, dated the Closing Date or the
Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to
the Representatives, to the effect set forth in Annex D hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
and 10b-5 Statement of Counsel for the Underwriters.</I> The Representatives shall have received on and as of the Closing Date
or the Additional Closing Date, as the case may be, an opinion and 10b-5 statement, addressed to the Underwriters, of Simpson Thacher
&amp; Bartlett LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and
such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such
matters.</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Legal Impediment to Issuance and Sale.</I> No action shall have been taken and no statute, rule, regulation or order shall have
been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing
Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares; and no injunction or order
of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date,
as the case may be, prevent the issuance or sale of the Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Good
Standing</I>. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case
may be, satisfactory evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization
and their good standing in such other jurisdictions as the Representatives may reasonably request, in each case in writing or any
standard form of telecommunication from the appropriate governmental authorities of such jurisdictions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exchange
Listing.</I> The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be, and the Maximum
Number of Conversion Shares shall have been approved for listing on the New York Stock Exchange, subject to official notice of
issuance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Lock-up
Agreements</I>. The &ldquo;lock-up&rdquo; agreements, each substantially in the form of Exhibit A hereto, between you and certain
officers and directors of the Company relating to sales and certain other dispositions of shares of Common Stock or certain other
securities, delivered to you on or before the date hereof, shall be full force and effect on the Closing Date or the Additional
Closing Date, as the case may be (for the avoidance of doubt, such agreements can be the agreements provided pursuant to the Common
Stock Underwriting Agreement).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certificate
of Designations</I>. The Certificate of Designations shall have been filed with the Secretary of State for the State of Delaware
and become effective and the Company shall have delivered a certified copy thereof to the Representatives.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Additional
Documents.</I> On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished
to the Representatives such further certificates and documents as the Representatives may reasonably request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">All opinions, letters, certificates and
evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if
they are in form and substance reasonably satisfactory to counsel for the Underwriters.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
and Contribution</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification
of the Underwriters.</I> The Company agrees to indemnify and hold harmless each Underwriter and each person, if any, who controls
any Underwriter within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act, against any and all
losses, liabilities, claims, damages and expenses whatsoever as incurred (including but not limited to reasonable attorneys&rsquo;
fees and any and all expenses reasonably and necessarily incurred in investigating, preparing or defending against any litigation,
commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint
or several, to which they or any of them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as
such losses, liabilities, </P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">claims, damages or expenses (or actions in
respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement for the registration of the Shares, as originally filed or any amendment thereof, or
arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading; or (ii) any untrue statement or alleged untrue statement
of a material fact contained in any related Preliminary Prospectus, any Issuer Free Writing Prospectus, the Pricing
Disclosure Package or the Prospectus, or in any supplement thereto or amendment thereof, or arise out of or are based upon
the omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that
the Company will not be liable in any such case to the extent, but only to the extent, that any such loss, liability, claim,
damage or expense arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged
omission made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of
any Underwriter through the Representatives expressly for use therein; it being understood and agreed that the only such
information furnished by any Underwriter consists of the information described as such in paragraph (b) below.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification
of the Company.</I> Each Underwriter severally, and not jointly, agrees to indemnify and hold harmless the Company, each of the
directors of the Company, each of the officers of the Company who shall have signed the Registration Statement, and each other
person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange
Act, against any losses, liabilities, claims, damages and expenses whatsoever as incurred (including but not limited to reasonable
attorneys&rsquo; fees and any and all expenses reasonably and necessarily incurred in investigating, preparing or defending against
any litigation, commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation)
to which they or any of them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such losses,
liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon (i) any untrue statement
or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares, as originally
filed or any amendment thereof, or arise out of or are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading; or (ii) upon any untrue statement
or alleged untrue statement of a material fact contained in any related Preliminary Prospectus, any Issuer Free Writing Prospectus,
the Pricing Disclosure Package or the Prospectus, or in any supplement thereto or amendment thereof, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they </P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">were made, not misleading, in each case to the
extent, but only to the extent, that any such loss, liability, claim, damage or expense arises out of or is based upon any
such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in
conformity with written information furnished to the Company by or on behalf of such Underwriter expressly for use in the
Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free
Writing Prospectus, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package that has
subsequently been amended), it being understood and agreed upon that the only such information furnished by any Underwriter
consists of the following information in the Prospectus furnished on behalf of each Underwriter: the names of the
Underwriters and their respective allocations; the concession and reallowance figures appearing in the third paragraph under
the caption &ldquo;Underwriting&rdquo;, the information relating to the Underwriters&rsquo; stabilization activities
contained in the fifteenth, sixteenth and seventeenth paragraphs under the caption &ldquo;Underwriting&rdquo; and the
information relating to any relationships between the Underwriters and the Company contained in the nineteenth and twentieth
paragraph under the caption &ldquo;Underwriting&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice
and Procedures.</I> Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement
of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such
subsection, notify each party against whom indemnification is to be sought in writing of the commencement thereof (but the failure
so to notify an indemnifying party shall not relieve it from any liability which it may have under this Section 7). In case any
such action is brought against any indemnified party, and it notifies an indemnifying party of the commencement thereof, the indemnifying
party will be entitled to participate therein, and to the extent it may elect by written notice delivered to the indemnified party
promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel reasonably
satisfactory to such indemnified party. Notwithstanding the foregoing, the indemnified party or parties shall have the right to
employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such indemnified
party or parties unless (i) the employment of such counsel shall have been authorized in writing by one of the indemnifying parties
in connection with the defense of such action, (ii) the indemnifying parties shall not have employed counsel reasonably satisfactory
to the indemnified parties to have charge of the defense of such action within a reasonable time after notice of commencement of
the action, or (iii) such indemnified party or parties shall have reasonably concluded that there may be defenses available to
it or them which are different from or additional to those available to one or all of the indemnifying parties (in which case the
indemnifying parties shall not have the right to direct the defense of such action on behalf of the indemnified party or parties),
in any of which events such fees and expenses shall be borne by the indemnifying parties. Anything in this subsection to the contrary
notwithstanding, an indemnifying party shall not be liable for any settlement of any claim or action effected without its written
consent; provided, however, that such consent was not unreasonably withheld. No indemnifying party shall, without the written consent
of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any indemnified party
is or could have been a party and indemnification could have been sought hereunder by such indemnified party, unless such settlement
(x) includes an unconditional release of such indemnified party, in form and substance reasonably satisfactory to such indemnified
party, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to
or any admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Expenses
of Counsel.</I> If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party
for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated
by Section 7(c) hereof effected without its written consent if (i) such settlement is entered into more than 45 days after receipt
by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such
settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed
such indemnified party in accordance with such request prior to the date of such settlement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Contribution</I>.
In order to provide for contribution in circumstances in which the indemnification provided for in this Section 7(e) is for any
reason held to be unavailable from any indemnifying party or is insufficient to hold harmless a party indemnified thereunder, then
the indemnifying parties shall contribute to the aggregate losses, claims, damages, liabilities and expenses of the nature contemplated
by such indemnification provision (including any investigation, legal and other expenses incurred in connection with, and any amount
paid in settlement of, any action, suit or proceeding or any claims asserted, but after deducting in the case of losses, claims,
damages, liabilities and expenses suffered by the Company any contribution received by the Company from persons, other than the
Underwriters, who may also be liable for contributions, including persons who control the Company within the meaning of Section
15 of the Securities Act or Section 20(a) of the Exchange Act, officers of the Company who signed the Registration Statement and
directors of the Company) as incurred to which the Company and one or more of the Underwriters may be subject, in such proportions
as is appropriate to reflect the relative benefits received by the Company and the Underwriters from the offering of the Shares
or, if such allocation is not permitted by applicable law or indemnification is not available as a result of the indemnifying party
not having received notice as provided in this Section 7, in such proportion as is appropriate to reflect not only the relative
benefits referred to above but also the relative fault of the Company and the Underwriters in connection with the statements or
omissions which resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations.
The relative benefits received by the Company and the Underwriters shall be deemed to be in the same proportion as (x) the total
proceeds from the offering (net of underwriting discounts and commissions but before deducting expenses) received by the Company
and (y) the underwriting discounts and commissions received by the Underwriters, respectively, in each case as set forth in the
table on the cover page of the Prospectus. The relative fault of the Company and of the Underwriters shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to
state a material fact relates to information supplied by the Company or the Underwriters and the parties&rsquo; relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters
agree that it would not be just and equitable if contribution pursuant to this Section 7(e) were determined by pro rata allocation
(even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take
account of the equitable considerations referred to above.</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Notwithstanding the provisions of this Section
7(e), in no case shall any Underwriter be liable or responsible for any amount in excess of the underwriting discount applicable
to the securities purchased by such Underwriter hereunder. Notwithstanding the provisions of this Section 7(e) and the preceding
sentence, no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section
7(e), each person, if any, who controls an Underwriter within the meaning of Section 15 of the Securities Act or Section 20(a)
of the Exchange Act shall have the same rights to contribution as such Underwriter, and each person, if any, who controls the
Company within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act, each officer of the Company
who shall have signed the Registration Statement and each director of the Company shall have the same rights to contribution as
the Company, subject in each case to this Section 7(e). Any party entitled to contribution will, promptly after receipt of notice
of commencement of any action, suit or proceeding against such party in respect of which a claim for contribution may be made
against another party or parties, notify each party or parties from whom contribution may be sought, but the omission to so notify
such party or parties shall not relieve the party or parties from whom contribution may be sought from any obligation it or they
may have under this Section 7 or otherwise. The obligation of the Underwriters to contribute pursuant to this Section 7 shall
be several in proportion to their respective underwriting obligations and not joint.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effectiveness
of Agreement</U>. This Agreement shall become effective as of the date first written above.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.
This Agreement may be terminated in the absolute discretion of the Representatives, by notice to the Company, if after the execution
and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional
Closing Date (i) trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange
or The Nasdaq Stock Market; (ii) trading of any securities issued or guaranteed by the Company shall have been suspended on any
exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared
by federal or New York State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change
in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives,
is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares
on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement,
the Pricing Disclosure Package and the Prospectus.</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Defaulting
Underwriter</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
on the Closing Date or the Additional Closing Date, as the case may be, any <FONT STYLE="letter-spacing: -0.15pt">Underwriter </FONT>defaults
on its obligation to purchase the Shares that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters
may in their discretion arrange for the purchase of such Shares by other persons satisfactory to the Company on the terms contained
in this Agreement. If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange
for the purchase of such Shares, then the Company shall be entitled to a further period of 36 hours within which to procure other
persons satisfactory to the non-defaulting Underwriters to purchase such Shares on such terms. If other persons become obligated
or agree to purchase the Shares of a defaulting Underwriter, either the non-defaulting Underwriters or the Company may postpone
the Closing Date or the Additional Closing Date, as the case may be, for up to five full business days in order to effect any changes
that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and
the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement
to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &ldquo;Underwriter&rdquo;
includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto
that, pursuant to this Section 10, purchases Shares that a defaulting Underwriter agreed but failed to purchase.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the
Closing Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh of the aggregate number of Shares
to be purchased on such date, then the Company shall have the right to require each non-defaulting Underwriter to purchase the
number of Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&rsquo;s pro rata share (based
on the number of Shares that such Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or
Underwriters for which such arrangements have not been made.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the
Closing Date or the Additional Closing Date, as the case may be, exceeds one-eleventh of the aggregate amount of Shares to be purchased
on such date, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement or, with respect
to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case
may be, shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant
to this Section 10 shall be without liability on the part of the Company, except that the Company will continue to be liable for
the payment of expenses as set forth in Section&nbsp;11 hereof and except that the provisions of Section 7 hereof shall not terminate
and shall remain in effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter
for damages caused by its default.</P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Expenses</U><I>.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will pay all reasonable and necessary expenses incident to the performance of its obligations under this Agreement, including
(i) the preparing, printing or other production and filing of the Registration Statement (as originally filed) and all amendments
thereto, (ii) the preparation, issuance and delivery of the Shares to the Underwriters, (iii) the reasonable fees and disbursements
of the Company&rsquo;s counsel and accountants, (iv) the qualification of the Shares and the Conversion Shares under securities
laws in accordance with the provisions of Section 4(f) hereof, including filing fees and the reasonable fees and disbursements
of counsel for the Underwriters in connection therewith and in connection with the preparation of any Blue Sky Memorandum, (v)
the printing or other production and delivery to the Underwriters in quantities as hereinabove stated of copies of the Preliminary
Prospectus, any Issuer Free Writing Prospectus and the Prospectus and any amendments or supplements thereto, (vi) the production
and delivery to the Underwriters of copies of any Blue Sky Memorandum reasonably requested by the Representatives, (vii) the fees
and expenses, if any, incurred in connection with the listing of the Shares and the Conversion Shares on the New York Stock Exchange,
(viii) the cost of preparing stock certificates, (ix) the costs and charges of any transfer agent and any registrar and (x) (A)
the fees and expenses, if any, incurred in connection with any filing with, and clearance of the offering by, the Financial Industry
Regulatory Authority, Inc. and (B) the reasonable fees and expenses of counsel for the Underwriters in connection therewith.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
(i) this Agreement is terminated pursuant to Section 9, (ii) the Company for any reason fails to tender the Shares for delivery
to the Underwriters or (iii) the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the
Company agrees to reimburse the Underwriters for all out-of-pocket costs and expenses (including the fees and expenses of their
counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Persons
Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each
Underwriter referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person
any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser
of Shares from any Underwriter shall be deemed to be a successor merely by reason of such purchase.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival</U>.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriters
contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate
delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless
of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors,
officers, controlling persons or affiliates referred to in Section 7 hereof.</P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Defined Terms</U>. For purposes of this Agreement, (a) except where otherwise expressly provided, the term &ldquo;affiliate&rdquo;
has the meaning set forth in Rule 405 under the Securities Act; (b) the term &ldquo;business day&rdquo; means any day other than
a day on which banks are permitted or required to be closed in New York City; (c) the term &ldquo;subsidiary&rdquo; has the meaning
set forth in Rule 405 under the Securities Act; and (d) the term &ldquo;significant subsidiary&rdquo; has the meaning set forth
in Rule 1-02 of Regulation S-X under the Exchange Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into
law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective
clients, including the Company, which information may include the name and address of their respective clients, as well as other
information that will allow the Underwriters to properly identify their respective clients.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notices.</I>
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c/o
J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (Facsimile: (212) 622-8358), Attention Equity Syndicate
Desk; and BofA Securities, Inc., One Bryant Park, New York, New York 10036 Facsimile: (646) 855 3073, Attention: Syndicate Department
with a copy to: Facsimile: (212) 230-8730 Attention: ECM Legal. Notices to the Company shall be given to it at Boston Scientific
Corporation, 300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234 (fax: 508-683-4350); Attention of the General Counsel
and Corporate Secretary with a copy to the Assistant General Counsel.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Governing
Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and
construed in accordance with the laws of the State of New York.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Submission
to Jurisdiction</I>. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in
the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of
any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought
in such court shall be conclusive and binding upon the Company and may be enforced in any court to the jurisdiction of which Company
is subject by a suit upon such judgment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Waiver
of Jury Trial.</I> Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of
or relating to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Recognition
of the U.S. Special Resolution Regimes</I>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i) In the event that any Underwriter
that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter
of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer
would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed
by the laws of the United States or a state of the United States.</P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii) In the event that any Underwriter
that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution
Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no
greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed
by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">As used in this Section 16(e):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;BHC
Act Affiliate&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with,
12 U.S.C. &sect; 1841(k).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;Covered
Entity&rdquo; means any of the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 119pt; text-indent: 0pt; text-align: justify">(i)
a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 119pt; text-indent: 0pt; text-align: justify">(ii)
a &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 119pt; text-indent: 0pt; text-align: justify">(iii)
a &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;Default
Right&rdquo; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81,
47.2 or 382.1, as applicable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;U.S.
Special Resolution Regime&rdquo; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Bail-in
Clause.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i) Notwithstanding and to the
exclusion of any other term of this Agreement or any other agreements, arrangements, or understanding between the Company and any
BRRD Party, the Company acknowledges and accepts that a BRRD Liability arising under this Agreement may be subject to the exercise
of Bail-in Powers by the Relevant Resolution Authority, and acknowledges, accepts, and agrees to be bound by:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(A) the effect of the exercise of
Bail-in Powers by the Relevant Resolution Authority in relation to any BRRD Liability of any BRRD Party to the Company under this
Agreement, that (without limitation) may include and result in any of the following, or some combination thereof:</P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(1) the reduction of all, or a
portion, of the BRRD Liability or outstanding amounts due thereon;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(2) the conversion of all, or a
portion, of the BRRD Liability into shares, other securities or other obligations of the relevant BRRD Party or another person,
and the issue to or conferral on the Company of such shares, securities or obligations;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(3) the cancellation of the BRRD
Liability;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(4) the amendment or alteration
of any interest, if applicable, thereon, the maturity or the dates on which any payments are due, including by suspending payment
for a temporary period; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(B) the variation of the terms of
this Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of Bail-in Powers by the
Relevant Resolution Authority.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii) For the purposes of this Section
16(f), the following definitions shall apply:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;Bail-in Legislation&rdquo;
means in relation to the United Kingdom or a member state of the European Economic Area which has implemented, or which at any
time implements, the BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU Bail-in Legislation
Schedule from time to time;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;Bail-in Powers&rdquo; means
any Write-down and Conversion Powers as defined in the EU Bail-in Legislation Schedule, in relation to the relevant Bail-in Legislation;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;BRRD&rdquo; means Directive
2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms, as amended;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;BRRD Liability&rdquo; means
a liability in respect of which the relevant Write Down and Conversion Powers in the applicable Bail-in Legislation may be exercised;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;BRRD Party&rdquo; means any
Underwriter which qualifies as an institution or entity referred to in paragraphs (a), (b), (c) or (d) of Article 1 of the BRRD,
as implemented in the applicable Bail-in Legislation;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;EU Bail-in Legislation Schedule&rdquo;
means the document described as such, then in effect, and published by the Loan Market Association (or any successor person) from
time to time at http://www.lma.eu.com/pages.aspx?p=499 (or any such successor webpage); and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 107pt; text-indent: 0pt; text-align: justify">&ldquo;Relevant Resolution Authority&rdquo;
means the resolution authority with the ability to exercise any Bail-in Powers in relation to the relevant BRRD Party.</P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Counterparts.</I>
This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication),
each of which shall be an original and all of which together shall constitute one and the same instrument. The words &ldquo;execution,&rdquo;
&ldquo;signed,&rdquo; &ldquo;signature,&rdquo; &ldquo;delivery,&rdquo; and words of like import in or relating to this Agreement
or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or
the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually
executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties
hereto consent to conduct the transactions contemplated hereunder by electronic means.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments
or Waivers.</I> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom,
shall in any event be effective unless the same shall be in writing and signed by the parties hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Headings.</I>
The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning
or interpretation of, this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If the foregoing is in accordance with
your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Very truly yours,</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">BOSTON SCIENTIFIC CORPORATION</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Robert J. Castagna</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Robert J. Castagna</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Vice President and Treasurer</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Accepted: As of the date first written above</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">J.P. MORGAN SECURITIES LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0">For itself and on behalf of the<BR>
several Underwriters listed<BR>
in Schedule 1 hereto.&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Derek Brown</TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-align: center">
    <TD>&nbsp;</TD>
    <TD>Authorized Signatory</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">Accepted: As of the date first written above</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">BOFA SECURITIES, INC.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">For itself and on behalf of the<BR>
several Underwriters listed<BR>
in Schedule 1 hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Milton Hsu</TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-align: center">
    <TD>&nbsp;</TD>
    <TD>Authorized Signatory</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">SCHEDULE 1</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: right">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 5.4pt">Underwriters</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Number of Shares</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; padding-left: 5.4pt">J.P. Morgan Securities LLC&#9;</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">2,406,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">BofA Securities, Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,406,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Citigroup Global Markets Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">656,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Goldman Sachs &amp; Co. LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">656,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Wells Fargo Securities, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">350,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Morgan Stanley &amp; Co. LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">350,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Barclays Capital Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">350,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">RBC Capital Markets, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">350,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">BNP Paribas Securities Corp.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">175,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">DNB Markets, Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">175,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">MUFG Securities Americas Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">175,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">SG Americas Securities, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">175,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Standard Chartered Bank&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">175,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">TD Securities (USA) LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">175,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">U.S. Bancorp Investments, Inc.&#9;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">175,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right; padding-bottom: 2.5pt; padding-left: 5.4pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,750,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">SCHEDULE 2</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Material Subsidiaries</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>Boston Scientific Scimed, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Target Therapeutics, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Boston Scientific Group plc</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>Boston Scientific Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD>Guidant Delaware Holding Corporation</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD>Cardiac Pacemakers, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD>Boston Scientific de Costa Rica S.R.L.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD>Bravo Bidco Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD>Boston Scientific Medical Device Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD>BTG Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 12pt">11.</FONT></TD><TD>BTG International (Holdings) Limited</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">ANNEX A</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Pricing Disclosure
Package</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-indent: -0.5in">Final term sheet containing the
terms of the Shares and the Mandatory Convertible Preferred Stock, substantially in the form of Annex B</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Pricing Information
Provided Orally by Underwriters</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">None.</TD><TD></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">ANNEX B</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Issuer Free Writing Prospectus</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Filed Pursuant to Rule 433</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Supplementing the<BR>
Preliminary Prospectuses<BR>
dated May 20, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Registration No. 333-238526</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Boston Scientific Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(the &ldquo;Issuer&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Pricing Term Sheet</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">May 21, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Concurrent Offerings of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">25,550,000 Shares of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(the &ldquo;Common Stock Offering&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">8,750,000 Shares of 5.50% Mandatory Convertible
Preferred Stock, Series A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(the &ldquo;Mandatory Convertible Preferred
Stock Offering&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This pricing term sheet relates only to the securities described
below and should be read together with (i)&nbsp;in the case of investors purchasing in the Common Stock Offering, the Issuer&rsquo;s
preliminary prospectus supplement dated May 20, 2020 relating to the Common Stock Offering (the &ldquo;Common Stock Preliminary
Prospectus Supplement&rdquo;), and (ii)&nbsp;in the case of investors purchasing in the Mandatory Convertible Preferred Stock Offering,
the Issuer&rsquo;s preliminary prospectus supplement dated May 20, 2020 relating to the Mandatory Convertible Preferred Stock Offering
(the &ldquo;Mandatory Convertible Preferred Stock Preliminary Prospectus Supplement&rdquo; and, together with the Common Stock
Preliminary Prospectus Supplement, the &ldquo;Preliminary Prospectus Supplements&rdquo;), each as filed with the Securities and
Exchange Commission (the &ldquo;SEC&rdquo;) pursuant to Rule 424(b) under the Securities Act of 1933, as amended, and (ii) the
accompanying prospectus dated May 20, 2020, included in the Registration Statement (File No. 333-238526), in each case, including
the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Boston Scientific Corporation has increased the size of the
Common Stock Offering to $875,087,500 (or $1,006,350,625 if the underwriters&rsquo; option to purchase additional shares of common
stock is exercised) and the Mandatory Convertible Preferred Stock Offering to $875,000,000 (or $1,006,250,000 if the underwriters&rsquo;
over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock is exercised). The final prospectus
supplement, dated May 21, 2020, relating to the Common Stock Offering and the final prospectus supplement, dated May 21, 2020,
relating to the Mandatory Convertible Preferred Stock Offering will reflect conforming changes relating to increases in the size
of the offerings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 12pt; margin: 12pt 0 0">Neither the Common Stock Offering nor the Mandatory Convertible
Preferred Stock Offering is contingent on the completion of the other offering. Certain capitalized terms used in this pricing
term sheet that are not defined herein but that are defined in the Common Stock Preliminary Prospectus Supplement or the Mandatory
Convertible Preferred Stock Preliminary Prospectus Supplement, as applicable, have the respective meanings given to such terms
in such Preliminary Prospectus Supplement.&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 35%; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Issuer:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 64%; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Boston Scientific Corporation, a Delaware corporation</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Pricing Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">May 21, 2020</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Trade Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">May 22, 2020</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Settlement Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">May 27, 2020 (T+2) </FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR></TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 35%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 64%"><FONT STYLE="font-size: 10pt"><B><U>Common Stock Offering</U></B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Title of Securities:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Common stock, par value $0.01 per share, of the Issuer (&ldquo;Common Stock&rdquo;)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Number of Shares of Common Stock Offered: </FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">25,550,000 shares (or 29,382,500 shares if the underwriters of the Common Stock Offering exercise in full their option to purchase additional shares of Common Stock)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Common Stock Outstanding after Common Stock Offering:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><BR>
<BR>
1,672,427,242 shares (or 1,676,259,742 shares if the underwriters of the Common Stock Offering exercise in full their option to purchase additional shares of common stock), based on shares outstanding as of March 31, 2020</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Symbol/Exchange:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">BSX/The New York Stock Exchange (&ldquo;NYSE&rdquo;)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Last Reported Sale Price of Common Stock on the NYSE on the Pricing Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">$34.79 per share of Common Stock</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Public Offering Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">$34.25 per share of Common Stock</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Underwriting Discount:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">$1.0275 per share of Common Stock</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">$26,252,625 in aggregate (or $30,190,518.75 in aggregate if the
        underwriters of the Common Stock Offering exercise in full their option to purchase additional shares of Common Stock)</P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Net Proceeds:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The net proceeds from the Common Stock Offering, after deducting underwriting discounts and commissions and estimated offering expenses, will be approximately $847.3 million (or approximately $974.7 million if the underwriters of the Common Stock Offering exercise in full their option to purchase additional shares of Common Stock)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">CUSIP / ISIN:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">101137 107 / US1011371077</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Joint Bookrunners:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">J.P. Morgan Securities LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BofA Securities, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Citigroup Global Markets Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Goldman Sachs &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Wells Fargo Securities, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Morgan Stanley &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Barclays Capital Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">RBC Capital Markets, LLC</P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Co-Managers:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Cowen and Company, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Evercore Group L.L.C.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Stifel, Nicolaus &amp; Company, Incorporated</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">SVB Leerink LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Scotia Capital (USA) Inc.</P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><B><U>Mandatory Convertible Preferred Stock Offering</U></B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Title of Securities:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share, of the Issuer (the &ldquo;Mandatory Convertible Preferred Stock&rdquo;)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Number of Shares of Mandatory Convertible Preferred Stock Offered:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><BR>
<BR>
8,750,000 shares (or 10,062,500 shares if the underwriters of the Mandatory Convertible Preferred Stock Offering exercise in full their over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock)</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR></TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 35%"><FONT STYLE="font-size: 10pt">Public Offering Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 64%"><FONT STYLE="font-size: 10pt">$100.00 per share of Mandatory Convertible Preferred Stock</FONT></TD>
    </TR>
<TR>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Underwriting Discount:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">$3.00 per share of Mandatory Convertible Preferred Stock</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">$26,250,000 in aggregate (or $30,187,500 in aggregate if the underwriters
        of the Mandatory Convertible Preferred Stock Offering exercise in full their option to purchase additional shares of Mandatory
        Convertible Preferred Stock)</P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Net Proceeds:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The net proceeds from the Mandatory Convertible Preferred Stock Offering, after deducting underwriting discounts and commissions and estimated offering expenses, will be approximately $847.3 million (or approximately $974.6 million if the underwriters of the Mandatory Convertible Preferred Stock Offering exercise in full their over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock).</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Use of Proceeds:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The Issuer intends to use a portion of the combined net proceeds from the Mandatory Convertible Preferred Stock Offering and the Common Stock Offerings of $1,694.6 million (or $1,949.3 million if the underwriters for both offerings exercise their options in full) to repay in full the remaining $750.0 million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it will be terminated. The remaining proceeds will be used for general corporate purposes, which may include refinancing or repayment of other outstanding indebtedness and funding potential future acquisitions and investments.</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Liquidation Preference:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">$100.00 per share of the Mandatory Convertible Preferred Stock.</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Dividends:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">5.50<FONT STYLE="font-family: Times-Roman,serif">% of the liquidation
        preference of $100.00 per share of Mandatory Convertible Preferred Stock per annum. Dividends will accumulate from the most recent
        date as to which dividends shall have been paid or, if no dividends have been paid, from the first original issue date of the Mandatory
        Convertible Preferred Stock, and, to the extent the Issuer&rsquo;s board of directors, or an authorized committee thereof, declares</FONT>
        <FONT STYLE="background-color: white">(out of funds legally available for payment in the case of dividends paid in cash or if legally
        permitted to be issued in the case of dividends paid in shares of Common Stock)&nbsp;</FONT>a dividend payable with respect to
        the Mandatory Convertible Preferred Stock, the Issuer will pay such dividends in cash, by delivery of shares of Common Stock or
        through any combination of cash and shares of Common Stock, as determined by the Issuer in its sole discretion; provided that any
        unpaid dividends will continue to accumulate on the Mandatory Convertible Preferred Stock, subject to certain exceptions. The Issuer
        will pay the relevant dividend in shares of common stock until it amends or terminates its Term Loans and Revolving Credit Facility
        that contain a restriction on its ability to pay cash dividends on its capital stock, or such restrictions are no longer effective
        under the terms of such credit agreements. The Issuer intends to use a portion of the net proceeds from the Mandatory Convertible
        Preferred Stock Offering and the Common Stock Offering to repay in full remaining borrowings under, and terminate, the April 2021
        Term Loan. Following consummation of the Mandatory Convertible Preferred Stock Offering, the Issuer intends to seek amendments
        to its Revolving Credit Facility and the February 2021 Term Loan to permit it to pay cash dividends and other distributions on
        the Mandatory Convertible Preferred Stock. There can be no assurance that the Issuer will be successful in securing any such amendment.</P>
        <P STYLE="font: 10pt Times-Roman,serif; margin: 0"></P>
        <P STYLE="font: 10pt Times-Roman,serif; margin: 0"></P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR></TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">The expected dividend payable on the first Dividend Payment Date of September
        1, 2020 is approximately $1.4361 per share of the Mandatory Convertible Preferred Stock. Each subsequent dividend is expected to
        be $1.375 per share of the Mandatory Convertible Preferred Stock.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 35%"><FONT STYLE="font-size: 10pt">Dividend Payment Dates:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 64%"><FONT STYLE="font-size: 10pt">March 1, June 1, September 1 and December 1 of each year, commencing on September 1, 2020, and to, and including, June 1, 2023</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Dividend Regular Record Dates: </FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">February 15, May 15, August 15 and November 15 immediately preceding the relevant Dividend Payment Date</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Initial Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Times-Roman,serif">$100.00, <I>divided by</I> the Maximum Conversion Rate (as defined below), which is initially </FONT><FONT STYLE="font-size: 10pt">$34.25 and equal to the Common Stock Public Offering Price per share in the concurrent Common Stock Offering described above</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Threshold Appreciation Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">$100.00, <I>divided by</I> the Minimum Conversion Rate (as defined below), which is initially $41.96, which represents an approximate 22.50% appreciation of the Initial Price</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Mandatory Conversion Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The second business day immediately following the last Trading Day of the Settlement Period. The Mandatory Conversion Date is expected to be June 1, 2023.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 1pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Conversion Rate:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0">Upon conversion on the Mandatory Conversion Date, the conversion
        rate for each share of Mandatory Convertible Preferred Stock will not be more than 2.9197 shares of the Issuer&rsquo;s Common Stock
        (the &ldquo;Maximum Conversion Rate&rdquo;) and not less than 2.3834 shares of its Common Stock (the &ldquo;Minimum Conversion
        Rate&rdquo;), depending on the Applicable Market Value of its Common Stock, as described below, and subject to certain anti-dilution
        adjustments.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The &ldquo;Applicable Market Value&rdquo; of the Issuer&rsquo;s
        Common Stock is the Average VWAP per share of its Common Stock over the 20 consecutive Trading Day period commencing on, and including,
        the 21st Scheduled Trading Day immediately preceding June 1, 2023 (the &ldquo;Settlement Period&rdquo;). The conversion rate will
        be calculated as described in the Mandatory Convertible Preferred Stock Preliminary Prospectus Supplement and the following table
        illustrates hypothetical conversion rates per share of the Mandatory Convertible Preferred Stock (assuming no anti-dilution adjustments
        and assuming that dividends are declared and paid in cash and subject to the provisions described in the Mandatory Convertible
        Preferred Stock Preliminary Prospectus Supplement with respect to any fractional share of Common Stock).</P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 1pt; padding-left: 3pt">&nbsp;</TD></TR></TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; width: 35%">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; width: 31%"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0">Assumed <BR>
Applicable Market Value <BR>
of Common Stock</P></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; width: 1%"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; width: 32%"><B>Conversion Rate (number of shares of Common Stock to be received
    upon mandatory conversion of each share of the Mandatory Convertible Preferred Stock)</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Times-Roman,serif">Greater than the Threshold Appreciation Price</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">2.3834 <FONT STYLE="font-family: Times-Roman,serif">shares of Common Stock, which is the Minimum Conversion Rate </FONT></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Times-Roman,serif">Equal to or less than the Threshold Appreciation Price but greater
than or equal to the Initial Price</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Times-Roman,serif">Between </FONT><FONT STYLE="font-size: 10pt">2.3834 <FONT STYLE="font-family: Times-Roman,serif">and </FONT>2.9197 <FONT STYLE="font-family: Times-Roman,serif">shares of Common Stock, determined by dividing $100.00 by the Applicable Market Value </FONT></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Times-Roman,serif">Less than the Initial Price</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">2.9197 <FONT STYLE="font-family: Times-Roman,serif">shares of Common Stock, which is the Maximum Conversion Rate </FONT></FONT></TD></TR>
<TR>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Early Conversion at the Option of the Holder:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Other than during a Fundamental Change Conversion Period, at any time prior to June 1, 2023, holders of the Mandatory Convertible Preferred Stock have the option to elect to convert their shares of the Mandatory Convertible Preferred Stock, in whole or in part, at the Minimum Conversion Rate.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Conversion at the Option of the Holder Upon Fundamental Change; Fundamental Change Dividend Make-Whole Amount:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <BR>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><BR>
If a Fundamental Change occurs on or prior to June 1, 2023, holders
        of the Mandatory Convertible Preferred Stock will have the right during the Fundamental Change Conversion Period to convert their
        shares of the Mandatory Convertible Preferred Stock, in whole or in part, into shares of Common Stock (or Units of Exchange Property
        as described in the Mandatory Convertible Preferred Stock Preliminary Prospectus) at the Fundamental Change Conversion Rate described
        below.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Holders who convert their Mandatory Convertible Preferred Stock
        within the Fundamental Change Conversion Period will also receive (1) a &ldquo;Fundamental Change Dividend Make-Whole Amount&rdquo;
        equal to the present value (calculated using a discount rate of 5.00% per annum) of all dividend payments (excluding any Accumulated
        Dividend Amount) on their shares of the Mandatory Convertible Preferred Stock for (i) the partial dividend period, if any, from,
        and including, the Fundamental Change Effective Date to, but excluding, the next Dividend Payment Date and (ii) all remaining full
        dividend periods from, and including, the Dividend Payment Date following the Fundamental Change Effective Date to, but excluding,
        the Mandatory Conversion Date, as described in the Mandatory Convertible Preferred Stock Preliminary Prospectus, and (2) the Accumulated
        Dividend Amount, which equals the aggregate amount of accumulated and unpaid dividends, if any, that have not been declared for
        dividend periods prior to the relevant Fundamental Change Effective Date, including (but subject to certain exceptions) for the
        partial dividend period, if any, from, and including, the Dividend Payment Date immediately preceding such Fundamental Change Effective
        Date to, but excluding, such Fundamental Change Effective Date.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR></TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">The Issuer may satisfy the Fundamental Change Dividend Make-Whole
        Amount and/or the Accumulated Dividend Amount in cash, by delivery of shares of Common Stock or through any combination of cash
        and shares of Common Stock, as determined by the Issuer in its sole discretion, subject to the limitations in its Term Loans and
        Revolving Credit Facility that contain a restriction on its ability to pay cash distributions on its capital stock. The Issuer
        intends to use a portion of the net proceeds from the Mandatory Convertible Preferred Stock Offering and the Common Stock Offering
        to repay in full remaining borrowings under, and terminate, the April 2021 Term Loan. Following consummation of the Mandatory Convertible
        Preferred Stock Offering, the Issuer intends to seek amendments to its Revolving Credit Facility and the February 2021 Term Loan
        to permit it to pay cash dividends and other distributions on the Mandatory Convertible Preferred Stock. There can be no assurance
        that the Issuer will be successful in securing any such amendment.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 35%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; width: 64%">&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Fundamental Change Conversion Rate:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Times-Roman,serif">The following table sets forth the Fundamental Change Conversion Rate per share of the Mandatory Convertible Preferred Stock for each Fundamental Change Share Price and Fundamental Change Effective Date set forth below:</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    </TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 7pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 3pt">Fundamental <BR> Change <BR> Effective Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="59" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fundamental Change Share Price</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-size: 11pt; padding-bottom: 1pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">10.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">15.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">20.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">25.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">30.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">34.25</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">37.50</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">40.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">41.96</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">45.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">50.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">55.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">60.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">75.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: right">100.00</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 3pt">May 27, 2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8542</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7933</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6255</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5532</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5037</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4729</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4529</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4394</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4214</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3988</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3828</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3715</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3544</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3477</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 3pt">June 1, 2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8856</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8539</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6998</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6145</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5520</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5122</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4687</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4455</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4169</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3973</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3842</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3660</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3601</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 3pt">June 1, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9050</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9007</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8724</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8033</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7052</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6193</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5225</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4965</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4633</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3878</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3739</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3716</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 3pt">June 1, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3834</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>




<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The exact Fundamental Change Effective Date and Fundamental Change Share Price may not be set forth in the table, in which case:</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 34%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 62%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Wingdings">&#159;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">if the Fundamental Change Share Price is between two Fundamental Change Share Prices in the table or the Fundamental Change Effective Date is between two Fundamental Change Effective Dates in the table, the Fundamental Change Conversion Rate will be determined by a straight-line interpolation between the Fundamental Change Conversion Rates set forth for the higher and lower Fundamental Change Share Price amounts and the earlier and later Fundamental Change Effective Dates, as applicable, based on a 365- or 366-day year, as applicable;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Wingdings">&#159;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">if the Fundamental Change Share Price is in excess of $100.00 per share (subject to adjustment in the same manner as the Fundamental Change Share Prices set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Minimum Conversion Rate; and</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font: 10pt Wingdings">&#159;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">if the Fundamental Change Share Price is less than $10.00 per share (subject to adjustment in the same manner as the Fundamental Change Share Prices set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Maximum Conversion Rate.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Floor Price:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Initially $11.9875 (approximately 35% of the Initial Price), subject to adjustment as described in the Mandatory Convertible Preferred Stock Preliminary Prospectus.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Maximum Number of Shares of Common Stock Issuable Upon Conversion (Exclusive of Shares Issuable as Payment of Dividends):</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt"><BR>
<BR>
25,547,375 shares (or 29,379,482 shares if the underwriters of the Mandatory Convertible Preferred Stock Offering exercise in full their option to purchase additional shares of Mandatory Convertible Preferred Stock)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR></TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 34%; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Symbol/Exchange:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 65%; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">The Issuer intends to apply to list the Mandatory Convertible Preferred Stock on the NYSE under the symbol &ldquo;BSX PR A&rdquo; and, if approved, the Issuer expects trading to commence within 30 days of the first original issue date of the Mandatory Convertible Preferred Stock</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">CUSIP / ISIN:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">101137 206 / US1011372067</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; text-indent: 1in">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-size: 10pt">Bookrunners:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">J.P. Morgan Securities LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BofA Securities, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Citigroup Global Markets Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Goldman Sachs &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Wells Fargo Securities, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Morgan Stanley &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">Barclays Capital Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -2.25pt">RBC Capital Markets, LLC</P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; text-indent: 1in">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Co-Managers:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BNP Paribas Securities Corp.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">DNB Markets, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">MUFG Securities Americas Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">SG Americas Securities, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Standard Chartered Bank</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">TD Securities (USA) LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">U.S. Bancorp Investments, Inc.</P></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>The Issuer has filed a registration statement (including a prospectus)
with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) for the offerings to which this communication relates.
Before you invest, you should read the applicable Preliminary Prospectus Supplement referred to above and the accompanying prospectus
in that registration statement for a more complete information about the Issuer and the applicable offering. You may get these
documents for free by visiting EDGAR on the SEC website at <I>www.sec.gov</I>. Alternatively, the Issuer, any underwriter or any
dealer participating in the applicable offering will arrange to send you the prospectus and the applicable Preliminary Prospectus
Supplement if you request it by calling J.P. Morgan Securities LLC at (866) 803-9204 or BofA Securities, Inc. at 1-800-294-1322.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>The information in this pricing term sheet should be read
in conjunction with the applicable Preliminary Prospectus Supplement and the prospectus. The information in this pricing term sheet
supersedes the information in the applicable Preliminary Prospectus Supplement and the prospectus to the extent it is inconsistent
with the information in the applicable Preliminary Prospectus Supplement or the prospectus. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"><B>Any legends, disclaimers or other notices that may appear
below are not applicable to this communication and should be disregarded. Such legends, disclaimers or other notices have been
automatically generated as a result of this communication having been sent via Bloomberg or another system.</B></P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">ANNEX C</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0; text-align: center">Form of Opinion of Vice President, Chief
Corporate Counsel and Assistant Secretary of the Company</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">ANNEX D</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0; text-align: center">Form of Opinion of Counsel for the Company</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right; text-indent: 0.5in">EXHIBIT A</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: center">FORM OF LOCK-UP AGREEMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: right">May [&#9679;], 2020</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">J.P. MORGAN SECURITIES LLC<BR>
BOFA SECURITIES, INC.<BR>
As Representatives of<BR>
the several Underwriters listed in<BR>
Schedule 1 to the Underwriting<BR>
Agreement referred to below<BR>
<BR>
c/o J.P. Morgan Securities LLC<BR>
383 Madison Avenue<BR>
New York, NY 10179</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">c/o BofA Securities, Inc.<BR>
One Bryant Park<BR>
New York, New York 10036</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Re:&#9;Boston Scientific Corporation
--- Public Offering</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">Ladies and Gentlemen:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The undersigned understands that you, as
Representatives of the several Underwriters, propose to enter into an underwriting agreement (the &ldquo;Underwriting Agreement&rdquo;)
with Boston Scientific Corporation, a Delaware corporation (the &ldquo;Company&rdquo;), providing for the public offering (the
&ldquo;Public Offering&rdquo;) by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the &ldquo;Underwriters&rdquo;),
of common stock, $0.01 par value per share, of the Company (the &ldquo;Shares&rdquo;). Capitalized terms used herein and not otherwise
defined shall have the meanings set forth in the Underwriting Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In consideration of the Underwriters&rsquo;
agreement to purchase and make the Public Offering of the Shares, and for other good and valuable consideration receipt of which
is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of the Representatives on behalf
of the Underwriters, the undersigned will not, and will not cause any direct or indirect affiliate to, during the period beginning
on the date of this letter agreement (this &ldquo;Letter Agreement&rdquo;) and ending at the close of business 90 days after the
date of the final prospectus relating to the Public Offering (the &ldquo;Prospectus&rdquo;) (such period, the &ldquo;Restricted
Period&rdquo;), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any
shares of common stock, $0.01 par value per share, of the Company </P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">(the &ldquo;Common Stock&rdquo;) or any securities convertible
into or exercisable or exchangeable for Common Stock (including without limitation, Common Stock or such other securities which
may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange
Commission and securities which may be issued upon exercise of a stock option or warrant) (collectively with the Common Stock,
&ldquo;Lock-Up Securities&rdquo;), (2) enter into any hedging, swap or other agreement or transaction that transfers, in whole
or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction described in
clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise, (3) make any demand for or exercise
any right with respect to the registration of any Lock-Up Securities, or (4) publicly disclose the intention to do any of the foregoing.
The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions
or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option,
or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed
or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by the undersigned
or any other person) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any Lock-Up Securities,
whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of Lock-Up Securities,
in cash or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Notwithstanding the foregoing, the undersigned
may:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)&nbsp; transfer the undersigned&rsquo;s
Lock-Up Securities:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(i) as a bona fide gift or gifts, or
for bona fide estate planning purposes,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(ii) by will or intestacy,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(iii) to any trust for the direct or
indirect benefit of the undersigned or the immediate family of the undersigned, or if the undersigned is a trust, to a trustor
or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes of this Letter Agreement, &ldquo;immediate
family&rdquo; shall mean any relationship by blood, current or former marriage, domestic partnership or adoption, not more remote
than first cousin),</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(iv) to a partnership, limited liability
company or other entity of which the undersigned and the immediate family of the undersigned are the legal and beneficial owner
of all of the outstanding equity securities or similar interests,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(v) to a nominee or custodian of a person
or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) above,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(vi)&nbsp;if the undersigned is a corporation,
partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited liability
company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933,
as amended) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing or managed by or
under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned
is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or
(B) as part of a distribution to members or shareholders of the undersigned,</P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(vii) by operation of law, such as pursuant
to a qualified domestic order, divorce settlement, divorce decree or separation agreement,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(viii) to the Company from an employee
of the Company upon death, disability or termination of employment, in each case, of such employee,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(ix) as part of a sale of the undersigned&rsquo;s
Lock-Up Securities acquired in open market transactions after the closing date for the Public Offering,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(x) to the Company in connection with
the vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase shares of Common
Stock (including, in each case, by way of &ldquo;net&rdquo; or &ldquo;cashless&rdquo; exercise), including for the payment of exercise
price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options,
warrants or rights, provided that any such shares of Common Stock received upon such exercise, vesting or settlement shall be subject
to the terms of this Letter Agreement, and provided further that any such restricted stock units, options, warrants or rights are
held by the undersigned pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award plan,
each such agreement or plan which is described in the Registration Statement, the Pricing Disclosure Package and the Prospectus,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(xi) pursuant to a bona fide third-party
tender offer, merger, consolidation or other similar transaction that is approved by the Board of Directors of the Company and
made to all holders of the Company&rsquo;s capital stock involving a Change of Control (as defined below) of the Company (for purposes
hereof, &ldquo;Change of Control&rdquo; shall mean the transfer (whether by tender offer, merger, consolidation or other similar
transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of shares of
capital stock if, after such transfer, such person or group of affiliated persons would hold at least a majority of the outstanding
voting securities of the Company (or the surviving entity)); <U>provided</U> that in the event that such tender offer, merger,
consolidation or other similar transaction is not completed, the undersigned&rsquo;s Lock-Up Securities shall remain subject to
the provisions of this Letter Agreement; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(xii) pursuant to a trading plan pursuant
to Rule 10b5-1 under the Exchange Act (a &ldquo;10b5-1 Plan&rdquo;) that was in effect as of, and only shares scheduled for sale
thereunder on, the date hereof;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><U>provided</U> that (A) in the case of any transfer or distribution
pursuant to clause (a)(i), (ii), (iii), (iv), (v), (vi) and (vii), such transfer shall not involve a disposition for value and
each donee, devisee, transferee or distributee shall execute and deliver to the Representatives a lock-up letter in the form of
this Letter Agreement, (B) in the case of any transfer or distribution pursuant to clause (a) (i), (ii), (iii), (iv), (v), (vi),
(ix) and (x), no filing by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or other public announcement shall be required or shall be made
voluntarily in connection with such transfer or distribution (other than a filing on a Form 5 made after the expiration of the
Restricted Period referred to above) and (C) in the case of any sale or disposition of Lock-Up Securities pursuant to clause (a)(xii),
that no filing under Section 16(a) of the Exchange Act or other public announcement shall be required or shall be voluntarily made
in connection with such sale or disposition during the 90-day restricted period (other than, if required, a Section 16 filing,
which filing shall indicate that such transaction was effected pursuant to a 10b5-1 Plan);</P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b) exercise options, settle restricted
stock units or other equity awards or exercise warrants outstanding as of the date granted pursuant to plans described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus; provided that any Lock-up Securities received upon such exercise,
vesting or settlement shall be subject to the terms of this Letter Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c) convert outstanding preferred stock,
warrants to acquire preferred stock or convertible securities into shares of Common Stock or warrants to acquire shares of Common
Stock; provided that any such shares of Common Stock or warrants received upon such conversion shall be subject to the terms of
this Letter Agreement; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d) establish trading plans pursuant
to Rule 10b5-1 under the Exchange Act for the transfer of shares of Lock-Up Securities; <U>provided</U> that (1) such plans do
not provide for the transfer of Lock-Up Securities during the Restricted Period and (2) no filing by any party under the Exchange
Act or other public announcement shall be required or made voluntarily in connection with such trading plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In furtherance of the foregoing, the
Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby
authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter
Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The undersigned hereby represents and
warrants that the undersigned has full power and authority to enter into this Letter Agreement. All authority herein conferred
or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal
representatives of the undersigned.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The undersigned understands that, if
the Underwriting Agreement does not become effective by June 30, 2020, or if the Underwriting Agreement (other than the provisions
thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be
sold thereunder, the undersigned shall be released from all obligations under this Letter Agreement. The undersigned understands
that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this
Letter Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This Letter Agreement and any claim,
controversy or dispute arising under or related to this Letter Agreement shall be governed by and construed in accordance with
the laws of the State of New York.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Any signature to, and delivery of, this
Letter Agreement shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each
of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof
or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions
contemplated hereunder by electronic means.</P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0 3.5in"></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD></TD>
    <TD COLSPAN="3">Very truly yours,</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">[<I>NAME OF STOCKHOLDER</I>]</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"></P>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>4
<FILENAME>ss174270_ex0301.htm
<DESCRIPTION>CERTIFICATE OF DESIGNATIONS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>
<P STYLE="text-align: right; margin: 0"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>CERTIFICATE OF DESIGNATIONS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>OF</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>5.50% MANDATORY CONVERTIBLE PREFERRED STOCK,
SERIES A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>OF</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>BOSTON SCIENTIFIC CORPORATION</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Boston Scientific Corporation, a Delaware corporation
(the &ldquo;<U>Corporation</U>&rdquo;), hereby certifies that, pursuant to the provisions of Sections 103, 141 and 151 of the General
Corporation Law of the State of Delaware, (a)&nbsp;on May 19, 2020, the board of directors of the Corporation (the &ldquo;<U>Board
of Directors</U>&rdquo;), pursuant to authority conferred upon the Board of Directors by the Third Restated Certificate of Incorporation
of the Corporation (as such may be amended, modified or restated from time to time, the &ldquo;<U>Third Restated Certificate of
Incorporation</U>&rdquo;), delegated to its Pricing Committee (the &ldquo;<U>Pricing Committee</U>&rdquo;), the power to create,
designate, authorize and provide for the issuance of shares of a new series of the Corporation&rsquo;s undesignated preferred stock,
to be designated the &ldquo;5.50% Mandatory Convertible Preferred Stock, Series A,&rdquo; and to establish the number of shares
to be included in such series, and to fix the powers, designations, preferences, rights and qualifications, limitations or restrictions
and other term thereof, to be set forth in this Certificate of Designations (the &ldquo;<U>Certificate of Designations</U>&rdquo;);
and (b) on May 21, 2020, the Pricing Committee adopted the resolution set forth immediately below, which resolution is now, and
at all times since its date of adoption has been, in full force and effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">RESOLVED, that, pursuant to the authority
conferred upon the Board of Directors by the Third Restated Certificate of Incorporation, which authorizes the issuance of up to
50,000,000 shares of preferred stock, par value $0.01 per share, a series of preferred stock be, and hereby is, created and designated
the 5.50% Mandatory Convertible Preferred Stock, Series A, and that the designation and number of shares of such series, and the
voting powers, designations, preferences, rights and qualifications, limitations or restrictions and other terms thereof, which
will be set forth in the Certificate of Designations, as it may be amended from time to time as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;<B>Part&nbsp;1.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Designation and Number of Shares</U></B>. Pursuant to the Third Restated Certificate
of Incorporation, there is hereby created out of the authorized and unissued shares of preferred stock of the Corporation, par
value $0.01 per share (&ldquo;<U>Preferred Stock</U>&rdquo;), a series of Preferred Stock consisting of 10,062,500 shares of Preferred
Stock designated as the &ldquo;5.50% Mandatory Convertible Preferred Stock, Series A&rdquo; (the &ldquo;<U>Mandatory Convertible
Preferred Stock</U>&rdquo;). Such number of shares may be decreased by resolution of the Board of Directors or any duly authorized
committee thereof, subject to the terms and conditions hereof and the requirements of applicable law; <U>provided</U> that no decrease
shall reduce the number of shares of Mandatory Convertible Preferred Stock to a number less than the number of such shares then
outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Part&nbsp;2.</B></FONT><B><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Standard Provisions</U></FONT></B><FONT STYLE="font-size: 10pt">. The Standard Provisions
contained in <U>Annex A</U> attached hereto are incorporated herein by reference in their entirety and shall be deemed to be a
part of this Certificate of Designations to the same extent as if such provisions had been set forth in full in the Certificate
of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Corporation has caused
this Certificate of Designations to be duly executed this 26<SUP>th</SUP> day of May, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">BOSTON SCIENTIFIC CORPORATION</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Robert J. Castagna</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 36%"><FONT STYLE="font-size: 10pt">Robert J. Castagna</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Vice President and Treasurer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[Signature Page to Certificate of Designations
of Mandatory Convertible Preferred Stock]</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><U>ANNEX A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>STANDARD PROVISIONS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;1.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>General Matters; Ranking</U></B>. Each share of Mandatory Convertible Preferred Stock
shall be identical in all respects to every other share of Mandatory Convertible Preferred Stock. The Mandatory Convertible Preferred
Stock, with respect to dividend rights and/or distribution rights upon the liquidation, winding-up or dissolution, as applicable,
of the Corporation, shall rank (i)&nbsp;senior to each class or series of Junior Stock, (ii)&nbsp;on parity with each class or
series of Parity Stock, (iii)&nbsp;junior to each class or series of Senior Stock and (iv)&nbsp;junior to the Corporation&rsquo;s
existing and future indebtedness and other liabilities. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;2.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Standard Definitions</U></B>. As used herein with respect to Mandatory Convertible Preferred
Stock:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Accumulated Dividend Amount</U>&rdquo;
means, with respect to any Fundamental Change, the aggregate amount of accumulated and unpaid dividends, if any, that have not
been declared for Dividend Periods prior to the relevant Fundamental Change Effective Date, including for the partial Dividend
Period, if any, from, and including, the Dividend Payment Date immediately preceding such Fundamental Change Effective Date to,
but excluding, such Fundamental Change Effective Date, subject to the proviso in Section&nbsp;9(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>ADRs</U>&rdquo; shall have the meaning
set forth in Section&nbsp;14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Agent Members</U>&rdquo; shall have
the meaning set forth in Section 20(a).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Applicable Market Value</U>&rdquo;
means the Average VWAP per share of Common Stock over the Settlement Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Average Price</U>&rdquo; shall have
the meaning set forth in Section&nbsp;3(c)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Average VWAP</U>&rdquo; per share
over a certain period means the arithmetic average of the VWAP per share for each Trading Day in the relevant period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Averaging Period</U>&rdquo; shall
have the meaning set forth in Section 13(a)(v).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo; shall
have the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo; means any
day other than a Saturday or Sunday or any other day on which commercial banks in New York City are authorized or required by law
or executive order to close or be closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>By-Laws</U>&rdquo; means the Amended
and Restated By-Laws of the Corporation, as they may be amended or restated from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Certificate of Designations</U>&rdquo;
shall have the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Clause A Distribution</U>&rdquo; shall
have the meaning set forth in Section&nbsp;13(a)(iii)(A).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Clause B Distribution</U>&rdquo; shall
have the meaning set forth in Section&nbsp;13(a)(iii)(B).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Clause C Distribution</U>&rdquo; shall
have the meaning set forth in Section&nbsp;13(a)(iii)(B)(1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>close of business</U>&rdquo; means
5:00 p.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo; means the
common stock, par value $0.01 per share, of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Conversion and Dividend Disbursing
Agent</U>&rdquo; means Computershare Inc., the Corporation&rsquo;s duly appointed conversion and dividend disbursing agent for
Mandatory Convertible Preferred Stock, and any successor appointed under Section&nbsp;15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Conversion Date</U>&rdquo; shall mean
the Mandatory Conversion Date, the Fundamental Change Conversion Date or the Early Conversion Date, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Corporation</U>&rdquo; shall have
the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Depositary</U>&rdquo; means DTC or
its nominee or any successor appointed by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Dividend Payment Date</U>&rdquo; means
March 1, June 1, September 1 and December 1 of each year to, and including, June 1, 2023, commencing on September 1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Dividend Period</U>&rdquo; means the
period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial
Dividend Period shall commence on,&nbsp;and include, the Initial Issue Date and shall end on, and exclude, the September 1, 2020
Dividend Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Dividend Rate</U>&rdquo; shall have
the meaning set for in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>DTC</U>&rdquo; means The Depository
Trust Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Early Conversion</U>&rdquo; shall
have the meaning set forth in Section&nbsp;8(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Early Conversion Additional Conversion
Amount</U>&rdquo; shall have the meaning set forth in Section&nbsp;8(b)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Early Conversion Average Price</U>&rdquo;
shall have the meaning set forth in Section 8(b)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Early Conversion Date</U>&rdquo; shall
have the meaning set forth in Section&nbsp;10(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Early Conversion Settlement Period</U>&rdquo;
shall have the meaning set forth in Section&nbsp;8(b)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Effective Date</U>,&rdquo; shall mean
the first date on which the shares of Common Stock trade on the Relevant Stock Exchange, regular way, reflecting the relevant share
split or share combination, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.05in 12pt 0; text-indent: 0.5in">&ldquo;<U>Ex-Date</U>&rdquo; means
the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without
the right to receive the issuance, dividend or distribution in question, from the Corporation or, if applicable, from the seller
of the Common Stock on such exchange or market (in the form of due bills or otherwise) as determined by such exchange or market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo; means the
Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Exchange Property</U>&rdquo; shall
have the meaning set forth in Section&nbsp;14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Expiration Date</U>&rdquo; shall have
the meaning set forth in Section&nbsp;13(a)(v).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fixed Conversion Rates</U>&rdquo;
means the Maximum Conversion Rate and the Minimum Conversion Rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Floor Price</U>&rdquo; shall have
the meaning set forth in Section&nbsp;3(e)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A &ldquo;<U>Fundamental Change</U>&rdquo; shall
be deemed to have occurred, at any time after the Initial Issue Date of the Mandatory Convertible Preferred Stock, if any of the
following occurs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.75in; text-indent: -13.5pt">(i) any &ldquo;person&rdquo;
or &ldquo;group&rdquo; (as such terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act, whether or not applicable),
other than the Corporation, any of its Wholly-Owned Subsidiaries or any of the Corporation&rsquo;s or its Wholly-Owned Subsidiaries&rsquo;
employee benefit plans, filing a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person
or group has become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
of more than 50% of the total voting power in the aggregate of all classes of capital stock then outstanding entitled to vote generally
in elections of the Corporation&rsquo;s directors;</P>
<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.75in; text-indent: -13.5pt">(ii) the consummation of (A)
any recapitalization, reclassification or change of the Common Stock (other than changes resulting from a subdivision or combination
or change in par value) as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities,
other property or assets (including cash or a combination thereof); (B) any consolidation, merger or other combination of the Corporation
or binding share exchange pursuant to which the Common Stock will be converted into, or exchanged for, stock, other securities
or other property or assets (including cash or a combination thereof); or (C) any sale, lease or other transfer or disposition
in one transaction or a series of transactions of all or substantially all of the consolidated assets of the Corporation and its
Subsidiaries taken as a whole, to any person other than one or more of its Wholly-Owned Subsidiaries; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.75in; text-indent: -13.5pt">(iii) the Common Stock (or other
Exchange Property) ceases to be listed or quoted for trading on any of NYSE, the NASDAQ Global Select Market or the NASDAQ Global
Market (or another U.S. national securities exchange or any of their respective successors).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">However, a transaction or transactions described
in clause (i) or clause (ii) above will not constitute a Fundamental Change if at least 90% of the consideration received or to
be received by holders of Common Stock, excluding cash payments for fractional shares or pursuant to statutory appraisal rights,
in connection with such transaction or transactions consists of shares of common stock that are listed or quoted on any of NYSE,
the NASDAQ Global Select Market or the NASDAQ Global Market (or any of their respective successors) or will be so listed or quoted
when issued or exchanged in connection with such transaction or transactions and as a result of such transaction or transactions
such consideration (excluding cash payments for fractional shares or pursuant to statutory appraisal rights) becomes the Exchange
Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Conversion</U>&rdquo;
shall have the meaning set forth in Section&nbsp;9(a)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Conversion Date</U>&rdquo;
shall have the meaning set forth in Section&nbsp;10(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Conversion Period</U>&rdquo;
means the period commencing on, and including, the Fundamental Change Effective Date and ending at the close of business on the
date that is 20 calendar days after the Fundamental Change Effective Date (or, if later, the date that is 20 calendar days after
the date of notice of such Fundamental Change), but in no event later than June 1, 2023. If the Corporation provides the Fundamental
Change Notice later than the second Business Day following the Fundamental Change Effective Date, the Fundamental Change Conversion
Period shall be extended by a number of days equal to the number of days from, and including, the Fundamental Change Effective
Date to, but excluding, the date of such Fundamental Change Notice; <U>provided</U>, <U>however</U>, that the Fundamental Change
Conversion Period shall not be extended beyond June 1, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Conversion Rate</U>&rdquo;
means, for any Fundamental Change Conversion, the conversion rate per share of Mandatory Convertible Preferred Stock set forth
in the table below for the Fundamental Change Effective Date and the Fundamental Change Share Price applicable to such Fundamental
Change:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">&nbsp;<B>Fundamental Change Effective Date</B></FONT></TD>
    <TD COLSPAN="16" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 7pt"><B>Fundamental Change Share Price</B></FONT></TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 23%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$10.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$15.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$20.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$25.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$30.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$34.25 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$37.50 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$40.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$41.96 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$45.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$50.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$55.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$60.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 5%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$75.00 </B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 6%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt"><B>$100.00 </B></FONT></TD>
    <TD STYLE="width: 1%; font-size: 12pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">May 27, 2020</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.8542 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.7933 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.7095 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.6255 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.5532 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.5037 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4729 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4529 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4394 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4214 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3988 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3828 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3715 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3544 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3477 </FONT></TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">June 1, 2021</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.8856 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.8539 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.7863 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.6998 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.6145 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.5520 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.5122 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4863 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4687 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4455 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4169 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3973 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3842 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3660 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3601 </FONT></TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">June 1, 2022</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.9050 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.9007 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.8724 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.8033 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.7052 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.6193 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.5610 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.5225 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4965 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4633 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4248 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.4014 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3878 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3739 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3716 </FONT></TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">June 1, 2023</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.9197 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.9197 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.9197 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.9197 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.9197 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.9197 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.6667 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.5000 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3834 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3834 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3834 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3834 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3834 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3834 </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 7pt">2.3834 </FONT></TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The exact Fundamental Change Share Price and Fundamental Change
Effective Date may not be set forth in the table, in which case:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD>if the Fundamental Change Share Price is between two Fundamental Change Share Price amounts in the table above or the Fundamental
Change Effective Date is between two Fundamental Change Effective Dates in the table above, the Fundamental Change Conversion Rate
shall be determined by a straight-line interpolation between the Fundamental Change Conversion Rates set forth for the higher and
lower Fundamental Change Share Price amounts and the earlier and later Fundamental Change Effective Dates, as applicable, based
on a 365 or 366-day year, as applicable;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>if the Fundamental Change Share Price is in excess of $100.00 per share (subject to adjustment in the same manner as adjustments
are made to the Fundamental Change Share Price set forth in the first row of the table above), then the Fundamental Change Conversion
Rate shall be the Minimum Conversion Rate; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD>if the Fundamental Change Share Price is less than $10.00 per share (subject to adjustment in the same manner as adjustments
are made to the Fundamental Change Share Price set forth in the first row of the table above), then the Fundamental Change Conversion
Rate shall be the Maximum Conversion Rate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;The Fundamental Change Share Prices in
the column headings in the table above are each subject to adjustment as of any date on which the Fixed Conversion Rates are adjusted.
The adjusted Fundamental Change Share Prices shall equal (x) the Fundamental Change Share Prices applicable immediately prior to
such adjustment, <I>multiplied by </I>(y) a fraction, the numerator of which is the Minimum Conversion Rate immediately prior to
the adjustment giving rise to the Fundamental Change Share Price adjustment and the denominator of which is the Minimum Conversion
Rate as so adjusted. The Fundamental Change Conversion Rates set forth in the table above are each subject to adjustment in the
same manner and at the same time as each Fixed Conversion Rate as set forth in Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Conversion Right</U>&rdquo;
shall have the meaning set forth in Section 9(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Dividend Make-Whole
Amount</U>&rdquo; shall have the meaning set forth in Section&nbsp;9(a)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Effective Date</U>&rdquo;
shall mean the effective date of the relevant Fundamental Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Notice</U>&rdquo;
shall have the meaning set forth in Section&nbsp;9(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Fundamental Change Share Price</U>&rdquo;
means, for any Fundamental Change, the price paid or deemed paid per share of Common Stock in such Fundamental Change, which shall
equal (i)&nbsp;if all holders of Common Stock receive only cash in such Fundamental Change, the amount of cash paid per share of
Common Stock in such Fundamental Change, and (ii)&nbsp;in all other cases, the Average VWAP per share of Common Stock over the
10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Fundamental Change Effective
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Global Preferred Share</U>&rdquo;
shall have the meaning set forth in Section&nbsp;20(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo; means each Person
in whose name shares of Mandatory Convertible Preferred Stock are registered, who shall be treated by the Corporation and the Registrar
as the absolute owner of those shares of Mandatory Convertible Preferred Stock for the purpose of making payment and settling conversions
and for all other purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Initial Issue Date</U>&rdquo; means
May 27, 2020, the first original issue date of shares of Mandatory Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Initial Price</U>&rdquo; means $100.00,
<I>divided by</I> the Maximum Conversion Rate, which quotient is initially equal to $34.25.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Junior Stock</U>&rdquo; means (i)&nbsp;the
Common Stock and (ii)&nbsp;each other class or series of capital stock of the Corporation established after the Initial Issue Date,
the terms of which do not expressly provide that such class or series ranks either (x) senior to the Mandatory Convertible Preferred
Stock as to dividend rights or distribution rights upon its liquidation, winding-up or dissolution or (y) on parity with Mandatory
Convertible Preferred Stock as to dividend rights or distribution rights upon the Corporation&rsquo;s liquidation, winding-up or
dissolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Last Reported Sale Price</U>&rdquo;
on any date means (i) the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask
prices or, if more than one in either case, the average of the average bid and the average ask prices) on such date as reported
in composite transactions for the Relevant Stock Exchange; (ii) if the Common Stock is not listed for trading on the Relevant Stock
Exchange on such date, the last quoted bid price for the Common Stock in the over-the-counter market on such date as reported by
OTC Markets Group Inc. or a similar organization; and (iii) if the Common Stock is not so quoted, the average of the mid-point
of the last bid and ask prices for the Common Stock on such date from each of at least three nationally recognized independent
investment banking firms selected by the Corporation for this purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Liquidation Dividend Amount</U>&rdquo;
shall have the meaning set forth in Section&nbsp;4(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Liquidation Preference</U>&rdquo;
means, as to Mandatory Convertible Preferred Stock, $100.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Mandatory Conversion</U>&rdquo; shall
have the meaning set forth in Section&nbsp;7(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Mandatory Conversion Additional Conversion
Amount</U>&rdquo; shall have the meaning set forth in Section&nbsp;7(c)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Mandatory Conversion Date</U>&rdquo;
means the second Business Day immediately following the last Trading Day of the Settlement Period. The Mandatory Conversion Date
is expected to be June 1, 2023. If the Mandatory Conversion Date occurs after June 1, 2023 (whether because a Scheduled Trading
Day during the Settlement Period is not a Trading Day due to the occurrence of a Market Disruption Event or otherwise), no interest
or other amounts will accrue as a result of such postponement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Mandatory Conversion Rate</U>&rdquo;
shall have the meaning set forth in Section&nbsp;7(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Mandatory Convertible Preferred Stock</U>&rdquo;
shall have the meaning set forth in Part&nbsp;1 of this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Market Disruption Event</U>&rdquo;
means (i) a failure by the Relevant Stock Exchange to open for trading during its regular trading session; or (ii) the occurrence
or existence, prior to 1:00 p.m., New York City time, on any Scheduled Trading Day for the Common Stock, for more than a one half-hour
period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements
in price exceeding limits permitted by the Relevant Stock Exchange or otherwise) in the Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Maximum Conversion Rate</U>&rdquo;
shall have the meaning set forth in Section&nbsp;7(b)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Minimum Conversion Rate</U>&rdquo;
shall have the meaning set forth in Section&nbsp;7(b)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Nonpayment</U>&rdquo; shall have the
meaning set forth in Section&nbsp;6(b)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Nonpayment Remedy</U>&rdquo; shall
have the meaning set forth in Section&nbsp;6(b)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>NYSE</U>&rdquo; means The New York
Stock Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Officer</U>&rdquo; means the Chief
Executive Officer, the Chief Financial Officer, the President, any Executive Vice President, any Senior Vice President, any Vice
President, any Assistant Vice President, the Treasurer, any Assistant Treasurer, the Secretary or any Assistant Secretary of the
Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>open of business</U>&rdquo; means
9:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Parity Stock</U>&rdquo; means any
class or series of capital stock of the Corporation established after the Initial Issue Date, the terms of which expressly provide
that such class or series shall rank on parity with Mandatory Convertible Preferred Stock as to dividend rights and distribution
rights upon the Corporation&rsquo;s liquidation, winding-up or dissolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo; means any individual,
partnership, firm, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association,
joint venture, governmental authority or other entity of whatever nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Preferred Stock</U>&rdquo; shall have
the meaning set forth in Part 1 of this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Preferred Stock Directors</U>&rdquo;
shall have the meaning set forth in Section&nbsp;6(b)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Pricing Committee</U>&rdquo;
shall have the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Prospectus Supplement</U>&rdquo;
means the preliminary prospectus supplement dated May 20, 2020 relating to the offering and sale of the Mandatory Convertible Preferred
Stock, as supplemented by the related pricing term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Record Date</U>&rdquo; means, with
respect to any dividend, distribution or other transaction or event in which the holders of the Common Stock (or other applicable
security) have the right to receive any cash, securities or other property or in which the Common Stock (or such other security)
is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders
of the Common Stock (or such other security) entitled to receive such cash, securities or other property (whether such date is
fixed by the Board of Directors or a duly authorized committee thereof, statute, contract or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Record Holder</U>&rdquo; means, with
respect to any Dividend Payment Date, a Holder of record of Mandatory Convertible Preferred Stock as such Holder appears on the
stock register of the Corporation at the close of business on the related Regular Record Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Registrar</U>&rdquo; initially means
Computershare Inc., the Corporation&rsquo;s duly appointed registrar for Mandatory Convertible Preferred Stock and any successor
appointed under Section&nbsp;15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Regular Record Date</U>&rdquo; means,
with respect to any Dividend Payment Date, the February 15, May 15, August 15 and November 15, as the case may be, immediately
preceding the relevant Dividend Payment Date. These Regular Record Dates shall apply regardless of whether a particular Regular
Record Date is a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Relevant Stock Exchange</U>&rdquo;
means NYSE or, if the Common Stock is not then listed on NYSE, on the principal other U.S. national or regional securities exchange
on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange,
on the principal other market on which the Common Stock is then listed or admitted for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Reorganization Event</U>&rdquo; shall
have the meaning set forth in Section&nbsp;14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Scheduled Trading Day</U>&rdquo; means
any day that is scheduled to be a Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo; means the
Securities Act of 1933, as amended, and the rules&nbsp;and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Senior Stock</U>&rdquo; means each
class or series of capital stock of the Corporation established after the Initial Issue Date, the terms of which expressly provide
that such class or series shall rank senior to Mandatory Convertible Preferred Stock as to dividend rights or distribution rights
upon the Corporation&rsquo;s liquidation, winding-up or dissolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Settlement Period</U>&rdquo; means
the 20 consecutive Trading Day period commencing on, and including, the 21st Scheduled Trading Day immediately preceding June 1,
2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Share Dilution Amount</U>&rdquo; means
the increase in the number of diluted shares of Common Stock outstanding (determined in accordance with U.S. generally accepted
accounting principles, and as measured from the Initial Issue Date) resulting from the grant, vesting or exercise of equity-based
compensation to directors, employees and agents and equitably adjusted for any stock split, stock dividend, reverse stock split,
reclassification or similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Shelf Registration Statement</U>&rdquo;
means a shelf registration statement filed with the Securities and Exchange Commission in connection with the issuance of or resales
of shares of Common Stock issued as payment of a dividend on shares of the Mandatory Convertible Preferred Stock, including dividends
paid in connection with a conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Spin-Off</U>&rdquo; means a payment
of a dividend or other distribution on the Common Stock of shares of capital stock of any class or series, or similar equity interest,
of or relating to a Subsidiary or other business unit of the Corporation that are, or, when issued, will be, listed or admitted
for trading on a U.S. national securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo; means, with
respect to any Person, any corporation, association, partnership or other business entity of which more than 50% of the total voting
power of shares of capital stock or other interests (including partnership interests) entitled (without regard to the occurrence
of any contingency) to vote in the election of directors, managers, general partners or trustees thereof is at the time owned or
controlled, directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii)
one or more Subsidiaries of such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Third Restated Certificate of Incorporation</U>&rdquo;
shall have the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Threshold Appreciation Price</U>&rdquo;
means $100.00, <I>divided by</I> the Minimum Conversion Rate, which quotient is initially equal to approximately $41.96.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo; means a day
on which (i) there is no Market Disruption Event and (ii) trading in Common Stock generally occurs on the Relevant Stock Exchange;
<U>provided</U> that if the Common Stock is not listed or admitted for trading, &ldquo;<U>Trading Day</U>&rdquo; means any Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo; shall initially
mean Computershare Inc., the Corporation&rsquo;s duly appointed transfer agent for Mandatory Convertible Preferred Stock and any
successor appointed under Section&nbsp;15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Trigger Event</U>&rdquo; shall have
the meaning set forth in Section&nbsp;13(a)(iii)(A).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Unit of Exchange Property</U>&rdquo;
shall have the meaning set forth in Section&nbsp;14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Valuation Period</U>&rdquo; shall
have the meaning set forth in Section 13(a)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Voting Preferred Stock</U>&rdquo;
means any other class or series of Preferred Stock, ranking equally with Mandatory Convertible Preferred Stock as to dividends
and to the distribution of assets upon liquidation, dissolution or winding-up and upon which like voting rights for the election
of directors have been conferred and are exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo; per share of Common
Stock on any Trading Day means the per share volume-weighted average price as displayed on Bloomberg page&nbsp;&ldquo;BSX&lt;EQUITY&gt;AQR&rdquo;
(or its equivalent successor if such page&nbsp;is not available) in respect of the period from the scheduled open of trading until
the scheduled close of trading of the primary trading session on such Trading Day (or if such volume-weighted average price is
not available, the market value per share of Common Stock on such Trading Day as determined, using a volume-weighted average method,
by a nationally recognized independent investment banking firm retained by the Corporation for this purpose).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Wholly-Owned Subsidiary</U>&rdquo;
means, with respect to any Person, any Subsidiary of such Person, except that, solely for purposes of this definition, the reference
to &ldquo;more than 50%&rdquo; in the definition of &ldquo;Subsidiary&rdquo; shall be deemed to be replaced by a reference to &ldquo;100%&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;3.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Dividends</U></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Rate</U>. Subject to the rights of holders of any class or series of Senior Stock, Holders
shall be entitled to receive, when, as and if declared by the Board of Directors (or an authorized committee thereof) out of funds
of the Corporation legally available for payment, in the case of dividends paid in cash, and shares of Common Stock legally permitted
to be issued, in the case of dividends paid in shares of Common Stock, cumulative dividends at the rate per annum of 5.50% of the
Liquidation Preference per share of Mandatory Convertible Preferred Stock (the &ldquo;<U>Dividend Rate</U>&rdquo;) (equivalent
to $5.50 per annum per share), payable in cash, by delivery of shares of Common Stock or through any combination of cash and shares
of Common Stock pursuant to Section 3(c), as determined by the Corporation in its sole discretion (subject to the limitations set
forth in Section 3(e)). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">If declared, dividends on Mandatory Convertible
Preferred Stock shall be payable quarterly on each Dividend Payment Date at such annual rate, and dividends shall accumulate from
the most recent date as to which dividends shall have been paid or, if no dividends have been paid, from the Initial Issue Date,
whether or not in any Dividend Period or Dividend Periods there have been funds legally available or shares of Common Stock legally
permitted for the payment of such dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">If declared, dividends shall be payable on the
relevant Dividend Payment Date to Record Holders on the immediately preceding Regular Record Date, whether or not such Record Holders
early convert their shares of Mandatory Convertible Preferred Stock, or such shares are automatically converted, after a Regular
Record Date and on or prior to the immediately succeeding Dividend Payment Date. If a Dividend Payment Date is not a Business Day,
payment shall be made on the next succeeding Business Day, without any interest or other payment in lieu of interest accruing with
respect to this delay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">The amount of dividends payable on each share
of Mandatory Convertible Preferred Stock for each full Dividend Period (subsequent to the initial Dividend Period) shall be computed
by dividing the Dividend Rate by four. Dividends payable on Mandatory Convertible Preferred Stock for the initial Dividend Period
and any other partial Dividend Period shall be computed based upon the actual number of days elapsed during such period over a
360-day year (consisting of twelve 30-day months). Accumulated dividends on shares of Mandatory Convertible Preferred Stock shall
not bear interest, nor shall additional dividends be payable thereon, if they are paid subsequent to the applicable Dividend Payment
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">No dividend shall be paid unless and until the
Board of Directors, or an authorized committee of the Board of Directors, declares a dividend payable with respect to the Mandatory
Convertible Preferred Stock. No dividend shall be declared or paid upon, or any sum of cash or number of shares of Common Stock
set apart for the payment of dividends upon, any outstanding shares of Mandatory Convertible Preferred Stock with respect to any
Dividend Period unless all dividends for all preceding Dividend Periods have been declared and paid upon, or a sufficient sum of
cash or number of shares of Common Stock has been set apart for the payment of such dividends upon, all outstanding shares of Mandatory
Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">Holders shall not be entitled to any dividends
on Mandatory Convertible Preferred Stock, whether payable in cash, property or shares of Common Stock, in excess of full cumulative
dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">Except as described in this Section&nbsp;3(a),
dividends on Mandatory Convertible Preferred Stock converted to Common Stock shall cease to accumulate, and all other rights of
Holders will terminate, from and after the applicable Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Priority of Dividends</U>. So long as any share of Mandatory Convertible Preferred Stock
remains outstanding, no dividend or distribution shall be declared or paid on Common Stock or any other class or series of Junior
Stock, and no Common Stock or any other class or series of Junior Stock or Parity Stock shall be, directly or indirectly, purchased,
redeemed or otherwise acquired for consideration by the Corporation or any of its Subsidiaries unless all accumulated and unpaid
dividends for all preceding Dividend Periods have been declared and paid in full in cash, shares of the Common Stock or a combination
thereof, or a sufficient sum of cash or number of shares of Common Stock has been set apart for the payment of such dividends upon,
all outstanding shares of Mandatory Convertible Preferred Stock. The foregoing limitation shall not apply to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any dividend or distribution payable in shares of Common Stock or other Junior Stock, together with cash in lieu of any
fractional share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>purchases, redemptions or other acquisitions of Common Stock, other Junior Stock or Parity Stock in connection with the
administration of any benefit or other incentive plan, including any employment contract, in the ordinary course of business (including
purchases to offset the Share Dilution Amount pursuant to a publicly announced repurchase plan, or acquisitions of shares of Common
Stock surrendered, deemed surrendered or withheld in connection with the exercise of stock options or the vesting of restricted
stock or restricted stock units); <U>provided</U> that the number of shares purchased to offset the Share Dilution Amount shall
in no event exceed the Share Dilution Amount;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>purchases of Common Stock or other Junior Stock pursuant to a contractually binding agreement to buy such securities that
existed prior to the date of the Prospectus Supplement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any dividends or distributions of rights in connection with a stockholders&rsquo; rights plan or any redemption or repurchase
of rights pursuant to any stockholders&rsquo; rights plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the exchange or conversion of Junior Stock for or into other Junior Stock or of Parity Stock for or into other Parity Stock
(with the same or lesser aggregate liquidation preference) or Junior Stock and, in each case, the payment of cash solely in lieu
of fractional shares; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the deemed purchase or acquisition of fractional interests in shares of Common Stock, other Junior Stock or Parity Stock
pursuant to the conversion or exchange provisions of such shares or the security being converted or exchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;When dividends on shares of the Mandatory
Convertible Preferred Stock (i)&nbsp;have not been declared and paid in full on any Dividend Payment Date (or, in the case of Parity
Stock having dividend payment dates different from such Dividend Payment Dates, on a dividend payment date falling within a regular
dividend period related to such Dividend Payment Date), or (ii)&nbsp;have been declared but a sum of cash or number of shares of
Common Stock sufficient for payment thereof has not been set aside for the benefit of the Holders thereof on the applicable Regular
Record Date, no dividends may be declared or paid on any shares of Parity Stock unless dividends are declared on the shares of
Mandatory Convertible Preferred Stock such that the respective amounts of such dividends declared on the shares of Mandatory Convertible
Preferred Stock and such shares of Parity Stock shall be allocated pro rata among the Holders of the shares of the Mandatory Convertible
Preferred Stock and the holders of any shares of Parity Stock then outstanding. For purposes of calculating the pro rata allocation
of partial dividend payments, the Corporation shall allocate those payments so that the respective amounts of those payments for
the declared dividend bear the same ratio to each other as all accumulated and unpaid dividends per share on the shares of Mandatory
Convertible Preferred Stock and all declared and unpaid dividends per share on such shares of Parity Stock bear to each other (subject
to their having been declared by the Board of Directors, or an authorized committee thereof, out of legally available funds); <U>provided</U>,
<U>however</U>, that any unpaid dividends on the Mandatory Convertible Preferred Stock will continue to accumulate except as described
herein. For purposes of this calculation, with respect to non-cumulative Parity Stock, the Corporation shall use the full amount
of dividends that would be payable for the most recent dividend period if dividends were declared in full on such non-cumulative
Parity Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">Subject to the foregoing, and not otherwise, such
dividends as may be determined by the Board of Directors (or an authorized committee thereof) may be declared and paid (payable
in cash or other property or securities) on any securities, including Common Stock and other Junior Stock, from time to time out
of any funds legally available for such payment, and Holders shall not be entitled to participate in any such dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Method of Payment of Dividends</U>. (i)&nbsp;Subject to the limitations set forth in Section
3(e), the Corporation may pay any declared dividend (or any portion of any declared dividend) on the shares of Mandatory Convertible
Preferred Stock, whether or not for a current Dividend Period or any prior Dividend Period, as determined in the Corporation&rsquo;s
sole discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(A)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">in cash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(B)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">by delivery of shares of Common Stock; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(C)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">through any combination of cash and shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The Corporation shall make each payment of a declared dividend on the shares of Mandatory
Convertible Preferred Stock in cash, except to the extent the Corporation elects to make all or any portion of such payment in
shares of Common Stock. The Corporation shall give notice to Holders of any such election, and the portion of such payment that
will be made in cash and the portion that will be made in shares of Common Stock, no later than 10 Scheduled Trading Days prior
to the Dividend Payment Date for such dividend, <U>provided</U>, <U>however</U>, that if the Corporation does not provide timely
notice of this election, the Corporation will be deemed to have elected to pay the relevant dividend in cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">All cash payments to which a Holder is entitled in connection with a declared dividend on
the shares of Mandatory Convertible Preferred Stock will be rounded to the nearest cent. If the Corporation elects to make any
such payment of a declared dividend, or any portion thereof, in shares of Common Stock, such shares shall be valued for such purpose,
in the case of any dividend payment or portion thereof, at 97% of the Average VWAP per share of Common Stock over the five consecutive
Trading Day period commencing on, and including, the seventh Scheduled Trading Day prior to the applicable Dividend Payment Date
(such average, the &ldquo;<U>Average Price</U>&rdquo;). If the five Trading Day period to determine the Average Price ends on or
after the relevant Dividend Payment Date (whether because a Scheduled Trading Day is not a Trading Day due to the occurrence of
a Market Disruption Event or otherwise), then the Dividend Payment Date will be postponed until the second Business Day after the
final Trading Day of such five Trading Day period; <U>provided</U> that no interest or other amounts shall accrue as a result of
such postponement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">No fractional shares of Common Stock shall be delivered to the Holders in payment or partial
payment of a dividend. The Corporation shall instead, to the extent it is legally permitted to do so (including in compliance with
the Corporation&rsquo;s indebtedness), pay a cash amount (computed to the nearest cent) to each Holder that would otherwise be
entitled to receive a fraction of a share of Common Stock based on the Average Price with respect to such dividend. In the event
the Corporation cannot pay cash in lieu of a fractional share, the Corporation shall instead round up to the nearest whole share
for each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Notwithstanding the foregoing, in no event shall the number of shares of Common Stock to be
delivered in connection with any declared dividend, including any declared dividend payable in connection with a conversion, exceed
a number equal to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> the declared dividend, <I>divided by</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>$11.9875, subject to adjustment in a manner inversely proportional to any anti-dilution adjustment to each Fixed Conversion
Rate as provided in Section&nbsp;13 (such dollar amount, the &ldquo;<U>Floor Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">To the extent that the amount of any declared
dividend exceeds the product of (x) the number of shares of Common Stock delivered in connection with such declared dividend and
(y) 97% of the Average Price, the Corporation shall, to the extent it is able to do so under applicable law and in compliance with
the Corporation&rsquo;s indebtedness, notwithstanding any notice by the Corporation to the contrary, pay such excess amount in
cash (computed to the nearest cent). To the extent that the Corporation is not able to pay such excess amount in cash under applicable
law and in compliance with the terms of its indebtedness, the Corporation will not have any obligation to pay such amount in cash
or deliver additional shares of Common Stock in respect of such amount, and such amount shall not form a part of the cumulative
dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred Stock.</P>
<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;(f)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">To the extent that a Shelf Registration Statement is required in the Corporation&rsquo;s reasonable
judgment in connection with the issuance of, or for resales of, Common Stock issued as payment of a dividend on the shares of Mandatory
Convertible Preferred Stock, including dividends paid in connection with a conversion, the Corporation shall, to the extent such
a Shelf Registration Statement is not currently filed and effective, use its commercially reasonable efforts to file and maintain
the effectiveness of such a Shelf Registration Statement until the earlier of such time as all such shares of Common Stock have
been resold thereunder and such time as all such shares are freely tradable without registration by holders thereof that are not,
and have not been within the three months preceding, &ldquo;affiliates&rdquo; of the Corporation for purposes of the Securities
Act. To the extent applicable, the Corporation shall also use its commercially reasonable efforts to have such Common Stock approved
for listing on NYSE (or if the Common Stock is not listed on NYSE, on the principal other U.S. national or regional securities
exchange on which the Common Stock is then listed), and qualified or registered under applicable state securities laws, if required;
<U>provided</U> that the Corporation will not be required to qualify as a foreign corporation or to take any action that would
subject it to general service of process in any such jurisdiction where it is not presently qualified or where it is not presently
subject to taxation as a foreign corporation and such qualification or action would subject it to such taxation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;4.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Liquidation, Dissolution or Winding-Up</U></B><I>.</I> (a)&nbsp;In the event of any
voluntary or involuntary liquidation, winding-up or dissolution of the Corporation, each Holder shall be entitled to receive, per
share of Mandatory Convertible Preferred Stock, the Liquidation Preference of $100.00 per share of the Mandatory Convertible Preferred
Stock, plus an amount (the &ldquo;<U>Liquidation Dividend Amount</U>&rdquo;) equal to accumulated and unpaid dividends on such
share, whether or not declared, to, but excluding, the date fixed for liquidation, winding-up or dissolution to be paid out of
the assets of the Corporation legally available for distribution to its stockholders, after satisfaction of debt and other liabilities
owed to the Corporation&rsquo;s creditors and holders of shares of any Senior Stock and before any payment or distribution is made
to holders of any Junior Stock, including, without limitation, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">If, upon the voluntary or involuntary liquidation, winding-up or dissolution of the Corporation,
the amounts payable with respect to (1) the Liquidation Preference plus the Liquidation Dividend Amount on the shares of Mandatory
Convertible Preferred Stock and (2) the liquidation preference of, and the amount of accumulated and unpaid dividends (to, but
excluding, the date fixed for liquidation, winding-up or dissolution) on, all Parity Stock, if applicable, are not paid in full,
the Holders and all holders of any such Parity Stock shall share equally and ratably in any distribution of the Corporation&rsquo;s
assets in proportion to their respective liquidation preferences and amounts equal to the accumulated and unpaid dividends to which
they are entitled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">After the payment to any Holder of the full amount of the Liquidation Preference and the Liquidation
Dividend Amount for each of such Holder&rsquo;s shares of Mandatory Convertible Preferred Stock, such Holder as such shall have
no right or claim to any of the remaining assets of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Neither the sale, lease nor exchange of all or substantially all of Corporation&rsquo;s assets
or business (other than in connection with the liquidation, winding-up or dissolution of the Corporation), nor its merger or consolidation
into or with any other Person, shall be deemed to be the voluntary or involuntary liquidation, winding-up or dissolution of the
Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;5.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>No Redemption; No Sinking Fund</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Mandatory Convertible Preferred Stock shall
not be subject to any redemption, sinking fund or other similar provisions. However, at the Corporation&rsquo;s option, it may
purchase or exchange the Mandatory Convertible Preferred Stock from time to time in the open market, by tender or exchange offer
or otherwise, without the consent of, or notice to, Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;6.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Voting Rights</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>General</U>. Holders shall not have any voting rights other than those set forth in this
Section&nbsp;6, except as specifically required by Delaware law or by the Third Restated Certificate of Incorporation from time
to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Right to Elect Two Directors Upon Nonpayment. (i)&nbsp;Whenever dividends on any shares of
Mandatory Convertible Preferred Stock have not been declared and paid for the equivalent of six or more Dividend Periods (including,
for the avoidance of doubt, the Dividend Period commencing on, and including, the Initial Issue Date and ending on, but excluding,
September 1, 2020), whether or not for consecutive Dividend Periods (a &ldquo;Nonpayment&rdquo;), the authorized number of directors
on the Board of Directors shall, at the next annual meeting of the stockholders or at a special meeting of stockholders as provided
below, automatically be increased by two and Holders, voting together as a single class with holders of any and all other series
of Voting Preferred Stock then outstanding, shall be entitled, at the Corporation&rsquo;s next annual meeting of stockholders
or at a special meeting of stockholders as provided below, to vote for the election of a total of two additional members of the
Board of Directors (the &ldquo;Preferred Stock Directors&rdquo;); provided, however, that the election of any such Preferred Stock
Directors will not cause the Corporation to violate the corporate governance requirements of NYSE (or any other exchange or automated
quotation system on which the Corporation&rsquo;s securities may be listed or quoted) that requires listed or quoted companies
to have a majority of independent directors; and <U>provided</U>&nbsp;<U>further</U> that the Board of Directors shall, at no
time, include more than two Preferred Stock Directors. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
In the event of a Nonpayment, the holders of record of at least 25% of the shares of Mandatory Convertible Preferred Stock and
any other series of Voting Preferred Stock may request that a special meeting of stockholders be called to elect such Preferred
Stock Directors (<U>provided</U>, <U>however</U>, that if the next annual or a special meeting of stockholders is scheduled to
be held within 90 days of the receipt of such request, the election of such Preferred Stock Directors shall be included in the
agenda for, and shall be held at, such scheduled annual or special meeting of stockholders). The Preferred Stock Directors shall
stand for reelection annually, at each subsequent annual meeting of the stockholders, so long as the Holders continue to have such
voting rights. At any meeting at which the Holders are entitled to elect Preferred Stock Directors, the holders of record of a
majority of the then outstanding shares of Mandatory Convertible Preferred Stock and all other series of Voting Preferred Stock,
present in person or represented by proxy, shall constitute a quorum and the vote of the holders of a majority of such shares of
Mandatory Convertible Preferred Stock and other Voting Preferred Stock so present or represented by proxy at any such meeting at
which there shall be a quorum shall be sufficient to elect the Preferred Stock Directors. Whether a plurality, majority or other
portion in voting power of Mandatory Convertible Preferred Stock and any other Voting Preferred Stock have been voted in favor
of any matter shall be determined by reference to the respective liquidation preference amounts of the Mandatory Convertible Preferred
Stock and such other Voting Preferred Stock voted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
and when all accumulated and unpaid dividends on Mandatory Convertible Preferred Stock have been paid in full, or declared and
a sum or number of shares of Common Stock sufficient for such payment shall have been set aside for the benefit of the Holders
(a &ldquo;<U>Nonpayment Remedy</U>&rdquo;), the Holders shall immediately and, without any further action by the Corporation, be
divested of the voting rights described in this Section 6(b), subject to the revesting of such rights in the event of each subsequent
Nonpayment. If such voting rights for the Holders and all other holders of Voting Preferred Stock shall have terminated, the term
of office of each Preferred Stock Director so elected shall terminate at such time and the authorized number of directors on the
Board of Directors shall automatically decrease by two.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">(iv)&nbsp;&#9;&nbsp; Any
Preferred Stock Director may be removed at any time, with or without cause, by the Holders of a majority in voting power of
the outstanding shares of Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock then
outstanding (voting together as a single class), when they have the voting rights described in this Section 6(b). In the
event that a Nonpayment shall have occurred and there shall not have been a Nonpayment Remedy, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment) may be
filled by the written consent of the Preferred Stock Director remaining in office, except in the event that such vacancy is
created as a result of such Preferred Stock Director being removed or if no Preferred Stock Director remains in office, such
vacancy may be filled by a vote of the Holders of a majority in voting power of the outstanding shares of Mandatory
Convertible Preferred Stock and any other series of Voting Preferred Stock then outstanding (voting together as a single
class) when they have the voting rights described above; <U>provided</U>, <U>however</U>, that the election of any such
Preferred Stock Directors to fill such vacancy will not cause the Corporation to violate the corporate governance
requirements of NYSE (or any other exchange or automated quotation system on which the Corporation&rsquo;s securities may be
listed or quoted) that requires listed or quoted companies to have a majority of independent directors. The Preferred Stock
Directors shall each be entitled to one vote per director on any matter that shall come before the Board of Directors for a
vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Other Voting Rights</U>. So long as any shares of Mandatory Convertible Preferred Stock
are outstanding, the Corporation shall not, without the affirmative vote or consent of the Holders of at least two-thirds in voting
power of the outstanding shares of Mandatory Convertible Preferred Stock and all other series of Voting Preferred Stock at the
time outstanding and entitled to vote thereon (subject to the last paragraph of this Section&nbsp;6(c)), voting together as a single
class, given in person or by proxy, either in writing without a meeting or by vote at an annual or special meeting of such stockholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">amend
or alter the provisions of the Third Restated Certificate of Incorporation so as to authorize or create, or increase the authorized
number of, any class or series of Senior Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">amend,
alter or repeal any provision of the Third Restated Certificate of Incorporation or the Certificate of Designations so as to adversely
affect the special rights, preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">consummate
a binding share exchange or reclassification involving the shares of Mandatory Convertible Preferred Stock or a merger or consolidation
of the Corporation with another entity, unless in each case: (i) the shares of Mandatory Convertible Preferred Stock remain outstanding
and are not amended in any respect or, in the case of any such merger or consolidation with respect to which the Corporation is
not the surviving or resulting entity, are converted into or exchanged for preference securities of the surviving or resulting
entity or its ultimate parent; and (ii) the shares of the Mandatory Convertible Preferred Stock that remain outstanding or such
shares of preference securities, as the case may be, have such rights, preferences, privileges and voting powers that, taken as
a whole, are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers of
the Mandatory Convertible Preferred Stock immediately prior to the consummation of such transaction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.25in"><U>provided</U>, <U>however</U>, that
in the event a transaction would trigger voting rights under clauses (ii) and (iii) above, clause (iii) shall govern; <U>provided</U>,
<U>further</U>, <U>however</U>, that for all purposes of this Section 6(c):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD><FONT STYLE="font-size: 10pt">any increase in the number of the Corporation&rsquo;s authorized but unissued shares of Preferred
Stock,</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD><FONT STYLE="font-size: 10pt">any increase in the number of the Corporation&rsquo;s authorized or issued shares of Mandatory
Convertible Preferred Stock, and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD><FONT STYLE="font-size: 10pt">the creation and issuance, or an increase in the authorized or issued number, of any class or
series of Parity Stock or Junior Stock, </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">shall be deemed not to adversely affect the rights, preferences,
privileges or voting powers of the Mandatory Convertible Preferred Stock and shall not require the affirmative vote or consent
of Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If any amendment, alteration, repeal, binding
share exchange, reclassification, merger or consolidation specified in this Section&nbsp;6(c)&nbsp;would adversely affect the rights,
preferences, privileges or voting powers of one or more but not all series of Voting Preferred Stock (including the Mandatory Convertible
Preferred Stock for this purpose), then only the series of Voting Preferred Stock the rights, preferences, privileges or voting
powers of which are adversely affected and entitled to vote, shall vote as a class in lieu of all other series of Voting Preferred
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without
the consent of the Holders, so long as such action does not adversely affect the special rights, preferences, privileges or voting
powers of the Mandatory Convertible Preferred Stock, the Corporation may amend, alter, supplement or repeal any terms of the Mandatory
Convertible Preferred Stock for the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD>to cure any ambiguity, omission or mistake, or to correct or supplement any provision contained in the Certificate of Designations
that may be defective or inconsistent with any other provision contained in the Certificate of Designations; or</TD></TR></TABLE>
<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>to make any provision with respect to matters or questions relating to the Mandatory Convertible Preferred Stock that is not
inconsistent with the provisions of the Third Restated Certificate of Incorporation or the Certificate of Designations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition, without the consent of the Holders, the Corporation
may amend, alter, supplement or repeal any terms of the Mandatory Convertible Preferred Stock in order to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD>conform the
terms of the Mandatory Convertible Preferred Stock to the description thereof in the &ldquo;Description of Mandatory
Convertible Preferred Stock&rdquo; section of the Prospectus Supplement; or</TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>file a certificate of correction with respect to the Certificate of Designations to the extent permitted by Section 103(f)
of the Delaware General Corporation Law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Prior to the close of business on the applicable Conversion Date, the shares of Common Stock issuable upon conversion of
the Mandatory Convertible Preferred Stock shall not be deemed to be outstanding for any purposes and Holders shall have no rights,
powers or preferences with respect to such shares of Common Stock by virtue of holding the Mandatory Convertible Preferred Stock,
including the right to vote on any amendment to the Corporation&rsquo;s Third Restated Certificate of Incorporation or this Certificate
of Designations that would adversely affect the rights of holders of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The number of votes that each share of Mandatory Convertible Preferred Stock and any Voting Preferred Stock participating
in the votes set forth in this Section 6 shall have and shall be in proportion to the liquidation preference of such share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The rules and procedures for calling and conducting any meeting of the Holders (including, without limitation, the fixing
of a record date in connection therewith), the solicitation and use of proxies at such a meeting, the obtaining of written consents
and any other procedural aspect or matter with regard to such a meeting or such consents shall be governed by any rules the Board
of Directors, in its discretion, may adopt from time to time, which rules and procedures shall conform to the requirements of the
Third Restated Certificate of Incorporation, the By-Laws, applicable law and the rules of any national securities exchange or other
trading facility on which the Mandatory Convertible Preferred Stock is listed or traded at the time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;7.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Mandatory Conversion on the Mandatory Conversion Date</U></B>. (a)&nbsp;Each outstanding
share of Mandatory Convertible Preferred Stock shall automatically convert (unless previously converted in accordance with Section&nbsp;8
or Section&nbsp;9) on the Mandatory Conversion Date (&ldquo;<U>Mandatory Conversion</U>&rdquo;), into a number of shares of Common
Stock equal to the Mandatory Conversion Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The &ldquo;<U>Mandatory Conversion Rate</U>&rdquo; shall, subject to adjustment in accordance
with Section&nbsp;7(c), be as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">if the Applicable Market Value is greater than the Threshold Appreciation Price, then the
Mandatory Conversion Rate shall be equal to 2.3834 shares of Common Stock per share of Mandatory Convertible Preferred Stock (the
&ldquo;<U>Minimum Conversion Rate</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">if the Applicable Market Value is less than or equal to the Threshold Appreciation Price but
equal to or greater than the Initial Price, then the Mandatory Conversion Rate per share of Mandatory Convertible Preferred Stock
shall be equal to $100.00 <I>divided by</I> the Applicable Market Value, rounded to the nearest ten-thousandth of a share of Common
Stock; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">if the Applicable Market Value is less than the Initial Price, then the Mandatory Conversion
Rate shall be equal to 2.9197 shares of Common Stock per share of Mandatory Convertible Preferred Stock (the &ldquo;<U>Maximum
Conversion Rate</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>provided</U> that the Fixed Conversion Rates are each subject
to adjustment in accordance with the provisions of Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">If
the Corporation declares a dividend for the Dividend Period ending on, but excluding, June 1, 2023, the Corporation shall pay such
dividend to the Record Holders as of the immediately preceding Regular Record Date, in accordance with Section&nbsp;3. If on or
prior to June 1, 2023, the Corporation has not declared all or any portion of the accumulated and unpaid dividends on the Mandatory
Convertible Preferred Stock through June 1, 2023, the Mandatory Conversion Rate shall be adjusted so that Holders receive an additional
number of shares of Common Stock equal to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the amount of such accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock that have not been
declared (&ldquo;<U>Mandatory Conversion Additional Conversion Amount</U>&rdquo;), <I>divided by</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the greater of (x) the Floor Price and (y) 97% of the Average Price (calculated using June 1, 2023 as the applicable Dividend
Payment Date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">To the extent that the Mandatory Conversion
Additional Conversion Amount exceeds the product of such number of additional shares and 97% of the Average Price, the Corporation
shall, to the extent it is able to do so under applicable law and in compliance with the Corporation&rsquo;s indebtedness, declare
and pay such excess amount in cash (computed to the nearest cent) <U>pro rata</U> per share to the Holders. To the extent that
the Corporation is not able to pay such excess amount in cash under applicable law and in compliance with its indebtedness, the
Corporation shall not have any obligation to pay such amount in cash or deliver additional shares of Common Stock in respect of
such amount, and such amount will not form a part of the cumulative dividends that may be deemed to accumulate on the shares of
Mandatory Convertible Preferred Stock.<FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">For the avoidance of doubt, the Mandatory
Conversion Rate shall in no event exceed the Maximum Conversion Rate, subject to adjustment in accordance with the provisions of
Section 13, and exclusive of any amounts owing in respect of any Mandatory Conversion Additional Conversion Amount or any accrued
and unpaid dividends paid at the Corporation&rsquo;s election in shares of Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;<B>Section&nbsp;8.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Early Conversion at the Option of the Holder</U></B>. (a)&nbsp;Other than during a Fundamental
Change Conversion Period, subject to satisfaction of the conversion procedures set forth in Section 10, the Holders shall have
the right to convert their Mandatory Convertible Preferred Stock, in whole or in part (but in no event less than one share of Mandatory
Convertible Preferred Stock), at any time prior to June 1, 2023 (&ldquo;<U>Early Conversion</U>&rdquo;), into shares of Common
Stock at the Minimum Conversion Rate, subject to adjustment in accordance with Section 8(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">If, as of any Early Conversion Date, the Corporation has not declared all or any portion of
the accumulated and unpaid dividends for all full Dividend Periods ending on a Dividend Payment Date prior to such Early Conversion
Date, the Minimum Conversion Rate shall be adjusted, with respect to the relevant Early Conversion, so that the Holders converting
their Mandatory Convertible Preferred Stock at such time receive an additional number of shares of Common Stock equal to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such amount of accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock that have not been declared
for such prior full Dividend Periods (the &ldquo;<U>Early Conversion Additional Conversion Amount</U>&rdquo;), <I>divided by</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the greater of (x) the Floor Price and (y) the Average VWAP per share of the Common Stock over the 20 consecutive Trading
Day period (the &ldquo;<U>Early Conversion Settlement Period</U>&rdquo;) commencing on, and including, the 21st Scheduled Trading
Day immediately preceding the Early Conversion Date (such average VWAP, the &ldquo;<U>Early Conversion Average Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.75in">To the extent that the Early Conversion
Additional Conversion Amount exceeds the product of such number of additional shares and the Early Conversion Average Price, the
Corporation shall not have any obligation to pay the shortfall in cash or deliver shares of Common Stock in respect of such shortfall.</P>
<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.75in">Except as set forth in the first sentence
of this Section&nbsp;8(b), upon any Early Conversion of any shares of Mandatory Convertible Preferred Stock, the Corporation shall
make no payment or allowance for unpaid dividends on such shares of Mandatory Convertible Preferred Stock, unless such Early Conversion
Date occurs after the Regular Record Date for a declared dividend and on or prior to the immediately succeeding Dividend Payment
Date, in which case the Corporation shall pay such dividend on such Dividend Payment Date to the Record Holder of the converted
shares of Mandatory Convertible Preferred Stock as of such Regular Record Date, in accordance with Section&nbsp;3.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;Section&nbsp;9.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Fundamental Change Conversion</U></B><I>.</I> (a)&nbsp;If a Fundamental Change occurs
on or prior to June 1, 2023, the Holders shall have the right (the &ldquo;<U>Fundamental Change Conversion Right</U>&rdquo;) during
the Fundamental Change Conversion Period to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>convert their shares of Mandatory Convertible Preferred Stock, in whole or in part (but in no event less than one share
of Mandatory Convertible Preferred Stock) (any such conversion pursuant to this Section&nbsp;9(a)&nbsp;being a &ldquo;<U>Fundamental
Change Conversion</U>&rdquo;) into a number of shares of Common Stock (or Units of Exchange Property in accordance with Section
14) equal to the Fundamental Change Conversion Rate per share of Mandatory Convertible Preferred Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 31.5pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>with respect to such converted shares of Mandatory Convertible Preferred Stock, receive an amount equal to the present value,
calculated using a discount rate of 5.00% per annum, of all dividend payments (excluding any Accumulated Dividend Amount) on such
shares for (a) the partial Dividend Period, if any, from, and including, the Fundamental Change Effective Date to, but excluding,
the next Dividend Payment Date and (b) all remaining full Dividend Periods from, and including, the Dividend Payment Date following
the Fundamental Change Effective Date to, but excluding, the Mandatory Conversion Date (the &ldquo;<U>Fundamental Change Dividend
Make-Whole Amount</U>&rdquo;), payable in cash to the extent the Corporation is able to do so under applicable law and in compliance
with it indebtedness; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 31.5pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>with respect to such converted shares of Mandatory Convertible Preferred Stock, receive the Accumulated Dividend Amount
payable in cash or shares of Common Stock,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">subject, in the case of clauses (ii)&nbsp;and (iii),&nbsp;to the
Corporation&rsquo;s right to deliver shares of Common Stock in lieu of all or part of such amounts as set forth in Section 9(d);
<U>provided</U> that, if the Fundamental Change Effective Date or the Fundamental Change Conversion Date falls after the Regular
Record Date for a Dividend Period for which the Corporation has declared a dividend and prior to the next Dividend Payment Date,
the Corporation shall pay such dividend on the relevant Dividend Payment Date to the Record Holders as of such Regular Record Date,
in accordance with Section&nbsp;3, and the Accumulated Dividend Amount shall not include the amount of such dividend, and the Fundamental
Change Dividend Make-Whole Amount shall not include the present value of the payment of such dividend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
exercise the Fundamental Change Conversion Right, a Holder must submit its shares of Mandatory Convertible Preferred Stock for
conversion at any time during the Fundamental Change Conversion Period. Holders that submit their shares of Mandatory Convertible
Preferred Stock during the Fundamental Change Conversion Period shall be deemed to have exercised their Fundamental Change Conversion
Right. Holders who do not submit their shares for conversion during the Fundamental Change Conversion Period shall not be entitled
to convert their Mandatory Convertible Preferred Stock at the relevant Fundamental Change Conversion Rate or to receive the relevant
Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Corporation shall provide written notice
(the &ldquo;<U>Fundamental Change Notice</U>&rdquo;) to Holders of the Fundamental Change Effective Date no later than the second
Business Day immediately following such Fundamental Change Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fundamental Change Notice shall state:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the event causing the Fundamental Change;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the anticipated Fundamental Change Effective Date or actual Fundamental Change Effective Date,
as the case may be;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">that Holders shall have the right to effect a Fundamental Change Conversion in connection
with such Fundamental Change during the Fundamental Change Conversion Period;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iv)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the Fundamental Change Conversion Period; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(v)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the instructions a Holder must follow to effect a Fundamental Change Conversion in connection
with such Fundamental Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Not later than the second Business Day following the Fundamental Change Effective Date, the
Corporation shall notify Holders of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the Fundamental Change Conversion Rate (if notice is provided to Holders prior to the anticipated
Fundamental Change Effective Date, specifying how the Fundamental Change Conversion Rate will be determined);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the Fundamental Change Dividend Make-Whole Amount and whether the Corporation will pay such
amount in cash, shares of Common Stock (or to the extent applicable, Units of Exchange Property) or a combination thereof, specifying
the combination, if applicable; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the Accumulated Dividend Amount as of the Fundamental Change Effective Date and whether the
Corporation will pay such amount in cash, shares of Common Stock (or to the extent applicable, Units of Exchange Property) or a
combination thereof, specifying the combination, if applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">(i)&nbsp;For any shares of Mandatory Convertible Preferred Stock that are converted during
the Fundamental Change Conversion Period, in addition to the Common Stock issued upon conversion at the Fundamental Change Conversion
Rate, the Corporation shall, at its option (subject to satisfaction of the requirements of this Section 9):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(A)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">pay the Fundamental Change Dividend Make-Whole Amount in cash (computed to the nearest cent),
to the extent the Corporation is able to do so under applicable law and in compliance with its indebtedness;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(B)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">increase the number of shares of Common Stock (or Units of Exchange Property) to be issued
upon conversion by a number equal to (x)&nbsp;the Fundamental Change Dividend Make-Whole Amount <I>divided by</I> (y)&nbsp;the
greater of (i) the Floor Price and (ii) 97% of the Fundamental Change Share Price; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(C)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">pay the Fundamental Change Dividend Make-Whole Amount through any combination of cash and
shares of Common Stock (or Units of Exchange Property) in accordance with the provisions of clauses (A)&nbsp;and (B)&nbsp;above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">In addition, to the extent that the Accumulated Dividend Amount exists as of the Fundamental
Change Effective Date, the converting Holder shall be entitled to receive such Accumulated Dividend Amount upon such Fundamental
Change Conversion. The Corporation shall, at its option, pay the Accumulated Dividend Amount (subject to satisfaction of the requirements
of this Section 9):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(A)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">in cash (computed to the nearest cent), to the extent the Corporation is able to do so under
applicable law and in compliance with its indebtedness;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(B)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">in an additional number of shares of Common Stock (or Units of Exchange Property) equal to
(x)&nbsp;the Accumulated Dividend Amount <I>divided by</I> (y)&nbsp;the greater of (i) the Floor Price and (ii) 97% of the Fundamental
Change Share Price; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(C)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">through any combination of cash and shares of Common Stock (or Units of Exchange Property)
in accordance with the provisions of clauses (A)&nbsp;and (B)&nbsp;above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The Corporation shall pay the Fundamental Change Dividend Make-Whole Amount and the Accumulated
Dividend Amount in cash, except to the extent the Corporation elects on or prior to the second Business Day following the relevant
Fundamental Change Effective Date to make all or any portion of such payments in Common Stock (or Units of Exchange Property).
If the Corporation elects to deliver Common Stock (or Units of Exchange Property) in respect of all or any portion of the Fundamental
Change Dividend Make-Whole Amount or the Accumulated Dividend Amount, to the extent that the Fundamental Change Dividend Make-Whole
Amount or the Accumulated Dividend Amount or the dollar amount of any portion thereof paid in Common Stock (or Units of Exchange
Property) exceeds the product of (x) the number of additional shares the Corporation delivers in respect thereof and (y) 97% of
the Fundamental Change Share Price, the Corporation shall, to the extent it is able to do so under applicable law and in compliance
with the Corporation&rsquo;s indebtedness, pay such excess amount in cash (computed to the nearest cent). To the extent that the
Corporation is not able to pay such excess amount in cash under applicable law and in compliance with its indebtedness, the Corporation
shall not have any obligation to pay such amount in cash or deliver additional shares of Common Stock in respect of such amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iv)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">No fractional shares of Common Stock (or, to the extent applicable, Units of Exchange Property)
shall be delivered by the Corporation to converting Holders in respect of the Fundamental Change Dividend Make-Whole Amount or
the Accumulated Dividend Amount. The Corporation shall instead, to the extent it is able to do so under applicable law and in compliance
with its indebtedness, pay a cash amount (computed to the nearest cent) to each a converting Holder that would otherwise be entitled
to receive a fraction of a share of Common Stock (or to the extent applicable, Units of Exchange Property) based on the Average
VWAP per share of Common Stock (or to the extent applicable, Units of Exchange Property) over the five consecutive Trading Day
period commencing on, and including, the seventh Scheduled Trading Day immediately preceding the relevant Fundamental Change Conversion
Date. In the event the Corporation cannot pay cash in lieu of a fractional share, the Corporation shall instead round up to the
nearest whole share for each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Corporation is prohibited from paying or delivering, as the case may be, the Fundamental Change Dividend Make-Whole Amount
(whether in cash or in shares of Common Stock), in whole or in part, due to limitations of applicable law, then the Fundamental
Change Conversion Rate will instead be increased by a number of shares of Common Stock equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(A)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the cash amount of the aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole
Amount, <I>divided by</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(B)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the greater of (i) the Floor Price and (ii) 97% of the Fundamental Change Share Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">To the extent that the cash amount
of the aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount exceeds the product of such number of additional
shares and 97% of the Fundamental Change Share Price, the Corporation shall not have any obligation to pay the shortfall in cash
or deliver additional shares of Common Stock in respect of such amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;10.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Conversion Procedures</U></B><I>.</I> (a)&nbsp;Pursuant to Section&nbsp;7, on the Mandatory
Conversion Date, any outstanding shares of Mandatory Convertible Preferred Stock shall mandatorily and automatically convert into
shares of Common Stock. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A Holder of shares of the Mandatory Convertible
Preferred Stock that are mandatorily converted shall not be required to pay any transfer or similar taxes or duties relating to
the issuance or delivery of the Common Stock upon conversion, except that such Holder shall be required to pay any tax or duty
that may be payable relating to any transfer involved in the issuance or delivery of the Common Stock in a name other than the
name of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A certificate representing the shares of Common
Stock issuable upon conversion shall be issued and delivered to the converting Holder or, if Mandatory Convertible Preferred Stock
being converted are in book-entry form, the shares of Common Stock issuable upon conversion shall be delivered to the converting
Holder through book-entry transfer through the facilities of the Depositary, in each case, together with delivery by the Corporation
to the converting Holder of any cash to which the converting Holder is entitled, only after all applicable taxes and duties, if
any, payable by the converting Holder have been paid in full, on the later of (i) the Mandatory Conversion Date and (ii) the Business
Day after the Holder has paid in full all applicable taxes and duties, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Person or Persons entitled to receive the
shares of Common Stock issuable upon Mandatory Conversion shall be treated as the record holder(s)&nbsp;of such shares of Common
Stock as of the close of business on the Mandatory Conversion Date. Prior to the close of business on the Mandatory Conversion
Date, the Common Stock issuable upon conversion of Mandatory Convertible Preferred Stock on the Mandatory Conversion Date shall
not be deemed to be outstanding for any purpose and Holders shall have no rights, powers or preferences with respect to such Common
Stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on
the Common Stock, by virtue of holding Mandatory Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To effect an Early Conversion pursuant to Section 8, a Holder must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>complete and manually sign the conversion notice on the back of the Mandatory Convertible Preferred Stock certificate or
a facsimile of such conversion notice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>deliver the completed conversion notice and the certificated shares of Mandatory Convertible Preferred Stock to be converted
to the Conversion and Dividend Disbursing Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if required, furnish appropriate endorsements and transfer documents; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if required, pay all transfer or similar taxes or duties, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Notwithstanding the foregoing, to effect an Early Conversion
pursuant to Section 8 of shares of Mandatory Convertible Preferred Stock held in global form, the Holder must, in lieu of the foregoing,
comply with the applicable procedures of DTC (or any other Depositary for the shares of Mandatory Convertible Preferred Stock held
in global form appointed by the Corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">The Early Conversion shall be effective on the
date on which a Holder has satisfied the foregoing requirements, to the extent applicable (&ldquo;<U>Early Conversion Date</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">A Holder shall not be required to pay any transfer
or similar taxes or duties relating to the issuance or delivery of Common Stock upon conversion, but such Holder shall be required
to pay any tax or duty that may be payable relating to any transfer involved in the issuance or delivery of Common Stock in a name
other than the name of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">A certificate representing the shares of Common
Stock issuable upon conversion shall be issued and delivered to the converting Holder or, if Mandatory Convertible Preferred Stock
being converted are in book-entry form, the shares of Common Stock issuable upon conversion shall be delivered to the converting
Holder through book-entry transfer through the facilities of the Depositary, in each case, together with delivery by the Corporation
to the converting Holder of any cash to which the converting Holder is entitled, only after all applicable taxes and duties, if
any, payable by the Holder have been paid in full, on the latest of (i)&nbsp;the second Business Day immediately succeeding the
Early Conversion Date, (ii)&nbsp;the second Business Day immediately succeeding the last day of the Early Conversion Settlement
Period, if applicable, and (iii)&nbsp;the Business Day after the Holder has paid in full all applicable taxes and duties, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">The Person or Persons entitled to receive the
shares of Common Stock issuable upon Early Conversion shall be treated for all purposes as the record holder(s)&nbsp;of such shares
of Common Stock as of the close of business on the applicable Early Conversion Date. Prior to the close of business on such applicable
Early Conversion Date, the shares of Common Stock issuable upon conversion of any shares of Mandatory Convertible Preferred Stock
shall not be deemed to be outstanding for any purpose, and Holders shall have no rights, powers or preferences with respect to
such shares of Common Stock, including voting rights, rights to respond to tender offers for the Common Stock and rights to receive
any dividends or other distributions on the Common Stock, by virtue of holding shares of Mandatory Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">In the event that an Early Conversion is effected
with respect to shares of Mandatory Convertible Preferred Stock representing less than all the shares of Mandatory Convertible
Preferred Stock held by a Holder, upon such Early Conversion, the Corporation shall execute and instruct the Registrar and Transfer
Agent to countersign and deliver to the Holder thereof, at the expense of the Corporation, a certificate evidencing the shares
of Mandatory Convertible Preferred Stock as to which Early Conversion was not effected, or, if Mandatory Convertible Preferred
Stock is held in book-entry form, the Corporation shall cause the Registrar and Transfer Agent to reduce the number of shares of
Mandatory Convertible Preferred Stock represented by the global certificate by making a notation on Schedule I attached to the
global certificate or otherwise notate such reduction in the register maintained by such Registrar and Transfer Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)<FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To effect a Fundamental Change Conversion pursuant to Section 9, a Holder must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>complete and manually sign the conversion notice on the back of the Mandatory Convertible Preferred Stock certificate or
a facsimile of such conversion notice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>deliver the completed conversion notice and the certificated shares of Mandatory Convertible Preferred Stock to be converted
to the Conversion and Dividend Disbursing Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if required, furnish appropriate endorsements and transfer documents; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if required, pay all transfer or similar taxes or duties, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Notwithstanding the foregoing, to effect a Fundamental Change
Conversion pursuant to Section 9 of shares of Mandatory Convertible Preferred Stock held in global form, the Holder must, in lieu
of the foregoing, comply with the applicable procedures of DTC (or any other Depositary for the shares of Mandatory Convertible
Preferred Stock held in global form appointed by the Corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">The Fundamental Change Conversion shall be effective
on the date on which a Holder has satisfied the foregoing requirements, to the extent applicable (the &ldquo;<U>Fundamental Change
Conversion Date</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">A Holder shall not be required to pay any transfer
or similar taxes or duties relating to the issuance or delivery of Common Stock upon conversion, but such Holder shall be required
to pay any tax or duty that may be payable relating to any transfer involved in the issuance or delivery of Common Stock in a name
other than the name of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">A certificate representing the shares of Common
Stock issuable upon conversion shall be issued and delivered to the converting Holder or, if Mandatory Convertible Preferred Stock
being converted are in book-entry form, the shares of Common Stock issuable upon conversion shall be delivered to the converting
Holder through book-entry transfer through the facilities of the Depositary, in each case, together with delivery by the Corporation
to the converting Holder of any cash to which the converting Holder is entitled, only after all applicable taxes and duties, if
any, payable by the converting Holder have been paid in full, on the later of (i)&nbsp;the second Business Day immediately succeeding
the Fundamental Change Conversion Date and (ii)&nbsp;the Business Day after the Holder has paid in full all applicable taxes and
duties, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">The Person or Persons entitled to receive the
shares of Common Stock issuable upon such Fundamental Change Conversion shall be treated for all purposes as the record holder(s)&nbsp;of
such shares of Common Stock as of the close of business on the applicable Fundamental Change Conversion Date. Prior to the close
of business on such applicable Fundamental Change Conversion Date, the shares of Common Stock issuable upon conversion of any shares
of Mandatory Convertible Preferred Stock shall not be deemed to be outstanding for any purpose, and Holders shall have no rights,
powers or preferences with respect to the Common Stock, including voting rights, rights to respond to tender offers for the Common
Stock and rights to receive any dividends or other distributions on the Common Stock, by virtue of holding shares of Mandatory
Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">In the event that a Fundamental Change Conversion
is effected with respect to shares of Mandatory Convertible Preferred Stock representing less than all the shares of Mandatory
Convertible Preferred Stock held by a Holder, upon such Fundamental Change Conversion the Corporation shall execute and instruct
the Registrar and Transfer Agent to countersign and deliver to the Holder thereof, at the expense of the Corporation, a certificate
evidencing the shares of Mandatory Convertible Preferred Stock as to which Fundamental Change Conversion was not effected, or,
if Mandatory Convertible Preferred Stock is held in book-entry form, the Corporation shall cause the Registrar and Transfer Agent
to reduce the number of shares of Mandatory Convertible Preferred Stock represented by the global certificate by making a notation
on Schedule I attached to the global certificate or otherwise notate such reduction in the register maintained by such Registrar
and Transfer Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">In the event that a Holder shall not by written notice designate the name in which shares
of Common Stock to be issued upon conversion of such Mandatory Convertible Preferred Stock should be registered or, if applicable,
the address to which the certificate or certificates representing such shares of Common Stock should be sent, the Corporation shall
be entitled to register such shares, and make such payment, in the name of the Holder as shown on the records of the Corporation
and, if applicable, to send the certificate or certificates representing such shares of Common Stock to the address of such Holder
shown on the records of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Shares of Mandatory Convertible Preferred Stock shall cease to be outstanding on the applicable
Conversion Date, subject to the right of Holders of such shares to receive shares of Common Stock issuable upon conversion of such
shares of Mandatory Convertible Preferred Stock and other amounts and shares of Common Stock, if any, to which they are entitled
pursuant to Sections 7, 8 or 9, as applicable and, if the applicable Conversion Date occurs after the Regular Record Date for a
declared dividend and prior to the immediately succeeding Dividend Payment Date, subject to the right of the Record Holders of
such shares of the Mandatory Convertible Preferred Stock on such Regular Record Date to receive payment of the full amount of such
declared dividend on such Dividend Payment Date pursuant to Section&nbsp;3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;11.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Reservation of Common Stock</U></B><I>.</I> (a)&nbsp;The Corporation shall at all times
reserve and keep available out of its authorized and unissued Common Stock, solely for issuance upon the conversion of shares of
Mandatory Convertible Preferred Stock as herein provided, free from any preemptive or other similar rights, a number of shares
of Common Stock equal to the maximum number of shares of Common Stock deliverable upon conversion of all shares of Mandatory Convertible
Preferred Stock (which shall initially equal a number of shares of Common Stock equal to the sum of the product of (i) 10,062,500
shares of Mandatory Convertible Preferred Stock, and (ii) the initial Maximum Conversion Rate. For purposes of this Section&nbsp;11(a),
the number of shares of Common Stock that shall be deliverable upon the conversion of all outstanding shares of Mandatory Convertible
Preferred Stock shall be computed as if at the time of computation all such outstanding shares were held by a single Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Notwithstanding the foregoing, the Corporation shall be entitled to deliver upon conversion
of shares of Mandatory Convertible Preferred Stock or as payment of any dividend on such shares of Mandatory Convertible Preferred
Stock, as herein provided, shares of Common Stock reacquired and held in the treasury of the Corporation (in lieu of the issuance
of authorized and unissued shares of Common Stock), so long as any such treasury shares are free and clear of all liens, charges,
security interests or encumbrances (other than liens, charges, security interests and other encumbrances created by the Holders).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">All shares of Common Stock delivered upon conversion of, or as payment of a dividend on, the
Mandatory Convertible Preferred Stock shall be duly authorized, validly issued, fully paid and non-assessable, free and clear of
all liens, claims, security interests and other encumbrances (other than liens, charges, security interests and other encumbrances
created by the Holders) and free of preemptive rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Prior to the delivery of any securities that the Corporation shall be obligated to deliver
upon conversion of Mandatory Convertible Preferred Stock, the Corporation shall use commercially reasonable efforts to comply with
all federal and state laws and regulations thereunder requiring the registration of such securities with, or any approval of or
consent to the delivery thereof by, any governmental authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The Corporation hereby covenants and agrees that, if at any time the Common Stock shall be
listed on NYSE or any other national securities exchange or automated quotation system, the Corporation shall, if permitted by
the rules&nbsp;of such exchange or automated quotation system, list and use its commercially reasonable efforts to keep listed,
so long as the Common Stock shall be so listed on such exchange or automated quotation system, all Common Stock issuable upon conversion
(including, for the avoidance of doubt, with respect to the Mandatory Conversion Additional Conversion Amount or Early Conversion
Additional Conversion Amount) of,&nbsp;or issuable in respect of the payment of dividends, the Accumulated Dividend Amount and
the Fundamental Change Dividend Make-Whole Amount on, the Mandatory Convertible Preferred Stock; <U>provided</U>, <U>however</U>,
that if the rules of such exchange or automated quotation system permit the Corporation to defer the listing of such Common Stock
until the earlier of (x) the first conversion of Mandatory Convertible Preferred Stock into Common Stock in accordance with the
provisions hereof and (y) the first payment of any dividends, any Accumulated Dividend Amount or any Fundamental Change Dividend
Make-Whole Amount on the Mandatory Convertible Preferred Stock, the Corporation covenants to list such Common Stock issuable upon
the earlier of (1) the first conversion of the Mandatory Convertible Preferred Stock and (2) the first payment of any dividends,
any Accumulated Dividend Amount or any Fundamental Change Dividend Make-Whole Amount on the Mandatory Convertible Preferred Stock
in accordance with the requirements of such exchange or automated quotation system at such time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;12.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Fractional Shares</U></B><I>.</I> (a)&nbsp;No fractional shares of Common Stock shall
be issued to Holders as a result of any conversion of shares of Mandatory Convertible Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">In lieu of any fractional shares of Common Stock otherwise issuable in respect of the shares
of Mandatory Convertible Preferred Stock of any Holder that are converted on the Mandatory Conversion Date pursuant to Section&nbsp;7
or at the option of the Holder pursuant to Section&nbsp;8 or Section&nbsp;9, the Corporation shall pay an amount in cash (computed
to the nearest cent) equal to the product of (i)&nbsp;that same fraction and (ii)&nbsp;the Average VWAP of the Common Stock over
the five consecutive Trading Day period commencing on, and including, the seventh Scheduled Trading Day immediately preceding the
Mandatory Conversion Date, Early Conversion Date or Fundamental Change Conversion Date, as applicable. In the event that the Corporation
cannot pay cash in lieu of a fractional share, the Corporation shall instead round up to the nearest whole share for each Holder.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to any applicable rules and procedures of the Depositary, if more than one share of the Mandatory Convertible Preferred Stock is
surrendered for conversion at one time by or for the same Holder, the number of shares of full shares of Common Stock issuable
upon conversion thereof shall be computed on the basis of the aggregate number of shares of Mandatory Convertible Preferred Stock
so surrendered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;13.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Anti-Dilution Adjustments to the Fixed Conversion Rates</U></B><I>.</I> (a)&nbsp;Each
Fixed Conversion Rate shall be adjusted as set forth in this Section 13, except that the Corporation shall not make any adjustments
to the Fixed Conversion Rates if Holders participate (other than in the case of a share split or share combination), at the same
time and upon the same terms as holders of Common Stock and solely as a result of holding the Mandatory Convertible Preferred Stock,
in any of the transactions set forth in Sections 13(a)(i)-(vi) without having to convert their Mandatory Convertible Preferred
Stock as if they held a number of shares of Common Stock equal to (i) the Maximum Conversion Rate as of the Record Date for such
transaction, multiplied by (ii) the number of shares of Mandatory Convertible Preferred Stock held by such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Corporation exclusively issues shares of Common Stock as a dividend or distribution on shares of Common Stock, or
if the Corporation effects a share split or share combination, each Fixed Conversion Rate shall be adjusted based on the following
formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD ROWSPAN="2" STYLE="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = CR<SUB>0</SUB> &times;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 1pt solid">OS<SUB>1</SUB></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">OS<SUB>0</SUB></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">where,</TD><TD></TD></TR></TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 8%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately prior to the close of business on the Record Date of such dividend or distribution, or immediately prior to the open of business on the Effective Date of such share split or share combination, as applicable;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = </FONT></TD>
    <TD STYLE="width: 92%; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately after the close of business on such Record Date or immediately after the open of business on such Effective Date, as applicable;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">OS<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">the number of shares of Common Stock outstanding immediately prior to the close of business on such Record Date or immediately prior to the open of business on such Effective Date, as applicable, before giving effect to such dividend, distribution, share split or share combination; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">OS<SUB>1</SUB> = </FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">the number of shares of Common Stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Any adjustment made under this Section
13(a)(i) shall become effective immediately after the close of business on the Record Date for such dividend or distribution, or
immediately after the open of business on the Effective Date for such share split or share combination, as applicable. If any dividend
or distribution of the type set forth in this Section 13(a)(i) is declared but not so paid or made, each Fixed Conversion Rate
shall be immediately readjusted, effective as of the date the Board of Directors or a committee thereof determines not to pay such
dividend or distribution, to such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been
declared. For the purposes of this clause (i), the number of shares of Common Stock outstanding immediately prior to the close
of business on the Record Date and the number of shares of Common Stock outstanding immediately after giving effect to such dividend,
distribution, share split or share combination shall, in each case, not include shares that the Corporation holds in treasury.
The Corporation shall not pay any dividend or make any distribution on shares of Common Stock that it holds in treasury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Corporation issues to all or substantially all holders of Common Stock any rights, options or warrants entitling
them, for a period of not more than 60 calendar days after the announcement date of such issuance, to subscribe for or purchase
shares of Common Stock at a price per share that is less than the Average VWAP per share of Common Stock for the 10 consecutive
Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, each
Fixed Conversion Rate shall be increased based on the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD ROWSPAN="2" STYLE="width: 55%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = CR<SUB>0</SUB> &times;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 45%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">OS<SUB>0</SUB>
        + X</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">OS<SUB>0</SUB> + Y</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">where,</TD><TD></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="width: 91%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately prior to the close of business on the Record Date for such issuance; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately after the close of business on such Record Date;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">OS<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the number of shares of Common Stock outstanding immediately prior to the close of business on such Record Date;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">X = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">Y = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the number of shares of Common Stock equal to (i) the aggregate price payable to exercise such rights, options or warrants, <I>divided by</I> (ii) the Average VWAP per share of Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants. </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Any increase made under this Section
13(a)(ii) shall be made successively whenever any such rights, options or warrants are issued and shall become effective immediately
after the close of business on the Record Date for such issuance. To the extent that such rights, options or warrants are not exercised
prior to their expiration or shares of Common Stock are not delivered after the exercise of such rights, options or warrants, each
Fixed Conversion Rate shall be decreased to such Fixed Conversion Rate that would then be in effect had the increase with respect
to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of Common Stock
actually delivered, if any. If such rights, options or warrants are not so issued, each Fixed Conversion Rate shall be immediately
readjusted, effective as of the date the Board of Directors or a committee thereof determines not to pay such dividend or distribution,
to such Fixed Conversion Rate that would then be in effect if such Record Date for such issuance had not occurred.</P>
<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">For the purpose of this Section 13(a)(ii), in
determining whether any rights, options or warrants entitle the holders of Common Stock to subscribe for or purchase shares of
Common Stock at less than such Average VWAP per share for the 10 consecutive Trading Day period ending on, and including, the Trading
Day immediately preceding the date of announcement of such issuance, and in determining the aggregate offering price of such shares
of Common Stock, there shall be taken into account any consideration received by the Corporation for such rights, options or warrants
and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined
by the Board of Directors or a committee thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Corporation distributes shares of its capital stock, evidences of the Corporation&rsquo;s indebtedness, other assets
or property of the Corporation or rights, options or warrants to acquire its capital stock or other securities, to all or substantially
all holders of Common Stock, excluding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(A)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">dividends,
distributions or issuances as to which the provisions set forth in Section 13(a)(i) or Section 13(a)(ii) shall apply;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(B)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">dividends
or distributions paid exclusively in cash as to which the provisions set forth in Section 13(a)(iv) shall apply;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
dividends and distributions upon conversion of, or in exchange for, shares of Common Stock in connection with a recapitalization,
reclassification, change, consolidation, merger or other combination, share exchange, or sale, lease or other transfer or disposition
resulting in the change in the conversion consideration as set forth under Section 14;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(D)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
as otherwise set forth in Section 13(a)(vii), rights issued pursuant to a shareholder rights plan adopted by the Corporation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(E)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Spin-Offs
as to which the provisions set forth below in this Section 13(a)(iii) shall apply;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">then each Fixed Conversion Rate shall
be increased based on the following formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD ROWSPAN="2" STYLE="width: 55%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = CR<SUB>0</SUB> &times;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 45%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 1pt solid">SP<SUB>0</SUB></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">SP<SUB>0</SUB> &ndash; FMV</FONT></TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">where,</TD><TD></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="width: 91%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately prior to the close of business on the Record Date for such distribution; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately after the close of business on such Record Date;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">SP<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the Average VWAP per share of Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Ex-Date for such distribution; and </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">FMV = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the fair market value (as determined by the Board of Directors or a committee thereof) of the shares of capital stock, evidences of indebtedness, assets, property, rights, options or warrants so distributed, expressed as an amount per share of Common Stock on the Ex-Date for such distribution. </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Any increase made under the portion of
this Section 13(a)(iii) will become effective immediately after the close of business on the Record Date for such distribution.
If such distribution is not so paid or made, each Fixed Conversion Rate shall be immediately readjusted, effective as of the date
the Board of Directors or a committee thereof determines not to pay such dividend or distribution, to be such Fixed Conversion
Rate that would then be in effect if such distribution had not been declared.</P>
<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Notwithstanding the foregoing, if &ldquo;FMV&rdquo;
(as defined above) is equal to or greater than &ldquo;SP<SUB>0</SUB>&rdquo; (as defined above), or the difference is less than
$1.00, in lieu of the foregoing increase, each Holder shall receive, in respect of each share of Mandatory Convertible Preferred
Stock, at the same time and upon the same terms as holders of Common Stock, the amount and kind of the Corporation&rsquo;s capital
stock, evidences of the Corporation&rsquo;s indebtedness, other assets or property of the Corporation or rights, options or warrants
to acquire its capital stock or other securities that such Holder would have received if such Holder owned a number of shares of
Common Stock equal to the Maximum Conversion Rate in effect on the Record Date for the distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">With respect to an adjustment pursuant
to this Section 13(a)(iii) where there has been a Spin-Off, each Fixed Conversion Rate shall be increased based on the following
formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD ROWSPAN="2" STYLE="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = CR<SUB>0</SUB> &times;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 57%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid">FMV<SUB>0</SUB>
        + MP<SUB>0</SUB></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">MP<SUB>0</SUB></FONT></TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">where,</TD><TD></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>0</SUB> =</FONT></TD>
    <TD STYLE="width: 91%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately prior to the open of business on the Ex-Date for the Spin-Off;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> =</FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately after the open of business on the Ex-Date for the Spin-Off;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">FMV<SUB>0</SUB> =</FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the Average VWAP per share of the capital stock or similar equity interest distributed to holders of Common Stock applicable to one share of Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Ex-Date for the Spin-Off (the &ldquo;<U>Valuation Period</U>&rdquo;); and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">MP<SUB>0</SUB> =</FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the Average VWAP per share of Common Stock over the Valuation Period.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 35pt">The increase to each Fixed Conversion
Rate under the preceding paragraph will be calculated as of the close of business on the last Trading Day of the Valuation Period
but will be given effect as of immediately after the open of business on the Ex-Date of the Spin-Off. Because the Corporation shall
make the adjustment to each Fixed Conversion Rate with retroactive effect, the Corporation shall delay the settlement of any conversion
of the Mandatory Convertible Preferred Stock where any date for determining the number of shares of Common Stock issuable to a
Holder occurs during the Valuation Period until the second Business Day after the last date for determining the number of shares
of Common Stock issuable to a Holder with respect to such conversion occurs.&nbsp;If such dividend or distribution is not so paid,
each Fixed Conversion Rate shall be decreased, effective as of the date the Board of Directors or a committee thereof determines
not to make or pay such dividend or distribution, to be such Fixed Conversion Rate that would then be in effect if such dividend
or distribution had not been declared.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 35pt">For purposes of this Section 13(a)(iii)
(and subject in all respects to Section 13(a)(i) and Section 13(a)(ii)):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">(A)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">rights, options or warrants distributed by the Corporation to all or substantially all holders
of the Common Stock entitling them to subscribe for or purchase shares of the Corporation&rsquo;s capital stock, including Common
Stock (either initially or under certain conditions), which rights, options or warrants, until the occurrence of a specified event
or events (&ldquo;<U>Trigger Event</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;are
deemed to be transferred with such shares of the Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;are
not exercisable; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;are
also issued in respect of future issuances of the Common Stock,</P>
<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">shall be deemed not to have been distributed for purposes
of this Section 13(a)(iii) (and no adjustment to the Fixed Conversion Rates under this Section 13(a)(iii) shall be required) until
the occurrence of the earliest Trigger Event, whereupon such rights, options or warrants shall be deemed to have been distributed
and an appropriate adjustment (if any is required) to the Fixed Conversion Rates shall be made under this Section 13(a)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any such right, option or warrant, including any such existing rights, options or warrants distributed prior to the Initial Issue
Date, are subject to events, upon the occurrence of which such rights, options or warrants become exercisable to purchase different
securities, evidences of indebtedness or other assets, then the date of the occurrence of any and each such event shall be deemed
to be the date of distribution and Record Date with respect to new rights, options or warrants with such rights (in which case
the existing rights, options or warrants shall be deemed to terminate and expire on such date without exercise by any of the holders
thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in the event of any distribution (or deemed distribution) of rights, options or warrants, or any Trigger Event or other
event (of the type described in the immediately preceding clause (B)) with respect thereto that was counted for purposes of calculating
a distribution amount for which an adjustment to the Fixed Conversion Rates under this clause (iii) was made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
the case of any such rights, options or warrants that shall all have been redeemed or repurchased without exercise by any holders
thereof, upon such final redemption or repurchase (x) the Fixed Conversion Rates shall be readjusted as if such rights, options
or warrants had not been issued and (y) the Fixed Conversion Rates shall then again be readjusted to give effect to such distribution,
deemed distribution or Trigger Event, as the case may be, as though it were a cash distribution pursuant to Section 13(a)(iv),
equal to the per share redemption or repurchase price received by a holder or holders of Common Stock with respect to such rights,
options or warrants (assuming such holder had retained such rights, options or warrants), made to all holders of Common Stock as
of the date of such redemption or repurchase; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
the case of such rights, options or warrants that shall have expired or been terminated without exercise by any holders thereof,
the Fixed Conversion Rates shall be readjusted as if such rights, options and warrants had not been issued;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in"><U>provided</U> that, in each case, such rights, options
or warrants are deemed to be transferred with such shares of the Common Stock and are also issued in respect of future issuances
of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">For purposes of Section 13(a)(i), Section
13(a)(ii) and this Section 13(a)(iii), if any dividend or distribution to which this Section 13(a)(iii) is applicable includes
one or both of:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">(A)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">a dividend or distribution of shares of Common Stock to which Section 13(a)(i) is applicable
(the &ldquo;<U>Clause A Distribution</U>&rdquo;); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
issuance of rights, options or warrants to which Section 13(a)(ii) is applicable (the &ldquo;<U>Clause B Distribution</U>&rdquo;),</P>

<P STYLE="font: 10pt/200% Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">then:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such
dividend or distribution, other than the Clause A Distribution and the Clause B Distribution, shall be deemed to be a dividend
or distribution to which this Section 13(a)(iii) is applicable (the &ldquo;<U>Clause C Distribution</U>&rdquo;) and any Fixed Conversion
Rate adjustment required by this Section 13(a)(iii) with respect to such Clause C Distribution shall then be made; and</P>
<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Clause A Distribution and Clause B Distribution shall be deemed to immediately follow the Clause C Distribution and any Fixed Conversion
Rate adjustment required by Section 13(a)(i) and Section 13(a)(ii) with respect thereto shall then be made, except that, if determined
by the Corporation (I) the &ldquo;Record Date&rdquo; of the Clause A Distribution and the Clause B Distribution shall be deemed
to be the Record Date of the Clause C Distribution and (II) any shares of Common Stock included in the Clause A Distribution or
Clause B Distribution shall be deemed not to be &ldquo;outstanding immediately prior to the close of business on such Record Date
or immediately prior to the open of business on such Effective Date&rdquo; within the meaning of Section 13(a)(i) or &ldquo;outstanding
immediately prior to close of business on such Record Date&rdquo; within the meaning of Section 13(a)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any cash dividend or distribution is made to all or substantially all holders of Common Stock, each Fixed Conversion
Rate shall be adjusted based on the following formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD ROWSPAN="2" STYLE="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = CR<SUB>0</SUB> &times;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 57%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 1pt solid">SP<SUB>0</SUB></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">SP<SUB>0</SUB> &ndash; C</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">where,</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="width: 91%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately prior to the close of business on the Record Date for such dividend or distribution;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately after the close of business on the Record Date for such dividend or distribution;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">SP<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the Last Reported Sale Price per share of Common Stock on the Trading Day immediately preceding the Ex-Date for such dividend or distribution; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">C = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the amount in cash per share the Corporation distributes to all or substantially all holders of Common Stock.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Any increase made under this Section
13(a)(iv) shall become effective immediately after the close of business on the Record Date for such dividend or distribution.
If such dividend or distribution is not so paid, each Fixed Conversion Rate shall be decreased, effective as of the date the Board
of Directors or a committee thereof determines not to make or pay such dividend or distribution, to be such Fixed Conversion Rate
that would then be in effect if such dividend or distribution had not been declared.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Notwithstanding the foregoing, if &ldquo;C&rdquo;
(as defined above) is equal to or greater than &ldquo;SP<SUB>0</SUB>&rdquo; (as defined above), or if the difference is less than
$1.00, in lieu of the foregoing increase, each Holder shall receive, for each share of Mandatory Convertible Preferred Stock, at
the same time and upon the same terms as holders of shares of Common Stock, the amount of cash that such Holder would have received
if such Holder owned a number of shares of Common Stock equal to the Maximum Conversion Rate on the Record Date for such cash dividend
or distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Corporation or any of its Subsidiaries make a payment in respect of a tender or exchange offer for Common Stock,
to the extent that the cash and value of any other consideration included in the payment per share of Common Stock exceeds the
Average VWAP per share of Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day
next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer (the &ldquo;<U>Expiration
Date</U>&rdquo;), each Fixed Conversion Rate shall be increased based on the following formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = CR</FONT><FONT STYLE="font-size: 7pt">0</FONT><FONT STYLE="font-size: 10pt">&nbsp;x </FONT></TD>
    <TD STYLE="width: 60%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 1pt solid">AC + (SP<SUB>1</SUB>
        x OS<SUB>1</SUB>)</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 58.6pt; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">OS</FONT><FONT STYLE="font-size: 7pt">0</FONT><FONT STYLE="font-size: 8pt">&nbsp;</FONT><FONT STYLE="font-size: 10pt">x SP<SUB>1</SUB></FONT></TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">where,</TD><TD></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">CR<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="width: 91%; padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately prior to the close of business on the Expiration Date;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt; width: 9%"><FONT STYLE="font-size: 10pt">CR<SUB>1</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt; width: 91%"><FONT STYLE="font-size: 10pt">such Fixed Conversion Rate in effect immediately after the close of business on the Expiration Date;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">AC = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the aggregate value of all cash and any other consideration (as determined by the Board of Directors or a committee thereof) paid or payable for shares purchased in such tender or exchange offer;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">OS<SUB>0</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the number of shares of Common Stock outstanding immediately prior to the Expiration Date (prior to giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer);</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">OS<SUB>1</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the number of shares of Common Stock outstanding immediately after the Expiration Date (after giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer); and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">SP<SUB>1</SUB> = </FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-size: 10pt">the Average VWAP of Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the Expiration Date (the &ldquo;<U>Averaging Period</U>&rdquo;).</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The increase to each Fixed Conversion
Rate under the preceding paragraph will be calculated at the close of business on the last Trading Day of the Averaging Period
but will be given effect as of immediately after the close of business on the Expiration Date. Because the Corporation will make
the adjustment to each Fixed Conversion Rate with retroactive effect, the Corporation shall delay the settlement of any conversion
of Mandatory Convertible Preferred Stock where any date for determining the number of shares of Common Stock issuable to a Holder
occurs within the Averaging Period until the second Business Day after the last date for determining the number of shares of Common
Stock issuable to a Holder with respect to such conversion occurs.&nbsp; For the avoidance of doubt, no adjustment under this Section
13(a)(v) will be made if such adjustment would result in a decrease in any Fixed Conversion Rate, except as set forth in the immediately
succeeding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">In the event that the Corporation or
one of its Subsidiaries is obligated to purchase shares of Common Stock pursuant to any such tender offer or exchange offer, but
the Corporation or such Subsidiary is permanently prevented by applicable law from effecting any such purchases, or all such purchases
are rescinded, then each Fixed Conversion Rate shall again be adjusted to be such Fixed Conversion Rate that would then be in effect
if such tender offer or exchange offer had not been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">For the avoidance of doubt, for purposes
of this clause (v), the term &ldquo;tender offer&rdquo; is used as such term is used in the Exchange Act and the term &ldquo;exchange
offer&rdquo; means an exchange offer that constitutes a tender offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.75in; text-indent: 0.25in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 31.5pt"><FONT STYLE="font-size: 10pt">&nbsp;(A)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the record date for a dividend or distribution on shares of the Common Stock occurs after
the end of the 20 consecutive Trading Day period used for calculating the Applicable Market Value and before the Mandatory Conversion
Date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(B)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">such dividend or distribution would have resulted in an adjustment of the number of shares
of Common Stock issuable to the Holders had such record date occurred on or before the last Trading Day of such 20-trading day
period, </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">then the Corporation shall deem the Holders to be holders
of record of Common Stock, for each share of their Mandatory Convertible Preferred Stock, of a number of shares of Common Stock
equal to the Mandatory Conversion Rate for purposes of that dividend or distribution, and in such a case, the Holders would receive
the dividend or distribution on Common Stock together with the number of shares of Common Stock issuable upon mandatory conversion
of Mandatory Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Corporation has a rights plan in effect upon conversion of the Mandatory Convertible Preferred Stock into Common
Stock, the Holders shall receive, in addition to any shares of Common Stock received in connection with such conversion, the rights
under the rights plan. However, if, prior to any conversion, the rights have separated from the shares of Common Stock in accordance
with the provisions of the applicable rights plan, each Fixed Conversion Rate will be adjusted at the time of separation as if
the Corporation distributed to all or substantially all holders of Common Stock, shares of its capital stock, evidences of indebtedness,
assets, property, rights, options or warrants as set forth in Section 13(a)(iii), subject to readjustment in the event of the expiration,
termination or redemption of such rights.</P>
<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> The Corporation may (but is not required to), to the extent permitted by law and the rules of NYSE or any other securities
exchange on which the shares of Common Stock or the Mandatory Convertible Preferred Stock is then listed, increase each Fixed Conversion
Rate by any amount for a period of at least 20 Business Days if such increase is irrevocable during such 20 Business Days and the
Board of Directors (or a duly authorized committee thereof) determines that such increase would be in the best interest of the
Corporation. The Corporation may also (but is not required to) increase each Fixed Conversion Rate as it deems advisable in order
to avoid or diminish any income tax to holders of Common Stock resulting from any dividend or distribution of shares of Common
Stock (or issuance of rights or warrants to acquire shares of Common Stock) or from any event treated as such for income tax purposes
or for any other reason. However, in either case, the Corporation may only make such discretionary adjustments if it makes the
same proportionate adjustment to each Fixed Conversion Rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Corporation shall not adjust the Fixed Conversion Rates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>upon the issuance of shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends
or interest payable on securities of the Corporation and the investment of additional optional amounts in Common Stock under any
plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>upon the issuance of any shares of Common Stock or rights or warrants to purchase such shares of Common Stock pursuant to
any present or future benefit or other incentive plan or program of or assumed by the Corporation or any of its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>upon the issuance of any shares of Common Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible
security not described in (B) of this Section 13(a)(ix) and outstanding as of the Initial Issue Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(D)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>for a change in par value of the Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(E)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>for stock repurchases that are not tender offers referred to in Section 13(a)(v), including structured or derivative transactions
or pursuant to a stock repurchase program approved by the Board of Directors; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(F)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>for accumulated dividends on the Mandatory Convertible Preferred Stock, except as described in Sections 7, 8 and 9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Adjustments to each Fixed Conversion Rate will be calculated to the nearest 1/10,000th of a share. No adjustment to any
Fixed Conversion Rate will be required unless the adjustment would require an increase or decrease of at least 1% of the Fixed
Conversion Rate; <I>provided</I>, <I>however</I>, that if an adjustment is not made because the adjustment does not change the
Fixed Conversion Rates by at least 1%, then such adjustment will be carried forward and taken into account in any future adjustment.
Notwithstanding the foregoing, on each date for determining the number of shares of Common Stock issuable to a Holder upon any
conversion of the Mandatory Convertible Preferred Stock the Corporation shall give effect to all adjustments that otherwise had
been deferred pursuant to this clause (x), and those adjustments will no longer be carried forward and taken into account in any
future adjustment. Except as otherwise provided above, the Corporation will be responsible for making all calculations called for
under the Mandatory Convertible Preferred Stock. These calculations include, but are not limited to, determinations of the Fundamental
Change Share Price, the VWAPs, the Average VWAPs, the Last Reported Sale Price and the Fixed Conversion Rates of the Mandatory
Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For the avoidance of doubt, if an adjustment is made to the Fixed Conversion Rates, no separate inversely proportionate
adjustment will be made to the Initial Price or the Threshold Appreciation Price because the Initial Price is equal to $100.00
<I>divided by</I> the Maximum Conversion Rate (as adjusted in the manner described herein) and the Threshold Appreciation Price
is equal to $100.00 <I>divided by</I> the Minimum Conversion Rate (as adjusted in the manner described herein).</P>
<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Whenever any provision of the Certificate of Designations requires the Corporation to calculate the VWAP per share of Common
Stock over a span of multiple days, the Board of Directors, or any authorized committee thereof, shall make appropriate adjustments
(including, without limitation, to the Applicable Market Value, the Early Conversion Average Price, the Fundamental Change Share
Price and the Average Price, as the case may be) to account for any adjustments to the Fixed Conversion Rates (as the case may
be) that become effective, or any event that would require such an adjustment if the Ex-Date, Effective Date, Record Date or Expiration
Date, as the case may be, of such event occurs during the relevant period used to calculate such prices or values, as the case
may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I>Whenever
the Fixed Conversion Rates and the Fundamental Change Conversion Rates set forth in the table in the definition of &ldquo;Fundamental
Change Conversion Rate&rdquo; are to be adjusted, the Corporation shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;compute
such adjusted Fixed Conversion Rates and Fundamental Change Conversion Rates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;within
10 Business Days after the Fixed Conversion Rates are to be adjusted, provide or cause to be provided, a written notice to the
Holders of the occurrence of such event; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;within
10 Business Days after the Fixed Conversion Rates are to be adjusted, provide or cause to be provided, to the Holders, a statement
setting forth in reasonable detail the method by which the adjustments to the Fixed Conversion Rates and Fundamental Change Conversion
Rates were determined and setting forth such adjusted Fixed Conversion Rates and Fundamental Change Conversion Rates.&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;14.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Recapitalizations, Reclassifications and Changes of Common Stock</U></B>. In the event
of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any consolidation or merger of the Corporation with or into another Person (other than a merger or consolidation in which
the Corporation is the surviving corporation and in which the Common Stock outstanding immediately prior to the merger or consolidation
is not exchanged for cash, securities or other property of the Corporation or another Person);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&nbsp;any sale, transfer, lease or conveyance to another Person of all or substantially all of the property and assets of
the Corporation;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any reclassification of Common Stock into securities including securities other than Common Stock; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> any statutory exchange of securities of the Corporation with another Person (other than in connection with a merger or
acquisition),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">in each case, as a result of which the Common Stock would be converted
into, or exchanged for, stock, other securities or other property or assets (including cash or any combination thereof) (each,
a &ldquo;<U>Reorganization Event</U>&rdquo;), each share of Mandatory Convertible Preferred Stock outstanding immediately prior
to such Reorganization Event shall, without the consent of the Holders, become convertible into the kind of stock, other securities
or other property or assets (including cash or any combination thereof) that such Holder would have been entitled to receive if
such Holder had converted its Mandatory Convertible Preferred Stock into Common Stock immediately prior to such Reorganization
Event (such stock, other securities or other property or assets (including cash or any combination thereof), the &ldquo;<U>Exchange
Property</U>,&rdquo; with each &ldquo;<U>Unit of Exchange Property</U>&rdquo; meaning the kind and amount of such Exchange Property
that a holder of one share of Common Stock is entitled to receive).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If the transaction causes the Common Stock to
be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon
any form of stockholder election), the Exchange Property into which the Mandatory Convertible Preferred Stock shall be convertible
shall be deemed to be the weighted average of the types and amounts of consideration actually received by the holders of Common
Stock. The Corporation shall notify Holders of the weighted average as soon as practicable after such determination is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The number of Units of Exchange Property the
Corporation shall deliver for each share of Mandatory Convertible Preferred Stock converted following the effective date of such
Reorganization Event shall be determined as if references in Section&nbsp;7, Section&nbsp;8 and Section&nbsp;9 to shares of Common
Stock were to Units of Exchange Property (without interest thereon and without any right to dividends or distributions thereon
which have a Record Date that is prior to the date such shares of Mandatory Convertible Preferred Stock are actually converted).
For the purpose of determining which of clauses (i), (ii)&nbsp;and (iii)&nbsp;of Section&nbsp;7(b)&nbsp;shall apply upon Mandatory
Conversion, and for the purpose of calculating the Mandatory Conversion Rate if clause (ii)&nbsp;of Section&nbsp;7(b)&nbsp;is applicable,
the value of a Unit of Exchange Property shall be determined in good faith by the Board of Directors or an authorized committee
thereof (which determination will be final), except that if a Unit of Exchange Property includes common stock or American Depositary
Receipts (&ldquo;<U>ADRs</U>&rdquo;) that are traded on a U.S. national securities exchange, the value of such common stock or
ADRs shall be the average over the 20 consecutive Trading Day period used for calculating the Applicable Market Value of the volume
weighted Average Prices for such common stock or ADRs, as displayed on the applicable Bloomberg screen (as determined in good faith
by the Board of Directors or an authorized committee thereof (which determination will be final)); or, if such price is not available,
the average market value per share of such common stock or ADRs over such period as determined, using a volume-weighted average
method, by a nationally recognized independent investment banking firm retained by the Corporation for this purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The above provisions of this Section&nbsp;14
shall similarly apply to successive Reorganization Events, and the provisions of Section&nbsp;13 shall apply to any shares of capital
stock or ADRs of the Corporation (or any successor thereto) received by the holders of Common Stock in any such Reorganization
Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Corporation (or any successor thereto) shall,
as soon as reasonably practicable (but in any event within 20 calendar days) after the occurrence of any Reorganization Event,
provide written notice to the Holders of such occurrence and of the kind and amount of the cash, securities or other property that
constitute the Exchange Property. Failure to deliver such notice shall not affect the operation of this Section&nbsp;14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;15.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Transfer Agent, Registrar, and Conversion and Dividend Disbursing Agent</U></B>. The
duly appointed Transfer Agent, Registrar and Conversion and Dividend Disbursing Agent for Mandatory Convertible Preferred Stock
shall be Computershare Inc. The Corporation may, in its sole discretion, remove the Transfer Agent, Registrar or Conversion and
Dividend Disbursing Agent in accordance with the agreement between the Corporation and the Transfer Agent, Registrar or Conversion
and Dividend Disbursing Agent, as the case may be; <U>provided</U> that if the Corporation removes Computershare Inc., the Corporation
shall appoint a successor transfer agent, registrar or conversion and dividend disbursing agent, as the case may be, who shall
accept such appointment prior to the effectiveness of such removal. Upon any such removal or appointment, the Corporation shall
give notice thereof to the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;16.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Record Holders</U></B>. To the fullest extent permitted by applicable law, the Corporation
and the Transfer Agent may deem and treat the Holder of any shares of Mandatory Convertible Preferred Stock as the true and lawful
owner thereof for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;17.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Notices</U></B><I>.</I> All notices or communications in respect of Mandatory Convertible
Preferred Stock shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid,
or if given in such other manner as may be permitted in this Certificate of Designations, in the Third Restated Certificate of
Incorporation or the By-Laws and by applicable law. Notwithstanding the foregoing, if the shares of Mandatory Convertible Preferred
Stock are represented by Global Preferred Shares, such notices may also be given to the Holders in any manner permitted by DTC
or any similar facility used for the settlement of transactions in Mandatory Convertible Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;18.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>No Preemptive Rights</U></B>. The Holders shall have no preemptive or preferential rights
to purchase or subscribe for any stock, obligations, warrants or other securities of the Corporation of any class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;19.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Other Rights</U></B>. The shares of Mandatory Convertible Preferred Stock shall not
have any rights, preferences, privileges or voting powers or relative, participating, optional or other special rights, or qualifications,
limitations or restrictions thereof, other than as set forth herein or in the Third Restated Certificate of Incorporation or as
provided by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;20.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Book-Entry Form</U></B>. (a)&nbsp;The Mandatory Convertible Preferred Stock shall be
issued in the form of one or more permanent global shares of Mandatory Convertible Preferred Stock in definitive, fully registered
form eligible for book-entry settlement with the global legend as set forth on the form of Mandatory Convertible Preferred Stock
certificate attached hereto as <U>Exhibit&nbsp;A</U> (each, a &ldquo;<U>Global Preferred Share</U>&rdquo;), which is hereby incorporated
in and expressly made part of this Certificate of Designations. The Global Preferred Shares may have notations, legends or endorsements
required by law, stock exchange rules, agreements to which the Corporation is subject, if any, or usage (<U>provided</U> that any
such notation, legend or endorsement is in a form acceptable to the Corporation). The Global Preferred Shares shall be deposited
on behalf of the Holders represented thereby with the Registrar, at its New York office as custodian for the Depositary, and registered
in the name of the Depositary, duly executed by the Corporation and countersigned and registered by the Registrar as hereinafter
provided. The aggregate number of shares represented by each Global Preferred Share may from time to time be increased or decreased
by adjustments made on the records of the Registrar and the Depositary or its nominee as hereinafter provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Section&nbsp;20(a)&nbsp;shall apply only
to a Global Preferred Share deposited with or on behalf of the Depositary. The Corporation shall execute and the Registrar shall,
in accordance with this Section&nbsp;20(a), countersign and deliver any Global Preferred Shares that (i)&nbsp;shall be registered
in the name of Cede&nbsp;&amp; Co. or other nominee of the Depositary and (ii)&nbsp;shall be delivered by the Registrar to Cede&nbsp;&amp;
Co. or pursuant to instructions received from Cede&nbsp;&amp; Co. or held by the Registrar as custodian for the Depositary pursuant
to an agreement between the Depositary and the Registrar. Members of, or participants in, the Depositary (&ldquo;<U>Agent Members</U>&rdquo;)
shall have no rights under this Certificate of Designations with respect to any Global Preferred Share held on their behalf by
the Depositary or by the Registrar as the custodian of the Depositary, or under such Global Preferred Share, and the Depositary
may be treated by the Corporation, the Registrar and any agent of the Corporation or the Registrar as the absolute owner of such
Global Preferred Share for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Corporation,
the Registrar or any agent of the Corporation or the Registrar from giving effect to any written certification, proxy or other
authorization furnished by the Depositary or impair, as between the Depositary and its Agent Members, the operation of customary
practices of the Depositary governing the exercise of the rights of a holder of a beneficial interest in any Global Preferred Share.
The Holder of the Global Preferred Shares may grant proxies or otherwise authorize any Person to take any action that a Holder
is entitled to take pursuant to the Global Preferred Shares, this Certificate of Designations or the Third Restated Certificate
of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Owners of beneficial interests in Global Preferred
Shares shall not be entitled to receive physical delivery of certificated shares of Mandatory Convertible Preferred Stock, unless
(x)&nbsp;the Depositary notifies the Corporation that it is unwilling or unable to continue as Depositary for the Global Preferred
Shares and the Corporation does not appoint a qualified replacement for the Depositary within 90 days or (y)&nbsp;the Depositary
ceases to be a &ldquo;clearing agency&rdquo; registered under the Exchange Act and the Corporation does not appoint a qualified
replacement for the Depositary within 90 days. In any such case, the Global Preferred Shares shall be exchanged in whole for definitive
stock certificates that are not issued in global form, with the same terms and of an equal aggregate Liquidation Preference, and
such definitive stock certificates shall be registered in the name or names of the Person or Persons specified by the Depositary
in a written instrument to the Registrar.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(b)&nbsp;<U>Signature</U>. Two Officers permitted
by applicable law shall sign each Global Preferred Share for the Corporation, in accordance with the Corporation&rsquo;s By-Laws
and applicable law, by manual or facsimile signature. If an Officer whose signature is on a Global Preferred Share no longer holds
that office at the time the Registrar countersigned such Global Preferred Share, such Global Preferred Share shall be valid nevertheless.
A Global Preferred Share shall not be valid until an authorized signatory of the Registrar manually countersigns such Global Preferred
Share. Each Global Preferred Share shall be dated the date of its countersignature. The foregoing paragraph shall likewise apply
to any certificate representing shares of Mandatory Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;21.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Listing</U></B>. The Corporation hereby covenants and agrees that, if its listing application
for the Mandatory Convertible Preferred Stock is approved by NYSE, upon such listing, the Corporation shall use its commercially
reasonable efforts to keep the Mandatory Convertible Preferred Stock listed on NYSE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If the Global Preferred Share or Global Preferred
Shares, as the case may be, or the Mandatory Convertible Preferred Stock represented thereby shall be listed on NYSE or any other
stock exchange, the Depositary may, with the written approval of the Corporation, appoint a registrar (acceptable to the Corporation)
for registration of such Global Preferred Share or Global Preferred Shares, as the case may be, or the Mandatory Convertible Preferred
Stock represented thereby in accordance with the requirements of such exchange. Such registrar (which may be the Registrar if so
permitted by the requirements of such exchange) may be removed and a substitute registrar appointed by the Registrar upon the request
or with the written approval of the Corporation. If the Global Preferred Share or Global Preferred Shares, as the case may be,
or the Mandatory Convertible Preferred Stock represented thereby, are listed on one or more other stock exchanges, the Registrar
will, at the request and expense of the Corporation, arrange such facilities for the delivery, transfer, surrender and exchange
of such Global Preferred Share or Global Preferred Shares, as the case may be, or the Mandatory Convertible Preferred Stock represented
thereby as may be required by law or applicable stock exchange regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;22.</B></FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><B><U>Stock Certificates</U></B>. (a)&nbsp; Shares of Mandatory Convertible Preferred Stock
may be represented by stock certificates substantially in the form set forth as Exhibit A hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 3pt; text-indent: 1in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
certificates representing shares of the Mandatory Convertible Preferred Stock shall be signed by any two authorized Officers of
the Corporation, in accordance with the By-Laws and applicable Delaware law, by manual or facsimile signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 3pt; text-indent: 1in"><FONT STYLE="font-weight: normal">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
stock certificate representing shares of the Mandatory Convertible Preferred Stock shall not be valid until manually countersigned
by an authorized signatory of the Registrar and Transfer Agent. Each stock certificate representing shares of the Mandatory Convertible
Preferred Stock shall be dated the date of its countersignature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 3pt; text-indent: 1in"><FONT STYLE="font-weight: normal">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Officer of the Corporation who has signed a stock certificate no longer holds that office at the time the Registrar and Transfer
Agent countersigns the stock certificate, the stock certificate shall be valid nonetheless.</FONT></P>

<P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 12pt 0 3pt; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Section&nbsp;23.</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Replacement Certificates</U>. <FONT STYLE="font-weight: normal">If any Mandatory Convertible
Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall, at the expense of the Holder,
issue, in exchange and in substitution for and upon cancellation of the mutilated Mandatory Convertible Preferred Stock certificate,
or in lieu of and substitution for the Mandatory Convertible Preferred Stock certificate lost, stolen or destroyed, a new Mandatory
Convertible Preferred Stock certificate of like tenor and representing an equivalent Liquidation Preference of shares of Mandatory
Convertible Preferred Stock, but only upon receipt of evidence of such loss, theft or destruction of such Mandatory Convertible
Preferred Stock certificate and indemnity, if requested, reasonably satisfactory to the Corporation and the Transfer Agent.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><U>EXHIBIT&nbsp;A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>[FORM&nbsp;OF FACE OF 5.50% MANDATORY CONVERTIBLE
PREFERRED STOCK, SERIES A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>CERTIFICATE]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[INCLUDE FOR GLOBAL PREFERRED SHARES]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&ldquo;<U>DTC</U>&rdquo;), TO THE CORPORATION OR THE TRANSFER
AGENT NAMED ON THE FACE OF THIS CERTIFICATE, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR IN
SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&nbsp;&amp; CO., OR TO SUCH
OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE
BY OR TO ANY PERSON IS WRONGFUL IN AS MUCH AS THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO. HAS AN INTEREST HEREIN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED
TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&rsquo;S NOMINEE AND TRANSFERS
OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE STATEMENT
WITH RESPECT TO SHARES. IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE TRANSFER AGENT NAMED ON THE FACE OF THIS
CERTIFICATE SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER
COMPLIES WITH THE FOREGOING RESTRICTIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<!-- Field: Page; Sequence: 36; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">Certificate Number [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">[Initial] Number of Shares of Mandatory
Convertible Preferred Stock [&nbsp;&nbsp;&nbsp;&nbsp; ]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">CUSIP 101137 206</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">ISIN US1011372067</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>BOSTON SCIENTIFIC CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">5.50% Mandatory Convertible Preferred Stock,
Series A<BR>
(par value $0.01 per share)<BR>
(Liquidation Preference as specified below)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Boston Scientific Corporation, a Delaware corporation
(the &ldquo;<U>Corporation</U>&rdquo;), hereby certifies that [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
(the &ldquo;<U>Holder</U>&rdquo;), is the registered owner of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ] [the number shown on <U>Schedule
I</U> hereto of] fully paid and non-assessable shares of the Corporation&rsquo;s designated 5.50% Mandatory Convertible Preferred
Stock, Series A, with a par value of $0.01 per share and a Liquidation Preference of $100.00 per share (the &ldquo;<U>Mandatory
Convertible Preferred Stock</U>&rdquo;). The shares of Mandatory Convertible Preferred Stock are transferable on the books and
records of the Registrar, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper
form for transfer. The designations, rights, privileges, restrictions, preferences and other terms and provisions of Mandatory
Convertible Preferred Stock represented hereby are and shall in all respects be subject to the provisions of the Certificate of
Designations of 5.50% Mandatory Convertible Preferred Stock, Series A of Boston Scientific Corporation dated May 27, 2020 as the
same may be amended from time to time (the &ldquo;<U>Certificate of Designations</U>&rdquo;). Capitalized terms used herein but
not defined shall have the meaning given them in the Certificate of Designations. The Corporation will provide a copy of the Certificate
of Designations to the Holder without charge upon written request to the Corporation at its principal place of business. In the
case of any conflict between this Certificate and the Certificate of Designations, the provisions of the Certificate of Designations
shall control and govern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Reference is hereby made to the provisions of
Mandatory Convertible Preferred Stock set forth on the reverse hereof and in the Certificate of Designations, which provisions
shall for all purposes have the same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Upon receipt of this executed certificate, the
Holder is bound by the Certificate of Designations and is entitled to the benefits thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Unless the Registrar and Transfer Agent have
properly countersigned, these shares of Mandatory Convertible Preferred Stock shall not be entitled to any benefit under the Certificate
of Designations or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">IN WITNESS WHEREOF, this certificate has been
executed on behalf of the Corporation by two Officers of the Corporation this [&nbsp; &nbsp;] of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
] [&nbsp;&nbsp; &nbsp;].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BOSTON SCIENTIFIC CORPORATION</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 4%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 45%; font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Name: </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Name: </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>COUNTERSIGNATURE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">These are shares of Mandatory Convertible Preferred
Stock referred to in the within-mentioned Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Dated: [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ], [&nbsp;&nbsp;&nbsp;
]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">COMPUTERSHARE INC.,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">as Registrar and Transfer Agent</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 4%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 45%; font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>[FORM&nbsp;OF REVERSE OF CERTIFICATE FOR
5.50% MANDATORY CONVERTIBLE PREFERRED STOCK, SERIES A]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Cumulative dividends on each share of Mandatory
Convertible Preferred Stock shall be payable at the applicable rate provided in the Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The shares of Mandatory Convertible Preferred
Stock shall be convertible in the manner and accordance with the terms set forth in the Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Corporation shall furnish without charge
to each Holder who so requests the powers, designations, limitations, preferences and relative, participating, optional or other
special rights of each class or series of stock of the Corporation and the qualifications, limitations or restrictions of such
preferences and/or rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>NOTICE OF CONVERSION</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(To be Executed by the Holder<BR>
in order to Convert 5.50% Mandatory Convertible Preferred Stock, Series A)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The undersigned hereby irrevocably elects to
convert (the &ldquo;<U>Conversion</U>&rdquo;) 5.50% Mandatory Convertible Preferred Stock, Series A (the &ldquo;<U>Mandatory Convertible
Preferred Stock</U>&rdquo;), of Boston Scientific Corporation (hereinafter called the &ldquo;<U>Corporation</U>&rdquo;), represented
by stock certificate No(s). [&nbsp;&nbsp;&nbsp;&nbsp; ] (the &ldquo;<U>Mandatory Convertible Preferred Stock Certificates</U>&rdquo;),
into common stock, par value $0.01 per share, of the Corporation (the &ldquo;<U>Common Stock</U>&rdquo;) according to the conditions
of the Certificate of Designations of Mandatory Convertible Preferred Stock (the &ldquo;<U>Certificate of Designations</U>&rdquo;),
as of the date written below. Holders that submit shares of Mandatory Convertible Preferred Stock during a Fundamental Change Conversion
Period shall be deemed to have exercised their Fundamental Change Conversion Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If Common Stock is to be issued in the name
of a Person other than the undersigned, the undersigned shall pay all transfer taxes payable with respect thereto, if any. Each
Mandatory Convertible Preferred Stock Certificate (or evidence of loss, theft or destruction thereof) is attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Capitalized terms used but not defined herein
shall have the meanings ascribed thereto in or pursuant to the Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Date of Conversion:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Applicable Conversion Rate:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4"><FONT STYLE="font-size: 10pt">Shares of Mandatory Convertible Preferred Stock to be Converted:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Shares of Common Stock to be Issued:*</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Signature:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Address:**</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Fax No.:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 11%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 23%">&nbsp;</TD>
    <TD STYLE="width: 21%">&nbsp;</TD>
    <TD STYLE="width: 29%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>












<HR SIZE="1" NOSHADE ALIGN="LEFT" STYLE="width: 25%; color: black">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">*</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The Corporation is not required to issue Common Stock until the original Mandatory Convertible
Preferred Stock Certificate(s)&nbsp;(or evidence of loss, theft or destruction thereof) to be converted are received by the Corporation
or the Conversion and Dividend Disbursing Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">**</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Address where Common Stock and any other payments or certificates shall be sent by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>ASSIGNMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">FOR VALUE RECEIVED, the undersigned assigns
and transfers the shares of 5.50% Mandatory Convertible Preferred Stock, Series A evidenced hereby to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Insert assignee&rsquo;s social security or
taxpayer identification number, if any)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Insert address and zip code of assignee)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">and irrevocably appoints:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">as agent to transfer the shares of 5.50% Mandatory
Convertible Preferred Stock, Series A evidenced hereby on the books of the Transfer Agent. The agent may substitute another to
act for him or her.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Date:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Signature:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">(Sign exactly as your name appears on the other side of this Certificate)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Signature&nbsp;Guarantee:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 88%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(Signature must be guaranteed by an &ldquo;eligible
guarantor institution&rdquo; that is a bank, stockbroker, savings and loan association or credit union meeting the requirements
of the Transfer Agent, which requirements include membership or participation in the Securities Transfer Agents Medallion Program
(&ldquo;<U>STAMP</U>&rdquo;) or such other &ldquo;signature guarantee program&rdquo; as may be determined by the Transfer Agent
in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><U>SCHEDULE I</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Boston Scientific Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Global Preferred Share<BR>
5.50% Mandatory Convertible Preferred Stock, Series A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Certificate Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The number of shares of Mandatory Convertible
Preferred Stock initially represented by this Global Preferred Share shall be [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ]. Thereafter the
Registrar and Transfer Agent shall note changes in the number of shares of Mandatory Convertible Preferred Stock evidenced by this
Global Preferred Share in the table set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 23%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Amount&nbsp;of&nbsp;Decrease<BR>
in&nbsp;Number&nbsp;of&nbsp;Shares<BR>
Represented&nbsp;by&nbsp;this<BR>
Global&nbsp;Preferred&nbsp;Share</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 22%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Amount&nbsp;of&nbsp;Increase&nbsp;in<BR>
Number&nbsp;of&nbsp;Shares<BR>
Represented&nbsp;by&nbsp;this<BR>
Global&nbsp;Preferred&nbsp;Share</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 22%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Number&nbsp;of&nbsp;Shares<BR>
Represented&nbsp;by&nbsp;this<BR>
Global&nbsp;Preferred<BR>
Share&nbsp;following<BR>
Decrease&nbsp;or&nbsp;Increase</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 27%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Signature&nbsp;of<BR>
Authorized&nbsp;Officer&nbsp;of<BR>
Transfer&nbsp;Agent&nbsp;and<BR>
Registrar</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25pt">&nbsp;</P>



<HR SIZE="1" NOSHADE ALIGN="LEFT" STYLE="width: 25%; color: black">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">(I)</FONT><FONT STYLE="font-size: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Attach Schedule I only to Global Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ss174270_ex0501.htm
<DESCRIPTION>OPINION OF SHEARMAN AND STERLING LLP REGARDING THE LEGALITY OF THE SHARES OF COMMON STOCK
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt/50pt Times New Roman, Times, Serif; text-align: center"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 12; width: 248"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 7pt/16pt Arial Narrow, Helvetica, Sans-Serif; margin: 8pt 0 0 0; text-transform: uppercase; letter-spacing: 0.5pt; text-align: center">599
        Lexington Avenue<BR>
        New York, NY 10022-6069</P>
        <P STYLE="font: 7pt/16pt Arial Narrow, Helvetica, Sans-Serif; margin: 0; text-transform: uppercase; letter-spacing: 0.5pt; text-align: center">+1.212.848.4000</P></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 24pt 4.75in; text-align: right">May 27, 2020</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0">Boston Scientific Corporation</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0">300 Boston Scientific Way</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Marlborough, Massachusetts 01752-1234</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #141414">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have acted as counsel to Boston Scientific Corporation,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the purchase and sale of an aggregate of 29,382,500
shares of common stock, $0.01 par value per share (the &ldquo;<U>Shares</U>&rdquo;) of the Company, pursuant to the Underwriting
Agreement dated May 21, 2020 (the &ldquo;<U>Underwriting Agreement</U>&rdquo;), among the Company and J.P. Morgan Securities LLC
and BofA Securities, Inc., as representatives (the &ldquo;<U>Representatives</U>&rdquo;) of the several underwriters named in Schedule
1 therein. The Shares include 3,832,500 shares purchased pursuant to the Representatives&rsquo; full exercise of the option set
forth in Section 2(a) of the Underwriting Agreement (the &ldquo;<U>Option Shares</U>&rdquo;). This opinion is being furnished in
accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In that connection, we have reviewed originals or copies of
the Underwriting Agreement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have also reviewed the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The automatic shelf registration statement on Form
S-3 (Registration No. 333-238526) filed by the Company under the Securities Act, with the Securities and Exchange Commission (the
&ldquo;<U>Commission</U>&rdquo;) on May 20, 2020 (such registration statement, including the documents incorporated by reference
therein and the information deemed to be part thereof at the time of effectiveness pursuant to Rule 430B under the Securities Act,
hereinafter referred to as the &ldquo;<U>Registration Statement</U>&rdquo;).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>The base prospectus, dated May 20, 2020 and forming a part of the Registration Statement with respect to the offering from
time to time of the securities described therein, which was included as part of the Registration Statement at the time it became
effective on May 20, 2020 (the &ldquo;<U>Base Prospectus</U>&rdquo;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>The preliminary prospectus supplement relating to the Shares, dated May 20, 2020 (the &ldquo;<U>Preliminary Prospectus Supplement</U>&rdquo;)
(the Base Prospectus, as amended and supplemented by the Preliminary Prospectus Supplement, in the form first filed by the Company
pursuant to Rule&nbsp;424(b) under the Securities Act with the Commission, including the documents incorporated by reference therein,
hereinafter collectively referred to as the &ldquo;<U>Preliminary Prospectus</U>&rdquo;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD>The final prospectus supplement relating to the Shares, dated May 21, 2020 (the &ldquo;<U>Final Prospectus Supplement</U>&rdquo;)
(the Base Prospectus, as amended and supplemented by the Final Prospectus Supplement, in the form first filed by the Company pursuant
to Rule&nbsp;424(b)&nbsp;under the Securities Act with the Commission, including the documents incorporated by reference therein,
hereinafter collectively referred to as the &ldquo;<U>Prospectus</U>&rdquo;).</TD></TR></TABLE>
<BR>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: bold 9.5pt Arial Narrow, Helvetica, Sans-Serif"><FONT STYLE="font-size: 9pt">SHEARMAN.COM</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 6pt/8pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt">Shearman &amp; Sterling LLP is a limited liability partnership organized in the United States under the laws of the state of Delaware, which laws limit the personal liability of partners.</TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD>The pricing term sheet relating to the Shares, dated May 21, 2020, attached as Annex B to the Underwriting Agreement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD>Copies of the certificate of incorporation and by-laws of the Company, as amended through the date hereof.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD>Originals or copies of such other records of the Company, certificates of public officials and officers of the Company and
agreements and other documents as we have deemed necessary as a basis for the opinions expressed below.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD>The notice dated May 22, 2020, delivered by the Representatives to the Company in connection with the Representatives&rsquo;
full exercise of the option to purchase the Option Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In our review of the Underwriting Agreement and other documents,
we have assumed:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The genuineness of all signatures.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>The authenticity of the originals of the documents submitted to us.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>The conformity to authentic originals of any documents submitted to us as copies.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD>As to matters of fact, the truthfulness of the representations made in the Underwriting Agreement and in certificates of public
officials and officers of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD>That the Underwriting Agreement is the legal, valid and binding obligation of each party</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 1in; text-indent: 0in">thereto, other than the Company, enforceable
against each such party in accordance</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 1in; text-indent: 0in">with its terms.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 1in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have not independently established the validity of the
foregoing assumptions.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We do not express any opinion with respect to the laws of
any jurisdiction other than the laws of the State of New York and the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Based upon the foregoing and upon such other investigation
as we have deemed necessary, we are of the opinion that the Shares have been duly authorized by the Company and, when issued and
delivered as provided in the Underwriting Agreement, the Shares will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">This opinion letter is provided solely in connection with
the sale of the Shares pursuant to the Registration Statement and is not to be relied upon for any other purpose.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We hereby consent to the reference to our firm under the heading
&ldquo;Legal Matters&rdquo; in the Preliminary Prospectus and the Prospectus. We also hereby consent to the filing of this opinion
with the Commission as an exhibit to the Company&rsquo;s Current Report on Form 8-K being filed on the date hereof and incorporated
by reference into the Registration Statement. In giving this consent, we do not hereby admit that we come within the category of
persons whose consent is required under Section 7 of the Securities Act, or the rules and regulations of the Commission thereunder.</P>
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Very truly yours,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">/s/ Shearman &amp; Sterling LLP</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">RA/alk/gl/is/jx</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">KT</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>6
<FILENAME>ss174270_ex0502.htm
<DESCRIPTION>OPINION OF SHEARMAN AND STERLING LLP REGARDING THE LEGALITY OF THE SHARES OF MANDATORY CONVERTIBLE PREFERRED STOCK
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 4.75in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.2</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 24pt 4.75in; text-align: right"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt/50pt Times New Roman, Times, Serif; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 11px; width: 247px"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 7pt/16pt Arial Narrow, Helvetica, Sans-Serif; margin: 0; text-transform: uppercase; letter-spacing: 0.5pt; text-align: center">599
        Lexington Avenue<BR>
        New York, NY 10022-6069</P>
        <P STYLE="font: 7pt/16pt Arial Narrow, Helvetica, Sans-Serif; margin: 0; text-transform: uppercase; letter-spacing: 0.5pt; text-align: center">+1.212.848.4000</P></TD></TR>
</TABLE>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 24pt 4.75in; text-align: right">May 27, 2020</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0">Boston Scientific Corporation</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0">300 Boston Scientific Way</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Marlborough, Massachusetts 01752-1234</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #141414">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have acted as counsel to Boston Scientific Corporation,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the purchase and sale of an aggregate of 10,062,500
shares of 5.50% Mandatory Convertible Preferred Stock, Series A, with a liquidation preference of $100.00 per share (the &ldquo;<U>Shares</U>&rdquo;)
of the Company, pursuant to the Underwriting Agreement dated May 21, 2020 (the &ldquo;<U>Underwriting Agreement</U>&rdquo;), among
the Company and J.P. Morgan Securities LLC and BofA Securities, Inc., as representatives (the &ldquo;<U>Representatives</U>&rdquo;)
of the several underwriters named in Schedule 1 therein. The Shares include 1,312,500 shares purchased pursuant to the Representatives&rsquo;
full exercise of the option set forth in Section 2(a) of the Underwriting Agreement (the &ldquo;<U>Option Shares</U>&rdquo;). This
opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act of
1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;). The Shares are convertible into shares of the Company&rsquo;s common
stock, $0.01 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;), as provided in the Certificate of Designations (as defined
below).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In that connection, we have reviewed originals or copies of
the following documents:</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(a)</TD><TD STYLE="width: 86%">The
Underwriting Agreement; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(b)</TD><TD STYLE="width: 86%">The Certificate of Designations, including the annexed specimen certificate (the &ldquo;<U>Certificate of Designations</U>&rdquo;),
filed by the Company with the Secretary of State of the State of Delaware on May 26, 2020 as an amendment to the Company&rsquo;s
Third Restated Certificate of Incorporation.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">The documents described in the foregoing clauses (a) and (b)
are collectively referred to herein as the &ldquo;<U>Opinion Documents</U>.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have also reviewed the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(a)</TD><TD STYLE="width: 86%">The automatic shelf registration statement on Form S-3 (Registration No. 333-238526) filed by the Company under the Securities
Act, with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) on May 20, 2020 (such registration statement,
including the documents incorporated by reference therein and the information deemed to be part thereof at the time of effectiveness
pursuant to Rule 430B under the Securities Act, hereinafter referred to as the &ldquo;<U>Registration Statement</U>&rdquo;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(b)</TD><TD STYLE="width: 86%">The base prospectus, dated May 20, 2020 and forming a part of the Registration Statement with respect to the offering from
time to time of the securities described therein, which was included as part of the Registration Statement at the time it became
effective on May 20, 2020 (the &ldquo;<U>Base Prospectus</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: bold 9.5pt Arial Narrow, Helvetica, Sans-Serif"><FONT STYLE="font-size: 9pt">SHEARMAN.COM</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 6pt/8pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt">Shearman &amp; Sterling LLP is a limited liability partnership organized in the United States under the laws of the state of Delaware, which laws limit the personal liability of partners.</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(c)</TD><TD STYLE="width: 86%">The preliminary prospectus supplement relating to the Shares, dated May 20, 2020 (the &ldquo;<U>Preliminary Prospectus Supplement</U>&rdquo;)
(the Base Prospectus, as amended and supplemented by the Preliminary Prospectus Supplement, in the form first filed by the Company
pursuant to Rule&nbsp;424(b) under the Securities Act with the Commission, including the documents incorporated by reference therein,
hereinafter collectively referred to as the &ldquo;<U>Preliminary Prospectus</U>&rdquo;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(d)</TD><TD STYLE="width: 86%">The final prospectus supplement relating to the Shares, dated May 21, 2020 (the &ldquo;<U>Final Prospectus Supplement</U>&rdquo;)
(the Base Prospectus, as amended and supplemented by the Final Prospectus Supplement, in the form first filed by the Company pursuant
to Rule&nbsp;424(b)&nbsp;under the Securities Act with the Commission, including the documents incorporated by reference therein,
hereinafter collectively referred to as the &ldquo;<U>Prospectus</U>&rdquo;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(e)</TD><TD STYLE="width: 86%">The pricing term sheet relating to the Shares, dated May 21, 2020, attached as Annex B to the Underwriting Agreement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(f)</TD><TD STYLE="width: 86%">Copies of the certificate of incorporation and by-laws of the Company, as amended through the date hereof, including the Certificate
of Designations.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(g)</TD><TD STYLE="width: 86%">Originals or copies of such other records of the Company, certificates of public officials and officers of the Company and
agreements and other documents as we have deemed necessary as a basis for the opinions expressed below.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(h)</TD><TD STYLE="width: 86%">The notice dated May 22, 2020, delivered by the Representatives to the Company in connection with the Representatives&rsquo;
full exercise of the option to purchase the Option Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In our review of the Opinion Documents and other documents,
we have assumed:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(a)</TD><TD STYLE="width: 86%">The genuineness of all signatures.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(b)</TD><TD STYLE="width: 86%">The authenticity of the originals of the documents submitted to us.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(c)</TD><TD STYLE="width: 86%">The conformity to authentic originals of any documents submitted to us as copies.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(d)</TD><TD STYLE="width: 86%">As to matters of fact, the truthfulness of the representations made in the Underwriting Agreement and in certificates of public
officials and officers of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 7%">(e)</TD><TD STYLE="width: 86%">That the Underwriting Agreement is the legal, valid and binding obligation of each party thereto,
                                                         other than the Company, enforceable against each such party in accordance with its terms.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 1in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have not independently established the validity of the
foregoing assumptions.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We do not express any opinion with respect to the laws of
any jurisdiction other than the laws of the State of New York and the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Based upon the foregoing and upon such other investigation
as we have deemed necessary, we are of the opinion that:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Shares have been duly authorized by the Company and, when issued and delivered as provided in the Underwriting Agreement, the Shares
will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
shares of Common Stock issuable pursuant to the Certificate of Designations upon the conversion of the Shares and pursuant to payment
of dividends in Common Stock with respect to the Shares, have been duly authorized and reserved for issuance by all necessary corporate
action and such shares of Common Stock, when issued and delivered as provided in the Certificate of Designations, will be validly
issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">This opinion letter is provided solely in connection with
the sale of the Shares pursuant to the Registration Statement and is not to be relied upon for any other purpose.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We hereby consent to the reference to our firm under the heading
&ldquo;Legal Matters&rdquo; in the Preliminary Prospectus and the Prospectus. We also hereby consent to the filing of this opinion
with the Commission as an exhibit to the Company&rsquo;s Current Report on Form 8-K being filed on the date hereof and incorporated
by reference into the Registration Statement. In giving this consent, we do not hereby admit that we come within the category of
persons whose consent is required under Section 7 of the Securities Act, or the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Very truly yours,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">/s/ Shearman &amp; Sterling LLP</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">RA/alk/gl/is/jx</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">KT</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ss174270_ex9901.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY BOSTON SCIENTIFIC CORPORATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings
of Common Stock and Mandatory Convertible Preferred Stock</B></P>

<P STYLE="font: 12pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">MARLBOROUGH, Mass. (May 27, 2020) - Boston
Scientific Corporation (NYSE: BSX) completed the concurrent offerings of (i) 29,382,500 shares of its common stock, which includes
the exercise in full by the underwriters of their option to purchase up to 3,832,500 additional shares of common stock, at a public
offering price of $34.25 per share and (ii) 10,062,500 shares of its 5.50% Mandatory Convertible Preferred Stock, Series A (&ldquo;Mandatory
Convertible Preferred Stock&rdquo;), which includes the exercise in full by the underwriters of their overallotment option to purchase
up to 1,312,500 additional shares of Mandatory Convertible Preferred Stock, at a price to the public and liquidation preference
of $100.00 per share (collectively, the &ldquo;offerings&rdquo;).</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The net proceeds from the Common Stock offering
and the Mandatory Convertible Preferred Stock offering were approximately $974.7 million and $974.6 million respectively, which
includes the exercise of the underwriters&rsquo; options in full, in each case after deducting underwriting discounts and commissions
and estimated offering expenses.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Boston Scientific used a portion
of the combined net proceeds from the offerings of $1,949.3 million to repay in full the remaining $750.0 million outstanding under
its $1.25 billion term loan credit facility maturing on April 20, 2021 and to pay related fees, expenses and premiums, after which
it was terminated. The remaining proceeds will be used for general corporate purposes, which may include refinancing or repayment
of other outstanding indebtedness and funding potential future acquisitions and investments.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">J.P. Morgan, BofA Securities,&nbsp;Citigroup,
Goldman Sachs &amp; Co. LLC, Wells Fargo Securities, Morgan Stanley, Barclays and RBC Capital Markets acted as joint book-running
managers for the offerings.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The offerings were made pursuant to an effective
shelf registration statement on file with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;). Each offering was
made by means of a prospectus and related prospectus supplement only. An electronic copy of each prospectus supplement, together
with the accompanying prospectus, is available on the SEC&rsquo;s website at www.sec.gov. Alternatively, copies of each prospectus
supplement and accompanying prospectus relating to either offering or information concerning this offering may be obtained by contacting
the joint book-running managers: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
New York 11717, Telephone: (866) 803-9204, Email: prospectus-eq_fi@jpmchase.com; or BofA Securities, NC1-004-03-43, 200 North College
Street, 3rd floor, Charlotte, NC 28255-0001, Attn: Prospectus Department, Email: dg.prospectus_requests@bofa.com.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Nothing herein shall constitute an offer to
sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state or
jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>About Boston Scientific</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Boston Scientific transforms lives through
innovative medical solutions that improve the health of patients around the world.&nbsp; As a global medical technology leader
for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs
and reduce the cost of healthcare.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Cautionary Statement Regarding Forward-Looking
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E, of the Securities Exchange
Act of 1934, as amended. Forward-looking statements may be identified by words like &ldquo;anticipate,&rdquo; &ldquo;expect,&rdquo;
&ldquo;project,&rdquo; &ldquo;believe,&rdquo; &ldquo;plan,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;aiming&rdquo;
and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available
to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include,
among other things, statements regarding the intended use of proceeds.&nbsp; If our underlying assumptions turn out to be incorrect,
or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed
or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other
factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those
contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance
on any of our forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Factors that may cause such differences include,
among other things: future economic, political, competitive, reimbursement and regulatory conditions; new product introductions;
expected pricing environment; demographic trends; intellectual property; litigation; financial market conditions; and future business
decisions made by us and our competitors.&nbsp;New risks and uncertainties may arise from time to time and are difficult to predict,
including those that have emerged or have increased in significance or likelihood as a result of the COVID-19 pandemic. All of
these factors are difficult or impossible to predict accurately and many of them are beyond our control.&nbsp;For a further list
and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A
-&nbsp;Risk Factors&nbsp;in our most recent Annual Report on&nbsp;Form 10-K&nbsp;filed with the Securities and Exchange Commission,
which we may update in Part II, Item 1A -&nbsp;Risk Factors&nbsp;in Quarterly Reports on Form 10-Q we have filed or will file hereafter.&nbsp;We
disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations
or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual
results will differ from those contained in the forward-looking statements.&nbsp;This cautionary statement is applicable to all
forward-looking statements contained in this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="5">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 16%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 16%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">CONTACT:</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt; text-align: right"><FONT STYLE="font-size: 10pt">Media:</FONT></TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Kelly Leadem</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: right"><FONT STYLE="font-size: 10pt">Investors:</FONT></TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Susie Lisa, CFA</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">508-683-5543 (office)</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">508-683-5565 (office)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Media Relations</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Investor Relations</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Boston Scientific Corporation</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Boston Scientific Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt; color: blue">media@bsci.com</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt; color: blue"><U>BSXInvestorRelations@bsci.com</U></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  1 7,# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  S!#0# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#N?BI\4(?
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M^]6Z /-?CCK&I:'X!2[TJ^GL[@WL:>; Y5MI5\C([<"OG+_A8_C3_H:-5_\
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M $8U;/C_ ,/_ -CGP[?1IM@U31+.X&.@<1*KCZY ;_@58WBS_D<M<_["$_\
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M )"=U_UV?^9K[E\/_P#(N:9_UZ1?^@"@#1HHHH *^<?VE/\ D/Z'_P!>K_\
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MT>Y9MTT,7V67/7='\N3[D '\:[.OG_\ 9LUW_D,^'Y'_ +M["OY(_P#[3KZ
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MC^!/^2>>&O\ L%6O_HI: /BG4+&?3-2NK"Y7;/;2O#(OHRD@_J*]M_9O\/\
MFZCJWB&5/E@06D!/3<V&?\0 O_?5<U\>O#_]C_$-[Z--L&J1+<#'0./E<?7(
M#?\  J]Z^%'A_P#X1OX<:5:NFVXGC^U3Y&#OD^;!]PNU?PH \<_:1_Y'+2?^
MP?\ ^U'KI_V:_P#D7M<_Z^D_] KF/VD?^1RTG_L'_P#M1ZZ?]FO_ )%[7/\
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M:Q[M2TL--%@<R1_QI^0R/<8[UA_LW?\ (FZM_P!A#_VFE>T4 ? %>K_L\_\
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M[R@ HHHH ^$->_Y&+4_^ON7_ -#-?:_A+_D3-#_[!\'_ *+6OBC7O^1BU/\
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M?!FCZE!J%AH4,%W;MOBD$DA*GUY;%%% '6T444 </_PI[P#_ -"Y!_W]E_\
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M312QDD!D88(X]03110!R=M\)_ UG=PW5OX?A2:%UDC<2R?*P.0?O>HKLZ**
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' 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>bsx-20200521.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /a5Zs7xRiXgOn8uCZHwsWayFqcPtwpN9+Ykxum15bfnKrychgIY5fyv9kA8mocsP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:BSX="http://BSX/20200521" elementFormDefault="qualified" targetNamespace="http://BSX/20200521">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://BSX/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20200521_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20200521_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20200521_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="BSX_CommonStock0.01ParValuePerShareMember" name="CommonStock0.01ParValuePerShareMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BSX_Sec0.625SeniorNotesDue2027Member" name="Sec0.625SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>bsx-20200521_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://BSX/role/Cover" xlink:href="bsx-20200521.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://BSX/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="loc_us-gaapScheduleOfCapitalizationEquityLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bsx-20200521.xsd#BSX_CommonStock0.01ParValuePerShareMember" xlink:label="loc_BSXCommonStock0.01ParValuePerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BSXCommonStock0.01ParValuePerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="bsx-20200521.xsd#BSX_Sec0.625SeniorNotesDue2027Member" xlink:label="loc_BSXSec0.625SeniorNotesDue2027Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BSXSec0.625SeniorNotesDue2027Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>bsx-20200521_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bsx-20200521.xsd#BSX_CommonStock0.01ParValuePerShareMember" xlink:label="BSX_CommonStock0.01ParValuePerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BSX_CommonStock0.01ParValuePerShareMember" xlink:to="BSX_CommonStock0.01ParValuePerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BSX_CommonStock0.01ParValuePerShareMember_lbl" xml:lang="en-US">Common Stock, $0.01 par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="bsx-20200521.xsd#BSX_Sec0.625SeniorNotesDue2027Member" xlink:label="BSX_Sec0.625SeniorNotesDue2027Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BSX_Sec0.625SeniorNotesDue2027Member" xlink:to="BSX_Sec0.625SeniorNotesDue2027Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BSX_Sec0.625SeniorNotesDue2027Member_lbl" xml:lang="en-US">0.625% Senior Notes due 2027</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xml:lang="en-US">Schedule of Capitalization, Equity [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>bsx-20200521_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://BSX/role/Cover" xlink:href="bsx-20200521.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://BSX/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="loc_us-gaapScheduleOfCapitalizationEquityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapScheduleOfCapitalizationEquityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bsx-20200521.xsd#BSX_CommonStock0.01ParValuePerShareMember" xlink:label="loc_BSXCommonStock0.01ParValuePerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BSXCommonStock0.01ParValuePerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bsx-20200521.xsd#BSX_Sec0.625SeniorNotesDue2027Member" xlink:label="loc_BSXSec0.625SeniorNotesDue2027Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BSXSec0.625SeniorNotesDue2027Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MKC_\KL*N-W9G_['Q1;"IX===-%]02P,$%     @ T*Z[4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MG.[V9ZC%H-[.!?>_1/$#4$L#!!0    ( -"NNU P _>^-P$  "("   /
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M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<ZV200J#,!  OR)Y0%=MZ:&HIUZ\MOU
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M2NU!7PW_R?(+4$L! A0#%     @ T*Z[4!\CSP/     $P(   L
M     ( !     %]R96QS+RYR96QS4$L! A0#%     @ T*Z[4"?HAPZ"
ML0   !               ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " #0KKM0<&/-!>\    K @  $0              @ &9 0  9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " #0KKM0F5R<(Q &  "<)P  $P
M        @ &W @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -"N
MNU 4Q#1!Z@(  #$.   8              "  ?@(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " #0KKM0KE9<5:,"  ":!@  %
M        @ $8#   >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4    " #0
MKKM0NJ$YBM<!   R!@  #0              @ 'M#@  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( -"NNU P _>^-P$  "("   /              "  >\0
M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #0KKM0_\ F"+T   "% @
M&@              @ %3$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " #0KKM0"X_8 R$!  !7!   $P              @ %($P
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "@ * ( "  ":%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000947871-20-000519-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000947871-20-000519-xbrl.zip
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M+P)DT<#>^YLE%G/=NOXJ^(M:)*\!*&)B=7"5#2P&9-3 'ON;]>M[3N+3S86
M]JR=I6-7 J$Y;>2X_:7OF]U-\0"%!4@ <&![]_"4: $!U;IH<*<66&1'CU&
M1E+1KJ,R+_=@55($(FM@T2#[0IK"T4'&SCTL@ 801 -K N-P2HE_2SDJG,]D
MS%S%L"L!I-# .L 58D\B7"E_,Q;<Q]@\Z9/;^[G"?+-2 JZ2JRX.9-K$$?[7
M%V9';\B6=Z&*_K26CKEPA:? SU6"I9I <(V\T$^^GL_%P=7F'L^P,)N"'O!:
M7>GLGHJ'?Z7N[F$\3!I(,[,0\:&[HUIG_Z2_2ZZ;'^;/A^DK?P%02P,$%
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MZAJ'>- : YC8:^72(XM<S'A?Q7!X%?ED^PO9@;5KZ,R2 =BLHZ&('&)#[PR
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MP1A5"T +\21:7@3Z+ I!LA3=N^&KFZ[Y)[ZYV,3_6N"8\"W_!U!+ P04
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M[KOK:L=*34^:S=ELUF#\"<VX>)2-F,.JZRND4KFNJS5OK7Z6Q4\I88\GYM<
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MT[M"]\BBHV,6B'99@N?O\,(%HV *I1%@+N\,WB..GB 3)!9]$E=W4$5;*)
M,WAW^!Z)/*!Y-]&1DR%9/O-7#<9:!,HGP/0=)(9'3%T6<S'E&S<4.CS55_>B
MPQ/G$%-1$(HLP+Q^#V$\@CM/$BVI7/UCXFF[<)6:@^]5A@K)(4)0: [V0W,
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MMT@E*$^;A:AUDX_ZV]4WYI?Y(SCZR/]02P,$%     @ T*Z[4*H\D)C/(0
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M>:X1"WF6,X$")K-":/ENV9UW*&%B7J@TT*.)47"MNL\E+1Y"7D);LIRT3.P
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MK<?[RW*;7GRK7UZTJY?TO*\6;O.C(VG<5:OO6O[%8^_M6TZ6_P=02P,$%
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M+A:O:NRF!GV02\GF\8/N.DAX:"=)=CF<:ZJVNDI,0O9E4!0VSV"WP$#.(G0
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M?ARZ>RW9O%1R5CC$BZUT]%R2J6:!&8<%>T/Q*K#+V_&+:GGNK>?]1[V^; 3
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MB_FNV8PNR^\KV>YRG,0(29_M.E\S2YIW:%0(D#36GQ1^ZYYL@$EY!(R1<7=
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M+1/8[R5:*XN+LD,?IB#B!?=[PI)5$3?@"RWA>\JI#@,M^@HE:X7K/9Q>[:8
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MS ^65?R._SD%4^54B3J@ZTJ<N-:>V)0 <(8&%1:GHR@?F03]$FN4W/)FB_!
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MI!7W1M#.<U0T9O2+Y9R<QULGY];)>6].SDVX-U?"-MA*F?5*&18NQ0+I(ID
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M%5O_SRN@M9;]7G*/6R%OW>V=NY?+;N JFW9O.[4$D2ZY:6>P5SCV+/AUD@W
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MYEAA3O[!0T!O?; ,8>^(#RD3C79=2L88,2LG$^LZ2$I_V<@ E;J^G>2/%5)
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M*/REY3NID+*\Q_AYJN<=_0;ZA/!W'Z(O0.SV4,&NJL]T792X?2 O:QKO(W>
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M8&LD&;2SGH?4_48-1]F=Z1RULV98;O"&&ONQ.Y ?;AGY+-D?=I/\M #>)TY
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M8F'&702/\')CRQX=&QCXCI/XK#[ ,;7<&:(B0<3^'D7CK' > G%UEC%!2'$
M1V"VI N?RN:;,$N4ZB 93YC K3!S9/P)"\1L[)&@=P*QOS?P^A%WV,2IAKX0
MF!-Y;P>P&P#JY;L/9[?*V0)H-QY$#[Z"\4/CS=7;AX>'HT#TCT;>_9M?KMX>
M&6<.L"@VC;T7SDSWKYC4O%*+?6 *(GP$$ C+@3^G%IX"]M2B>660LF 5G!U@
M^3X1"'4*A27CUN$+"6J+,%&\@_M[VA;:0QK+1_=Z0"U">]@>U'%PZODV!>+C
MX*3;K1DG]=;A:;/>QO45&@?X:./PI%X_;)ZV#QNM9A.X_WS^G8HU6+2!GONZ
MQJDZJ1!*@2&F(+/)P86M48.Q %J01-\31/=$E'W/_2MRN5MNS*MK,8/"?[(E
MW#AW-9CV]X)H"EJ)& A.2,F]]F1P5+-A4)IHYT-.S,/FML"*\)$FI9XZNQ12
M.BXVM>G-MK;I9\!DCABA=]6D!LN.!2]AH-&7'6U=+Z0$'I(Z* Q@'<+R]_>H
M2Z6!*3YX64-;':$I)TFY [2B&Y@*)!@<TV( TAQ;U*X&Q=@"(=D3PMW?LR)0
M*"W2!!T44:[PJ:LU9B9C\^;("=FQF@,%!D'BP6%0&H0@OBSCW/$\#'R/6-#P
MM,$,-G:R,7Y+H5Z=M#_6T*E!%T09V_4JREA%&5>+,CZ.%N=1=G-]UT7Z8NG9
M]?7E?XR+34S X!9O[WLX(%! ?9[:KNR+_CLF9L+A$&!J#"B8%V-;#/?WT*CT
M4+B!?ANY@7!(F)X%>.Q8(+Y 8_!%B(>)#"1=L.ZX$13!?_A\QEE0/^KH3HIM
MS[.2Q&E4$J>2.*M)G#(RP )9].X99)$2-<I>WIY,T5>\8S&S?.J5)$^SDCR5
MY-FVY"DUFUS^Y[>K\ZLOQMGF)-5<6?7Y]I/Q^;WQ\?/%OP^_WAAG'VXO+S]=
M7G_9WM12&&-7G/_^\Q^GW>/3U_^GFN-L -DJ^/SY]L/9-7K-OMY>?;FZO".?
M,J4,GW]^?Z9]81I7UQ='_-598-R**>B,>$4&_6B8;\1?48:3 ':V'..KGD6,
MN5.4V<_/W?7'8A"!Y=Y0+H[X:;"3Y30C7^2=EN0#T'.;^[]X"[Q>_$SKI&5\
MLL#,AX/F[%ZXD>#/$5%_>OXWT[C^$Z12X_AT0]C=(%^\>HLK+ [BTR(^N\(X
M]V>HEM]8_K?<RN1O*(9;W4V I'QXQ<QR*WX%@GU][@4AYN_W;?C<'MI]0]D4
M<-KO[QV"]+J)>@Y\KG+&-PG:J[<?8;NEK_X#0$!.KE\W-T6Q3/JBDN<#0 G0
M*_^.X2'IS9IY$5YDW]_+,Y QCW=,],E-O8#<7(1DS$[T8&F)LYK"%S&_Z($(
MG:^,F*54;$+Z#Q=N%@!LO!..]6"1BS_^/#6-U-74N 3SO4UA%:7.37F[8R\Y
MOKZ_)]_/T$(<.^G-YN+%<*T)7Q9:+$V251<C!H:*P=[?@XWH\]63 ',?3>.G
M^E&]@;Y_X]YR(I'<6#0SMF\Z_D-7&=2X1RHK =2? ;F0 R/"<@=CX0N;/97H
MTB07X(--40\QI/(/,)7CL!,2AY\(RZ404NYV8_&2C[9O*5^1*QX=")(N)%K2
M" X0$?M["9&F[H# ^B?6-UYBAA34<(Q1DYX=QE[:D><-Z"/<'/(%IV'Q15_8
M4W++4L1M?\\.".M85J/_S?4>'#$8J41;G7?50P@P<Z])8085S9KZ-D"!ZPL%
M8T#>,\(O<^R-93I@)X=$8%GLY">G"!)0!"]7_67TK8BP-3,&MH^7Z#R4!?)W
M:SBT'1M]-J%G&H.(D$>0 AX]]('#9B+Q  Q,,DDF,%W-#5&TI*0(?"SI^2-_
MFQ,@!)]P.7[*B.D[**M@V%X4  D'@7$JLY*M8<A9T$#>6A+RD)*3M:@'A4!E
MAG,11>B,E@0S8I . O3N\ZH9M?+96Q&$OMT'161_[X:^3N350:/&H@E$%Y&$
M"2SF.";N;.A;?&&1/\%_:1/D;2;8!/TA1=6F3M]%#X.ZI(8<^18%@-1C)BN
M^/0#!1(S(SL"$\45%Z#$P*QP-QARU!(TG2EO@BDIQ9GIM(*!3XIL)C>N-B'T
M]#M[\6YP$!76&:ME_235' -YL##/5Q?&5%4>(>/K]#>R>^H^H!:T5RR)T:U0
MGE>I9^%=H@<97DG D/(  TQ4<4=,E(8)_[L@?OM\Q]5[D&5XLDR*@KL/!^+
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M\1 EA$Q]3S-]A[GNM)MSV,4\VW<X.SI4LS@1(=X\C8P':)X&ZAPT)UV._\;
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M8R.H5=VR0H14PZBTD2_8>I"'5\F<2KG@*XFWR+[?:GZ$;KS#K8V\OB%90ML
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M3B^]=4&W?(&&6.S,&(%("ZU$+3G.3%T-@09+..09\/E+<MC/"5 !&$82 ]L
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M:>EP)O9(<D219[-+7L6>"U+'K\$8G#,$@76JM!A'E'.&-A F/&GMD5<759=
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M6'W\9I%_X9!P/X:#UU2#4QICRK\4C1*YEI#:%SC%PN!E@?'.OT6S^=/AX/]
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MM0F^I1 ;[QFOV2O]6<J&G0PS2L>ZB3&;KF1W#C$ M)&OL?0:<VDJ.B.%P.5
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MWU_SN[CF?+O+%==;8K#.O/S;383N7&_4!=JB1LQ/T%56NO?<@B<V0!/M-C6
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MFP6,S87:(([0'JHSK8@,JH,B(Z'!)4V'Q%K7J8%:1OAOWL^L8;Y\E9S\V[X
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M7&>Y(5\@T?[\[/]M',GO7WXD?X^IC9KEVHAPSA\IPBRZ2.6:3[29)>Q5$@M
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M/']W\?'=V^#B[/SEVX_GK\[/X-L/[]]]./UX_N[M79Y,Z]0V^.%_[@R?8^9
M^X$?U=F&KR0<6B7AQ_)'8!4CF%#PC_W@+ )F>IE%W\AVOP7;N+;&9]_L9"E=
MO3[;?V)S]O=%7'+# C1A/R*@Z:+ =K"KYBV*R@9DSD8%V/U@?_!@O4R+PWO3
MXMZTV'S8:,.D?$K:>0Q3/#7YLM3W<)J 8D_.T"K.N!_;)E[)^7WX9@9">_?A
MEU-0BUZ>_?KA_./YRPL$0MO<>WYXAJF"257&*:,9UZ&#?WZ.C+Z,KZEXRL-T
MXZZK_$!;Z]6Z4?(]6Q,M:GE3N^FET9A9D3*.VLT+V*U/P?,BO\F6:N4/3];5
MRGD*[;QCA;(@"0C_QF)ZBA7EQ>W6] %[!S9[H_ZXN_S\W:M3YQ*'P?G;LXW$
M1^PK[O B;W:BWPI#V(3PWB@C>).DB*[X]W+Q)^(#FZ.;S8GU%EI<IJ@>W2NJ
M]XKJQA75NR#L W_["6SOAV<79W]_^>)7H++#35Z>UE?=D<K7(.X^4ZZI?'42
M?QJTL\D6K6\5(Y]'$_3O2]#B9/\!DI(K8NN4KS_0$0]=VNMRD;8MA"]8!YMQ
M9MBUU+>UQMIK"I01O.:RP,)O/+:\ #JX'.T<'3P(CXX?AT<G)[O=.O2C@[\V
M^4['7G9C0O_MOYYT\96Z%[O3V]TRCQ4LZ_#Q7UO)_RA\</ 0UGW0];N5K_J*
MK?_M"FBM9;][[G$KUK6[O4OWLN\&KK-I=[93/8BTYZ:=P5[AV//@ES0?@6+-
MN>_EUC;OX<EVM^XKB>R7/)W,\!)'XZLR^%LT ]WC+-^OW^0_RVYMCM!^B].T
M#%Z!#,Z]2[JEC3L^.0@/#KX;,E-14459&M]NG\ZVO5V;H[/G43%.08T.SJ)Y
M4E&7T^TPLN^,PCX\/S-;)#S_3WL9-TA=;]]C85$RBDI7C\/V#ELALL-')]\3
MD;UX^]P2U[8NXK;W:'/4]>;75[]X3;IF8 :.H^TI8]\9>5W\8K?H#] IOE]"
MN] :K#,PFBNJSGJ.,*!_PDW[2A+#']@+N?/KQ>GN/7FU;)KC".IR)R&8-E#9
M&&0E,#3%4V@1#.L[F7JZN?H>QCKC+#^LUNWY0VF=YML\MZ/]D\Z3^YA7V')Y
M^<IH@"\X'OI=,,D7HS3^RA/J'DH.Z7'XJ%WS[-B-7@?U3::0]?%MWX__)QN_
M5RSP^#X6>!\+W'S2VA]"\"8N>/0=7EHEIS?8IP3QP"^TTW*"8:P[>]\713A_
M.W_Q\>___0/EG=1F=/BU55,'JVXTQT'K-XV2'UKOH#;>W3<:>K/M)_QSAFAW
MJ'LV+^J??&>.[,Y\A#?&%6)@%-$\7L +RO_033E>1BZ_4(ALGH[_X[;EP;)M
M>8T@X/'D/VY33NRF_+)()H@Y]2).HQL$3_A[GA+ZK--[^#]N?Q[:_3F+"I!I
M8U!$Q_$L^A07_ZG\Y=&RBS1!V.FRBH(/\++@8O_#_NO_O!UZ[.Q0$5WGP?-D
M,L[_8YG,DV4$\R:>$.;1B_@:"^#^4_?H\,#9I(^__,?NP\^OWKW]Z$Y6#>8C
M- 0/417&)YYYFW6.!@&WWP!*VA'!5>ZNV,7OQ\2Z'_^;&+^77^K!O5_JWB_U
M)_%+G;Y]^_)_@]--O.#H@2;91U*.V.>_/S]_]KY(QFB&O$C*<9IC.?QP #KX
M)]C8GW]\OLFZM([6%WLBFEX16"<U+"NOL)T<8B)&"2'"4-L)[8%!U6R<Q6TP
M%]]@G!I+=@1JO$H0S/J] <Z^J/+QIQ#[AB%&394@2J3BS"B^Z&F6Q9^#YQLJ
MIQU]V3&<(ZSE+.)>!N\5^^9=01,>>1V<2^]\OEIG61/5B'&#:K>9U8@OTERT
M1_8R[>5MGL56C^NI=O36Q?K$UNX'NQ_L/VNP9;K8R;TN=J^+]=/%UJ/!S6I$
M=ZW ;49E^!(-].!KQS_'!G=%\*J(8^K9@BH(:!W4VF71'5W\ZO>^2E)0:]XO
MBG(1,33V!RS$?W!\?'?OO%C,G<93!BD E$3L49IAXS2[]+CD;R>$R/TFN@V.
M#D+X_T<'=S=![.Y<5AP*"-[F^\  CO>.CA^?'#V\@Y<J"P+EL^DV]((22ZR
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ML2%AG7!5X4HTH1NE!-B":S'%P?49;87:%3#Q&O4$79(VXCGLGR4^>>42VDL
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MSF&KL>>@(]R1__*/._R7_W$XQHMT&S-+G1*M$"V9/8J<P0ZAQ0%$Q'SI(AP
MGT%CL "<PU_48$)D%BR$'!W$#CN6W?ZDWTJ)I/DH.\MP$?6!0<A@-M58@M-V
M\,P*!1 T=6P 2*,8CL9*0 +!LS*!\/S>0'LWEANA3.\9NVKQEC3V $8^ZH +
M0(7?I6 S-: %.1@V"LUNNSL9*F$#7(=[<[']+1-BIS^<ADXDS$K&]5J>Y\<@
M%65E0:PZ06J/'Z0?XB6,O->-X>@"-'_/*Q4Y3,L?P9ZOI$1L-2:!2&W'*$>K
M2W-H^I3X/G4RX:D8@IW(E!P,.%_L1![5>2%Z%+J<B_RI"_"%N)U)/HY(PP0^
ML!L)BN818I:\E+*G]G#XZY#GLU@$_Z(]:I&EO4/J[*9)YS+65#L>JD^KEH&N
M^G1K<LOD^$8Q6$* UXD^.)NB6=-+5+L.D6\ST\Y+\X;&ZQOK)<@=UZ;'VO3X
MLDV/_89F*%!:,6OG&GWN[FCJ<['6&F9L#JE>K?D6K41,)HE':<@Z%:*XMD*I
M1;/-P[7:]P4&C4_R]M=8[S([!EQ!:QDRC+7L&%M([]^S&RK2-',>T^3B"F7H
M8W)LR!#9\IA_2D:B)T6\-1V(8B$7&(;2,,S,X ML<D6GM,SLI(]><'1VVEEF
MU2$M$/9DS\ G/ZE!@\(SX&8.QQD=)MQ8B5$6QU06TO3H G%C@6**8:"L3#-I
M@O*'@KM\L'"6 E%&N_SGY2<2EEJ-16+M_/YV=QXFR9!PMZ;\F$!^.ZE0TGZI
MO+SS$6P4%\VN=@HYQ<C9V*6B5;[C)1:6(<4<JX)Y\Y&R0>:DR$2AG5+"=SG!
MS*1@$LYHHK)48S_@5#0?G4G4CA@]NBJ4-X-J&E\8YJ1RMKB@$2-R(E+2C#M'
M=33&(*: 5+XLR]0R>[=P)/F87YG6%2C5,635-.5I*O8W\Q+6A<1>25-JK$SG
MQD#D6!4MA+R0ZV 505=[1:;] >"8(W,(*CZMPO63KQ(D\8$V1MG(>WV)"9WT
M';X4B&NRZ4H&!U"W9GP<?L&>3W33L_',<G=W@N*45&V29SBN? 8M:A-LM5J0
MXCGP!1O*^L+V)T+J"&BHAU/_9PR(WC[D1'H]+&]1OJBF968M9=+^DP1ZL7U0
MZ([,ACP3]1$I4OWT$928*(<0Q27I3:+BF*FA0Z^(E%Z2A"$@R:&A,[5"S2<1
M:JP3C:$J5IT"QC1D4FRY$&^7G(?47#/@0W,ZLAHB"(Z'7YZ1*WT_-F"^2GTI
M<G4B@\>*A,16)68[Z&C-+W@;&%H J(1*J2X@&W8C]$\$X4SIS\0? R=,E7P*
M8I=6]06<(SW$$8ZF6LE[DNL&<6'2#E.(:]VG23HJ5%25 ]@"I+!R(Z*-%:$H
MS]D(&=0V%YQBNNDTA8D]L(!9F/<3^!X@1S(VEF3D466<(^[XFQ!3F3X,DJ2/
MB@W:>=/7T2IHDI>8 A4D':N9U:6*?6TY I,YB8D&36<@XQ8$%M&TA8ID(*\N
MP"NF+"MIN1RD"S6-Z7@6HFZ>@D'R$;H"B()5]M/4FJ)=@0B7=Z"VQ#4?3=5H
MEXQ2G$QEID5!L?BLX%QG:OS#^<G\ZR"VHU3:2])2$&DQL((P,C5O \)I8$-?
M5'BPEEGEI#:KU&:5BIM55,40HYTMH9=K[/8X'%M_61HV/A#Y\MT.DK:5[3<?
M?B.&$Z"Z,?-!#36SSQ9W=-AP"7/-$.26.B=9;%WT7'>]QX[7>ZQ]N-YSS<,"
M6GK4]E<T$873^,]/EQ^N3G^]P-)2-U\_G__K'Y\__7SQ!<N.__<I#Z9P925^
M^-==X1FFHZUJ&EMXLS6UFZT:@+T"R2>WFZHL[:L3N9NN;45[W8=6)\>ZV^4U
MI$B'?HHQBV0VM#_NJYMY7DBCGC1HN/#S5Y/VJ"XT::(;R1%S<IO:& H)\E]=
M2,BLYR6 \_\!4$L#!!0    ( -"NNU#00-+)2Z4  $\$!0 3    <W,Q-S0R
M-S!?97@P,S Q+FAT;>R]:W/;2-(F^IT1_ ]8[SL35"RLUL7RI=WC"/G2T]K3
M;7LM=?<[<>)\ $E0PC0)< !0LO;7G[Q5H0HH@"!%2A3%O4Q;) $4JK*R\O+D
MDS_]<O';K^^ZG9]^^73Z$?[KX?_YZ>+LXM=/[W[Z@?\+W_X@7__T_LO'?WGG
M%__Z]=,_GHV2./_1.SR8YMY%- DS[W-XXWU+)D'L\P>^=QZFT>@97 B7?E77
M38+T,HI_] Z>P2.^OC._RL/O^?-@'%W"UVET>96_]<Q?OW_WZ?M5U(]R[WC_
M\*<?WLOUYAW:#LJZ\=_C?C9]NY*;O?7,=QB$<1ZF,/+?WWWX].WB[.>S#Z<7
MG[PO/WL?/YV?_?/SZ<79E\_G/_WP^VK>I/;A7WY>_S-.]D\._N;]=OKYX^G%
MEV__\CY\^?P'OO/[7S]Y7[]]^OG3MV^?/L*#OWSX?_QNY_S3M[-/Y][I=KS[
M^R_P7I^]\P]GGS[3*L/;?_OZY1NM[YH?OW;A7?T#HG@8XK4'^R=1_.S=^R3+
MD]@['T3P:32*!MZ'))TF:9!'"=PK\#Z&X^ F2$-O4'S>[?3RJ]#[^WCXGUGR
M%C=8\1W.^-]3^F+/]Z["-.S?PNND>',89WX5Y+XWG:79+(AS+T\\O-,T3:ZC
M#*[.O&0$(Q_D]._#@V/?.WQQZ 7QT#L\.<0O\>?_#.,P#<;=CO%<[]?@1GU_
MG@=YB'^HP?M>+]CCN81?_A;<>H=O?._HX.C IPOZ29 .\8)AE,+#DS13MS*?
M4'KI]WA1MX./45?9+V^^93#+KY(TRF$NDG@4IFDX]&93N"G>\[UZO+Z1!Y.&
MWUQ<1?#-MS##-QIZ'W@>!_)Z9[&U**XA!YF7S097( :W7C_T@DD(ZS_TO4DR
MQ 6!IZ9>JFX_2I.)EX/XT+K ?WEVBE=N'$ZW8XW'GHMA. XOZ2*X=91GWM<T
M&D3Q)8QV,HGR/ S+TUOY@7U#$IOD)DSQAH,TA'N#:AN&&>P?_+>:\?\;DO20
MA U#;P3OBY=&&2[-@*8QNP(1H14/O!CV408[)W1)P-_3#)^>>;-8/PAO'<J"
MPE8:_ 6C@!'!7!L_,=Y,5#6,*8"%OH7;Q]<XC?UQ"'.B[G1.=Z(]#",Y]>6]
MZ57@[K@ _7&47=&=X]FD#_.@WT0-((H'XQFL-OR#A8!?S%=W&47?BVG,?#U@
MW'N^O%8(<P1_D$&0T87_F8&.HD7GWXTC6![^0PD3K!S]W>W@!0D\ R8]3"?X
MM#1,1K[' \S"'!<DO\(1YE=15A;PC\:(RO+1\%-34M[R('K]/4^V_M&AN?6K
M<A@,DZE:-'B;9#RCK60,=C()AQ$\=XQ[:IS<^-[-503S:_P:WB7&+^#9,(#<
M"\9CVE&P'2,4.]P"0QDZ/1 ONH+=V@]#T+LP'Z,97 (/'+  AZ,1J(8?UW@4
MK/"L@?][>#3-W<_Y]NG\RZ]_?/KHUQP&6E5V.^O2E6K!M([(*DIA-H7Q=#LG
M!_[! ?U_0TV4=[PW#5+O.AC/0N^_#O8/#KTI"#S]'$_00IV4KH.UYKTHIV0$
M,\F:;$@?%PH$=C0,;SG5P;L=9II>T=CC]$59=]"_*KKB*NQVKI,<]\G:E(5G
MZXJL4!:T5MW.300;HJHUPB:E >//8*^5CK_J08<_&R5CV,M9_18[NO,6^^GG
M+Y\OS+L^ST#X>'/I#?C^W=<@S?F/PWUVM?"ZVJN/BXL7_5_T+QOOS2.#,8'&
M_5B2G<]:=LY)=MC8?O]NW_M:VM+U6Y.LEM+>I(5'#:JL1]D3R2Q7A[+>N+Q3
M9C%N7=Q7=7O4<9K3M@6Y=NU;KV<:(M;6LLT0<WN7?HB67A9EM&O@VT/0(B^/
M_!-+D^A+P"NC:PRC(<CN;#<HLZ%T=#KOTNTTO.B^=XY*H:(M9%\-0URC#*Z$
MY3).09ETA\Z&S1_$M]YP!F=HL9BH\=4QK+=_-NO_&ZY2LL3* 5<=YG<8L>[@
MWRIE!4/XSPP>!;L]9[MN.AV#N.%<@4/PUH,Y$(-PB&_)ZC%.]'MT._!^H&U@
M+F:#T&EDX;]:K099_^KR<9B1#Q27[TDJEV\,WZ Q/\MAM\ +QI?[:H\^V-F_
M;LUGZ;PC2^>]?TBU]_N[<UP#E-ZOVD5E-2<K4C\\OL4^Z#YR2,MW(>,F#Z*8
M[7-XU&D<A]\Y*N,%>1X,KD(V#5" 4C+G17G)YW 9;3<Y>>4XC%(/77FX[);V
M TLR;5+8$$,QO8-N![2?Z-,YAK=LO Q.3P^6%NY.IZI(K>&[7P5#LE_M(YH,
MV>I1S9ZS\9R5BKDMTC_]C^?/O9^C<#S\T?L:7(9OX??_F>&DP6V]Y\\E^OK3
MQ[,_[$CI\SR9_NB]G.I@Z/-^DN?)1#[K)^DP3/5G[\<!['?<+* !HR$(T,4I
MAN ^?/KUUZ^G'S^>??[G/YX=/*._S[^>?E!_RR/E;@.P0X)I!D-3_WKKW43#
M_ JGX.!O;[VJG%Y\4_<@+30(QBJ0!..W(TOC<$17?%17R*V/C_]6S-G%1]<O
M7ORM.4CEOJI\WQ\NON'_X,3 ?V'&'9,_A35ZW@=5_-?S?@B"!&\:C&^"VTPO
M0].ZP.M5 ]Z&@04B83W8$(X?4#I8(.ZH!N\A=G?VV?OS[.+SI_-S[\]?/GW[
M].5GOQ( 0I=R$,PR]B'F;W34$W@FA]_#P8R]8+CHZ.5/Y[]_?9=?_?0#_A<\
MUUL^_V[9E=Z_OZ.IV%'F#BKOL(77S=I@M1L1TRG-F^V9$BH0=4/J]8?>AR\X
M\,__>'8\[U"<$]@67:FVU$H'5MZO&WWS>=-X^Z,Y68XQ'94UL-(E?=+GAX8^
M;WS2#]D/(%Q@T>7>_][W/@1@O\'6NLM*E73IR9&M2^M^][+]SYK?Z#,<^36S
M5]+R\^^UVIEQ2\(2XG$1Y>.:=YQSY1_1@(S]+!J2202VU@5Z#[,T3._IU>9]
MJ!XMQ^W=HWH'W@O4RB5-_7SU$<2MR;?M'K![P.X!6_Z -=S^_STGNQP.$_)8
MT39O,-W)F6X5COK_U)3<HXM]M'.Q=RYV.Q=[^8U#62>*V9U^_OSIO]<&;Y+G
MW =N[?P"$5W?/GI?OWWYX^S\'O!J#Q\'%O#/_:2_'OO_+I2^$]04'!,YK#7L
M\V]!_%<47Q9INT^!RD*TSFZH3 G"37"A43%BL)>S)]D45I/B2B'<X%;2NXL]
M@2/H<WXJZ3,?M'A^I1Z,SQU&F.4!UZQ(2O^0I/ Q)I[[G*62KS3$8!S]9Q8-
M%5 @HAS,\]G4X^M4<HM2RT5BR7?AKWR)OJ<PTUXO$@A:%L910KBE$"=\, XR
M2H@5F<3_/:-?R#OUHJ@ KTT#0I'1>UJ7PTH4F4C^47&]NL&_9_,>?1X6CR:?
MMA==5RZNP45U.^%W27CBE:,9F2^H ?IY.(PQ]U4D^<=1T(_&40[/W?>>0H;+
MTFQ'.\VV.LVFTVL?PU$41WF1I4.M=@I;.RM29F4-T4ZS_/C@$KJ"!V@ P.E@
M,)O,QI1)_*@TY.DDF<6YD?7O=B9A@!B:\I1AYO[G&4P;)MA!WW^X"N)+ 8L&
MEY<I(3V]@.Y'Z7?C<0S7F ;14.MF>$*$N?M;1H1Y5\%UZ,5)WNU0,G$8@IK"
MXP"QFWJT7^&5DV'F35-#)Z7A.+Q&W$EU=-XG M!%<.N/A ]E="3J*H4)Q81H
M!!>H9W0[_)!B>(@;8DB4OIK?NAA6<(N/I6=80,%I&@Y">AQE3><.$%X)CA0X
MH;SPNWY4NTLKD E.T29X+EM*Z$TOV+O'U,U:)?KC-Q/V*><N21+.  HRS"">
MD49FVK8U7VS+5%RB /X6(K:D9DX83RB3XKGFQ#LZ0.%8_[#O<5X*$-!O0?H7
MO/0?"/VJ*CR2F%,X"M!1_>//TZ\&+@RT&2*%L62"8677(2N/\S#/QX0X$M6T
M+=(D\X XZ7!9:>+Q'O<&>V2+KF9J;-/H7B<#A<*<"RT?X 2@0 14\1+ !$Q)
M%KQ"KM ROYJ$X"AY@=Q-_(:2I.&I1$;Z11K0N?$QN%4P&GW.3;=/U/!5>0=5
MI*W;*2MTM^XZ/ ;=U;O>EK.M"I]<>&98: 81V S9MLS*+(O(I81]8<X';S4P
MU[H=@JDPHAPAEX%WC@%U^A0\7#2C;A40E7]&'\12'(!0U# =H$78!_\]PWG$
M8?\K2?_R/J!_C=O40"(3H)V IX2#'0<WH Y2@=*@<4;!9ZI7&B<9_HEA$_KW
MMFSA][?/?PUNLNIZT)'*Z'LNR-%@<+G$"=!F"/1M&;[?6+.V)3/9KKQ)A=^>
MW.[_,$90FW<*.K&(Y"U[8(@#0*<&VB>]TVTY.F2:WJ]GFMYOV31]6-<T]0ZW
M9:;DY!IY?3E^*ZJ^VSGY\># F^Y/]OW2>;E-ZMEP IVG'9>R8-WHW!+!ZLEW
M7Y/4E+0_?NM]H;+4[$=\E@CW6W::X>M=3G\U.7UC"=3DO_4N;J<PS-,TZ$>#
MMQ[!,&F!/B<X[<=6/EU=A=_L$ (+[F*,^&>JH%%'<>$8Z,_@<XP84CBMNL5!
M 4QGF$<E9_TL'NQ7P/>:+H"KW*;3)(K19!W83]4IRJ%^JA=0#&^$6;V6)7]X
M)W1DLME@ &H9W1K]0*0K2$O'T\G6*&(]F1C[KD:H<+DX0E6>27T1KYPCKE[Z
MG2>)@D]!.G;<Q,H';\WTN@@]V@7_MM#M^!A.DPQ>*'6$'#Y>?* T/%([Q,D$
MK*-011=<FU)8"Q[@U%_W'+ER80XS\;<@'5QYASZB'4+\[WDXS2EKX3'CS\=P
MH/X$$XEBH;=A@ &42@Y.W>+HX.C8Y\A-3+0>:*,5M[WW:J7[F>=*M-2P0B4
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M+W#O= ^!P,A?*KLO^K^B3].0MJ;F#<?-K]P[AU/9,W0S_RQ#>/!L3#J _-(
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MTSQ![115S2^I51:G8\QL/EHN)0%4>_<>X_W+-%=H,8@U-%?00;BK* ^?9],
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M=6A':F+OC8)H/ ,O3,S=&N<'=4("QK/EW(AVP<! &E[.T&507V6@:LEKP%"
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MG,#CX4Q5"?V0=2E;R2! M6*P[SVN<L#&^OVB94&[,[4")#*.1U;"A@I*N8<
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M;+?2=6M-U+M4($!ZIG@!?4:ZWP#UB[)YIP'&VJ,ICM%,:PIB HD.6).S"LI
MEY&KR7_"_NU''!C<TZ5F&3%QD&:A6)Q"5)%BR<-T0I;V50&LKE -"QZP9(^K
M,M[VCC][K+'&>Q#C0R X9VOR-?KY\!B6$XR&Y[WK:(]<7$0S7@77PE8B=A3>
M+DK;TF4RU(L V 1'602"5[2K=$+CC)+Y,KZ:X<7&._O>!*8R@B7DI+.&WRU?
MX*8@:#;!RB/JVKW=G(AG59P3:)7Q+ .#5<$GL@8R!A.[8=?=>ZR$G*4'F%F-
M'$^F,L^LA2[QV;YKJTG!:BA,B%$R'B<W1#:"E:"S<; R\LR#)BDIR621-#63
MI.4DZNFO9__\_(]G'SY]OOCT[5DY3:CRI.U&6IMY?8;9XXMO*K5W\='[]N5/
M&!4\^*C\S%>'\,QI,$1%^YP )S]Z)_LO,*FH/L7DJ_[0/%H+ZM=2;K7Y,/[P
M[:?SW]^_._SI!_R/]P]//CB0#_Y.@/.W6JM<?#3>I"EC+*]T]&:15WHF-Z<'
MK$!S65-12;;W*=E^6"3;OYR;D\%I694AIE5L>.-GU7FYWY64P1^HP1<+IL8O
M.>Z'VHI-^(4_SSY>_/*/9XA.>+;LV#@%?U!)P+=!./ N+4,%#I[5@0@.]H_H
M96_0I_+5C]Y5 04X!ZT5TL)>BP7J6$ %M=BXKXU]6YK)-@KE0"N4I57'F\,E
MA\"T$,[C*U('82FZTZ:YM&GAJ3Q+W0%-F*?:1R33,'8]X9-N.V<]9/Z!;<6-
MFI6U$AD'",94$::2T%M_ 4S4BQTFZN$P42^>$B9J$U3K8G:!0\.Z3013Z=78
M2PM:=VU4PYNC]0]L815=%#37-ZFR%'1:<[E+]W+3$DOY-NG4]=B#=YY3VP"<
MM]AK'DRK0D"SM&ZQ\WC>>L\];N<ON>^Q5O,N(PH_B5 B2X=Y\ONE<W_>82V,
MZX]%FEJJCDV6)M[[JUW%_4;_:B5QL8.Z7BZG5K@9+AJ&'F/SS2!VMZ."J3IF
M ^,W6QLOH%[K IR-]F^WTUX#.ZQ?_8P%S=]][\R&;U'>W(Z>24 :K*C&+(#,
M'WRF:2*0B1L#_UG"!4])2@O0%#-3[0K[]I2#X20A--]8E"*@/%1D3N^3 .8=
M/OT8I?"KA#E# \IO(W@WU)F]88@!?IQ4&J-0@@O11>U*J;W@/HXI 7)#M$KP
MF)C>HCBAY[A!WE4P%.[4,"[(-KBBG+ "Y:IR^ '"AV':Z].?2YXA%>K9LE2K
M'B?KU32X%(NH&@W7MMBO<5(9S: Y<)RI*DS;9"3:4O^ZW^VX"284C,"N&4Z+
M%%>[ #0/ ]ZE^N1=#Y[6>0+)#2"( ;D/4!/V4>2$2X+XA&M3>+>:.(-A0J0O
M;H(T)= M%Y\K/O )X]L#!9J!NU%>4P,@7AZ Q(U!%H(4VQ*;U$((/9F!8TG'
MT-",6*CR;5$N_6P @L,JG:DD!E=!5D^,3:1WL('!9YV&:DNP7&4&G6@%,U3\
MN'Q'!:\X/#!10[ 5JK"A4-%6.2%#K0!">C*L&:I.3M@F90T#P U4FVGQ=HF6
MA1,M)R>M7=R7CSG[\F+^>SY8]H7#>B!6E?R+O'TQF/_E_?>C3L; "_QKEY#9
MG(3,8C'#2I2X70!Q+3'#-_>2E7D$"1CM':K3]*VWRJ#*$G.[8*1DK?.Y8+1T
MI='-15YLN9#E(D^XYSCD@\WD?Z]K\O($ >MSIU 749A%",Q_7N^+K#P6NLC+
M_>O!Q*V"+BRPUN+T2*<H;.SX'2NHLW#N7/K>3V?OV&]'3"!C8Q7$L*67E%R'
M+C?)55RQ3B\IOS);SXWFOOJ^4_7?8S16N6AS8[%&,)9_2YRZF0 "P7:)L?JY
M("UK\N.IF5O1/&Y^D+?;63;*JQ9CW[NPND5R54^;@5*C"1%EI#XV%&N48GN,
M2''(I+6 2+E-08!5O([>)2VDI:7;/0R5VWV'^"B&/TF:E8"8? $:)[Z(K'-_
M.)*=<M6&25%$#>K:*",0BD'.S;KUQ.KV;!A);[V\6:()P=K@1RW!O-=8>'W2
M@E;DKK'PQAVD ^+$TUW4Q#1B:4YV6)J'P]*</"4LS>J+!4J)GC)[L*</1DQP
M8(:(=RV:"' <4D5,NX VZX>ZH'A3&-IDM2Z'H8M@,VWC&CO*'5U>VFSJ=E82
M7>8'>.:4VL8F]03$C]GJM."&589MGU6KT80R^"N,F<D$>2F8.(:*]K,(6>5H
M?86+W]52N]".#:O+?9"HPHI+DI5M3,44ZM1/'76./*77P7A6O)HU-CKFC*(K
MK)_UI8&%/CW 6)&1MSYZUE+F^$"U-YN;26O*GNE#W2JO(4JJ8!JA/YNQ1$NS
MM:(.V+C+W],,.YEC"G,8]L$T03/95SU LBQ$X:3FG0EL[MQ):YRDC9J+=@ZQ
MMU0'9[#A:\8OORXAR&2.-<K/YZHC5!\/DB.Z2S4NBVG=@^809)QN+4%&JSI;
MD[ZHU+2UZ/2061T#A;Y!$4ZYBC0+6$S!*>&5W5M$X]R^764I8K,@;(K$O=\2
MB5M,OBH *VD';A4["I/(DM)VO:&2M<R!6_NLWH<%B"[ )"I 7=)QWEJ"&GKP
M*"[(P4;8H:\NH$L7Q[(,%+? <G YHZ+_&XC'G"*F*\NX.QU957QSGXPM=#+E
MXTF87H9I<:Q9"#ZVH]7 :*!9@!C<,85-]$6Y:HC)$D>D'11@XT)U"N!+[3R_
M8E3I)V+;IQ8/ $?NM.B]N*]U_[C NC,O 1SXF4%AU+!UKLFWDN[>$B\T8_12
M#\RV@_K==(P<0$.P69R6N\3M[V5N/BU"_C(%O_C+:)31],S7,_UPG-S4X3ZK
MI]F*WK<VE$PQI7FQ,V9/6Q@3M+U G1TF9]68'*,B^ORK752\6A#.\S4OI3UZ
M[^_Q$$R0M][/O_W1C,;9061V$)DM@LB8=N$.)O,(83(E/;8FW,)F@@0^?7_>
M),UXWX=:%CA'UK46HR#"RHOT+[!5.83="S(C*NTM&I3>LRE-\:^F6*@=\^1H
MIZ]#G7YC5#-+C  L)G2_8[_RC$G7"F[1!@F+YZ_\AF(^P-$ SX+=;:RO<+L5
M-]'ZZO&,*>IVSD;5C[&&8L$*-F?6OE4!&[.UKC=K+RD;I_;O=A8I8JLI7-/5
M?VV2]2]WR?J'2]:_W"7K5Z#>/C>W-87]\O?Q$'-C< #^/:5_=3M\/HWH< KZ
M8"10W:R&.L*FO:2&>Y)LE3O8EHW<S*O>BR*"I%0B3%K3JIJU8-W.?QWN'QSX
M)O^Q-6RMKWV3O5@4FR2I_1(#./U0'U&MFZ46/)S>DC2<;!\%NAF+]U<4#YM2
ME'*4=SNKR6MZ=TIK,O?R(GE- T@HZ\*Z^BK QHL*0:#TM/PDN2'Q<"'<2C@.
MBYV\CLFS. ]JSE>6/N-X77] \,]2=R$*RNK"?Q7%%1QAC:E!F U&;EP% A\,
M/!4I;7GJSPDW.L@>'VF\\<7QG>*-#QU;/'FUN;'%?K7>#P-Q-05_OZTU\+CF
MN&-Y\+M88T.L<1=IW.! 8RU7B^&;X]_J/'FP$%E9LVY2</'13&))'Z]A%IOC
MC!3O*!N+632)P/M&*\YL[&W&F%!::^DPB@8@Z(:8[3R6#6O.;RQ3M[)>#_\2
MW^>GW]_]$8QG;%)_I5MC=P-Q@O8>M#CNMZ\/*@CNE2G/UCV0<!U53//C$]4&
M5D< L4S/945+\,F(#>K(]C2 -T^#Z96*!2+)RD!Z"Q8AM-K@WSB '6"*IEQ0
MGJ)N!PFKU#,N0:"UKN*G+*>QY&E*K/>]]^& >)O*GJ) %HA#B'S:PGVIFS76
MJ5(HE:=)P'%%'G5=!Z-A. XX(@[^:SX.S3:.9E_7A9KXL.]$U$=J,Y?!].WK
M8M%]ZW:4[XK5/YDWG.E&ZN6%\XK&HZ"*$E Q[]5:X'(72T62T'I\%52_/4#M
M?I<<3P6>UU@R&O\^1ZS.YI& V0%GO]MIXW/J^KLU5(1U.Q)<)KG$8,>=@LQ+
M$*55.>F: LYK5&0_<R&,3<)6C2-@? ^+3+F[%C6KI;@924AF-)PKX,'X^PH^
M>*\>@;X@2+<9-M9T^+Q%XS])?_3^YP&X$0<'S4CQI8H=JH]8*X%8\U';E*LS
MC2A'A4X+_C&M4^V0FR(9PZ\F+<NOYH4W5:92&UOR3-7HIQ=&%%@$]2?CA,?P
MZ3L '1\PI)6[:F=[OJ #&TN%"RTL!9M2IAMX*/G1"'OY4'L^VM#TK\SK%0;>
M!=P=4:^?\!O3NOMQQ1!FW@X-I3R'BV"+TQ!+\> 4'8K>4[A;/!SI<# JQ3R'
M *P8.=OP7D>+OI=1BD[,SJO'LC:,]GC1T09C75==RDZ,9ODL#8U"#L<R^"T2
MEJ]V"<N'2UB^VB4L%S[QG[TSC$3246+-4;J([2?C6!L9%HX<5NY4"5DX<5+R
M47!+U33RJQ)]5+'C?=V@?;C'IPE#(NSCA#@LJ+\]N77&F>&S%T+YP[E4#.5Y
MJ9L3552+P9$TF:81L=\6K]UC_@<TW(O!-\^%36O2.#.KY8&MKQQXOX"N/1OA
MG)BL*[[NL:PGV+0\](_#[S"O^$E;,\N*KYZQJ>*=H8;'NF^BH<<J:[&TT4LF
MJ\(O<LBV[+ 5TX(WA.%&Q<E'Z!IEA*F\.A@R9KUI+2BL2.,J<!@Y/69YNL-J
MPC)ND#Q.K-/L46OCDMQ20K,?6C>S?"6\AYF>+;NK,4A/TUP4%HS4N_3@:.5Y
M'! O+>W'-@OKV''L9"H^::*V"36:=*B&BWTM=?UZ_];LDZD-:P7=NZ\-LTCY
MV1E8W1CVDT)ZLU%UHNC7C17K46R"ILC\G%")C09XPOP/ED[4LM?M\!-[)J'[
M,&0_8ZA&Y<:6*J+Q]WM[)?G!6:?MB?Y\ -X'PC!*!PGC)SEB1PGPH"2AC-W
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M(^2O=Q'RAXN0O]Y%R!_&YH>=TNW4*QVGPG'I&S/\PA4#IL+Z4+WSXMJA'?;
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M0]DN-5"H"ISX_?5GW?:M;A0VQB9!HYXD-E3MR]IKK\NSGK6[GA#3F[U_YPJ
ME:U[XM@5+,L*9.N-/:D*4OC=<S=JRQBT92?_$2-[YI(MYM.V=SF;5'<;\I2B
M-MYN41M/A]IX^S.A-C9/&>7I!"V,;W]]_-BW>=G!PK<]1AR\BB9:1_2U^7CA
M5]WFU3B/X*AHE[+(DWPPS[PB%5>-6BDFP6$.4\833LK=LR?;$+&+'SGUL#
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MIG,T#BU?&1:\9-DK+/GZT*7A,G/EPLUZ[2 #X=!UF47SSMED<2PIA<!6,'U
M^9MPY+QO,>KI";ITJ/E87]5K'PW\ =_I-HXVQW_U/3++5_(9+Z5;,M"@Z#(\
M;2Q-O&<SR?_R&6>T!2-WL,\I%^2. [CS*.ALD$K5;Y.%DL\0I(2;R%JL(OA%
M=X2K/&E[Q@Q\<"G-?4IH?C]Z+T%C'LC!;W"K&%:W'ZVL9J&=N7"U?K]X#X8!
M0X+#_V$;DVR%D9\D;(.&JFWKL;!^IF*#2)^ B[SGV47(6&3P;I6U+L^B>N 9
M^A05)4'@\N2+:R3 .(BO.>R;#4-B]#^64.>$80>?X:@C3Y'5'M'7SXA3CP\%
M@ID%M#.6$O1.?,LD+(,4NB6TT9O+D_,4C(CB+1C-5!EW5;R8W#0<R(U"62C8
M>][ZD(%NK\KN6HV,#9!"+7G\3P).^ AX4'V3&Y0>,9B'.XH]9L5-N'AR:QYD
M9_1.$;T652W KS*2IZWZ-=HPSW2G'+T0I]1]3H4,TG>8(V)EXZUS8[2"@Y!8
M=?+\A^B@QD B,!KGE*6Q: H6H/](,9<HY)R:*TM'UVL$,T[(P2SO!%QY7WYY
M[[92YWHU)EB!"11H<HTA%[P3<?9/,,%D\5^0AFZH4J4TWC]/4\?J^)OP$A/O
M240%_,M+54>DT>X[.'JL=[)(HKI!%%_[$[&)O!;:-#G,Y,OU1RB_OPBO+LT*
MLR]GK]W$RBA\@@7ZIF)*^R,24+*@9'R$\4-_AUSC7["HA)Q9R:J6]6F@="U"
M&&<C#AA)S2 5P-G?P6IL+2$$65RZN%']),]<R%GM>HV7>X=!FX\K>AR;L;GP
M%9W)9WDNRES#[EC)<F>^<C$)20 T58K]39L/1<7L2 #HHM1]-;A)9_H!TK?%
ME_H(PI9.@H(&!9C+RN[GBIIGKM3.+R!0XB-D@<C8]T^RJ@N!NK;B\HKTUDR5
MI-H2/F;F +*=$]@3Q%3<36E!4W2@-A>HHNZ<^C&7_3)6&!L;Z,,LVQ2,6/F+
M<&6VE<^&4<O5#I1NMN#B4W.;G.-3OP4X<0PX2%Q==!3.-;'$+\E.')9_3A:>
M+B069%ZF3D=2&=GR(ET3$5[=>:GX5F9D6#\3<?WM-,:]YW0#AXZXUL7&/*@<
M^&I$>[%;6YJP/=PF;)\N87NX3=@^1,C[#O ,[[$D]R++E!,:JL;P5KKZW,<8
M,PK<=(JA^)7.G TE XM*H%XKMLI8 YH8*]7 T=NXM-Y@67G57S?<?[^QVZ;S
MC]YZW"$]MZ*0@KKP^Y(UVU%VHBXP8IN#(RSJE^3]J1O*0N^ZQ8V)^FZ]QM<&
MV7"^DU)D5&7B1F*&.@-H9E)M;W C]3V@-VIWKUY3<"4I;R2PDH5FY 'BG3+B
MZWL'>0=,8H8:LIOD0G25VIF=2_F-4/Y-IS   CIF &:)IG^YRHXIS8E53#<3
M7FEX8H5AP1(;%HH&AS@,S;A7: WF"BK(Y744P?A]-"S+"<<GN3E_&@"U$-SA
ME7>O2H7KNH(?C'8UT%M#<$O&*T#$A-Z%9U[56C7!FX7I3[R3 !8[G/FX(UTT
M%:9H?%L\OR?=Q';93 $"$C,QF1.,8*^WY_%PD17#F/C*F&,S2J^Q,)@X8ZK7
M\%UFB1E.)W:/8CY^!$(UL6ANH]%\C,PERK)QL R)U9LNO90P:G+8X;1/1_Z=
MZ9UE,9T<C:((E?2UAP6_08:GWA$BL(SO(47>$D*TBP&EAJZ1GRI\'Q7 WOKA
MR#H8:@_&O&B\APXDIG!9>-_X%;P[SJP;'J89KT%^>/%?I*W*>HT3? V"@FL!
M8ZLVNI[0 N"%. WH5K3+.2_]"8%]KT*P[F-,&5K] .Q[D/5.F"C%LRZ3]-',
M 0)%9XAW3(F;RNHISR,)Q[#A" )B1<TN/<A\@D<L[\).&AJLX;[&?<-+S];_
M&;XCR9C!,%R9R<;K=L3[EV'Q10%[&NTN=F\L?B+%;)L;J]CX;:^X8!P!0UXB
M[;#IW/J=X[LQJ\3$ E$)2S8J87\$1\Z/">BV:R$$7. #?C5/@.#]"A^0BZ>P
MW4W:,NNQOJ'7S(G"""!J438*;S&JN! 2VWPO?\\[!5TX9SM16<HT'AFM11L@
ME1:X!%/EA!<<O"<4M;5C!UYML0.+L -]R>5YS6L\&G!@KM%O\&/6LI:IB_\\
M4>0I)V%R.8_I J4O&@A!'UT])JB93J.0>+\+7[+4.^BRK.1\6&&M8X:CQ6PO
MM">#7"8;XD]!3RR)$..CB5$:H)[&>*%1*4#A+*@IK3V)>JUX%@Y9G:&%]*_C
M@'L57 :S;T$.1Z<N2:@V#HPOEJQF'EST/QY(A*F]NWBO[?ST6'A9DISES8 5
MU6:(.&#0U%P,:BH^#RFVIS)PY4(3]PS-3/RBF33 C8Q80V+&C'P6ADGQ*+C!
MK^WIZI@!][90G'0X3W^TYUU(I9SS8S*(S0,+<)KU&I7#J3M&#&7WKME[!*!-
M?ICL2&OIH^*WK5U3_WNKJ2N@O#!6(P)C*5P6I*OY:(1!HCPB-K?I0LX)S5<M
M=):($YA^CV15ELQFR30J!H82R=,(GSB,",9>KV&#]U@?CRMI^Z XL![C@#QS
MZ^7U]DPL.A,=TJGZ,/S>?K]'%7=-R1U)S0*&!^83#85TN\WG2BVF;PO29\G\
MZBH<A-S;A-LGP04I?YF02\&M3(;*:I?$GX"A8CR15V$,9Y5 .R UX:CA@93/
M,-(QC0/L MA@;BGKP>R*D"<A!8*^[M]N3CL5(8#57U*!U%"5"OV;$!1*-R#H
M\S#UE7H-;G,7+T=1H;L79_XWSO]E- M2#)26L8LE45EEJ' Y-WL17B76:1]&
MT255A^IMHH<V;!<I,2R%NM55RL<3%U-6U-&:)_UCV@12<ARF\*[\03A".A\=
MZ:/Y.(VF;!H3?'Y5HNZ?3;^]V>JWQ?H-Y82(DC$:1AQECJN5XOJFM,XD0B6B
MOD348IS(HG)J1=5MLYL),I.JC75AG +.<%LI5AR:&TT'-<JQ;F(BD)Y;LX27
M)MU?;I/N3Y=T?_DS)]W7KF7?;K7L(BU[3IHL3[LNZ]OHD&R]QAEVE9TG#GX-
M)Z F"+?A*+B6FMJ(3,9I]"W@+%L<8.X0ZX@1+@;6YI12B0W##&H4\!1)*4:&
MV#_VD)'"5/Z )6FJLN7IB P8V," JX:-_G8: 3#Y!)>2+#8;O8S5Z"<ZWIYG
M,OYT=L_A_O9$+CJ11U'T]XO69 ;'[32*Q^90[OB"HN@OC7O$ZJ%D;EA6%/*2
M6FK&C.K4;2N]:W8OEE4 X437?^/IQ:#,G40U _)GZ*W@%EYK7JA+G&M <[7\
M"!T7EH&@KI@,W9,9N1.I&!H?6.?5G\W\P8TPS&".-/$(PWP37H8S7N@FQ8$9
M8._9^/I\!\Q%V#,8 -Q1?/XEL[:S<N!J 7(C@^_HV"7$33X,&""KDE<E;BQK
MZ (WD!P_L89GRGKE-205"']&<1((DX4FN>.F!5*O8&HZJ'E!PX3HJ;;7+HMP
M2N.D18IP+]V12IXG:!3LY(;7B7Q,>:T^IQUDN]V14A<!1+S0CG-4VVZ 9HUC
MMWQU+"@1(7!P-R+L;0H_OTH5(SB.]TPV4HNGG2^:40H%M>C7*/X;F4&)GB/Q
M!G-8T&'H3[3';) _G&>RCXB<SXD_UO@8^^.46PJ^(PHG'U.!SR..#TP>7*N2
M:?,&]1TK"Y7(+2>-%-4>\2+ZU[#OV%DW2[*7BDD0AC%_S4D@N8\1]@W"'<,_
M+TW#\*%-F3@D&(Y=34YG0TX\-V'3'I>;3G/7B^[M&8)K$/42I*:J*^*?_AI>
M!0XAG>T^W-?WA0T&P3X(W%JB:+/TL=!EM)G389:X"+PN,JHWQ6R3@D'DI@)S
M)]&P)=J.+9*)673,2;UH]@Y]Z$L.VW$P#.36]L?@11Y'>\;45#*460%/,)GI
M%YGX9^;(87&/^RX$9=++;.['<,)LP<*<)' ;.D<%0[T)1ODGO$P)Z7>R6$P*
MLK&I&3NOV/,^!:@=\%22RM>6.Q/X-])/L'&.E&V1[]LWJ,J=JKB.L-1;_=/+
MF*;2[=N+1857C;5+&"M)O[QC$)ZK3?+6EK*O>GUSE#9>@31HNN?R!]'(45^*
M6DBW2LGJ^T:.#B1BIVNKL.XX&\G.3,"_3*(1'EC.1&G4>,&2I3-48!#XLR1"
MIJ&%<7"L_L0?BV_%FRQ]TC/SXTUPLOS+S8^.RS57ZENDK/ ,A7\R-B$M*-P*
MW^_TN:_7%.)3,(OS&-OPF,U(W3;CJ1_&E)0O.3MX)SEBW\C"ETBBQB0% @TS
M44;K<=<(]-3%<4+-K[64:NQPY93!^=*2@5QG#;"79$#^AN_5:R;@JIY>9GY>
MQ\2K!6MIP\"(0U9#:.E]4@2,-@$1KN'F#J3*D,KW^)U,-VF5Z-&G7:;<PA$U
M%JL+3=!9Y-Y3VU''O]]HW.(Y'G.2C!Q9($L[O9;UFF,_(_3N,LBM@IW>W"48
MDE57(%%06)[7<%G/LB$$W/7:SG>Y9E/'@&KEPCQ>0<+PD/<PGR 4&X\**63E
M/ Q@2</)G*Q#ZXGJGBQ<!J6OG6:7BF/;X'TD'A6@$3X=^0.^6'-N88%XOMTG
M9">.<><N=[+HQ7)' B9^4F[I8!3XL0(&#>Y4\:QE^QN&90VX; YF2\\$?<8E
MID+,.AH]9#IT+?3/3#TJ4:I$(\7^K6(,"L!LR5:J3X.)>D@H ;W'AO'@J+<7
MHN(3A6Z%*YQ9;8WG<Q:"ARR\,)]U(+/!6#>IL%1#\G)&E&-[>H[I&=.?6KU_
MULER_EO"<4X2HLRMPX:TOLS89E0<]ZZ1MLGZ2E<0@<78([4]YW@+."#?(N^<
MW&U0:#J)S3ZD$V[U%.K^>E+JK2J)=NRL N2B]9G_'2=XX!(%$V!D41I^=$GY
M]CE'L:_\ 277 R]1<X+30D(H,T*Y3ZQ?HR*CPI^"L1L.>+SO$RF"5]$(JWFO
M:R6Y(8-2.[7DET;2;T%5##UBGH07H>X&"Z)9_C6Y4?BK,)QPE"JXX46(XKNL
M[\]+2L5V>B))_E!%@>]YK1(1,%Z<+Y$?74U)78C-6V33^K:-B^X/.%'^]$8>
M- K_#MCV01]<_*P[6TN8: KQTBQW/SZ+6N[?MFGEITLK_[9-*Z\QB76P36(M
M2F*=@6(&3>9FE&T#4V+I _!?)]R '2]+C#RQ"=?@1JP)]2PFJY8O4L;LJBNZ
M<OMCNTT6=F%N<%4TW1#RA@($.Z+=1.F/Q^A>XSV#)K"F10VN,"5%]OC?03!=
M8F#<CQDO=!S3CQ"';I>%!M#D*?*G"AB\E]GFO%R-OLC=I7::<"LWPBV9MOP9
M*I+1)I\RM5FD_%%.&*IAN4VFK&.G/&O%4JT^KN) 9>96SG)Z#U]-A3O-6\X"
M*UARB)RLT;3+LIQ[7H_+1O0Z</90!3<=0PX+HZ-ZS<&B+GS#KGH65^9(92(3
M+G*1H7FY*<S*Q')URTQ\69#," "[S+:3[;Z<^)?M%[W_0>+?($?8B+Z=[A<$
MC2/Y22J>7*]AR*2A' =9%Y6X#B8FTN@*/P(EKX4[0U##H53RDRDM<2&;33.A
M*E/N[#O4 Z*HV_J/0'9%A2D"?<K$2)N3.9>"*.7MI=/HP;7J4O435:$>'FY-
MI46F$LN:%6I.<B _*CA6'>JBA=3)TN>%IQQ>6AL@9- V(/0"C/&:@I=9I;7"
MS*@H!RFA.\@7.::K>.=-8)3^R(H.5?G_+!0H*?*^JZL*4R'#(114%&!?S+Y%
M=@1#AZERZ'T+0TQVU8FE7TX"T#FDWBN%E9[3;@V6V*UF3I!W5=N5$W'*"R2I
M8&+58!1NE%M,*,&FAT^DI#2K8J3J.<G!< DY:%\Q9Z2*B^:1"]]$W@V"! 7X
ME+/>J?"H5RTZ:F]HO<:96R?02*F$],L:^3_.!$G!*%,QT@6;<XFM^ [>K&"'
M*EWF[DW^<F][B^??XEB>;/)AZ8M\SUM\$MI<*E3QR.<*TW@.ZLNG!C"C*)D1
MC',43!A7!V(<W17V4M+V?<JFY\Q[0[##=#]I<U8:'6@72_$YX<_)CQK@)38:
M670LUABK4AQ:AXE+0B?@S 1SSM,-LV^O?@'8:UBR7KXW@3-6K3FK\TP8(0;]
ML5&\K(JCZCG+&-XBF<^L(,%H02UMJZ]T#-SX%C%^O LQ$\OA P)BD+#:(L&T
MV=^[FNE9,]I,?^0> LF",0S&DW!VUV F2?(:<3DMOJ,$IIN H4)/ST9#"@@_
MC(9\M$C9P>/&R3;L\4LD@%YM$T!/EP!Z]3,G@.[/#T, .;K"6__O8_NHW1>G
M@SWPE=/1R.M6?_Q3@@3S^?/TO/N)7W1^ZITVCUL>_/EJ[]7^K]ZG9N>DV3_O
M?O6.SSM_M+K]-FPZJ/5NZ[35[;905,Z/_PM>UNJV6SWOL5;#&NTQ#N*T?=SL
MM_YZY+<]^N+_V>X<GUV<M#S8 >_#V?E1\\RSEO9CL]OJ_;51$TQY#1>=LU:O
MY_4_MGN>M7$>_!/FV6MU^C#/HZ]>L^,U+_H?S[OM_VZ=U&O=EORVV6__0=+8
M_]CR3EJ?SWMM$L9^]Z+7!Y'\]+G9^=KPFEZG]<7[>M[]+_A9]_-Y%[YWWK&A
MXR?]8[?DJG].S[0_#GN /^IWFYT>; &X;Q]@"%ZG^0D&";_'7ZK3D9X1C*%S
M O]]34VS=P'?A8]V6Q_:O7X+M[7-3\+'XI..6R<M<248GW^^AR-I=^JUWL7Q
M1^\</MSE3S=[_*C_>]'JY2V<EUTWF+>WHX;VN?GU$\X('O*I"5(':Y#S]@8M
MQ+F';Z_7^/7PK7;_ZST'L-N@MZMU;7B?SUHG'UKX&G[Z1:_EP9\MU#[PPS^:
M9Q?FMU_:/5 X\"8>%<VCU>W!?L!0OG3/.Q].+\YP46%PGW#!FCU:7VO%S[]T
MX"W\AD;N@G^$+\%,VAW\ D@6?K;=V6@8G%KNGA9743"]UO%%%W<3],O9F7?4
M\L[:G]I]/'=X*/378$F_?#P_ ]$^NH!3<-['GWQN=OMT>#KGG]J=5JNGA$QV
M!Z7F&(X\GR7:4O@K";+^C:#?>NH9='3T>T'D3CTXDW@DJX_=<X9.THTB<0SG
M^Z39@3/[I=W_*'+1ZW?;Q_SX7JN/(@>_DE/9 \EMX2&IU^@;\.G/K>,^G0=2
MQWOX2;@+.RUZ!#_7%6]\#BS<"<C<ES:,\J1U!H>AJU2.^J"W0+V ]V:I$EI"
MZP<]6C4^/^T.WN"LQ$"0Z:.IMWQJ?H6Y-.'8@-7VE8YPN\L:X+QSVNY^@E<V
M^RG]A_KU#*]UO7CPGM:'<["AG67<D'.R?=CV8<_B8?=(K988;J6>]K__XYT3
M%T;R#E\F<=JM^[T:]WOK+Z?Z5N[G-JU\(;K<KJKJ<(WXGXOBZJMQ?Q8.[<\V
M%F7XH[_4P) H?\F(:O%DO#7-XM$<5HE&'%_TVI_A.0<'+U][A_O_?KPWM7M@
M9EWT^%7PIM>;'&(Y>G]TWNN#<=8[;J,G!1:<[7B64@P_1R<_]0*)%%4JSP.G
M%IX)+VO^?M2% >U,_5C:E?QC?V__P#0MV94/%&0\?*?4*1A%WW8W:@U39NY1
ME,RP#P81IJ*.3,'D#(9C8!,2[V#>PT0YK.^XT0X%H68%K$K?%BA?;]DLZ%^9
M 7%>T!V+=$6W*MQT(?FB ?WE_4FE<*RBDQOX(F(5$1F%]#QSS#BUB3%&B'JB
MJ[^$7 C)8BE3-(DF+[!_:9(P]LY!4N35: VE^!<&6DG2!13+.X^2WE#=B8VL
MP^M2XBY U.+\WC_ $MK;W[>^D5KK:I>4O1?W(V^3OE*4:J,E%"@L$C0E7.E8
M1+S2R!#\^LQ38Z%E?#!JXDEPIV'W"NRIN([L%"*3W##USU!EFKF!B'!(75GT
M^3S?H</Q:VCG%--<PR%^<PCIN/*3T+"F$M3MKE/15+"Q=@HM*D+ >7I$>,$?
M0DN1,*,R$2:I%&BZ>5"0829VR]:OJHFOEY)>_&*I=A(XT2?_SCM\W0"SX'!?
M\+3U&A7-"KP0_CH9*E82A]TGK<6*B^]=Z3WFYD0D-KP?1#<L;!&7\UF]AK@M
M*KD-U,(21PA!#*15L/ =WP1CA6A<R*;E]BDG3@INE..#>I[>Y>P'H9.=_7 (
MEG6?P@$<1C#'2?05C%QAJ?-2W\PE!<([00H5& B"2ZA6']MV(5 (2ZII+PC<
MK)AFH\G5""3<HIY(L1[H2N\R@NPJ8NA\11&U8"5]'(WH+<Q+L2$QI/P7=+6B
M-AQN1$25=U3KM8K PS2!'?*>@)[SA/I?M-W"3>(2"C,$M0<98A9],NC4"@,*
MM_BTX+TSEA42M(W>M(L4ZH6FI0G3TNB\>DU.*GSH,II/#,5."54(;5&*C 1O
M2N+1F FI*%$M;/9*$N7&0F@K"1BQQL'UG,;-TB(G#Z"235.,H)J3A;;8+$I5
M,IHD"FN)/#1,Z1T)Q0<^\#':#R[G:BP3.UR#[U<Y$/EZ&W/<QAS7U7"[37FY
M#D(/OJBT;\9WN"'FK0"\:*WT,^R%MJUUR34:5F%&#H40O.-/QWO^JX)?6Z_]
MY7Y$?7>-MX(Y0O:121^II0?AG*C"D_<+:H_2T_6+DB(C^?;Y/+3E#L3??/CX
M'"?4^3^_'*I'T&\>EM]9$,[[O+HWV6=)'>M[K)5LPZN#E%XK7C?WB[_=]WNO
M%GSQOA-::C"9#Y>C](_NWFG0<-[C4M?1)5U'!^HZ>H[S7>'B,)S47I^-GU(?
M;<9W6;6\89-\<BG;GJKMJ;K?J1([=4-2-]L7;%^P?<'3OJ TUO!F&VO8QAH>
MNQ[(+DDYOT#@>*_]H=/L7W1;&U>6DND0@9%8(;=<K@.ICLY24P)F0R**WQ=8
M\1Q&DVPG+">]MLEA\!/,@[Y;#&)HY'UD54BW;;"'@SWWM%H1\GZ!9QG!_EZ[
M<[S76)]5_O#A^TEI!F854]F&DK9.[PJ=WA_0Y]UZN-L7;%^P?<'V!4\9!'B[
M#0)L@P!K# *X+!K=UA_@1$B!OZGBA<_4:R7,&EXAL<;F<5VD7-#C^7C.W;J]
M84@$4T/J3T+M51C07AT^K;G,IOX=8="%ELPBO<3FN;IO9Q5D[R:''I;"\:M8
MC5[$@?4I62@8PD0(EO.(1AEM;5"A/\'R9MG^I<%?"KM-+5M(J!6T^R:">T.A
MN!DFR2WL&ZE:!*O_?+;LH'JO^WK-;79/E&XXH,'(3PCEF#"V'[G;2!)RH$P*
M_RVMO 8Y8_2(@]Z42IA6D*FQ_PL_2$-Y0N#D]@7;%VQ?L$X3_+?]K0F^-<'7
M:()WSOMMYL]AD[I':,P-,YM3+]CI4^O.EH(H2]6)%-92B72(Q914X! I@^]^
MI7X;74&--AK5>0BGMVI# Q.]C09$)!N,J)1R%M5K8O)F2@_IQTFJ?OJ>A9-%
M];FE#+ENK?3"VLL=+G;TKV"1/5!.(R%VKU 3[K0LR>OWX'6BG61WKXS6HM(<
M,]Y;FO=:CPEEF?KLCL=H9?-Z%C($-/+LULR&TJ,R2RM>#77#YJ(LD(AA*$6*
MBPL9JQ<HW:^X%9;"UR4&Q-*OJD&)ZV!/%( 4\B?S2[#*EZZ=&LZY";!W"@<'
MRW-GX#,<,VNW.0D@HB#1T=#J'Q $8T[Q4\F@:B5.DA?&Y4_SNN@(;+0WV+[R
M;+$B0@-2TJ:%\$P:]I(H^;I-+U>.PY+0!RQMU4C_0/6Z]^^H1E-5L'LS_SN,
M7$4]R!^7$G$N)IQ%1*3M3^ZXD4358E-;+'? 7;,IP$O8OV=<B[I+??-F,Q]9
M&$S3E\W=XH+*<F1,MRO*6?FJ@MIT93DL23*(PTO59(LA,;""Z5[TSR-L<A]0
M2(5JQ,< A=A%/>49V1-94Z. "A+R.=B+\N1\A7JCAR3KJT^Q:6*>MIJ%B6_:
M5'];V&9DR0N.U;)\(A@^RGK<?[HOJT_7N6]X5FVZ;-[]\U'W^"$3730YU6=H
MT:Z\?!92NBR695,GTAP.0>:2=_]<)%@;,9M3_SMX,7M/O3.%H+8WOQ8\TOW8
MP4&USU5\W.'+BI^K^-K#MSF!J)6!GM*&2O[_?O\($M/^;WC%P2]>Y[SW$2F@
MFV?M#[ M9ZW3_B_I,2.<$*R/*)9=_B7?S%J&;T'X&0]S"1H/*[31^N=SZ)M5
MK];+*IT3 P\ 36/=Z12M7;RBW+N+6^>AT1O%(:P:N(C5XB*VD;R32#>X^W@J
M?'L.E$U ,'=B@;DUT;5CFV-/FD59MA7FQDXDAPU_22[!GD='.M5WZ+E1"3]<
M/!]1/BM*G5Q/WC?<3E>T*%>M&G6CBRP=H.-4#U/=?A,I:;(;_ABMU7_H%-#3
MYI@.MCFF;8YIC3FF9@_+O+!#Q,9EEE+A']-JI=LZ;K7_:)UDHY!^0EU+L9_J
M4 <AI8FI=D[OEQU1][;.U,RB=QL5,DPGZMJ3!#-*O&1!H/ECDXBP.$DPF,?A
M#.ZGN%Z;^=_A@D(VN:%D==B(8F9;%<+=K'Q<T7K(C8T2]#_A%+3BD&DH99TV
M:Y(IJ2*"/RO#Z$^G40A6QV9)<GI2L%G$UX?A:9UX*#OR"QJ-%I]YASI8LEWI
M?MCH:/!XD$A6-W)%BE))J$2@GP8$1?1NPC%:?#=K953<Q,CYPN#C23J _*!
MYS.((ZXENKNF2/G"W=O!9?&"[W N4"TEWETTCRDEB3HJ\.-$G3T^0TDX##0)
MJN5J[SX'"5@B&:*E@5_W8>Z#-ID%1<+Q$($H#(>]JA8U>UTQIO=FG<&U1U"6
M.WI/O/$\(9[6:[4M%''Q)PH?$<#N<_1'/D&-O'7C;@%',.8!,\[>I3_YN\%
MD<LX^AM-I\2_Y=PK7,VC")X-A@9:8-RM.O8&<#$1)2S^>QP$U&2;Z94I<D51
M PT!<2\C1:9L?Q0&.!C-AYCU1=LMN0$;!W.\!J2-P3$^:SVV ?$R=!^<>)^"
MH3\:,>U_=!W[XWK-:E_9ZS<_?7;P*XCBQK[;?'SEDXE>:;W"6 *!CU-K!ZI
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MQ[@5PJ_A$R=Q@:F]7=E#__(084<,XV)HP1K#J_E(0C!41!@V'J,_0WW"M"Y
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M, AI4/BS[XG.$%##D&(W$@-(3PAV3T[+>K:%;M/33(_&F=S/DK:<D9.+=,9
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MLL<#U4I6-N!AJI)WW,MW.<N0JIXG/^>0*8YBPP/Z=NVZN5:%/=08Q(04#3!
MW!H PW854+A"96\9(YBFF]'2Q[. U8+'7AE*+@3F-K5Z=:S\8!G#HC:6;V]
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M_QZ&H;(?5[7P![+V%[/XP]K_ U!+ P04    " #0KKM0YDJB"_D-  "[0@
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M2G$'!_7!Q4O%/:"3AI&!)(I9A1T!NO;O4"I<WXF(XZF]+^#X/&XOX_K'WJ.
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M5X_@ \G,%.R2S<9RG_1^-^>+SUQ*9BI\+RW=MD4?E(1W!Q3;<H2U(E1ACH/
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M*T.G0[C$*Y]6$9P7UN2<!ENBU]O:$J<6-$]20\+VKU6<JY8XQI:IM2$R!47
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M8*ZV]HY;2_:634JS,:.R6:?2J;18L"MJW!:(68>^='C,C,0>4N6XJCH=-%C
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M$?",/:=!I-'27Z/X=L6./F> Q\SNC]\LOO*6]G!T9BWNA+R!"'?='ZN[52*
MT6RD@Y9(@*@8V;3X,E2A]028)T/H:)B[=#9H06SGQE^Y8+>_*P-PB"$0PH/N
M+RC@_2=^U6SX..)YE.:1L8JOM;,QT=P3H8KLV,EDPAT&,@6H4<K@^R]R09!%
MGLIN]@3Q..9X!$RK)B41CS'GN/$S9I:Q]/-F(U2!YFL344[0BG$9.4PI-71;
MY"4RD<\IM&8QJ2!<'-WX^!"@+$PW?O5L3-;0 =R9?99N #AI></XW(C \8;D
MJ(>.W9CJA//?L=(I681,"C?@UIBZ$FYFKN#Z$VMY<%M&3EG(!V]^.SEJ]W;0
MHB"KPL(T63-XR].J6?I98-0G,INF?(LV8YNF:[GS]V4^2_A( ZW(%SAU8RM%
MDO5-H41@!# WRAV[GT&W[ZMHJ-+ Z:2<7'BFV!:\D+B MN%R=UF@\O]:KBLL
M3MXBB]%9JA1:$I>)DY8X0080O7ZST?:\G8.T*.+)/]&^0D?4N:'&D,OWXYA\
M\%P10RCAE5@@U6W_XK_2S#><#7T_/^^%'_CIR52Q$'D2TA #YWMF9]R*^YC]
M%=4]HZ)9\)<2QBAY^Y6(LR-Y]JSSMSX\H*;Y#U\=%7;Z'1F4KAD-$ _G42[:
MY5S&#DT1=_[NG.ZT3<4U7P!=Z]1/D^[!#SSQ&5%8\\I"*X72Z\76E]2X "JM
M6FBWZ+1 NR"/Z':),ITM)U$^GN:*=H%#&7^U_-ALWFW(7+50\DT^IYUFHRQ]
MK+6B^,TJ7@G;U:Q"WUUSO)(9^P>SUF1V;T#C\@0((I!%X*&\\E3C+E4N''ZK
MG/X/B]RL":\WW8M-^:U?-/H<%W,]^9V]._]B&%K>HM=$?SQX0WR<_;"R=;LQ
M7EP[WTOWMN=[Z;O6;:P_;%WO@<L>>NS6DE:?);IK.N&;]I7;%!/Z)9=XC+,[
M6]S0OWIS=EDWT=S\8X"7_<'E[OX:+3M8SN0BR?L$^@?6?C5ES<<$__;AY_3W
M&C54_C7MW4_P%T7@^Y0P<O1(1OD",4_XIA[EZ6N*>@'TIL2I3F5+#%[UZY2_
MHO]_J5YF(Z=[A=CJOFQOO]QH;VUM;HA52VA+/?\&HNEO"K.]M528?\0N#XI!
MH"3C@<$WH/R'AM-RIK]))2_[!>?J%V[_#U3^8/Z_0>WO$22R#B>;'*B([LKD
MC\,TT'1+_LWK?H'[_7<'AQ=_E!%0!4!-GG<'R^Q1W'O\3=C[V3%.[R\0P_^$
M=A=I_N6_1OCJ2Y9=WIWG1K7+.YK;UW7 H) <_8N=@^<K<TOKEJU=XO&-TJT;
MO))/NBXJ_JU?%\WQ\WE)UNA/2_S?FM"?I/P74$L! A0#%     @ T*Z[4)BI
M6'3> P  -P\  !               ( !     &)S>"TR,#(P,#4R,2YX<V10
M2P$"% ,4    " #0KKM0V"1P<!<)  "X;@  %               @ $,!
M8G-X+3(P,C P-3(Q7V1E9BYX;6Q02P$"% ,4    " #0KKM0#69.;1L,  "@
MD0  %               @ %5#0  8G-X+3(P,C P-3(Q7VQA8BYX;6Q02P$"
M% ,4    " #0KKM0V"Y?#UT(  !3:0  %               @ &B&0  8G-X
M+3(P,C P-3(Q7W!R92YX;6Q02P$"% ,4    " #0KKM0JCR0F,\A   /N
M#P              @ $Q(@  <W,Q-S0R-S!?.&LN:'1M4$L! A0#%     @
MT*Z[4,Q"NI4KG0  [OL# !,              ( !+40  '-S,3<T,C<P7V5X
M,#$P,2YH=&U02P$"% ,4    " #0KKM0&+ 7A+NA  #E'P0 $P
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H<S$W-#(W,%]E>#DY,#$N:'1M4$L%!@     +  L QP(  )E2 @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6605726304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 21, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 21,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(508)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BSX_CommonStock0.01ParValuePerShareMember', window );">Common Stock, $0.01 par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BSX_Sec0.625SeniorNotesDue2027Member', window );">0.625% Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BSX_CommonStock0.01ParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BSX_CommonStock0.01ParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BSX_Sec0.625SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BSX_Sec0.625SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ss174270_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://BSX/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ss174270_8k.htm">ss174270_8k.htm</File>
    <File>bsx-20200521.xsd</File>
    <File>bsx-20200521_def.xml</File>
    <File>bsx-20200521_lab.xml</File>
    <File>bsx-20200521_pre.xml</File>
    <File>ss174270_ex0101.htm</File>
    <File>ss174270_ex0102.htm</File>
    <File>ss174270_ex0301.htm</File>
    <File>ss174270_ex0501.htm</File>
    <File>ss174270_ex0502.htm</File>
    <File>ss174270_ex9901.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ss174270_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "bsx-20200521_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "ss174270_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20200521_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20200521_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20200521.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "BSX",
   "nsuri": "http://BSX/20200521",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ss174270_8k.htm",
      "contextRef": "From2020-05-21to2020-05-21",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://BSX/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ss174270_8k.htm",
      "contextRef": "From2020-05-21to2020-05-21",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "BSX_CommonStock0.01ParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Stock, $0.01 par value per share"
       }
      }
     },
     "localname": "CommonStock0.01ParValuePerShareMember",
     "nsuri": "http://BSX/20200521",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "BSX_Sec0.625SeniorNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "0.625% Senior Notes due 2027"
       }
      }
     },
     "localname": "Sec0.625SeniorNotesDue2027Member",
     "nsuri": "http://BSX/20200521",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfCapitalizationEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Schedule of Capitalization, Equity [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r11": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r13": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r14": {
   "Name": "Forms 20-F, 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220 and 240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>ss174270_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BSX="http://BSX/20200521"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bsx-20200521.xsd" xlink:type="simple"/>
    <context id="From2020-05-21to2020-05-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="From2020-05-212020-05-21_custom_CommonStock0.01ParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BSX:CommonStock0.01ParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="From2020-05-212020-05-21_custom_Sec0.625SeniorNotesDue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BSX:Sec0.625SeniorNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-05-21to2020-05-21">0000885725</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-05-21to2020-05-21">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-05-21to2020-05-21">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2020-05-21to2020-05-21">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-05-21to2020-05-21">2020-05-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-05-21to2020-05-21">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-05-21to2020-05-21">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-05-21to2020-05-21">1-11083</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-05-21to2020-05-21">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-05-21to2020-05-21">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2020-05-21to2020-05-21">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-05-21to2020-05-21">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-05-21to2020-05-21">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-05-21to2020-05-21">(508)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-05-21to2020-05-21">683-4000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2020-05-21to2020-05-21">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-05-21to2020-05-21">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-05-21to2020-05-21">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-05-21to2020-05-21">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-05-212020-05-21_custom_CommonStock0.01ParValuePerShareMember">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-05-212020-05-21_custom_CommonStock0.01ParValuePerShareMember">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-05-212020-05-21_custom_CommonStock0.01ParValuePerShareMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2020-05-212020-05-21_custom_Sec0.625SeniorNotesDue2027Member">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-05-212020-05-21_custom_Sec0.625SeniorNotesDue2027Member">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-05-212020-05-21_custom_Sec0.625SeniorNotesDue2027Member">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-05-21to2020-05-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
